<SEC-DOCUMENT>0001437749-23-010081.txt : 20230412
<SEC-HEADER>0001437749-23-010081.hdr.sgml : 20230412
<ACCEPTANCE-DATETIME>20230412161609
ACCESSION NUMBER:		0001437749-23-010081
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20230412
DATE AS OF CHANGE:		20230412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEVA INC
		CENTRAL INDEX KEY:			0001173489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		IRS NUMBER:				770556376
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49842
		FILM NUMBER:		23815886

	BUSINESS ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-308-8328

	MAIL ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA  INC
		DATE OF NAME CHANGE:	20031208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PARTHUSCEVA INC
		DATE OF NAME CHANGE:	20021101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA INC
		DATE OF NAME CHANGE:	20020515
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ceva20230404_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:srt-types="http://fasb.org/srt-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:ceva="http://www.ceva-dsp.com/20221231" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"><head>
	<title>ceva20230404_def14a.htm</title>


	<!-- Generated by ThunderDome Portal - 4/10/2023 10:05:20 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="dei:EntityCentralIndexKey">0001173489</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="dei:DocumentType" id="c2">DEF 14A</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ceva-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources>
<xbrli:context id="d_2022-01-01_2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources>
</ix:header></div>
<div>&#xa0;</div>

<div>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><a href="#toc" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt">Table of Contents</a></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="-sec-ix-hidden:c2">SCHEDULE 14A</span></b><br />
<b>(Rule 14a-101)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INFORMATION REQUIRED IN PROXY STATEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SCHEDULE 14A INFORMATION</b><br />
<b>Proxy Statement Pursuant to Section 14(a) of the Securities</b><br />
<b>Exchange Act of 1934</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant &#x2612;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant &#x2610;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;&#xa0;Preliminary Proxy Statement</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Confidential, For Use of the Commission&#xa0;Only (as permitted by Rule 14a-6(e)(2))</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2612;&#xa0;Definitive Proxy Statement</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;&#xa0;Definitive Additional Materials</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;&#xa0;Soliciting Material under Rule 14a-12</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="dei:EntityRegistrantName" id="c3">CEVA, Inc.</ix:nonNumeric></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Registrant as Specified in Its Charter)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Filing Fee (Check all boxes that apply):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2612;&#xa0;No fee required.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;&#xa0;Fee paid previously with preliminary materials:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#x2610;&#xa0;Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>

</tbody></table>
</div>

<div>&#xa0;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">15245 Shady Grove Road, Suite 400</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Rockville, Maryland 20850</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Notice of Annual Meeting of Stockholders<br />
to be held on May 23, 2023</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the stockholders of CEVA, Inc.:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The annual meeting of stockholders of CEVA, Inc., a Delaware corporation, will be held on Tuesday, May 23, 2023, at 10:30 a.m., Eastern Time, virtually via the Internet. Stockholders will be able to listen, vote, and submit questions from any remote location that has Internet connectivity via live webcast by logging in at: www.virtualshareholdermeeting.com/CEVA2023. There will be no physical location for stockholders to attend. The purpose of the annual meeting is to consider and vote upon the following matters:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To elect seven directors, as specifically set forth in the attached proxy statement, to serve until the 2024 annual meeting of stockholders or until their successors are elected and qualified;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve an amendment and restatement of the 2002 Employee Stock Purchase Plan (the &#x201c;Purchase Plan&#x201d;);</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve an amendment and restatement of the 2011 Equity Incentive Plan (the &#x201c;2011 Plan&#x201d;);</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Advisory vote to approve named executive officer compensation;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To recommend, in a non-binding vote, whether a non-binding stockholder vote to approve the compensation of the Company&#x2019;s named executive officers should occur every one, two or three years;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To ratify the selection of Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) as independent auditors of the company for the fiscal year ending December 31, 2023; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To transact such other business as may properly come before the annual meeting, including any postponements or adjournments thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors presently has no knowledge of any other business to be transacted at the annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing items of business are more fully described in the attached proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On or about April 12, 2023, we will mail a Notice of Internet Availability of Proxy Materials to our stockholders of record on March 27, 2023. The notice will contain instructions on how to vote your shares and how to access an electronic copy of our proxy materials, including this proxy statement and our annual report to stockholders which contains our 2022 consolidated financial statements and other information of interest to you.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Holders of record of our common stock at the close of business on March 27, 2023 are entitled to receive the Notice of Internet Availability of Proxy Materials, this proxy statement and the 2022 annual report and to vote at the annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>The 2023 annual meeting will be held in a virtual meeting format only, via the Internet, with no physical in-person meeting. We urge you to attend the annual meeting virtually by logging into our live webcast at: www.virtualshareholdermeeting.com/CEVA2023. However, to ensure your representation at the annual meeting, please vote as soon as possible and refer to the specific instructions for voting on the Notice of Internet Availability of Proxy Materials.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By order of the board of directors,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Amir Panush</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amir Panush</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 12, 2023<br />
Rockville, Maryland</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING:</b> The notice, proxy statement and 2022 annual report are available at <span style="text-decoration: underline; ">http://proxyvote.com</span>.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="toc" title="toc" href="#"></a>TABLE OF CONTENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>P</b><b>age</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#proxy" style="-sec-extract:exhibit;">PROXY STATEMENT</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#notice" style="-sec-extract:exhibit;">Notice of Internet Availability of Proxy Materials</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">1</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#voting" style="-sec-extract:exhibit;">Voting of Proxies</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">1</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#stock" style="-sec-extract:exhibit;">Stockholders Entitled to Vote</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">2</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#quor" style="-sec-extract:exhibit;">Quorum; Votes Required</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">2</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#expense" style="-sec-extract:exhibit;">Expenses of Solicitation</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">3</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#secown" style="-sec-extract:exhibit;">Security Ownership of Certain Beneficial Owners and Management</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">3</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#equity" style="-sec-extract:exhibit;">Equity Compensation Plan Information</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">5</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#prop1" style="-sec-extract:exhibit;">PROPOSAL 1 - ELECTION OF SEVEN DIRECTORS</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">6</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#corpgov" style="-sec-extract:exhibit;">CORPORATE GOVERNANCE</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">10</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#exoff" style="-sec-extract:exhibit;">EXECUTIVE OFFICERS</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">23</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#excom" style="-sec-extract:exhibit;">EXECUTIVE COMPENSATION</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">24</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#comdis" style="-sec-extract:exhibit;">Compensation Discussion &amp; Analysis</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">24</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#report" style="-sec-extract:exhibit;">Report of the Compensation Committee of the Board of Directors</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">34</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#comtbl" style="-sec-extract:exhibit;">Compensation Tables</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">34</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#nonq" style="-sec-extract:exhibit;">Nonqualified Deferred Compensation</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">39</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#ceo" style="-sec-extract:exhibit;">CEO Compensation Pay Ratio</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">39</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#empagg" style="-sec-extract:exhibit;">Employment Agreements</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">39</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#potpay" style="-sec-extract:exhibit;">Potential Payments Upon Termination or Change of Control</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">43</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#payv" style="-sec-extract:exhibit;">Pay Versus Performance</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">44</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><a href="#ccinter" style="-sec-extract:exhibit;">Compensation Committee Interlocks and Insider Participation</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">50</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#dircom" style="-sec-extract:exhibit;">DIRECTOR COMPENSATION</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">51</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#prop2" style="-sec-extract:exhibit;">PROPOSAL 2 - APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2002 EMPLOYEE STOCK PURCHASE PLAN</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">53</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#prop3" style="-sec-extract:exhibit;">PROPOSAL 3 - APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY&#x2019;S 2011 EQUITY INCENTIVE PLAN</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">57</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#prop4" style="-sec-extract:exhibit;">PROPOSAL 4 - ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">64</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#prop5" style="-sec-extract:exhibit;">PROPOSAL 5 - ADVISORY VOTE ON THE FREQUENCY OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">66</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#prop6" style="-sec-extract:exhibit;">PROPOSAL 6 - RATIFICATION OF THE SELECTION OF KOST FORER GABBAY &amp; KASIERER (A MEMBER OF ERNST &amp; YOUNG GLOBAL) AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">67</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#audit" style="-sec-extract:exhibit;">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">69</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#stockpro" style="-sec-extract:exhibit;">STOCKHOLDER PROPOSALS FOR 2024 ANNUAL MEETING AND NOMINATIONS OF PERSONS FOR ELECTION TO THE BOARD OF DIRECTORS</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">70</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#house" style="-sec-extract:exhibit;">HOUSEHOLDING OF PROXY STATEMENT</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">71</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#other" style="-sec-extract:exhibit;">OTHER MATTERS</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">71</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#appa" style="-sec-extract:exhibit;">APPENDIX A - CEVA, INC. 2002 EMPLOYEE STOCK PURCHASE PLAN (AS AMENDED AND RESTATED ON MAY 23, 2023)</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">A-1</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: -9pt;"><a href="#appb" style="-sec-extract:exhibit;">APPENDIX B - CEVA, INC. 2011 EQUITY INCENTIVE PLAN (AS AMENDED AND RESTATED ON MAY 23, 2023)</a></p>
			</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">B-1</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<div>&#xa0;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><a id="proxy" title="proxy" href="#"></a><b>Proxy Statement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>For the Annual Meeting of Stockholders</i></b><br />
<b><i>to be held on May 23, 2023</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This proxy statement is furnished to you in connection with the solicitation of proxies by our board of directors for the annual meeting of stockholders to be held on Tuesday, May 23, 2023, at 10:30 a.m., Eastern Time, virtually via the Internet, including any postponements or adjournments thereof. You will be able to attend the annual meeting, vote, and submit questions via live webcast by logging in at: www.virtualshareholdermeeting.com/CEVA2023. There will be no physical location for stockholders to attend.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A Notice of Internet Availability of Proxy Materials, this proxy statement, any accompanying proxy card or voting instruction form and our 2022 annual report to stockholders will be made available on or about April 12, 2023 to our stockholders of record on March 27, 2023 at <span style="text-decoration: underline; ">http://proxyvote.com</span>. Paper copies of the proxy materials may be obtained by following the instructions on the Notice of Internet Availability of Proxy Materials. The 2022 annual report incorporates our annual report on Form 10-K for 2022, including financial statements and financial statement schedules, but excluding exhibits, as filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). We will provide copies of the exhibits to our annual report on Form 10-K upon the written request of any of our stockholders as of the record date for the annual meeting and payment of a fee, which fee shall be limited to our reasonable expenses in providing such exhibits. Please address your request to CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850, Attention: Corporate Secretary. Our annual report on Form 10-K, and the exhibits thereto, as well as our other filings with the SEC may be accessed, free of charge, at our website, www.ceva-dsp.com and on the SEC&#x2019;s website at www.sec.gov, as soon as practicable after filing. Our website and the information contained therein or connected thereto are not intended to be incorporated into this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="notice" title="notice" href="#"></a>Notice of Internet Availability of Proxy Materials</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under rules adopted by the SEC, we may furnish our proxy materials to our stockholders over the Internet, rather than mailing printed copies of those materials to each stockholder. Each stockholder who receives a Notice of Internet Availability of Proxy Materials has the right to vote on all matters presented at the annual meeting. Our stockholders will not receive a printed copy of the proxy materials unless requested. Instead, the Notice of Internet Availability of Proxy Materials will provide instructions as to how a stockholder may access and review a copy of our proxy materials on the Internet, including this proxy statement and our 2022 annual report. Internet distribution of our proxy materials is designed to expedite receipt by stockholders, lower the cost of the annual meeting, and conserve natural resources. However, if a stockholder would prefer to receive paper copies of our proxy materials, please follow the instructions included in the Notice of Internet Availability of Proxy Materials. If a stockholder shares an address with another stockholder and has received only one Notice of Internet Availability of Proxy Materials, such stockholder may write to us at the following address to request a separate copy of these materials at no cost to such stockholder: CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850, Attention: Corporate Secretary. Beneficial owners (i.e. holders of our common stock through a broker dealer, not in their own names) may contact their broker or other nominee to request a separate copy of these materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="voting" title="voting" href="#"></a>Voting of Proxies</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Voting by Proxy Card.</i> All shares entitled to vote and represented by properly executed proxy cards received prior to the annual meeting, and not revoked, will be voted at the annual meeting in accordance with the instructions indicated on those proxy cards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Voting by Telephone or the Internet</i>. A stockholder may vote his, her or its shares by calling the toll-free number indicated on the Notice of Internet Availability of Proxy Materials and following the recorded instructions or by accessing the website indicated on the Notice of Internet Availability of Proxy Materials and following the instructions provided. When a stockholder votes via the Internet or by telephone, his, her or its vote is recorded immediately. We encourage stockholders to vote using these methods whenever possible.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Voting by Attending the Meeting.</i> A stockholder of record may vote his, her or its shares at the virtual annual meeting. Stockholders who attend the virtual annual meeting should follow the instructions at www.virtualshareholdermeeting.com/CEVA2023 to vote during the meeting. If your shares are held in &#x201c;street name&#x201d; or by a broker or nominee, you should follow the instructions at www.virtualshareholdermeeting.com/CEVA2023 to vote during the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Revocability of Proxies. </i>Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before it is voted. If the shares of common stock are held in your name, you may revoke your proxy (1) by filing with our Corporate Secretary, before the taking of the vote at the annual meeting, a written notice of revocation or a duly executed proxy card, in either case dated later than the prior proxy relating to the same shares, or (2) by attending the annual meeting and voting at the meeting (although attendance at the annual meeting will not by itself revoke a proxy). Any written notice of revocation or subsequent proxy card must be received by our Corporate Secretary prior to the taking of the vote at the annual meeting. Such written notice of revocation or subsequent proxy card should be sent to CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850, Attention: Corporate Secretary. In light of disruptions caused by the coronavirus, or COVID-19, if you intend to revoke your proxy by providing such a written notice, we advise that you also send a copy via email to ir@ceva-dsp.com. If your shares are held in &#x201c;street name&#x201d; or by a broker or nominee, you should follow the directions provided by your broker or nominee regarding how to revoke your proxy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If no instructions are indicated on a properly executed proxy card, the shares represented by that proxy card will be voted as recommended by the board of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If a stockholder indicates on a proxy that the shares should be voted &#x201c;FOR&#x201d; approval of any matters presented at the annual meeting, the proxy holders will have discretion to vote the shares on any other matters which are properly presented at the annual meeting for consideration, including a motion to adjourn or postpone the annual meeting to another time or place for the purpose of soliciting additional proxies, unless a stockholder expressly withholds authorization for the proxies to use their discretion. Amir Panush and Yaniv Arieli have been selected as proxy holders by our board of directors and currently serve as our executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="stock" title="stock" href="#"></a>Stockholders Entitled to Vote</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has fixed March 27, 2023 as the record date for determination of stockholders entitled to vote at the annual meeting. Only holders of record of our common stock at the close of business on the record date are entitled to notice of and to vote at the annual meeting. On March 27, 2023, there were 23,416,026 shares of our common stock outstanding and entitled to vote. Each share of common stock will have one vote for each matter to be voted upon at the annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="quor" title="quor" href="#"></a>Quorum; Votes Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The holders of a majority of the shares of common stock issued and outstanding and entitled to vote at the annual meeting will constitute a quorum for the transaction of business at the annual meeting. Shares of our common stock held by stockholders present in person or represented by proxy, including shares held by stockholders that abstain or do not vote with respect to one or more of the matters presented for stockholder approval, will be counted for purposes of determining whether a quorum is present at the annual meeting. Virtual attendance at our annual meeting constitutes presence in person for purposes of quorum at the meeting. An automated system administered by Broadridge Financial Solutions Inc. will tabulate votes cast by proxy and a representative from Broadridge will act as inspector of elections to tabulate votes cast at the annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the General Corporation Law of the State of Delaware, abstentions are included in determining the number of shares voted on the proposals submitted to stockholders (other than the election of directors) and will have the same effect as a &#x201c;no&#x201d; vote on such proposals. A broker &#x201c;non-vote&#x201d; occurs when a broker or nominee holding shares for a beneficial owner does not vote on a particular matter because such broker or nominee does not have the discretionary voting authority to vote the shares for which it is the holder of record with respect to a particular matter at the annual meeting and such broker or nominee has not received voting instructions from the beneficial owner. Broker &#x201c;non-votes,&#x201d; and shares as to which proxy authority has been withheld with respect to any matter, are generally not deemed to be entitled to vote for purposes of determining whether stockholders&#x2019; approval of that matter has been obtained. If you provide voting instructions, your shares will be voted as you direct. If you do not furnish voting instructions with respect to shares registered in the name of organizations that are not governed by NASDAQ Rule 2251, those shares will not be voted at the meeting because such organizations do not have discretionary voting power. If you do not furnish voting instructions to brokerage firms that are governed by NASDAQ Rule 2251, one of two things can happen, dependent on whether a proposal is &#x201c;routine.&#x201d; Under NASDAQ Rule 2251, brokerage firms, banks, broker-dealers and other similar organizations have discretion to cast votes on routine matters, such as the ratification of the appointment of an independent auditor, without voting instructions from their clients. Brokerage firms, banks, broker-dealers and other similar organizations are not permitted, however, to cast votes on &#x201c;non-routine&#x201d; matters, such as the election of directors or votes on the compensation of the Company&#x2019;s named executive officers, without such voting instructions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">With respect to proposal 1 of this proxy statement, in an uncontested election, each director nominee will be elected by a majority of the shares present or represented by proxy and voting at the meeting with respect to his/her election (that is, the number of shares voted &#x201c;for&#x201d; that nominee exceeds the number of votes cast &#x201c;against&#x201d; that nominee). Virtual attendance at our annual meeting constitutes presence in person for purposes of the vote required under our bylaws. In an uncontested election, any nominee for director who fails to receive a greater number of votes cast &#x201c;for&#x201d; such individual&#x2019;s election than votes cast &#x201c;against&#x201d; such election shall promptly tender his or her resignation to our board of directors following certification of the stockholder vote. The nomination and corporate governance committee of the board will promptly consider the resignation offer and recommend to the board of directors the action to be taken with respect to such offered resignation. The board of directors will consider and act on the nomination and corporate governance committee&#x2019;s recommendation. Thereafter, the board of directors will disclose promptly its decision whether to accept the director&#x2019;s resignation and the reasons for the decision, if applicable, in a public filing with the Securities Exchange Commission within 90 days following the date of the certification of the annual meeting election results. Any director tendering a resignation under such circumstances will not participate in the decision-making by the nomination and corporate governance committee or the board of directors regarding whether or not to accept the resignation offer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">With respect to proposals 2, 3 and 6 of this proxy statement, the affirmative vote of a majority of shares of our common stock present or represented and voted at the annual meeting is required for approval. With respect to proposal 4 of this proxy statement, the affirmative vote of a majority of shares of our common stock present or represented and voted at the annual meeting is required for approval, although such vote will not be binding on us. With respect to proposal 5 of this proxy statement, we have determined to view the frequency vote that receives the greatest number of votes cast by the holders of our common stock entitled to vote at the meeting as the advisory vote of stockholders on the frequency of approval of the compensation, although such vote will not be binding on us. Abstentions will have no effect on the outcome of the election of the director nominees and will have the same effect as &#x201c;no&#x201d; votes on proposals 2, 3, 4 and 6. Broker &#x201c;non-votes&#x201d; will have no effect on any of the proposals. Virtual attendance at our annual meeting constitutes presence in person for purposes of the vote required under our bylaws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="expense" title="expense" href="#"></a>Expenses of Solicitation </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will bear all expenses of this solicitation, including the cost of preparing and mailing this solicitation material. We may reimburse brokerage firms, custodians, nominees, fiduciaries, and other persons representing beneficial owners of common stock for their reasonable expenses in forwarding solicitation material to such beneficial owners. Directors, officers and employees of the company may also solicit proxies by telephone, letter, electronic mail, facsimile or other means of communication. Such directors, officers and employees will not be additionally compensated, but they may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="secown" title="secown" href="#"></a>Security Ownership of Certain Beneficial Owners and Management</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information, as of March 27, 2023, regarding the beneficial ownership of shares of our common stock by (a) each person or entity known by us to own beneficially more than 5% of the outstanding shares of our common stock, (b) each of our &#x201c;named executive officers,&#x201d; as described under the heading &#x201c;<i>Executive Compensation&#xa0;&#x2013; Compensation Discussion &amp; Analysis</i>&#x201d;&#xa0;below, (c) each of our directors and director nominees, and (d) our current directors and executive officers as a group. The address of each of our directors and named executive officers is c/o CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission, and generally includes voting power and/or investment power with respect to the shares of common stock. The percentages are based on 23,416,026 shares of our common stock outstanding as of March 27, 2023. Shares of our common stock subject to equity-based awards currently exercisable or exercisable within 60 days of March 27, 2023 are deemed outstanding for purposes of computing the percentage beneficially owned by the person holding the options, but are not deemed outstanding for purposes of computing the percentage beneficially owned by any other person. Except as indicated by footnote, we believe that the persons named in this table, based on information provided by them, have sole voting and investment power with respect to the shares of common stock indicated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 55%;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares of Our Common Stock Beneficially<br />
			Owned</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 15%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity-based</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Awards</b><br />
			<b>Included in</b><br />
			<b>Shares of Our</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common<br />
			Stock</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Beneficially</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Owned </b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;"><b>Name of Beneficial Owner</b></p>
			</td>
			<td style="vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></p>
			</td>
			<td style="vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percent</b></p>
			</td>
			<td style="vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 15%;">&#xa0;</td>
			<td style="vertical-align: top; width: 15%;">&#xa0;</td>
			<td style="vertical-align: top; width: 15%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">BlackRock, Inc. (1)</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,959,938</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">16.9%</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">The Vanguard Group, Inc. (2)</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,639,558</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">11.3%</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Senvest Management, LLC (3)</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">1,177,226</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">5.0%</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 15%;">&#xa0;</td>
			<td style="vertical-align: top; width: 15%;">&#xa0;</td>
			<td style="vertical-align: top; width: 15%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;"><b><i>Directors and Named Executive Officers </i></b></p>
			</td>
			<td style="vertical-align: middle; width: 15%;">&#xa0;</td>
			<td style="vertical-align: top; width: 15%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 15%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Bernadette Andrietti</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 15%; text-align: center;">-</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Jaclyn Liu</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7,091</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Maria Marced</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">11,831</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Peter McManamon</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">311,916</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1.3%</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">28,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Sven-Christer Nilsson</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">29,177</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Louis Silver</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">108,567</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">78,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Gideon Wertheizer</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">128,836</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Yaniv Arieli</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60,171</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Issachar Ohana</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">29,397</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">*</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Michael Boukaya</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 15%; text-align: center;">-</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 55%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">All current directors and executive officers as a group (11 persons)</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">686,986</p>
			</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.9%</p>
			</td>
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">106,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">*</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Represents less than 1% of the outstanding shares of common stock.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">BlackRock, Inc. filed a Schedule 13G/A with the Securities and Exchange Commission on January 26, 2023, reporting aggregate beneficial ownership of 3,959,938 shares of our common stock as of December 31, 2022. The information contained in this table is derived from such filing. The address of the reporting person is 55 East 52nd Street, New York, NY 10022.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The Vanguard Group, Inc. filed a Schedule 13G/A with the Securities and Exchange Commission on February 9, 2023, reporting aggregate beneficial ownership of 2,639,558 shares of our common stock as of December 30, 2022. The information contained in this table is derived from such filing. The address of the reporting person is 100 Vanguard Blvd., Malvern, PA 19355.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Senvest Management, LLC filed a Schedule 13G with the Securities and Exchange Commission on January 27, 2023, reporting aggregate beneficial ownership of 1,177,226 shares of our common stock as of January 20, 2023. The information contained in this table is derived from such filing. The address of the reporting person is 540 Madison Avenue, 32nd Floor, New York, NY 10022.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="equity" title="equity" href="#"></a>Equity Compensation Plan Information </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth certain information regarding our equity compensation plans as of December 31, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 0%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Number of shares</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>to be issued upon</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>exercise of</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>outstanding<br />
			options,</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>warrants and<br />
			rights</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted average</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>exercise price of</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>outstanding<br />
			options,</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>warrants and<br />
			rights</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 0%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Number of<br />
			securities</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>remaining<br />
			available</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>for future issuance</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>under equity</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>compensation<br />
			plans</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 55%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="text-decoration: underline; "><b>Plan Category</b></span></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Equity compensation plans approved by security holders</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">CEVA 2003 Director Stock Option Plan (1)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-align: center;">106,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">$20.24</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">CEVA 2011 Stock Incentive Plan (1)</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: center;">879,277</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 12%; text-align: center; margin-left: 9pt;">464,946</td>
			<td style="width: 1%; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">CEVA 2002 Employee Stock Purchase Plan</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">n/a</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">n/a</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">89,238</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Total</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">985,277</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">$2.18</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;">554,184</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">&#xa0;As of December 31, 2022, up to an aggregate of 3,949,789 shares of common stock were authorized for grant under the 2011 Plan, plus the additional number of shares that would otherwise return to the Company&#x2019;s 2002 Stock Incentive Plan (the &#x201c;2002 Plan&#x201d;) or the 2003 Director Stock Option Plan as a result of forfeiture, termination or expiration of option and stock appreciation right awards previously granted under the 2002 Plan or 2003 Director Stock Option Plan, as applicable, each of which were rolled over to the 2011 Plan. The only awards outstanding under the 2011 Plan as of December 31, 2022 were restricted stock units (&#x201c;RSUs&#x201d;).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In addition to the equity compensation information in the above table, effective February 17, 2023, we granted to Amir Panush, our Chief Executive Officer,&#xa0;14,541 time-based RSUs, up to 28,354 short-term performance-based stock units (&#x201c;short-term PSUs&#x201d;) and 60,587 long-term performance-based stock units (&#x201c;long-term PSUs&#x201d;) as an inducement award material to Mr. Panush&#x2019; employment pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules on terms substantially similar to those of the 2011 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop1" title="prop1" href="#"></a>PROPOSAL 1 </b>- <b>ELECTION OF SEVEN DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless otherwise instructed, the persons named in the accompanying proxy will vote to elect as directors the seven nominees named below, all of whom are currently directors of CEVA. Each director will be elected to hold office until the 2024 annual meeting of stockholders and until his or her successor is elected and qualified. Each of the nominees has indicated his or her willingness to serve on our board of directors, if elected; however, if any nominee should be unable to serve, the person acting under the proxy may vote the proxy for a substitute nominee designated by our board of directors. Our board of directors has no reason to believe that any of the nominees will be unable to serve if elected.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth certain information with respect to our directors as of March 27, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director</b><br />
			<b>Since</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Principal Occupation, Other Business Experience and </b><br />
			<b>Other Directorships During the Past Five Years</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bernadette Andrietti(1)(2)</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">61</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2019</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ms. Andrietti has enjoyed a successful thirty plus year career with Intel Corporation, holding various executive positions, most recently as Vice President of Sales and Marketing of the EMEA region from March 2013 to October 2019 as well as serving as an industry consultant from November 2019 to February 2023. Ms. Andrietti holds a Baccalaureat Degree in Mathematics and Physics. She also has an engineering degree in MicroElectronics from ESIEE Paris. We believe Ms. Andrietti&#x2019;s qualifications to sit on our board include her expertise in sales, marketing and brand management relating to the semiconductor and hi technology industries based on her executive sales and marketing roles within Intel Corporation, her experience in fostering and achieving diversity within the corporate environment, and her experience in cybersecurity from her work at Intel Corporation.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jaclyn Liu</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">48</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2021</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ms. Liu has served as a member of our board of directors since February 2021. Ms. Liu is a senior Partner at Morrison &amp; Foerster LLP, an international law firm, and has more than 20 years of experience in advising public companies on corporate governance matters, M&amp;A strategies and China matters. She serves as outside general counsel to a number of public companies and provides big&#x2011;picture, critical value-adding strategic advice. She formerly served as co-chair of Morrison &amp; Foerster&#x2019;s Global Corporate Department of over 400 lawyers. Ms. Liu graduated from Harvard Law School. We believe Ms. Liu&#x2019;s qualifications to sit on our board include her expertise in legal matters, her corporate governance and public company expertise, her extensive M&amp;A expertise and her in-depth knowledge of ESG and cybersecurity matters for public companies.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director</b><br />
			<b>Since</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Principal Occupation, Other Business Experience and </b><br />
			<b>Other Directorships During the Past Five Years</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maria Marced(1)(3)</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">68</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2016</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 71%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ms. Marced joined our board of directors in December 2016. From 2007 to 2023, she has served as President of TSMC Europe BV, with responsibility for driving the development, strategy and management of TSMC&#x2019;s business in Europe. Before joining TSMC, Maria was Senior Vice President and General Manager of Sales and Marketing at NXP Semiconductors/Philips Semiconductors. Maria joined Philips Semiconductor in September 2003 as Senior Vice President and General Manager of the Connected Multimedia Solutions Business Unit overseeing Philips' semiconductor solutions for connected consumer applications. Previous to her work with Philips, Maria was employed at Intel where she developed her professional career for more than 19 years, reaching the top position in the Europe, Middle East and Africa region as Vice President and General Manager. She currently serves as Chairwoman of the EMEA Leadership Council of the GSA (Global Semiconductor Alliance). We believe Ms. Marced&#x2019;s qualifications to sit on our board include her years of executive experience in the high technology and semiconductor industries, her extensive knowledge of our sales channels, competitors and end markets, her deep understanding of our company and her technical expertise of the semiconductor industry.</p>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align: top; width: 12%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 71%; text-align: justify;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align: top; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Peter McManamon</p>
			</td>
			<td style="vertical-align: top; width: 1%; text-align: justify;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%; text-align: center;">74</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</p>
			</td>
			<td style="vertical-align: top; width: 9%; text-align: center;">2003</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>
			</td>
			<td style="vertical-align: top; width: 71%; text-align: justify;">Mr. McManamon has served as a member of our board of directors since April 2003 and has served as chairman of our board since May 2005. He was a business advisor with the Enterprise Ireland funded, Stanford University program entitled &#x201c;Strategic Leadership for CFOs.&#x201d;&#xa0;Mr. McManamon served as chief financial officer of Parthus Technologies plc from 1993 until March 2001, executive vice president of corporate development of Parthus Technologies plc from March 2001 until November 2002, a member of the board of directors of Parthus Technologies plc from 1993 until November 2002, and was one of the co-founders of Parthus Technologies plc. From May 2005 to August 2011, Mr. McManamon served as a partner of Atlantic Bridge, an investment company. In September 2011, he was appointed chairman of Atlantic Bridge. In December 2012, he completed his second five year term as a board member of The National Development Finance Agency, and as a member of the Audit Committee of the National Treasury Management Agency, appointments made by the Irish Government. He also served as a director of Openmind Networks, Ltd., a provider of SMS and MMS router solutions for mobile and wholesale operators until September 2017. He currently serves as a director of AMD Investments Limited. We believe Mr. McManamon&#x2019;s qualifications to sit on our board include his qualification as a Chartered Director, his extensive knowledge of our company, products, and strategies through his early involvement with Parthus Technologies, his knowledge of financial markets, financing operations and global organizations through his years of experience providing strategic and investment advisory services to various global companies as a partner of Atlantic Bridge, and his executive management and corporate strategy skills.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director</b><br />
			<b>Since</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Principal Occupation, Other Business Experience and </b><br />
			<b>Other Directorships During the Past Five Years</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sven-Christer Nilsson(2)(3)</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">75</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2002</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Mr. Nilsson has served as a member of our board of directors since November 2002. He served as a member of the board of directors of Parthus Technologies plc from March 2000 until November 2002. Mr. Nilsson is the founder and owner of RIPASSO AB since August 1999. Between 1982 and 1999 he held various positions with The Ericsson Group, the telecommunications equipment supplier, including president, Ericsson Radio Systems (Sweden), vice president, Mobile Switching Systems, executive vice president, Cellular Systems-American Standards, and, from 1998, President and Chief Executive Officer. Currently Mr. Nilsson serves as a member of the board of directors of MagleChemoswed AB, a Swedish medical device developer and manufacturer. Mr. Nilsson has a long tenure of board service with listed companies and government organizations, including AssaAbloy AB, the worldwide securities and locks company (2001-2015), SprintNextel Corporation (2008-2013), Ripasso Energy AB (2009-2015), Swedish ICT Research AB, an industrial research institute (Chair 2003-2009), The (Swedish) Public Service Broadcasting Foundation (Chair 2003-2011) and The Swedish Defense Materiel Authority (Chair 2009-2015). He also is a member of the Royal Swedish Academy of Engineering Sciences and of the Royal Swedish Academy of War Sciences. We believe Mr. Nilsson&#x2019;s qualifications to sit on our board include his senior leadership experience through his executive management roles at The Ericsson Group, his corporate governance expertise and stewardship as a result of his various directorships, including SprintNextel Corporation and AssaAbloy AB, his deep understanding of our company, his extensive knowledge of our sales channels, competitors and end markets, and his technical expertise of the baseband market, which is a market that we derive a significant portion of our revenues.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td colspan="1" style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 71%; text-align: justify;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Louis Silver(1)(3)</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td colspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">69</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%; text-align: center;">2002</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>
			</td>
			<td style="vertical-align: top; width: 71%; text-align: justify;">Mr. Silver has served as a member of our board of directors since April 2002. He is currently a corporate advisor and serves as Managing Director of Alba Capital S. A. and Wicklow Corp., private holding investment companies. From April 2005 until April 2015, Mr. Silver was a principal at RP Capital Group, an alternative investment firm focused on investment opportunities in EEMEA. Mr. Silver was a director of DSP Group until May 2012, and director of Scopus Video Networks Ltd., a former NASDAQ-listed company, until December 2008. We believe Mr. Silver&#x2019;s qualifications to sit on our board include his corporate legal experience which can assist the board in fulfilling its oversight responsibilities regarding legal and regulatory compliance, his years of experience providing strategic and investment advisory services to companies and his public company experience which allows him to understand the dynamics of the board overseeing an ever-changing mix of strategic, operational and compliance-related matters.</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director</b><br />
			<b>Since</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 71%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Principal Occupation, Other Business Experience and </b><br />
			<b>Other Directorships During the Past Five Years</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gideon Wertheizer</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">66</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2010</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 71%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Mr. Wertheizer has served as a member of our board of directors since January 2010. He held the position of our Chief Executive Officer between May 2005 and his retirement in December 2022, and currently serves part-time as Advisor to the CEO. Mr. Wertheizer has 34 years of experience in the semiconductor and Silicon Intellectual Property (SIP) industries. He previously served as our executive vice president and general manager of the DSP business unit. Prior to joining us in November 2002, Mr. Wertheizer held various executive positions at DSP Group, Inc., including such roles as executive vice president - strategic business development, vice president for marketing and vice president of VLSI design. Mr. Wertheizer holds a BsC for electrical engineering from Ben Gurion University in Israel and executive MBA from Bradford University in the United Kingdom. We believe Mr. Wertheizer&#x2019;s qualifications to sit on our board include his years of executive experience in the high technology and semiconductor industries, as well as his deep understanding of our company, people and products previously acquired as our Chief Executive Officer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Member of compensation committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Member of nomination and corporate governance committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Member of audit committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="corpgov" title="corpgov" href="#"></a>CORPORATE GOVERNANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Corporate Governance Overview</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors is committed to strong and effective corporate governance, and, as a result, it regularly monitors our corporate governance policies and practices to ensure compliance with applicable laws, regulations and rules, as well as best practices.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our corporate governance program features the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have an independent chairman of the board;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All of our directors, other than our former CEO, are independent;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All of our board members are up for election annually;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have a majority voting standard for the election of directors;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have a board of directors with deep industry expertise;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have enhanced diversity on our board with the appointment of three female directors in the last six years, one of whom is Asian American;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We periodically review succession planning for our Chief Executive Officer and other Board members;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have a robust stockholder engagement program;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have no stockholder rights plan in place;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our board committees regularly review and update, as necessary, the committee charters, which clearly establish the roles and responsibilities of each such committee, and such charters are posted on our website for review;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our board generally has an executive session among our non-employee and independent directors after every board meeting;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our board enjoys unrestricted access to the company&#x2019;s management, employees and professional advisers;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have a code of business conduct and ethics that is reviewed regularly for best practices and is posted on our website for review;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have a clear set of corporate governance guidelines that is reviewed regularly for best practices and is posted on our website for review;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We focus on employee engagement and retention;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are committed to corporate and social responsibility;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We provide board oversight and leadership on environmental, social and governance issues;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have adopted a sustainability policy covering, data privacy and security, resource conservation and recycling, environmental policy and employees, which is posted on our website for review;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We conduct an annual say-on-pay vote;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our charter documents have no supermajority voting provisions;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our insider trading policy prohibits hedging, pledging or shorting of our stock by all of our employees, including executive officers, and directors;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">None of our board members is serving on an excessive number of public company boards;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have established stock ownership requirements for our named executive officers and all of our directors to ensure that their interests remain aligned with the interests of the company and our stockholders;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">There are no family relationships among any of our directors or executive officers;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our board performs an annual self-assessment, led by the chair of the nomination and corporate governance committee, to evaluate its effectiveness in fulfilling its obligations; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our corporate governance documents do not contain a supermajority standard for the approval of a merger or a business combination, which transaction requires the affirmative vote of a majority of the outstanding shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Leadership Structure</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has a chairman who is a non-employee director. Our chairman is responsible for chairing board meetings and meetings of stockholders, assisting management in setting the agendas for board meetings, providing information to the board members in advance of meetings and between meetings and providing guidance to our Chief Executive Officer on corporate strategies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>The Board</b>&#x2019;<b>s Role in Risk Oversight</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors utilizes an enterprise-wide approach to risk management, designed to support the achievement of business objectives, including organizational and strategic objectives, improve long-term organizational performance and enhance stockholder value. The involvement of the full board in setting our business strategy is a key part of its assessment of management&#x2019;s plans to deal with business risks and determination of what constitutes an appropriate level of risk for the company. While our board has risk oversight responsibility, management is responsible for assessing and managing material risk exposures. Our board&#x2019;s role in the company&#x2019;s risk oversight process includes receiving regular reports from members of senior management on areas of material risk to the company, including operational, financial, legal and regulatory, cybersecurity, and strategic and reputational risks. While the full board has the ultimate oversight responsibility for the risk management process, various committees of the board also have responsibility for risk management. For example, financial, legal, IT, cybersecurity and general business risks, including internal controls and oversight of management&#x2019;s maintenance of the corporate risk register, are overseen by the audit committee. Risks that may be implicated by our executive compensation programs are overseen by the compensation committee and from time to time by the nomination and corporate governance committee. Upon identification of a risk, the assigned board committee or the full board discuss or review risk management and risk mitigation strategies. Additional review or reporting on enterprise risks is conducted as needed or as requested by the board or committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Independence</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has determined that all members of the board, except Mr. Wertheizer, our former CEO who currently serves part-time as Advisor to the CEO, are independent pursuant to the NASDAQ listing rules. In making this determination, our board of directors considered transactions and relationships between each director or his or her immediate family and the company and our subsidiaries, including those reported in the section below captioned, &#x201c;Transactions with Related Parties.&#x201d; The purpose of this review was to determine whether any such relationships or transactions were material and, therefore, inconsistent with a determination that the director is independent. As a result of this review, our board affirmatively determined that all of our directors, except Mr. Wertheizer, are independent under the standards set forth by the NASDAQ listing rules.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Relationships among Directors or Executive Officers</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There are no family relationships among any of our directors or executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board of Directors Meetings </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors met seven times during 2022 and acted by written consent three in 2022. All directors attended at least 75% of the meetings of our board of directors. It is the policy of our board that the independent directors shall meet separately with no members of management present in executive sessions on a routine basis, but no less than twice annually, to review and discuss, among other things, the company&#x2019;s strategy, performance and management effectiveness.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Committees</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has standing audit, compensation, and nomination and corporate governance committees - each of which operates under a charter that has been approved by the board. Current copies of each of the audit, compensation and nomination and corporate governance committee&#x2019;s charters are posted on the corporate governance section of our website, <span style="text-decoration: underline; ">www.ceva-dsp.com</span>. Our board also has an ad hoc investment committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The primary purpose of the audit committee is to assist the board of directors in fulfilling its responsibility to oversee the accounting and financial reporting processes of CEVA and audits of the financial statements of CEVA. The members of the audit committee are Maria Marced, Sven-Christer Nilsson and Louis Silver. Mr. Silver serves as the chairman of the audit committee. Zvi Limon, who served as director for part of 2022 until his retirement from the board on March 28, 2022, served as a member of the audit committee until his retirement from the board. Eliyahu Ayalon, who served as director for part of 2022 until his retirement from the board on August 12, 2022, served as a member of the audit committee until May 19, 2022, when he was replaced by Maria Marced. Mr. Nilsson has been determined as the audit committee financial expert. The audit committee met six times during 2022. All of the members of the audit committee are independent as defined by the NASDAQ listing standards and as defined under the independence requirements of Rule 10A-3 under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The primary purposes of the compensation committee are to discharge the responsibilities of the board of directors relating to compensation of CEVA&#x2019;s executive officers, to make recommendations with respect to new incentive compensation and equity-based plans and to make recommendations regarding director compensation and administration of CEVA&#x2019;s equity compensation plans. Effective March 28, 2022, the members of the compensation committee are Bernadette Andrietti, Maria Marced and Lou Silver. Mrs. Marced serves as the chairman of the compensation committee effective from March 28, 2022. Zvi Limon served as a chairman of the compensation committee until his retirement from the board on March 28, 2022. The compensation committee met five times in 2022 and acted by written consent three times in 2022. All of the members of the compensation committee are independent as defined by the NASDAQ listing standards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The primary purpose of the nomination and corporate governance committee is to recommend to the board of directors the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the board of directors a set of corporate governance principles applicable to CEVA and to oversee the evaluation of the board of directors and management. The members of the nomination and corporate governance committee are Sven-Christer Nilsson and Bernadette Andrietti. Mr. Nilsson serves as the chairman of the committee. Jackie Liu served as a member of the nomination and corporate governance committee for part of 2022 until March 9, 2022. The nomination and corporate governance committee met twice in 2022 and acted by written consent twice. All members of the nomination and corporate governance committee are independent, as defined by the NASDAQ listing standards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Audit Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The audit committee&#x2019;s responsibilities include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">appointing, approving the compensation of, and assessing the independence of our independent auditor;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">overseeing the work of our independent auditor, including through the receipt and consideration of certain reports from independent auditors;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing and approving non-audit related services performed by the independent auditor;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">evaluating the performance of and assessing the qualifications of the independent auditors;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing and discussing with management and the independent auditors our annual and quarterly financial statements and related disclosures;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">monitoring our internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">discussing our risk management policies;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">evaluating and monitoring our cybersecurity policies and controls;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">establishing policies regarding hiring employees from the independent auditor and procedures for the receipt and retention of accounting related complaints and concerns;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">meeting independently with our internal auditing staff, independent auditors and management;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing related-party transactions that would be disclosed pursuant to SEC rules; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">preparing the audit committee report required by SEC rules.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Audit Committee Financial Expert</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has determined that Mr. Nilsson qualifies as an audit committee financial expert, as defined by the applicable rules of the Exchange Act, pursuant to the fact that, among other things, he was the Chief Executive Officer and President of The Ericsson Group, and in those capacities had acquired the relevant experience and expertise and has the attributes set forth in the applicable rules as being required for an audit committee financial expert. Furthermore, each member of our audit committee has demonstrated that he is capable of (i) understanding generally accepted accounting principles (&#x201c;GAAP&#x201d;) and financial statements, (ii) assessing the general application of GAAP principles in connection with the accounting for estimates, accruals and reserves, (iii) analyzing and evaluating financial statements, (iv) understanding internal controls and procedures for financial reporting, and (v) understanding audit committee functions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Compensation Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee&#x2019;s responsibilities include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">determining the compensation of the executive officers, including the Chief Executive Officer;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">reviewing and making recommendations to the board with respect to our cash and equity incentive plans;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">reviewing and making recommendations to the board with respect to director compensation; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">administering CEVA&#x2019;s equity incentive plans.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nomination and Corporate Governance Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The nomination and corporate governance committee&#x2019;s responsibilities include identifying individuals qualified to become board members and recommending to the board the persons to be nominated for election as directors and to each of the board&#x2019;s committees. The committee assists the board in all matters relating to the establishment, implementation and monitoring of policies and processes regarding the recruitment and nomination of candidates to the board and committees of the board, and the development, evaluation and monitoring of our corporate governance processes and principles. The committee also is responsible for developing, implementing and monitoring compliance of our code of business conduct and ethics, and corporate guidelines and making recommendations to the board of revisions to the code and the guidelines from time to time as appropriate, as well as providing guidance to the board and management regarding CEVA&#x2019;s policies and practices relating to environmental, social and governance matters and other relevant sustainability matters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Annual Evaluation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">It is important to the company that the board and its committees are performing effectively and in the best interest of the company and its stockholders. The board performs an annual self-assessment, led by the chair of the nomination and corporate governance committee, to evaluate its effectiveness in fulfilling its obligations. As part of this annual self-assessment, directors are able to provide feedback on the performance of other directors. The chair of the nomination and corporate governance committee then follows up on this feedback and takes such further action as he deems appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Candidates</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The process to be followed by the nomination and corporate governance committee to identify and evaluate director candidates includes requests to board members and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to potential candidates and interviews of selected candidates by members of the committee and the board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In considering whether to recommend any particular candidate for inclusion in our board&#x2019;s slate of recommended director nominees, the nomination and corporate governance committee only considers candidates who have demonstrated executive experience, have experience in an applicable industry, or significant high level experience in accounting, legal or an applicable technical field. Other criteria will include the candidate&#x2019;s integrity, business acumen, knowledge of our business and industry, experience, diversity, diligence, conflicts of interest and the ability to act in the interests of all stockholders. The committee will not assign specific weights to particular criteria and no particular criterion is a prerequisite for each prospective nominee. We believe that the backgrounds and qualifications of our directors, considered as a group, should provide a composite mix of experience, knowledge and abilities that will allow the board to fulfill its responsibilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The nomination and corporate governance committee has adopted a policy of accepting recommendations from stockholders for consideration as potential director candidates. Stockholders who wish to submit a recommendation for potential director candidate for consideration should follow the procedures set forth under &#x201c;Stockholder Proposals for 2024 annual meeting and Nominations of Persons for Election to the Board of Directors.&#x201d; Assuming that appropriate biographical and background material has been provided on a timely basis, the committee will evaluate stockholder-recommended candidates by following substantially the same process, and applying substantially the same criteria, as it follows for candidates submitted by others. If the board determines to nominate a stockholder-recommended candidate and recommends his or her election, then his or her name will be included in our proxy materials for the next annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Stockholders also have the right under our by-laws to directly nominate director candidates, without any action or recommendation on the part of the nomination and corporate governance committee or the board, by following the procedures set forth under &#x201c;Stockholder Proposals for 2024 annual meeting and Nominations of Persons for Election to the Board of Directors.&#x201d;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have not received a director nominee recommendation from any stockholder (or group of stockholders) that beneficially owns more than five percent of our common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Diversity</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors is committed to actively seek women and minority director candidates for consideration. Approximately 43% of our board are comprised of women. Our board values diversity and diversity is one of the factors considered by our nomination and corporate governance committee in the director identification and nomination process. The nomination and corporate governance committee seeks to have a slate of candidates for election that represents a diverse set of views, experiences, professions, education, skills, geographic representation and backgrounds.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth certain diversity statistics as self-reported by the current members of our board of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td colspan="5" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Board Diversity Matrix (As of March 27, 2023)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Total Number of Directors</p>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Female</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Male</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Binary</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Gender</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Undisclosed</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Part I: Gender Identity</b></p>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Directors</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Part II: Demographic Background</b></p>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">African American or Black</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Alaskan Native or Native American</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Asian</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Hispanic or Latinx</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Native Hawaiian or Pacific Islander</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">White</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Two or More Races or Ethnicities</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">LGBTQ+</p>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Did Not Disclose Demographic Background</p>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Leadership Succession</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors is committed to adding new directors to infuse new ideas and fresh perspectives in the boardroom. As part of our board&#x2019;s succession planning, the nomination and corporate governance committee and our board regularly review the composition of the board and assess the balance of knowledge, experience, skills, expertise, tenure and diversity that is appropriate for the board and the company. In that regard, we added Ms. Andrietti to our board in 2019 and Ms. Liu in 2021, and three long-tenured directors retired recently, Mr. Bruce Mann in February 2021, Mr. Zvi Limon in March 2022 and Mr. Eliyahu Ayalon in August 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors also plans for succession to the position of Chief Executive Officer. To assist the board with its review, our Chief Executive Officer periodically provides the board with an assessment of senior executives and their potential to succeed to the position of Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">After notification of Mr. Wertheizer&#x2019;s desire to retire from his position as Chief Executive Officer, our nomination and corporate governance committee conducted an extensive search to find a successor, which included a review of both external and internal candidates. We selected Amir Panush to succeed Mr. Wertheizer effective January 1, 2023. Mr. Panush previously served as the CEO and General Manager of TDK Corporation&#x2019;s MEMS Sensors Business Group, and he has an excellent track record of leadership at large technology companies, strong relationships within the industry, and many intersections with CEVA&#x2019;s target markets. Furthermore, in connection to Mr. Wertheizer&#x2019;s retirement, we negotiated the terms of his retirement and entered into a consulting agreement with Mr. Wertheizer to provide support services for the transition.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Chief Executive Officer also provides the board with an assessment of potential successors to key positions. In addition, Dana Maor Megiddo, a seasoned human resources executive with years of experience joined the company in 2020, as VP People and is helping to reshape the company&#x2019;s processes for promotion of its employees, workforce training and the identification of the next generation of leaderships within the company. Furthermore, through invitation to its meetings and access to key employees, our board of directors has the opportunity to meet with leaders of our company and conduct its own analysis of the company&#x2019;s culture and employees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Tenure</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors recognizes that its current members have served on the board of directors for various tenures, with the shortest tenure being just over two years, but with few other directors serving for 10 years or more. Our board of directors believes that the board represents a balance of industry, technical and financial experiences, which provide effective guidance and oversight to management. Our governance policies reflect our belief that directors should not be subject to term limits. While term limits could facilitate fresh ideas and viewpoints being consistently brought to the board, we believe they are counterbalanced by the disadvantage of causing the loss of a director who over a period of time has developed insight into our strategies, operations, and risks and continues to provide valuable contributions to board deliberations. Nonetheless, we have heard our stockholders&#x2019; desire for board refreshment. Our board of directors is committed to adding new directors to infuse new ideas and fresh perspectives in the boardroom. Our nomination and corporate governance committee assesses the continuing independence of long-tenured directors from management as part of its determination on whether to nominate an incumbent director for re-election. In addition to the retirements of Mr. Mann in 2021, Mr. Limon in March 2022 and Mr. Ayalon in August 2022 we have undertaken various steps to augment our current board tenure, including the appointment of Ms. Andrietti to our board in 2019 and Ms. Liu in 2021. We will continue to monitor board tenure and consider changes as appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Stockholder Engagement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors and management focus on creating long-term, sustainable stockholder value. Key to this goal is stockholder engagement at conferences and in one-on-one meetings to discuss our financial performance, corporate governance practices, executive compensation programs and other matters. Our conversations with stockholders allow us to better understand our stockholders&#x2019; perspectives and provide us with useful feedback to calibrate our priorities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Since 2019, we have generally undertaken a comprehensive, annual stockholder engagement process to gain insights into our stockholders&#x2019; concerns and identify areas for improvement within our executive compensation program and corporate governance matters generally. In accordance with the importance that our board of directors places on stockholder engagement, the chair of our board of directors, Peter McManamon, conducts the stockholder outreach with assistance from management. In November and December 2021, our chairman reached out to our 14 largest stockholders (who at the time owned approximately 52% of our issued and outstanding common stock) in a letter summarizing recent developments of the company and offered to listen to their perspectives and concerns, if any, in follow-up, individualized engagements. Stockholders, who at the time owned approximately 12% of our issued and outstanding common stock responded to Mr. McManamon&#x2019;s letter. In 2022, we took a different approach to our engagement process given the changes to our management announced during the fourth quarter. Instead, we attended a number of investment bank-sponsored conferences and conducted one-on-one calls with both current shareholders and potential new investors. In this respect, we directly engaged with 11 of our largest 20 shareholders during 2022 (who as of December 31, 2022 owned approximately 34% of our issued and outstanding common stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We welcome the feedback we received during our engagement with our stockholders. The table below describes what we have heard from our stockholders in recent years and how we have implemented improvements to address our stockholders&#x2019; feedback.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 15%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>What We Heard</i></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 85%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>How We Responded</i></b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Long-term incentive awards should be more performance-based.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 85%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Starting from 2020, a substantial amount of the equity compensation for our Chief Executive Officer, and all of the equity compensation for our other executive officers, has been in the form of performance-based stock units. Moreover, in 2020, a group of key employees were granted equity compensation with vesting subject to performance-based metrics. Furthermore, in February 2023, we granted long-term performance-based stock units to each of Messrs. Panush, Arieli, Boukaya, and Toquet with vesting subject to performance-based metrics.</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">We should consider board tenure.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 85%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Our board of directors is committed to adding new directors to infuse new ideas and fresh perspectives in the boardroom. In addition to the appointment of Ms. Andrietti to our board in 2019, we added Ms. Liu to our board in 2021. In February 2021, March 2022 and August 2022, three long-tenured board members retired, Mr. Mann, Mr. Limon and Mr. Ayalon, respectively. We are considering undertaking additional steps to augment our current board composition in consideration of our current board tenure. We added Ms. Andrietti to our board in 2019 in consideration of her expertise in sales, marketing and brand management relating to the semiconductor and hi technology industries, and her experience in fostering and achieving diversity within the corporate environment. We added Ms. Liu to our board in 2021 in consideration of her expertise in corporate governance, M&amp;A and ESG matters for public companies.</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Consider ESG matters that are material to our business.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 85%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Our nomination and corporate governance committee is responsible for board oversight and leadership on environmental, social and governance issues. We also set up a taskforce within the company to oversee the creation of an ESG framework. We distilled our viewpoint and commitment to being a responsible corporate citizen in advancing environmental, social and governance initiatives in our sustainable policy, which is posted on the company section of our web site at <span style="text-decoration: underline; ">www.ceva-dsp.com/sustainability</span>.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">&#xa0;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">We have focused on corporate governance and human capital management as two priorities within ESG.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">We should focus on workforce engagement and retention matters that are material to our business.</p>
			</td>
			<td style="vertical-align: top; width: 85%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Dana Maor Megiddo, a seasoned human resources executive with years of experience, joined the company in 2020. Since then, she has focused on improving employee engagement, compensation and benefits, while increasing soft skills training for managers, for better performance reviews, retention and ability to hire in a very competitive market.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">&#xa0;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Furthermore, until the end of 2021, Ms. Andrietti served on the board of Cercle InterElles association, a leadership network of 15 companies in the technology and science fields dedicated to closing the gender gap in these fields and to promoting women leadership. Her expertise in this area provides guidance to management on promotion of diversity in the workforce.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Communicating with the Independent Directors by Stockholders</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The board will give appropriate attention to written communications that are submitted by stockholders, and will respond if and as appropriate. The chairman of the nomination and corporate governance committee, with the assistance of our corporate secretary, is primarily responsible for monitoring communications from stockholders and for providing copies or summaries to the other directors as he considers appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Communications are forwarded to all directors if they relate to important substantive matters and include suggestions or comments that the chairman of the nomination and corporate governance committee or the corporate secretary considers to be important for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances and matters as to which we tend to receive repetitive or duplicative communications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Stockholders who wish to send communications on any topic to the board should address such communications to Board of Directors c/o Corporate Secretary, CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Prohibition on Pledging and Hedging of Company Securities</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to our insider trading policy, all employees of the company, including executive officers, as well as directors, are prohibited from engaging in short-term or speculative securities transactions with respect to our common stock, such as short sales, puts, calls and other exchange-traded derivatives. Since the inception of the policy, no director or executive officer has pledged or hedged any company shares. Nonetheless, in 2020, the board of directors enhanced the policy to eliminate the availability of any waiver for pledging or hedging by directors and employees, including executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Code of Business Conduct and Ethics</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors adopted a code of business conduct and ethics. This code applies to all of our employees and is posted on the corporate governance section of our website at <span style="text-decoration: underline; ">www.ceva-dsp.com</span>. The code satisfies the requirements under the Sarbanes-Oxley Act of 2002, NASDAQ rules applicable to issuers listed on the NASDAQ Market and the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). The code, among other things, addresses issues relating to conflicts of interests, including internal reporting of violations and disclosures, and compliance with applicable laws, rules and regulations. The purpose of the code is to deter wrongdoing and to promote, among other things, honest and ethical conduct and to ensure to the greatest possible extent that our business is conducted in a legal and ethical manner. Any waivers to the code with respect to our executive officers and directors may be granted only by the audit committee. Any waivers to the code with respect to the remainder of the employees may be granted by the compliance officer, which is currently our Chief Financial Officer. Any waivers to the code and any amendments to the code applicable to our Chief Executive Officer, Chief Financial Officer, principal accounting officer, controller or persons performing similar functions, will be posted on our website.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our audit committee has also established procedures for (a) the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters, as well as any other complaints, and (b) the confidential, anonymous submission via a third party vendor by our employees of concerns regarding questionable accounting or auditing matters, as well as any other complaints.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Environmental, Social and Governance (ESG)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are committed to being a responsible corporate citizen in advancing environmental, social and governance initiatives. We recognize that certain ESG issues can have real financial impact over the long-term. This is why we are proactively working to better understand and manage ESG risks and opportunities that are relevant to our business. In that regard, our board of directors determined that the management and oversight of ESG matters are critical responsibilities of the board, has undergone training on the latest activities in ESG to set the tone for improvements within our company, and has delegated to the nominations and governance committee responsibility to oversee our ESG efforts and commitments. Using the technology and communication sector (semiconductor industry) standards issued by the Sustainability Accounting Standards Board as a guidepost, our ESG framework addresses environmental controls, resource conservation and recycling, employee engagement, diversity and inclusion, employee health and safety, corporate governance and business ethics.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Environmental</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We operate environmentally responsible practices within our business, recognizing our responsibility to our customers, stockholders, suppliers, employees and society at large. We are committed to protecting the environment and to operate our business sustainably. We strive to comply with regulatory and industry standards at all of our locations of business and expect all of our employees, vendors and visitors to act in an environmentally responsible manner and reduce carbon footprint. We recognize that this is a constant commitment and we endeavor to improve our operations through constant assessment with the goal of environmental sustainability in mind.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">By the very nature of our business as an IP developer and licensor of low-power signal processing technologies, our operations have a lower impact on the environment than traditional semiconductor businesses. We do not manufacture any products or purchase harmful chemicals that might have a negative impact on the environment, such as ozone-depleting chemicals (ODCs). Instead, we provide our customers with the blueprints required to develop chips that are smaller, cheaper, require less power (in some cases battery-free and even energy-harvesting) and have a positive impact on the wider environment. In fact, our technologies are energy-saving by design, always seeking to be lower power than the existing or alternative solutions in the market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Nevertheless, we recognize that our operations do have an impact on the environment through our energy consumption and general day-to-day office operations which generate waste and require water. We will continue to measure and endeavor to reduce our energy usage per capita at each of our sites and eliminate wasteful practices wherever possible.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The tenets of our environmental initiative are:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>People</b>: Promoting a people-first culture and sustaining an employee culture that embraces environmental stewardship, including educating our employees on sustainability at home, work and in the community at large.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Environmental controls</b>: Reducing energy usage and carbon footprint, and minimizing our impact on the environment, including, even prior to the COVID-19 pandemic, implementation of systems and processes to enable our employees to work from home, company-wide adoption of video conferencing and a dedicated VPN for our R&amp;D engineers to streamline collaboration efforts, as well as the promotion of video conferencing for our sales and marketing teams to connect with customers where possible, thereby reducing customer-related travel.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Resource conservation measures</b>: Eliminating wasteful practices wherever possible, including retrofitting our office spaces for energy efficiency and water conservation, using energy saving lighting and establishing other energy reduction programs and projects. As an example, over the last few years, we have changed all our office lighting to energy efficient LED bulbs and have seen significant energy savings and improvement in lighting quality in our employees&#x2019;&#xa0;workspaces.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Recycling</b>: Promoting and managing recycling programs to reduce waste. For example, our IT teams in all our offices worldwide recycle unwanted electronic goods as required, using specialized local recycling companies in each region. Furthermore, in some locations, we employ initiatives to recycle electronics in novel ways, as well as paper, plastic bottles and cans. In our Israel office, for example, once a year, we invite our employees to take home any old IT equipment for their personal use, reducing their need to buy similar equipment for their homes, and we also donate some of this equipment to the needy.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Energy-efficient technology</b>: Our products are designed for low power consumption. We set and track targets for energy consumption for each of our hardware and software technologies.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Social (Human Capital Management)</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our social commitment is reflected through our employees and our corporate culture. Our organization&#x2019;s culture can be described as an open, interactive and team oriented work philosophy where everyone&#x2019;s contribution is welcome and valued. We recognize that our employees are vital to the company success and we openly encourage our employees to develop their skills while working with the company. We endeavor to create a culture of innovation and inspiration where employees feel a strong sense of community and collective pride in the company&#x2019;s success through policies that promote employee well-being, encourage employee health and fitness, and promote personal and career development.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have three main company values and these were developed to help us deliver commitments made to employees and customers:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Respect for the individual</b>: This means treating everyone with dignity and as individuals. Having an open atmosphere where communication gives everybody the opportunity to contribute. Ensuring all employees commit to the company policy on equality. We strive to advance diversity and inclusion through various talent acquisition programs to attract, retain and develop a diverse, highly skilled work force. We are also committed to a respectful work environment free of physical and verbal harassment. We work to minimize the risks associated with the tasks our employees perform, and we take our responsibility for our employees&#x2019;&#xa0;health and safety very seriously<b>.</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Ethics and professionalism</b>: This means committing to an environment of trust and honesty. Ensuring our employees act with integrity in all aspects of business, understand company policies and procedures, and respect the values and culture of our diverse workforce.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Business and customer focus</b>: Our engineering teams strive to achieve the highest quality designs and support success for themselves, the company as a whole and our customers. This success translates into technology leadership, employee satisfaction and business achievements, together with our customers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Particularly, we are committed to equal opportunity and strive to reflect the diversity of the communities where we do business. We invest in building diverse talent pools and providing training to improve skill levels, where appropriate. We prohibit discrimination based on race, color, national origin, religion, religious creed, ancestry, sex, gender, gender identity, gender expression, sexual orientation, age, marital status, mental and/or physical disability, medical condition as defined by applicable law, military service or veteran status, genetic information, pregnancy, childbirth and related medical conditions, or any other category protected by applicable law. The electronic engineering sector in general performs poorly in terms of gender diversity. At CEVA, we are actively trying to improve gender diversity, both at Board level and within the workforce. Female representation on our board of directors is 42.9% (3 out of 7 directors), and female representation in our workforce overall is 26% as of December 31, 2022 (126 out of 487 employees). Our percentages for new women hires are similar, with women constituting 27% of new hires in 2022 compared to 38% in 2021 (which, for 2021, excludes the May 2021 acquisition of the Intrinsix team). We are committed to continuing to raise awareness amongst women, both inside and outside the company, about the exciting opportunities available to them at CEVA and to encourage them to embark on a career with us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our human capital successes are evident in the number and quality of hires we have made. Reinforcement of the culture we are building comes through engagement with our employees, the reward principles we apply to compensation and promotion decisions and through our various talent development initiatives. Our board of directors is actively engaged in human capital management. Our board periodically reviews management succession plans. More broadly, the board is regularly updated and consulted on key talent hires, as well as the company&#x2019;s human capital strategy. This strategy is continuously refined based on business drivers and the overall environment for talent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Governance</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">With respect to corporate governance, as noted in this proxy statement, our board of directors is composed of all independent directors except for Mr. Wertheizer, our former Chief Executive Officer. We have annual director election based on a majority voting standard. We have director and executive officer stock ownership requirement and a prohibition on pledging and hedging of our stock. Our board has executive sessions generally after all board meetings and our nomination and corporate governance committee conducts annual board evaluations. We have various stockholder protections, including voting rights for all shares, no poison pill and no supermajority voting provisions. Finally, we have a culture of high integrity and business ethics which starts with our code of conduct and business ethics. We have procedures to address compliance and ensure awareness of our policies and expectations for ethical behavior. We conduct quarterly communication meetings on a world-wide basis to update all employees on our financial, business and technology achievements and reinforce our corporate goals and values. See additional details about our corporate governance policies under the section titled &#x201c;Corporate Governance Overview&#x201d; as illustration of our board&#x2019;s commitment to strong and effective corporate governance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our sustainable policy, which reflects our core values, is posted on the company section of our web site at <span style="text-decoration: underline; ">www.ceva-dsp.com/sustainability.</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Workforce and COVID-19</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our commitment to our employees and our organization&#x2019;s culture became ever more important as we responded to the challenges of the COVID-19 pandemic. Like many companies around the world, we facilitated the majority of our employees to work from home and have since adopted a hybrid model that provides flexibility to each employee&#x2019;s circumstances. At CEVA, we recognize all of our employees&#x2019; needs and concerns, and have adopted flexible working arrangements to ensure they remain in good health and secure in the knowledge that they have the full support of the company and its resources. We arranged for technical support and various office supplies to be delivered to employees to enable the best work-from-home environment to ensure productivity and wellbeing. We use a range of technologies, including Zoom and Microsoft Teams, to communicate with our employees, conduct welfare activities, provide online training and recruit new employees to CEVA. Through the hard work and dedication of our employees, our business has gone from strength to strength during this uncertain period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cybersecurity and Data Protection</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We take various measures to ensure the integrity of our systems, including implementation of security controls and regular training of our employees with respect to measures we can take to enable us to thwart cybersecurity attacks. While the full board has the ultimate oversight responsibility, our audit committee review the risk management processes relating to cybersecurity on a regular basis. Further, all of our employees are trained at least annually on our information security procedures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Attendance at Stockholder Meetings</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have adopted a guideline providing that, in light of the geographic dispersion of our directors, the directors&#x2019; attendance at the annual meeting of stockholders is encouraged but not required. Our 2022 annual meeting of stockholders was conducted virtually due to COVID-19 travel restrictions and safety of the board members and management, and was attended by all directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Transactions with Related Parties</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">One of our directors, Jaclyn Liu, is a senior partner of Morrison &amp; Foerster LLP, our outside legal counsel. Aggregate fees paid to Morrison &amp; Foerster LLP for the year ended December 31, 2022 were approximately $0.5 million.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have entered into indemnification agreements with each of our directors and executive officers. Such agreements require us to indemnify such individuals to the fullest extent permitted by Delaware law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Review, Approval or Ratification of Transactions with Related Persons</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have adopted a written policy regarding related person transactions which is incorporated in the charter of the audit committee. Pursuant to this policy, our audit committee must review and approve any such transactions. There were no related party transactions in 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Legal Proceedings</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">To our knowledge, no material proceedings exist to which any director, officer or affiliate of CEVA, any owner of record or beneficially of more than 5% of any class of voting securities of CEVA, or any associate of any such director, officer, affiliate of CEVA, or security holder is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>No Supermajority Vote on Approval of Mergers or Other Business Combinations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our corporate governance documents do not contain a supermajority standard for the approval of a merger or a business combination. Such transactions require the affirmative vote of a majority of the outstanding shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Corporate Governance Guidelines</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors adopted a set of corporate governance guidelines which set forth the practices our board follows with respect to, among other things, the composition of the board and board committees, director responsibilities, director continuing education and performance evaluation of the board. The guidelines are posted on the IR section of our web site at <span style="text-decoration: underline; ">www.ceva-dsp.com</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">22</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="exoff" title="exoff" href="#"></a>EXECUTIVE OFFICERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth certain information with respect to our executive officers as of March 27, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Business Experience</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amir Panush</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">49</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Panush has served as our Chief Executive Officer since January 2023. He joined us from InvenSense, Inc., a TDK group company, where he served as Chief Executive Officer and General Manager of TDK Corporation&#x2019;s MEMS Sensors Business Group. Mr. Panush previously held various leadership positions at TDK following TDK&#x2019;s successful acquisition of InvenSense in 2017. Mr Panush joined Invensense in 2015, serving as head of the company&#x2019;s Strategy &amp; Corporate Development, where he drove strategic expansion and diversification efforts. Prior to joining InvenSense, from May 2011 to March 2015, Mr. Panush served in various capacities at Qualcomm, most recently as the Senior Director of Product Management and Business Development for the IoE/IoT client business. Prior to joining Qualcomm, Mr. Panush led strategic marketing and partnerships at Atheros Communications, which was later acquired by Qualcomm. His earlier industry roles spanned software engineering and project management leadership at Texas Instruments and Comsys Mobile, which was acquired by Intel. Mr. Panush holds a Master of Business Administration from Haas Business School, University of California at Berkeley and a bachelor&#x2019;s degree, Cum Laude, in Computer Science from Technion Institute of Technology in Israel.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yaniv Arieli</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">54</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Arieli has served as our Chief Financial Officer since May 2005. Prior to his current position, Mr. Arieli served as President of U.S. Operations and Director of Investor Relations of DSP Group beginning in August 2002 and Vice President of Finance, Chief Financial Officer and Secretary of DSP Group&#x2019;s DSP Cores Licensing Division prior to that time. Before joining DSP Group in 1997, Mr. Arieli served as an account manager and certified public accountant at Kesselman &amp; Kesselman, a member of PricewaterhouseCoopers, a leading accounting firm. Mr. Arieli is a CPA and holds a B.A. in Accounting and Economics from Haifa University in Israel and an M.B.A. from Newport University and is also a member of the National Investor Relation Institute.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gweltaz Toquet</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Toquet has served as our Chief Commercial Officer since January 2023. Mr. Toquet has more than 20 years of sales and management experience with the Company, most recently serving as our Vice President of Sales for Asia Pacific, India and Europe. In particular, Mr. Toquet has spent over 15 years as our Vice President of Sales for Asia Pacific based in Hong Kong, where he led the build-out and management of the sales and support functions in the region spanning China, Japan, Taiwan and Korea. Prior to joining the Company in 2002, Mr. Toquet held several roles in sales, business development, product marketing and business line management at Freehand DSP and Texas Instruments. Mr. Toquet holds a Master of Science in Engineering degree from Institut Sup&#xe9;rieur d&#x2019;Electronique de Paris (ISEP).</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Michael Boukaya</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">48</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 81%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Boukaya has served as our Chief Operating Officer since April 4, 2019. Mr. Boukaya was promoted to Executive Vice President and Chief Operating Officer in November 2022. Previously, he served as Vice President and General Manager of Wireless Business Unit from October 2014 to April 2019, and VP and Chief Architect with overall responsibility for the research and development of next generation DSP Cores, wireless platform architectures and multimedia processors from January 2006 to October 2014. Prior to joining CEVA, he was with the DSP Group since 1998, holding different engineering and R&amp;D management positions. Mr. Boukaya holds a B.Sc. in Electronic Engineering from Technion Technology Institute and graduated from Executive Program of Stanford Graduate School of Business. He holds several patents on DSP Technology.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">23</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="excom" title="excom" href="#"></a>EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="comdis" title="comdis" href="#"></a>Compensation Discussion &amp; Analysis</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Our named executive officers for the fiscal year ended December 31, 2022 are:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Gideon Wertheizer, our former Chief Executive Officer who transitioned to part-time employment as Advisor to the CEO effective January 1, 2023;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Yaniv Arieli, our Chief Financial Officer;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Issachar Ohana, our former Executive Vice President, World Wide Sales, whose employment with us terminated on December 31, 2022; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Michael Boukaya, our Executive Vice President and Chief Operating Officer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Overview of Compensation Philosophy and Objectives</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We operate in a very competitive, dynamic and challenging industry. The compensation committee, which establishes our compensation policy, seeks to achieve the following three broad goals in connection with our executive compensation program:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">enable CEVA to attract and retain qualified executive officers;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">create a performance-oriented environment by rewarding executive officers for the achievement of CEVA&#x2019;s business objectives, both short-term and long-term, and achievement within an individual executive officers&#x2019;&#xa0;particular area of responsibility; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">provide executive officers with equity incentives in CEVA so as to link a portion of an executive officer&#x2019;s compensation with the positive performance of the company as reflected in CEVA&#x2019;s common stock and strategic goals.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We believe that our executive officers&#x2019; compensation should not be based on the short-term performance of our stock, whether favorable or unfavorable, but rather that the price of our stock will, in the long-term, reflect our operating performance and ultimately the management of the company by our executive officers. Our policy for allocating between short-term and long-term compensation is to ensure adequate base compensation to attract and retain key personnel, while providing incentives to maximize long-term value for our company and our stockholders. We further believe that our executive officers&#x2019; total annual cash compensation should vary with the company&#x2019;s performance and that the higher an executive officer&#x2019;s level of responsibility within the company, the greater the percentage of such executive officer&#x2019;s compensation should be tied to the company&#x2019;s performance. However, notwithstanding the above principles, we rely upon judgment and not upon rigid guidelines or formulas in determining the amount and mix of compensation elements for each executive officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee believes that the company&#x2019;s executive compensation program closely links to the company&#x2019;s business strategies, aligns pay with performance and reflects competitive practices regarding executive compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee, which is comprised solely of independent, non-employee board members, has the authority and responsibility to establish our overall compensation strategy, including reviewing, analyzing and approving the compensation structure for our Chief Executive Officer, our executive and non-executive officers and other key employees each fiscal year; and administer our incentive compensation and benefit plans, 401(k) plan, and equity incentive and purchase plans. The compensation committee regularly updates the board of directors with respect to its undertakings in establishing the company&#x2019;s overall compensation strategy. Mses. Andrietti and Marced, and Mr. Silver were the members of the compensation committee in 2022 with Ms. Marced serving as the chair.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Executive Compensation Practices at a Glance</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline; ">What We Do</span></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline; ">What We Do Not Do</span></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-top: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Pay for Performance under Our Executive Bonus Plans. </b>We link pay to performance and stockholder interests by establishing annual executive bonus plans for our executive officers based solely on financial and business metrics established in advance by the compensation committee.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No </b>&#x201c;<b>Single Trigger</b>&#x201d;&#xa0;<b>Severance Payments: </b>We do not have &#x201c;single trigger&#x201d;&#xa0;severance payments owing solely on account of the occurrence of a change of control event.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Performance-Based Equity Awards for All Executive Officers. </b>We incentivize executive officers to achieve the company&#x2019;s strategic and business goals with the grant of equity awards to executive officers tied to performance metrics. In 2022, over 51% of the aggregate annual equity awards granted to our executive officers were in the form of performance-based stock units (&#x201c;PSUs&#x201d;) (with PSUs calculated at target).</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Re-Pricing of Equity Awards: </b>Our equity plans prohibit repricing of equity awards without stockholder approval.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Capped Incentives under Our Annual Executive Bonus Plans. </b>Except for the sales-based incentive plan for our sales organization heads, our annual executive bonus plans are capped for our executive officers and tied to their base salary for the relevant year.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Hedging or Pledging in Company Securities: </b>All of our employees, including executive officers, and directors are prohibited from engaging in any hedging or pledging transaction with respect to company equity securities.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Time-Based Equity Awards Generally Subject to Multi-Year Vesting. </b>Our time-based equity award grants to our executive officers are generally subject to a multi-year vesting schedule.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Guaranteed Bonuses:</b>&#xa0;We do not provide guaranteed minimum bonuses under our annual executive bonus plan.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Thorough Compensation Risk Assessment: </b>Our compensation committee conducts an annual assessment of the company&#x2019;s executive and broad-based compensation programs to ensure prudent risk management.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Nonqualified Defined Contribution or Other Deferred Compensation Plan. </b>We do not have any such plans.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Compensation Committee Independence and Experience:</b>&#xa0;Our compensation committee is comprised solely of independent directors who have extensive experience.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Special Perquisites or Retirement Benefits: </b>We do not provide special perquisites or retirement benefits to our executive officers that are not generally provided to all of our employees.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Independent Compensation Advisor: </b>Our compensation committee has the authority to select and engage its own independent advisor.</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>No Tax Gross-Ups: </b>We do not provide tax gross-ups.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Stock Ownership Policy:</b>&#xa0;Our named executive officers and all of our directors are subject to such a policy.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 58%; border-left: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Say-on-Pay: </b>We conduct an annual say-on-pay vote.</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#xa0;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 40%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Role of Chief Executive Officer in Compensation Decisions</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In its annual review of each executive officer&#x2019;s total compensation, the compensation committee takes into consideration the assessment of the performance of each executive officer by our Chief Executive Officer (other than his own performance, which is reviewed solely by the compensation committee), their accomplishments, and individual performance of each such executive officer, including our Chief Executive Officer&#x2019;s recommendation with respect to salary adjustments and annual equity award amounts. Our Chief Executive Officer&#x2019;s recommendations are generally approved by the compensation committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Role of Compensation Consultants in Compensation Decisions</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The charter of the compensation committee authorizes the committee to engage the services of consultants to assist in the determination of our executive officers&#x2019; compensation. The compensation committee engaged the services of Compensia, Inc., an independent compensation consultant, in 2022 to provide a summary of relative market practices with respect to certain compensation elements for executive officers and with respect to negotiating compensation for the Company&#x2019;s new chief executive officer and again in early 2023 with respect to incentive plan design and pay vs. performance presentations and analysis.&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Compensation Consultant Independence</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">To ensure independence, the compensation committee, as needed, will directly engage a compensation consultant and determine its independence. The compensation committee has determined that Compensia is independent under applicable SEC and Nasdaq rules, based on the committee&#x2019;s review of the services provided to the company, and concluded that no conflict of interest existed that would prevent Compensia from independently advising the compensation committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>2022 </i></b>&#x201c;<b><i>Say on Pay</i></b>&#x201d;<b><i> Advisory Vote on Executive Compensation </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our stockholders provide an advisory vote annually on executive compensation. At our 2022 annual meeting of stockholders, approximately 95% of the votes cast in the &#x201c;say on pay&#x201d; advisory vote were &#x201c;FOR&#x201d; approval of our executive compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Principal Elements of Executive Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Compensation of our executive officers consists of three principal components: base salary, annual cash incentive award payable pursuant to a performance-based bonus plan and long&#x2011;term equity incentive compensation. In 2022, long-term equity incentive compensation to our executive officers consisted of purely time-based restricted stock units (&#x201c;RSUs&#x201d;) and performance-based restricted stock units (&#x201c;PSUs&#x201d;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Base Salary</i>. The base salaries of our executive officers are reviewed annually and are set by the compensation committee. Base salaries for executive officers, including the Chief Executive Officer, are generally determined on an individual basis by evaluating (i) the executive&#x2019;s scope of responsibility and changes in job responsibility, performance, prior employment experience and salary history; (ii) our financial performance, including changes in our revenues and profits, during the year; (iii) competitive market conditions for executive compensation; and (iv) internal consistency within our salary structure. The base salaries of Messrs. Wertheizer, Arieli and Boukaya are denominated in New Israeli Shekel (NIS) in consideration that these executive officers reside in Israel. Mr. Ohana&#x2019;s base salary is denominated in U.S. dollars, as he resides in the U.S. In November 2022, the compensation committee approved salary increases of approximately 12.7% for Mr. Arieli and 18.8% for Mr. Boukaya. Prior to that, each of Messrs. Wertheizer, Ohana, Arieli, and Boukaya received a salary increase of approximately 5% in February 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Annual Cash Incentive Award</i>. The compensation committee believes that an annual performance-based cash award to supplement base salaries of executive officers provides an important incentive to the achievement of corporate goals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>2022 Executive Bonus Plan </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In February 2022, the compensation committee established a 2022 Executive Bonus Plan for each of Messrs. Wertheizer, Arieli and Boukaya, effective January 1, 2022 to December 31, 2022. The committee believed that the 2022 Executive Bonus Plan was an important part of maintaining the overall competitiveness of the company&#x2019;s executive compensation program.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Parameters of the 2022 Executive Plan are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 12%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighting</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 26%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Financial Target</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-right: 1px solid black; border-top: 1px solid black; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Threshold<br />
			for Receipt<br />
			of Bonus</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Linear Calculation<br />
			Between Threshold and<br />
			Target</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Linear Calculation between<br />
			Target and Maximum</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">40%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 26%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Specified 2022 revenue target approved by the board&#xa0;(the &#x201c;2022 Revenue Target&#x201d;)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">90% of the 2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">If we achieve&#xa0;between 90% and 100% of the 2022 Revenue Target, that percentage of the target bonus amount, subject to 40% weighting, would be payable</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">For the 2022 Revenue Target, if our&#xa0;actual result exceeds 100% of the target, every 1% achieved above the target, up to 110%, would result in an increase of 4% for Mr. Wertheizer and an increase of 2.5% for each of Messrs. Arieli and Boukaya in bonus payable, subject to 40% weighting</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">40%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 26%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Specified 2022 non-GAAP earnings per share approved by the board (the &#x201c;2022 EPS Target&#x201d;)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">90% of the 2022 EPS Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">If we achieve&#xa0;between 90% and 100% of the 2022 EPS Target, that percentage of the bonus amount, subject to 40% weighting, would be payable</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">For the 2022 EPS Target, if our actual result exceeds 100% of the target, every 1% achieved above the target, up to 110%, would result in an increase of 4% for Mr. Wertheizer and an increase of 2.5% for each of Messrs. Arieli and Boukaya in bonus payable, subject to 40% weighting</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">20%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 26%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Specified 2022 revenue target approved by the board for licensing, non-recurring engineering (&#x201c;NRE&#x201d;) and related revenues (excluding sensor fusion chip sales) attributed to North America (the &#x201c;2022 North America Target&#x201d;)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50% of the 2022 North America Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">If&#xa0;we achieve&#xa0;between 50% and 100% of the 2022 North America Target, that percentage of the bonus amount, subject to 20% weighting, would be payable</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 25%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">If we achieve&#xa0;above 100% of the 2022 North America Target, every 1% achieved above the target, up to 110%, would result in a 1.5% increase in bonus payable for each officer, subject to 20% weighting</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the 2022 Executive Bonus Plan, the target annual cash bonus award opportunities for each of Messrs. Wertheizer, Arieli and Boukaya are established as a percentage of each such executive officer&#x2019;s base salary for 2022. The target and maximum award opportunities for Messrs. Wertheizer, Arieli and Boukaya for 2022 are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 59%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Named Executive Officer </b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Target Award</b><br />
			<b>(as a percentage of base salary) </b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Maximum Award</b><br />
			<b>(as a percentage of base salary) </b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 59%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;">Gideon Wertheizer</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">70%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">110%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 59%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;">Yaniv Arieli</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">75%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 59%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;">Michael Boukaya</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">75%</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Payment of bonuses (if any) under the 2022 Executive Bonus Plan are made in 2023. Bonuses are paid in cash in a single lump sum, subject to payroll taxes and tax holdings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee believes revenue, EPS, and revenues related to licensing, NRE and related revenues attributed to North America are the appropriate targets to base the 2022 Executive Bonus Plan because these performance measures reflect management&#x2019;s efforts in determining new markets, developing new technologies and executing on initiatives to expand and grow the company. Such factors represent short term success or failure of the company and align management&#x2019;s interests with that of stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>2022 Executive Bonus Plan Payments. </i>In 2022, the company fell below the 2022 Revenue Target by 6%, EPS was below the 2022 EPS Target by 7%, and the performance in respect of the 2022 North America Target was below target by 40%. Based on the parameters of the 2022 Executive Bonus Plan, bonuses of $295,000, $130,000 and $105,000 were paid to each of Messrs. Wertheizer, Arieli and Boukaya under the 2022 Executive Bonus Plan.&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Mr. Wertheizer&#x2019;s bonus was calculated as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Weight</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.9%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Objective</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.3%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Results</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Calculation</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 6.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.3%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $134.7 million, ~6% below the 2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 94%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 37.6%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$127,750</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="vertical-align: top; width: 8.9%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 EPS Target</p>
			</td>
			<td style="vertical-align: top; width: 22.3%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual non-GAAP earnings per share was 78 cents, ~7% below the 2022 EPS Target.</p>
			</td>
			<td style="vertical-align: top; width: 14.4%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 93%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage:37.2%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$126,500</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 6.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">20% of Base Salary</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 North America Targets</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.3%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $20.3 million, ~40% below the 2022 North America Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 60%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 12%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$40,750</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Arieli&#x2019;s bonus was calculated as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Weight</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Objective</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.2%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Results</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Calculation</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $134.7 million, ~6% below the 2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 94%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 37.6%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$56,250</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="vertical-align: top; width: 8.4%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 EPS Target</p>
			</td>
			<td style="vertical-align: top; width: 22.2%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual non-GAAP earnings per share was 78 cents, ~7% below the 2022 EPS Target.</p>
			</td>
			<td style="vertical-align: top; width: 14.4%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 93%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 37.2%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$55,750</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">20% of Base Salary</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 North America Targets</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 22.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $20.3 million, ~40% below the 2022 North America Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 60%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 12%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$18,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Boukaya&#x2019;s bonus was calculated as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Weight</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Objective</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 21.8%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Results</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.9%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><b>Calculation</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 21.8%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $134.7 million, ~6% below the 2022 Revenue Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 94%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 37.6%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$45,500</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">40% of Target Bonus</p>
			</td>
			<td style="vertical-align: top; width: 8.4%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 EPS Target</p>
			</td>
			<td style="vertical-align: top; width: 21.8%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual non-GAAP earnings per share was 78 cents, ~7% below 2022 EPS Target.</p>
			</td>
			<td style="vertical-align: top; width: 14.9%; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 93%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 37.2%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$45,000</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.4%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">20% of Base Salary</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 North America Targets</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 21.8%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Actual 2022 revenues were $20.3 million, ~40% below the 2022 North America Target</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 14.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout percentage: 60%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Weighted percentage: 12%</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Payout: ~$14,500</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Compensation of Chief Executive Officer.</i> The determination by the compensation committee of the remuneration of Mr. Wertheizer in 2022 generally was based upon methods consistent with those used for our other executive officers. The compensation committee believes that the salary and long-term incentive compensation paid to Mr. Wertheizer in 2022 were appropriate based on our compensation policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Compensation of EVP, Worldwide Sales. </i>The annual cash compensation payable to Mr. Ohana was comprised of base salary, as determined in accordance with the criteria discussed above for all executive officers, and a commission-based cash bonus, payable quarterly based on the criteria discussed below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>2022 Incentive Bonus Plan for EVP, Worldwide Sales</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The process for setting the annual revenue target for Mr. Ohana&#x2019;s incentive plan begins with a discussion by our Chief Executive Officer and Chief Financial Officer of the strategic and operating plans for the relevant fiscal year. The compensation committee then reviews such objectives and, subject to any further adjustments, approves them. The annual revenue target set for Mr. Ohana&#x2019;s incentive plan generally required significant effort by Mr. Ohana to achieve.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In February 2022, the compensation committee approved a 2022 Incentive Plan for Mr. Ohana, effective as of January 1, 2022 (the &#x201c;Ohana 2022 Plan&#x201d;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In accordance with the Ohana 2022 Plan, Mr. Ohana&#x2019;s bonus was comprised of four components. The first component, based on annual revenue, was determined using a formula with a 2022 annual revenue target of $147.5 million multiplied by a specified commission rate. A commission multiplier of 1.0 is applied to the commission rate for annual revenue between 0% to 100% of target and a commission multiplier of 1.5 is applied to the commission rate for annual revenue in excess of 100% of target. Finally, the annual revenue component of Mr. Ohana&#x2019;s bonus was capped at $140,000. The second component, based on 2022 North America revenue, was determined using a formula with a specified 2022 North America revenue target of $34.0 million multiplied by a specified commission rate. A commission multiplier of 0.5 was applied to the commission rate for 2022 North America revenue between 0 to 50% of target, a commission multiplier of 1.0 was applied to the commission rate for 2022 North America revenue between 50% and 100% of target and a commission multiplier of 1.5 was applied to the commission rate for 2022 North America revenue in excess of 100% of target. Finally, the 2022 North American revenue component of Mr. Ohana&#x2019;s bonus was capped at $35,000. The third component of Mr. Ohana&#x2019;s bonus was a quarterly bonus of $6,000 each quarter if specified quarterly revenue targets, based on the 2022 annual revenue target, were achieved. The quarterly revenue targets in 2022 were $36.0 million for the first quarter, $34.0 million for the second quarter, $37.0 million for the third quarter and $40.5 million for the fourth quarter. The fourth and final component of Mr. Ohana&#x2019;s bonus was an additional bonus of $6,000 or $10,000 each time he successfully executed a new license agreement or integrated intellectual property services agreement, respectively, in each case meeting a certain predetermined royalty per chip and, in some cases, license fee threshold amount with a specified strategic customer (&#x201c;Strategic Accounts Agreements&#x201d;). The 2022 strategic account component of Mr. Ohana&#x2019;s bonus was capped at $42,000 if the company failed to achieve the 2022 annual revenue target, but Mr. Ohana would not be subject to any such cap if the 2022 annual revenue target was achieved. The commission-based bonus was payable quarterly based on the criteria discussed above and was subject to payroll taxes and tax withholdings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Based on the terms of the Ohana 2022 Plan, as amended, Mr. Ohana was paid an aggregate bonus of $149,000, comprised of: (i) an amount of $143,000 based on the annual revenue target and North America revenue target, (ii) an amount of $0 based on the quarterly revenue targets, and (iii) $6,000 based on the strategic account agreements the company executed with customers in 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Equity Incentive Programs</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We intend that our stock award program is the primary vehicle for offering long-term incentives and rewarding our executive officers and key employees. We also regard our stock award program as a key retention tool. In order to promote a longer term management focus and to provide an incentive for continued employment with us, we grant RSUs and PSUs to our executive officers and primarily RSUs to the rest of our employees. Under limited circumstances, we grant stock options and stock appreciation rights to certain employees and generally in small quantities. RSU awards generally become exercisable over a three-year period. Certain PSU awards vest immediately upon achievement of the underlying performance goals, and other PSU awards vest over a three-year period even after achievement of the underlying performance goals.&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The size of the equity award made to each executive officer is based upon the following factors:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">an evaluation of the executive officer&#x2019;s past performance;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the total compensation being paid to the executive officer;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the anticipated value of the executive officer&#x2019;s contribution to our future performance;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the executive officer&#x2019;s scope of responsibility;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the executive officer&#x2019;s current position with us;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the number of equity awards granted to the executive officer during previous fiscal years and the vesting status of such awards;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">comparability with equity awards made to our other executive officers; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">comparability with equity awards of similarly situated executive officers at peer companies.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In 2022, the compensation committee granted RSUs and PSUs to each of Messrs. Wertheizer, Arieli, Ohana and Boukaya. With respect to the PSU grants, the performance metrics were intended to align with the interests of our stockholders in both the short term and in the long term.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">After considering various factors, including historic practices and the views of our institutional investors pursuant to engagements with them by the chairman of the board and certain management members, the compensation committee approved 2022 equity awards to the executive officers in the aggregate equity grant value set forth below and weighted the time-based RSUs and short-term PSUs as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: auto;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity Grant Value</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighting (RSU/PSU)</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Gideon Wertheizer</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1.0 million</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">40%/60%</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Issachar Ohana</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0.4 million</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60%/40%</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Yaniv Arieli</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0.5 million</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60%/40%</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Michael Boukaya</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0.4 million</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60%/40%</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>2022 Restricted Stock Unit Award to Executive Officers</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Restricted Stock Unit Awards Granted</i>. In February 2022, Messrs. Wertheizer, Ohana, Arieli and Boukaya received grants of 9,935 RSUs, 5,961 RSUs, 7,451 RSUs and 5,961 RSUs, respectively, based on the above equity value figures. One-third of the RSUs granted in 2022 vest each year commencing on the first year anniversary of the grant date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Timing of Grants.</i> Equity incentive awards to our executive officers and other key employees are typically granted annually in conjunction with the review of the individual performance of our executive officers. Equity incentive awards are not necessarily granted to each executive officer during each year. Grants of equity incentive awards to newly hired executive officers who are eligible to receive them generally are made at the next regularly scheduled compensation committee meeting following their hire date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>2022 Short-Term Performance-Based Restricted Stock Unit Award to Executive Officers</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In establishing the performance metrics for the short-term PSU grants, the compensation committee attributed 50% weighting each to 2022 license, NRE and related revenues and to relative total stockholder return against the S&amp;P 500. The compensation committee determined that annual license, NRE and related revenue was the appropriate metric for a portion of the short-term PSU grant because, unlike royalty revenue which is dependent on a variety of factors outside of management&#x2019;s control, license, NRE and related revenue is a measure that management can control through anticipating market need and determining market reach, setting technology milestones and achieving them, as well as attentiveness and focus on achieving the actual licensing design wins. License, NRE and related revenue also drives long-term value creation. The compensation committee determined, after considering input from Compensia, that relative total stockholder return against the S&amp;P 500 was the appropriate metric for the other portion of the short-term PSU grant because the S&amp;P 500 is a widely known and accepted index representing broad investor base and generally consistent with performance of peers in the company&#x2019;s space.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In February 2022, each of Messrs. Wertheizer, Ohana, Arieli and Boukaya received short-term PSU grants with the target settlement amounts of 14,903 shares, 3,974 shares, 4,969 shares and 3,974 shares, respectively, based on the above equity value figures. Additionally, PSUs representing an additional 20%, meaning an additional 2,981, 795, 994 and 795 would be eligible for vesting for each of Messrs. Wertheizer, Ohana, Arieli and Boukaya, respectively, if the performance goals were achieved at maximum levels. Subject to achievement of the performance goals, as detailed below, one-third of the total number of shares of common stock earned in respect of the 2022 PSUs vest each year, with vesting commencing on the first anniversary of the grant date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The performance goals for the short-term PSU grants for 2022 with specified weighting are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 10%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Weighting</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 90%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Goals</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 90%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vesting of the full 50% of the PSUs occurs if we achieve&#xa0;the 2022 license, NRE and related revenue target approved by the board (the &#x201c;2022 License Revenue Target&#x201d;). The vesting threshold is achievement of 90% of 2022 License Revenue Target. If our&#xa0;actual result exceeds 90% of the 2022 License Revenue Target, every 1% increase of the 2022 License Revenue Target, up to 110%, would result in an increase of 2 % vesting of the eligible PSUs.</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 90%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vesting of the full 50% of the PSUs occurs if we achieve&#xa0;positive total shareholder return whereby the return on our stock for 2022 is greater than the S&amp;P 500 index. The vesting threshold is achieved if the return on our&#xa0;stock for 2022 is at least 90% of the S&amp;P 500 index. If the return on our&#xa0;stock, in comparison to the S&amp;P 500 index, is above 90% but less than 99% of the S&amp;P 500 index, 91% to 99% of the eligible PSUs would vest. If the return on our&#xa0;stock exceeds 100% of the S&amp;P 500 index, every 1% increase in comparison to the S&amp;P 500 index, up to 110%, would result in an increase of 2% vesting of the eligible PSUs.&#xa0;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based on the achievement of performance goals, the 2022 short-term PSU grant for each of Messrs. Wertheizer, Ohana, Arieli and Boukaya that vested was 7,269 shares, 1,938 shares, 2,423 shares and 1,938 shares, respectively, based on the following performance:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Weighting</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Goals</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Achievement</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">2022 License Revenue Target - Actual licensing, NRE and related revenues were $89.259 million, resulting in 98% achievement compared to target; as a result, 98% of the corresponding PSUs vested</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr.Wertheizer: 7,269 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Ohana: 1,938 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Arieli: 2,423 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Boukaya: 1,938 PSUs</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">50%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">S&amp;P 500 Index Target - Return on our common stock was down ~(41)% and the S&amp;P 500 index return was down ~(19)%; as a result, 0% of the corresponding PSUs vested</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 45%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr.Wertheizer: 0 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Ohana: 0 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Arieli: 0 PSUs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Mr. Boukaya: 0 PSUs</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Stock Ownership Guidelines for Executive Officers</i></b>&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In February 2016, the board adopted a set of stock ownership guidelines for our named executive officers so as to align this group&#x2019;s interests with those of our stockholders. Pursuant to the guidelines, each of our executive officers has five years from the later of the adoption of the policy or the date of their appointment as an executive officer to own (personally and collectively with members of the executive officer&#x2019;s immediate family or with family trusts) an amount of common stock valued at its fair market value equal to at least 100% of their then-current annual base salary, or 200% of such salary in respect of our Chief Executive Officer. Accordingly, certain of the named executive officers of the company, including Mr. Wertheizer, our former Chief Executive Officer, Mr. Arieli, our Chief Financial Officer, and Mr. Ohana, our former Executive Vice President, Worldwide Sales, were required to satisfy this requirement by February 2, 2021, and each has been in compliance with our stock ownership guidelines through their subsequent tenure as an executive officer (which for Mr. Wertheizer and Mr. Ohana ended on December 31, 2022). Mr. Boukaya, our Chief Operating Officer, will be required to meet this requirement on April 4, 2024, and each of Mr. Panush, our Chief Executive Officer, and Mr. Toquet, our Chief Commercial Officer, will be required to meet this requirement on January 1, 2028. For purposes of this ownership guideline, vested in-the-money equity awards and common stock acquired pursuant to the company&#x2019;s employee stock purchase plan are included in the minimum ownership calculation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Anti-Pledge/Hedging Policy. </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Pursuant to the company&#x2019;s insider trading policy, all employees of the company, including executive officers, are prohibited from engaging in short-term or speculative securities transactions with respect to our common stock, such as short sales, puts, calls and other exchange-traded derivatives. Since the inception of the policy, no executive officer has pledged or hedged any company shares. Nonetheless, in 2020, the board of directors enhanced the policy to eliminate the availability of any waiver for pledging or hedging by employees, including executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Retirement Benefits and Perquisites</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We do not offer any retirement benefits to our executive officers located in Israel, except to the extent certain social benefits are required pursuant to Israeli labor laws or are common practice in Israel, and such social benefits are applicable to all Israeli employees. Specifically, based on Israeli labor laws, an Israeli employee is entitled to severance pay upon termination of employment for any reason, including retirement, based on the most recent monthly salary of such employee multiplied by the number of years of employment of such employee. We make a payment of 8.333% of each employee&#x2019;s monthly base salary to an insurance or pension fund to pay for this future liability payable to our employees upon termination of their employment. In addition, we make a payment of 6% of each employee&#x2019;s monthly base salary to another insurance or pension fund, and this accrued amount may be withdrawn by the employee only upon retirement. We generally provide all of our Israeli employees with a car for business-related purposes and pay the associated expenses (excluding personal taxes on such benefit). Also, as is customary in Israel and for all Israeli employees, we provide our Israeli employees with a certain amount of monthly contributions (7.5% of their base salary) for the purpose of each employee&#x2019;s study and training. The amounts of the above-referenced benefits contributed by us to each of Messrs. Wertheizer, Arieli and Boukaya in 2022 are specified in the 2022 All Other Compensation Table of this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, we provide our U.S. employees, including Mr. Ohana, our only U.S.-based executive officer in 2022, with participation in our 401(k) plan. We provided a 100% match to any contribution made by participants to the 401(k) plan in 2022, subject to a maximum of 6% of the participant&#x2019;s compensation and specified IRS limits. The matching amount contributed by us to Mr. Ohana is shown in the 2022 All Other Compensation Table of this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Employment Agreements and Post-Termination Protection</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The compensation committee also recognizes that, from time to time, it is appropriate to enter into agreements with certain key employees to ensure that we continue to retain their services and to promote stability and continuity within our company. We have entered into employment agreements with our executive officers. The varied terms of their employment agreements reflect the importance of retaining their services and their potential contributions to the attainment of our long-term goals. None of the employment agreements with our executive officers provide for tax gross ups and none includes any &#x201c;single trigger&#x201d; change-in-control provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Financial Restatements</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee has not adopted a policy with respect to whether we will make retroactive adjustments to any cash- or equity-based incentive compensation paid to executive officers (or others) where the payment was predicated upon the achievement of financial results that were subsequently the subject of a restatement. Our compensation committee believes that this issue is best addressed when the need actually arises, when all of the facts regarding the restatement are known.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Tax and Accounting Treatment of Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Prior to the tax reform noted below, Section 162(m) of the Internal Revenue Code of 1986, as amended (Section 162(m)), generally disallowed a tax deduction to public companies for compensation over $1 million paid to its Chief Executive Officer and its four other most highly compensated executive officers resident in the United States, but provided that qualified performance-based compensation was not subject to the deduction limitation if certain requirements were met.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 22, 2017, the U.S. federal government enacted the Tax Cuts and Jobs Act, which substantially modified the Code and, among other things, eliminated compensation deductibility under Section 162(m). As modified, qualified performance-based compensation which had previously been excluded from the limitation computation is now subject to the $1 million limit. The reform also revised the includable listing of &#x201c;covered employees.&#x201d; Previously, Section 162(m) only applied to covered employees as of the end of the tax year and excluded the Chief Financial Officer. The reform expanded Section 162(m) to include any covered employee who meets the criteria as of any point during the year and now includes the Chief Financial Officer. As a result, going forward, any compensation amounts over $1 million paid to Mr. Ohana are not deductible by us (or any other person subject to U.S. federal income tax). While Mr. Ohana may receive future compensation in excess of the $1 million threshold due to issuance of new equity awards and the associated share price value, our expectation is that the loss of tax deductions will not have a material effect on our operating results or financial condition.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Compensation Policies and Practices and Risk Management</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our compensation committee considers potential risks when reviewing and approving the compensation programs for our executive officers and other employees. We have designed our compensation programs, including our incentive compensation plans, with specific features to address potential risks while rewarding employees for achieving long-term financial and strategic objectives through prudent business judgment and appropriate risk taking. The following elements have been incorporated in our programs available for our executive officers:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">A Balanced Mix of Compensation Components - The target compensation mix for our executive officers is composed of base salary, annual cash bonus incentives, and time-based and performance-based equity awards.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Financial Performance Factors - Our annual cash bonus plan for 2022 used companywide financial metrics based on the company&#x2019;s internal budget approved by the board to focus our executive officers on the achievement of objectives for the overall benefit of the company.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Capped Cash Incentive Awards - Annual cash bonus incentive awards for 2022 were capped at 110% of base salary for our Chief Executive Officer, and 75% of base salary for our Chief Financial Officer and Chief Operating Officer.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PSU Awards - Each of our executive officers received PSU awards in 2022 based on financial metrics to align their compensation incentives with that of our stockholders.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Multi-Year Vesting - Equity awards vest over multiple years requiring long-term commitment on the part of employees.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Stock Ownership Policy <b>- </b>Our named executive officers are subject to such a policy.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Hedging and Pledging - No hedging or pledging of our stock by executive officers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Competitive Positioning - The compensation committee has compared our executive compensation to our peers to ensure our compensation program is consistent with industry practice.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Corporate Governance Programs - We have implemented corporate governance guidelines, a code of conduct and business ethics, and other corporate governance measures and internal controls.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="report" title="report" href="#"></a>Report of the Compensation Committee of the Board of Directors </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation committee has reviewed and discussed the Compensation Discussion and Analysis set forth above with our management. Based on its review and discussions, the committee recommended to our board of directors that the Compensation Discussion and Analysis be included in this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Submitted by the Compensation Committee of the Board of Directors of CEVA, Inc.:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maria Marced (Chair)<br />
			Louis Silver</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bernadette Andrietti</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><a id="comtbl" title="comtbl" href="#"></a>Compensation Tables</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>2022 Summary Compensation </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The following table sets forth the total compensation awarded to, earned by or paid to our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name and Principal Position</b></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Salary </b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($) (1)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Bonus </b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Stock</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Awards</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)(2)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Option</b><br />
			<b>Awards</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Non-Equity</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Incentive Plan</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Compensation</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)(1)(3)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Change in</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Pension</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value and</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Nonqualified</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Deferred</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Compensation</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Earnings</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>All Other</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Compensation</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)(4)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Total</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">513,749</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">845,081</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">295,723</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">409,889</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>2,064,442</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Former Chief Executive Officer</i></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">506,910</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,242,867</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">410,660</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">740,244</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>2,900,681</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">475,729</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,989,128</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">438,735</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">143,393</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>3,046,985</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 22%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 5%; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Yaniv Arieli</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">319,494</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">414,119</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">130,762</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">107,997</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>972,372</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Chief Financial Officer</i></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">313,673</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">504,646</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">179,335</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">390,876</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>1,388,530</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">293,456</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">724,620</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">191,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100,120</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>1,309,796</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 22%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 5%; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Issachar Ohana</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">289,117</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">392,560</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,057,735</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>1,739,412</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" rowspan="2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Former Executive Vice President,&#xa0;Worldwide Sales</i></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">292,650</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">579,670</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">407,516</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>1,279,836</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">292,650</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">859,913</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">216,210</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>1,368,773</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 22%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 5%; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px; border-bottom: 1px solid black;">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 6%; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Michael Boukaya</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">258,425</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">386,225</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">105,464</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">90,409</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>840,523</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Chief Operating Officer </i></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">252,356</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">514,369</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">144,375</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">178,564</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>1,089,664</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 22%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">225,104</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">722,223</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">147,385</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#x2014;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80,953</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 6%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>1,175,665</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Messrs. Wertheizer&#x2019;s, Arieli&#x2019;s and Boukaya&#x2019;s 2022, 2021 and 2020 base salaries and annual cash awards to Messrs. Wertheizer and Arieli made pursuant to our 2022, 2021 and 2020 Executive Bonus Plans were denominated in New Israeli Shekel (NIS). The NIS amounts were translated into the U.S. dollar at the exchange rate of NIS into the U.S. dollars at the time of payment or accrual. For 2022, the base salaries of Messrs. Wertheizer, Arieli, Boukaya and Ohana were U.S. $507,000, U.S. $314,000, U.S. $252,000 and U.S. $307,282, respectively, on an annual basis, translated into NIS where applicable, and after giving effect to a 5% increase in each executive officer&#x2019;s salary in local currencies in January 2022.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The amounts shown in this column do not reflect compensation actually received by the named executive officer. Instead, the amounts represent the aggregate grant date fair value of the restricted stock unit awards based on FASB ASC No. 718, &#x201c;Stock Compensation&#x201d;&#xa0;(&#x201c;FASB ASC No. 718&#x201d;).</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The amounts set forth relate to annual cash awards made pursuant to our 2022, 2021 and 2020 executive bonus plans.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">See the table captioned &#x201c;2022 All Other Compensation&#x201d;&#xa0;below for greater detail.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The amounts set forth for Mr. Ohana includes commission-based cash bonus award made pursuant to Mr. Ohana&#x2019;s 2022, 2021 and 2020 incentive plans.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>2022 All Other Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The following table sets forth all other compensation awarded to, earned by or paid to each of our named executive officers during fiscal year 2022. The NIS amounts relating to the 2022 all other compensation for Messrs. Wertheizer, Arieli and Boukaya are translated into the U.S. dollar at the exchange rate of NIS into the U.S. dollars at the time of payment or accrual.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Separation Payments</b><br />
			<b>($)(1)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Car</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Allowance</b><br />
			<b>and Other Perquisites ($)(2)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Sales</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Commission</b><br />
			<b>($)(3)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Israeli Social Benefits</b><br />
			<b>($)(4)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Health</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Insurance</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Benefits</b><br />
			<b>($)(5)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Company</b><br />
			<b>Contributions</b><br />
			<b>to 401(k) Plan</b><br />
			<b>($)(6)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Study Fund</b><br />
			<b>($)(7)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Israeli Social Insurance</b><br />
			<b>($)(8)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>
			</td>
			<td colspan="2" style="vertical-align: bottom; width: auto; border-bottom: 1px solid black;"><b>Total ($)</b></td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gideon Wertheizer</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">256,621</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">53,433</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">78,314</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38,244</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,277</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>409,889</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yaniv Arieli</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23,959</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">47,098</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23,675</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,277</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>107,997</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Issachar Ohana</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#xa0;&#xa0;&#xa0;&#xa0;851,864</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">154,798</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">32,636</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18,437</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>1,057,735</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Michael Boukaya</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">19,001</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37,923</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#x2014;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">19,095</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,277</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>90,409</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Represents separation-related payments accrued in December 2022 in connection with the execution of separation agreements with each of Messrs. Wertheizer and Ohana, as follows:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 12%;"><b><b>Acceleration of</b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Israeli </b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Unvested</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Study </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Social </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Accrued </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>401(k) Plan </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Health</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Base Salary </b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 12%; padding: 0px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Shares of Restricted</b> </b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Fund</b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Benefits </b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Vacation </b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Make-</b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Insurance </b></b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 16%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Name</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><b>Stock Units ($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Pay ($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Whole ($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%;"><b><b>Total ($)</b></b></td>
			<td style="padding-bottom: 1px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">- (a)</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">161,282</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18,328</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">49,241</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,770</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">256,621</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issachar Ohana</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">639,820</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">93,937</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>-</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 8%; text-align: center; margin-left: 0pt;">-</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18,476</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">35,784</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">63,847</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 8%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">851,864</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(a)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pursuant to his separation agreement, following his retirement as an executive officer, Mr. Wertheizer is continuing as a part-time employee for six months, for which he will be compensated at a total base salary of approximately $244,373, and thereafter will serve as a consultant for an additional six months, for which he will receive total base salary payments of approximately $161,978. These salary payments will be in respect of services expected to be provided by Mr. Wertheizer in 2023.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">As is customary in Israel, and as is applicable generally to all our Israeli employees, we provide a car allowance for expenses relating to the use and maintenance of the car (excluding personal taxes on such benefit), which amounted to $23,820 $22,319 and $18,816 for Messrs. Wertheizer, Arieli and Boukaya, respectively. We also provide reimbursement of meal expenses incurred by each of Messrs.&#xa0;Wertheizer, Arieli and Boukaya for work-related purposes of $1,613, $1,640 and $1,185, respectively.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Relates to commission-based cash bonus award made pursuant to the Ohana 2022 Plan.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on Israeli labor laws, an Israeli employee is entitled to severance pay upon termination of employment for any reason, including retirement, based on the most recent monthly base salary (per specific criteria) of such employee multiplied by the number of years of employment of such employee. We make a payment of 8.333% of each employee&#x2019;s monthly base salary to an insurance or pension fund to pay for this future liability payable to our employees upon termination of their employment, taking into account the amounts already deposited in the insurance or pension fund. In addition, we make a payment of approximately 6% of each employee&#x2019;s monthly base salary to another insurance or pension fund, and this accrued amount may be withdrawn by the employee only upon retirement. The amounts represent the above referenced contributions, as well as other Israeli social benefit-related contributions, we made on behalf of each of Messrs.&#xa0;Wertheizer, Arieli and Boukaya.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents the value of the health insurance benefits provided to Mr. Ohana and his family, including general health PPO program, vision, dental, disability and life insurance. Similar health insurance benefits generally are provided to all of our U.S.-based employees.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">We provided our U.S. employees, including Mr. Ohana, our only U.S.-based named executive officer, with a 100% match to any contribution made by the participants in our 401(k) plan in 2022, subject to a maximum of 6% of the participant&#x2019;s compensation and specified IRS limits. This amount represents the matching amount contributed by us to Mr. Ohana&#x2019;s 401(k) account.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(7)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">As is customary in Israel applicable to all Israeli employees, we provide our Israeli employees with a certain amount of monthly contributions (7.5% of their base salary) for an employee&#x2019;s study and training purposes, which amounts contributed by us to Messrs.&#xa0;Wertheizer, Arieli and Boukaya in 2022 are as specified.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(8)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on Israeli labor laws, the Israeli Social Security Institute is entitled to monthly tax payments with an annual cap of $11,277 per employee paid by us for Messrs.&#xa0;Wertheizer, Arieli and Boukaya in 2022.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2022 Grants of Plan Based Awards </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth the plan based awards granted to Messrs. Wertheizer, Arieli, Ohana and Boukaya in fiscal year 2022.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<td style="vertical-align: middle; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="5" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Estimated Future Payouts</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Under Non-Equity Incentive</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Plan Awards (1)</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="5" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Estimated Future Payouts </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Under</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Equity Incentive Plan </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards (2)</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>All Other</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards:</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Grant</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Approval</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-Equity</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Incentive Plan</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Units Granted</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Threshold</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Target</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Maximum</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Threshold</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Target</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Maximum</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>shares of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>our</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>common</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>stock of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock or</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Units</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#) (3)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>All Other</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of</b><br />
			<b>Securities</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Underlying</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise or</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Base Price</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of Option</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($/Sh)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Closing</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Price on</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Grant</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($/Sh)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Grant Date</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fair Value of Stock and Option</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards ($)(4)</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Gideon</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">9,935</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">399,983</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Wertheizer</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">6,706</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">14,903</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">17,884</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">421,372</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">34,212</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">342,123</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">537,621</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="3" style="vertical-align: bottom; width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Yaniv</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">7,451</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">299,977</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Arieli</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/18/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">2,236</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">4,969</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">5,963</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">140,482</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/18/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">15,128</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">151,279</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">226,918</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Issachar</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">5,961</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">239,990</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Ohana</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">1,788</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">3,974</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">4,769</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">112,359</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Michael</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">5,961</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">239,990</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">Boukaya</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">1,788</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">3,974</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">4,769</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">40.26</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">112,359</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">02/17/2022</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">12,201</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">122,012</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; text-align: center; margin: 0pt;">183,018</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents the threshold, target and maximum amounts payable to Messrs. Wertheizer, Arieli and Boukaya pursuant to the 2022 Executive Bonus Plan, based on the exchange rate of NIS into U.S. dollars at December 31, 2022. For more information, see the discussion in the CD&amp;A under the caption &#x201c;Annual Cash Incentive Award.&#x201d;&#xa0;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents the threshold, target and maximum amounts associated with the grant of performance stock units pursuant to our 2011 Stock Incentive Plan. The performance stock units are subject to performance during calendar year 2022 and then vest over three years, with 1/3 vesting on each of the first three anniversaries of the grant date. For more information, see the discussion in the CD&amp;A under the caption &#x201c;2022 Short-Term Performance-Based Restricted Stock Unit Award to Executive Officers.&#x201d;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents the grant of restricted stock units pursuant to our 2011 Stock Incentive Plan. The restricted stock units vest over three years, with 1/3 vesting on each of the first three anniversaries of the grant date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>
			</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents the aggregate grant date fair value of the awards based on FASB ASC No. 718, &#x201c;Stock Compensation&#x201d;&#xa0;(&#x201c;FASB ASC No. 718&#x201d;). For a discussion of valuation assumptions under FASB ASC No. 718, see Note 1 to our 2022 Consolidated Financial Statements included in our 2022 annual report on Form 10-K.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Outstanding Equity Awards at Fiscal Year-End 2022</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information concerning unexercised restricted stock units held by each of our named executive officers as of December 31, 2022. The calculations are based on our closing stock price as of December 31, 2022. Our named executive officers held no outstanding options as of December 31, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 9pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 56%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Stock Awards </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Number of</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Shares or</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Units of</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Stock That</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Have Not</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Vested</b><br />
			<b>(#)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Market</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Value of</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Shares or</b></b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Units of Stock That Have Not Vested</b><br />
			<b>($) </b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested</b><br />
			<b>(#)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested</b><br />
			<b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; padding-bottom: 1px; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 5%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%;"><b>&#xa0;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 28%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td colspan="1" rowspan="3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">6,414</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">164,070</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">3,784</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">96,795</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">3,971</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">101,578</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">3,514</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">89,888</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">9,935</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">254,137</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">7,269</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(4)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">183,383</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 28%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 5%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td colspan="1" rowspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Yaniv Arieli</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">1,711</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">43,767</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">2,271</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">58,092</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">2,382</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(6)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">60,932</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">938</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(6)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">23,994</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">7,451</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(7)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">190,597</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 14%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 1%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">2,423</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(7)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">61,980</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 28%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 5%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Issachar Ohana</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">1,938</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(4)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">49,574</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 28%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 5%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 14%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
			<td style="width: 1%; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td colspan="1" rowspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; font-variant: normal; margin: 0pt;">Michael Boukaya</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">1,711</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">43,767</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">2,271</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(5)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">58,092</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">2,382</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(6)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">60,932</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">938</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(6)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">23,994</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">5,961</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(1)(7)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">152,482</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; width: 28%; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">-</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">1,938</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">(2)(7)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; vertical-align: top; text-align: center;">&#xa0;</td>
			<td style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt; vertical-align: top; text-align: center;">49,574</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 9pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Represents RSUs granted pursuant to our 2011 Plan.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Represents PSUs granted pursuant to our 2011 Plan.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fully vested on January 1, 2023.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fully vested on February 17, 2023.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fully vested on February 20, 2023.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Vested as to 50% on February 18, 2023 with 50% vesting on February 18, 2024.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(7)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Vested as to 33.3% on February 17, 2023, with 33.3% vesting on February 17, 2024 and 33.4% vesting on February 17, 2025.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>2022 Option Exercises and Stock Vested </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information for each of the named executive officers with respect to the vesting of restricted stock units during 2022. None of our named executive officers exercised options during 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="3" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock Awards (1)</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of Shares </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Acquired </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>on </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Vesting (#)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Value </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Realized </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>on </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Vesting ($)</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;25,007</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;1,003,781</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Yaniv Arieli</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;9,640</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;386,950</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issachar Ohana</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;25,188</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;819,387</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Michael Boukaya</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;9,973</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;389,943</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Reflects vesting of restricted stock units granted pursuant to our 2011 Plan. The value realized upon vesting represents the fair market value of our common stock on the date of vesting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="nonq" title="nonq" href="#"></a>Nonqualified Deferred Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We do not provide any nonqualified deferred contribution or other deferred compensation plans to our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="ceo" title="ceo" href="#"></a>CEO Compensation Pay Ratio </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We believe our executive compensation program must be internally consistent and equitable to motivate our employees to create stockholder value. We monitor the relationship between the compensation of our executive officers and the compensation of our non-managerial employees. For 2022, the total compensation of Gideon Wertheizer, our former Chief Executive Officer, of $2,064,442, as shown in the Summary Compensation Table above, was approximately 13.0&#xa0;times the total compensation of a median employee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our CEO to median employee pay ratio is calculated in accordance with SEC&#x2019;s rules pursuant to Item 402(u) of Regulation S-K. We included all employees, whether employed on a full-time or part-time. We annualized the compensation for any full-time employees that were not employed by us for all of 2022, and calculated amounts with respect to restricted stock unit awards based on FASB ASC No. 718. Otherwise, we did not make any assumptions, adjustments, or estimates with respect to total compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="empagg" title="empagg" href="#"></a>Employment Agreements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to Mr. Wertheizer&#x2019;s retirement from his position as the Chief Executive Officer and Mr. Ohana&#x2019;s separation, we entered into Separation and Release Agreements with each of them (in November 2022 for Mr. Wertheizer and December 2022 for Mr. Ohana) as discussed further below. Prior to the entering into of the Separation and Release Agreements, Mr. Wertheizer&#x2019;s and Mr. Ohana&#x2019;s employment at CEVA was governed by their respective employment agreements, as amended, originally entered into with each on November 1, 2002. Although each employment agreement is for an indefinite term, the employment of each of Messrs. Wertheizer and Ohana will be terminable at any time by us, other than for cause, upon the determination of our board of directors with not less than 30 days&#x2019; notice or by the individual with notice of not less than nine months in the case of Mr. Wertheizer and six months in the case of Mr. Ohana. If our board of directors determines that a termination of employment is based on the failure by either Messrs. Wertheizer or Ohana, as applicable, to perform his reasonably assigned duties, we are required to give notice or a cure period of not less than nine months in the case of Mr. Wertheizer and six months in the case of Mr. Ohana prior to termination. In the event of termination of employment (i) by us without cause, (ii) by either of Messrs. Wertheizer or Ohana for good reason (provided he gives notice to us and provides us with a cure period to correct the basis for the good reason termination), or (iii) by us or an acquiring or succeeding corporation after a change in control of our company, other than for cause, within 12 months after the change in control event, then either of Messrs. Wertheizer or Ohana, as applicable, would be entitled to the compensation, including medical and, to the extent applicable, pension benefits, to which he would otherwise have been entitled had he remained employed by us for two years, and any unvested options he holds will vest in full (although neither Messrs. Wertheizer or Ohana currently hold any unvested options); provided, that the provision of any such benefits is contingent upon the execution by either of Messrs. Wertheizer or Ohana, as applicable, a release in a form reasonably acceptable to us. If either of Messrs. Wertheizer or Ohana terminates his employment with us without good reason but after the provision of prior notice in accordance with the notice period requirements, irrespective of the date of the termination of actual employment, he would be entitled to compensation and benefits through the end of the notice period which is nine months in the case of Mr. Wertheizer and six months in the case of Mr. Ohana. If the employment of either of Messrs. Wertheizer or Ohana is terminated by death, any unvested options he holds would vest in full. In February 2021, Mr. Wertheizer&#x2019;s employment agreement was amended to provided that, as of July 1, 2021, our contributions to the severance pay component of Mr. Wertheizer&#x2019;s pension fund shall be in lieu of severance pay, in accordance with Section 14 of the Severance Pay Law, 1963-14, of Israel, and Mr. Wertheizer shall not be entitled to any other additional payments of severance pay with respect the period beginning on such date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 7, 2022, our board of directors and Mr. Wertheizer reached an understanding regarding his decision to retire from his position as the Chief Executive Officer, effective on the date the new Chief Executive Officer first commences service to us (the &#x201c;Transition Date&#x201d;), which was January 1, 2023. In connection with his decision to retire from the position of Chief Executive Officer, we entered into a Separation and Release Agreement, and subsequently a consulting services agreement with Mr. Wertheizer. Under the Separation and Release Agreement, which continues in full effect until six months following the Transition Date, Mr. Wertheizer will be entitled to his former monthly salary for when he was Chief Executive Officer, his 2022 annual bonus, if eligible, to be paid as scheduled in 2023 subject to the terms of the 2022 Executive Bonus Plan, any severance pay accrued in his pension fund and all other supplemental severance pay required under applicable law. Furthermore, Mr. Wertheizer&#x2019;s unvested time-based restricted stock units immediately vested in full on the Transition Date. The Separation and Release Agreement may be terminated immediately without the requirement to continue paying the salary set forth therein in the event for cause or if Mr. Wertheizer terminates his employment without good reason. The Separation and Release Agreement also contains customary provisions relating to, among other things, a release of claims, confidentiality, non-disparagement and assignment of inventions. In addition, Mr. Wertheizer entered into a consulting services agreement with us on November 7, 2022 (the &#x201c;Consulting Agreement&#x201d;). Pursuant to the Consulting Agreement, Mr. Wertheizer will provide transition support services to us for a six-month period commencing on the Retirement Date, with the scope of services to be coordinated between Mr. Wertheizer and the new Chief Executive Officer. As consideration for his services, Mr. Werthiezer will receive a consulting fee of approximately $26,942 per month (&#x201c;Monthly Consulting Fee&#x201d;). Under the terms of the Consulting Agreement, both the Company and Mr. Wertheizer may terminate the Consulting Agreement, effective immediately, upon written notice to the other party for any reason, provided that if we terminate&#xa0;the Consulting Agreement other than for cause or if Mr. Wertheizer terminates the Consulting Agreement with good reason, Mr. Wertheizer will be entitled to payment of an amount in lieu of the Monthly Consulting Fee that he would have received for the remainder of the term. The Consulting Agreement also contains customary provisions relating to, among other things, confidentiality and assignment of inventions requirements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 7, 2022, our board of directors and Mr. Ohana reached an understanding regarding his separation from employment, and we entered into a Separation and Release Agreement pursuant to which his last day of service as the EVP of Worldwide Sales of the Company was December 31, 2022 (the &#x201c;Separation Date&#x201d;). Pursuant to the Separation and Release Agreement, in exchange for certain releases and waivers, we agreed to provide the following benefits: (i) an amount equal to thirty days of his base salary in lieu of the notice required under his employment agreement payable on our first regular payroll date after the Separation Date; (ii) an amount equal to the base salary to which he would have been entitled had he remained employed with the Company for two years after the Separation Date (the &#x201c;Severance Period&#x201d;) as required under his employment agreement, payable in equal installments on the Company&#x2019;s regular payroll dates and paid less all applicable deductions and withholdings; (iii) continuation of his benefits under our group health plans until the Separation Date, after which he will be eligible to continue his participation in our group health insurance plan under applicable COBRA regulations in which case we will pay the applicable COBRA premiums for Mr. Ohana and his covered dependents until the earliest of a) the two year anniversary of the Separation Date, b) the date he becomes eligible for health insurance coverage from a new employer or through self-employment, or c) the date he is no longer eligible to continue coverage under COBRA; (iv) an amount equal to any unpaid incentive compensation he would have been eligible to earn under the Ohana 2022 Plan for achievement of specified revenue targets through December 31, 2022, less applicable deductions and withholdings in accordance with the terms of the Ohana 2022 Plan; (v) an amount equal to two years of the largest 401(k) Plan contribution allowed as if Mr. Ohana was still employed by the Company based on his base salary immediately prior to the date of the Separation Agreement, to be paid in equal installments on our&#xa0;regular payroll dates over the duration of the Severance Period less any applicable deductions, withholdings, or taxes; and (vi) accelerated vesting of certain time and performance-based restricted stock units previously awarded to Mr. Ohana pursuant to the terms of the 2011&#xa0;Plan, including to the extent applicable performance goals are achieved as determined by our board of directors or a committee thereof, vesting of such RSUs as of the date of determination of achievement of the performance goals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On August 18, 2005, we entered into an employment agreement with Mr. Arieli. The employment agreement was effective as of August 1, 2005 and shall continue in effect until terminated in accordance with its terms. Upon the termination of his employment, Mr. Arieli will be entitled to severance benefits in accordance with the laws of the State of Israel. In February 2021, Mr. Arieli&#x2019;s employment agreement was amended to provided that, as of July 1, 2021, our contributions to the severance pay component of Mr. Arieli&#x2019;s pension fund shall be in lieu of severance pay, in accordance with Section 14 of the Severance Pay Law, 1963-14, of Israel, and Mr. Arieli shall not be entitled to any other additional payments of severance pay with respect to the period beginning on such date. The employment of Mr. Arieli may be terminable at any time by either party and for any reason with six months prior written notice, except as further described below. If we terminate Mr. Arieli&#x2019;s employment without providing the requisite notice period, Mr. Arieli will be entitled to an amount equal to six months of his then applicable monthly base salary. In May 2007, to provide consistency with the employment agreements of Messrs. Wertheizer and Ohana, our board of directors determined that if Mr. Arieli resigns for good reason or if the company, or an acquiring or succeeding corporation after a change in control of our company, terminates him, other than for cause, within 12 months after the change in control event, then Mr. Arieli&#x2019;s then outstanding options would vest in full. In November 2013, to provide further consistency with the employment agreements of Messrs. Wertheizer and Ohana, our board of directors determined that if Mr. Arieli resigns for good reason or if the company, or an acquiring or succeeding corporation after a change in control of our company, terminates him, other than for cause, within 12 months after the change in control event, then he would be entitled to the compensation, including medical and, to the extent applicable, pension benefits, to which he would otherwise have been entitled had he remained employed by us for two years. In November 2022, Mr. Arieli&#x2019;s employment agreement was further amended to provide that, as of January 1, 2023, (i) his gross monthly salary increased by 12.7%, (ii) he will be requested to provide us six months&#x2019; prior written notice should he desire to terminate his employment and we must provide six months prior written notice to terminate his employment without cause, unless we pay him a sum equal to the salary he would otherwise be entitled to during the period, (iii) if he resigns for good reason, he will be entitled to payment of a sum equal to the salary that he would otherwise be entitled to during the six month period from the date of delivery of the resignation notice, and (iv) we may terminate his employment for cause without advance notice and without derogating from any remedy to which we may be entitled.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On April 4, 2019, we entered into an amended and restated employment agreement with Mr. Boukaya in connection with his appointment as Chief Operating Officer. The employment of Mr. Boukaya is terminable at any time by either party and for any reason with six months prior written notice, except as further described below. If the we terminate&#xa0;Mr. Boukaya&#x2019;s employment without providing the requisite notice period, Mr. Boukaya will be entitled to an amount equal to six months of his then applicable monthly base salary. Upon termination of his employment, Mr. Boukaya will be entitled to severance benefits in accordance with the laws of the State of Israel. In February 2021, Mr. Boukaya&#x2019;s employment agreement was amended to provided that, as of July 1, 2021, our contributions to the severance pay component of Mr. Boukaya&#x2019;s pension fund shall be in lieu of severance pay, in accordance with Section 14 of the Severance Pay Law, 1963-14, of Israel, and Mr. Boukaya shall not be entitled to any other additional payments of severance pay with respect the period beginning on such date. In November 2022, Mr. Boukaya&#x2019;s employment agreement was further amended to provide that, as of January 1, 2023, (i) his title will be changed to Executive Vice President and Chief Operating Officer, (ii) his gross monthly salary will be increased, (iii) he will be requested to provide us six months&#x2019; prior written notice should he desire to terminate his employment and we must provide six months prior written notice to terminate his employment without cause, unless we pay him a sum equal to the salary he would otherwise be entitled to during the period, (iv) he may resign for good reason, without advance notice, in which case he will be entitled to payment of a sum equal to the salary that he would otherwise be entitled to during the six month period from the date of delivery of the resignation notice, and (v) if within twelve months after a change in control, he terminates his employment with us for certain good reasons, or we terminate his employment without cause, he will be entitled to compensation he would otherwise have been entitled to had he remained employed with us for two years after such termination, based on his salary in effect on the date of termination, and all outstanding and unvested time-based equity awards granted by us to him will fully vest.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with his appointment as our Chief Executive Officer effective January 1, 2023, we entered into an employment agreement with Amir Panush on November 9, 2022, pursuant to which Mr. Panush will receive a gross monthly salary of approximately $42,540 and a signing bonus in the gross amount of approximately $170,160, subject to his service as an employee for at least 18 months. In addition, subject to the discretion of our board of directors, Mr. Panush will be entitled to an annual bonus. Furthermore, effective on the Transition Date, Mr. Panush was granted RSUs pursuant to the 2011 Plan with a value equal to $1,200,000, one-third of which will vest on each anniversary of the Transition Date, conditioned upon Mr. Panush&#x2019;s continued service with us through each such vesting date. We also granted Mr. Panush additional benefits, including an equity award with a value equal to $1,200,000 in the form of a combination of RSUs and PSUs, as well as a long-term PSU grant with a value equal to $2,000,000, as an inducement award material to Mr. Panush&#x2019; employment pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules on terms substantially similar to those of the 2011 Plan. The employment agreement also entitles Mr. Panush to receive additional customary benefits and reimbursement of certain expenses, including for car maintenance. Under the employment agreement, should Mr. Panush desire to terminate his employment with us, he is requested to provide at least three months&#x2019; prior written notice to us, and conversely, should we desire to terminate Mr. Panush&#x2019;s employment without cause, we must provide Mr. Panush with twelve months&#x2019; prior written notice, unless we provide Mr. Panush: (i) payment of a sum equal to the salary that he would otherwise be entitled to during such twelve-month period, (ii) the full amount of his annual bonus calculated based on 100% achievement of performance objectives, and (iii) the full acceleration of any equity awards subject to time-based vesting upon his termination date (together, the &#x201c;Entitlements&#x201d;). In addition, Mr. Panush may resign for good reason without advance notice, in which case we must provide him the aforementioned Entitlements. Furthermore, if, within twelve months after a change in control Mr. Panush terminates his employment with us for good reason or we terminate his employment without cause: (i) we must pay Mr. Panush an amount equal to the compensation to which he would otherwise have been entitled to had he remained employed by us for two years after such termination, based on his salary in effect on the date of termination; and (ii) the full acceleration of any equity awards subject to time-based vesting upon his termination date. The benefits provided for in connection with a change in control are subject to Mr. Panush&#x2019;s delivery of a release of claims in a form reasonably acceptable to us. The employment agreement also contains customary provisions relating to, among other things, employee representations and warranties, confidentiality, non-competition and assignment of inventions requirements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 7, 2002, our board of directors appointed Gweltaz Toquet, who previously served as the Company&#x2019;s Vice President of Sales for Europe and Asia Pacific, as Chief Commercial Officer (&#x201c;CCO&#x201d;) of the Company effective January 1, 2023 (the &#x201c;Promotion Date&#x201d;), in connection with which we entered into an addendum (the &#x201c;Addendum&#x201d;) to his prior employment agreement, which provides for, among other things, (i) an increase in Mr. Toquet&#x2019;s annual salary; (iii) Mr. Toquet&#x2019;s entitlement to participate in our sales commission plan, (iv) the grant of RSUs pursuant to the 2011 Plan effective on the Promotion Date with a value equal to $100,000, one-third of which will vest on each anniversary of the Promotion Date, conditioned upon Mr. Toquet&#x2019;s continued service with us through each such vesting date; (v) a notice requirement such that should Mr. Toquet desire to terminate his employment with us, he is requested to provide us with six months&#x2019; prior written notice, and conversely, should we desire to terminate Mr. Toquet&#x2019;s employment without cause, we must provide Mr. Toquet with six months&#x2019; prior written notice, unless we pay Mr. Toquet a sum equal to the salary that he would otherwise be entitled to during such six-month period; (vi) if Mr. Toquet resigns for good reason, we must pay him a sum equal to the salary that he would otherwise be entitled to during the six-month period from the date of delivery of the resignation notice; (vii) we may terminate Mr. Toquet&#x2019;s employment for cause without advance notice and without derogating from any remedy to which we may be entitled; and (viii) if, within twelve months after a change in control, Mr. Toquet terminates his employment with us for good reason or we terminate his employment without cause, he will receive pay in an amount equal to the compensation to which he would otherwise have been entitled to had he remained employed by us for one year after such termination, based on his salary in effect on the date of termination, and all outstanding and unvested time-based equity awards granted by us to Mr. Toquet will accelerate and vest in full. The benefits provided for in connection with a change in control are subject to Mr. Toquet&#x2019;s delivery of a release of claims in a form reasonably acceptable to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On February 16, 2021, we adopted a change to our vacation policy for all our employees. Under the vacation policy as revised, instead of accumulating each employee&#x2019;s balance of any accrued but unused vacation days, we pay out any accrued but unused vacation days in excess of two weeks. As part of implementing this new vacation policy, we paid out such accrued but unused vacation days in excess of two weeks to each employee. For Messrs. Wertheizer, Arieli and Ohana, the payment amount was approximately $434,410, approximately $176,632 and approximately $163,036, respectively, and the employment agreement for each of Messrs. Wertheizer, Arieli and Ohana was amended to reflect payment of such accrued but unused vacation days under the revised vacation policy. Mr. Boukaya did not have any accrued but unused vacation days as of the change in vacation policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In addition, the employment agreements for each of Messrs. Wertheizer, Arieli and Boukaya were amended to reference a new Israeli law that apply to all employees, including such executives. As of July 1, 2021, our contributions to the severance pay component of such executive&#x2019;s pension fund shall be in lieu of severance pay, in accordance with Section 14 of the Severance Pay Law, 1963-14, and such executive shall not be entitled to any other additional payments of severance pay with respect the period beginning on such date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="potpay" title="potpay" href="#"></a>Potential Payments Upon Termination or Change of Control</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As discussed above, on November 7 and December 7, 2022, each of Messrs. Wertheizer and Ohana, respectively, entered into agreements with respect to the separation of their service with us as executive officers, with their final day of such service on December 31, 2022. Detail regarding their separation payments is included above under &#x201c;2022 All Other Compensation.&#x201d; The subsequent tables set forth the potential amount of compensation to each of Messrs. Arieli and Boukaya in the event of termination of such executive officer&#x2019;s employment or a change in control of our company occurred as of December 31, 2022. The calculations for Messrs. Arieli and Boukaya are based on the exchange rate of NIS into the U.S. dollars at December 31, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name: Yaniv<br />
			Arieli</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination<br />
			for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Cause ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Voluntary<br />
			Termination<br />
			by Employee<br />
			After Provision<br />
			of Requisite<br />
			Notice ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination<br />
			by Company<br />
			After<br />
			Provision of<br />
			Requisite<br />
			Notice ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination<br />
			upon Death<br />
			of Employee<br />
			($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination</b><br />
			<b>w/o Cause<br />
			or</b><br />
			<b>for Good<br />
			Reason ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination</b><br />
			<b>w/o Cause or</b><br />
			<b>for Good<br />
			Reason within<br />
			12 months of<br />
			Change in<br />
			Control ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 21%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Base Salary</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">151,279</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">605,115</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">605,115</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">605,115</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vested/Unvested Shares of Restricted Stock Units</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">439,362</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">439,362</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">439,362</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">439,362</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Study fund</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">11,346</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">45,384</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">45,384</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">45,384</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Israeli Social Benefits</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">23,108</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">92,432</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">92,432</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">92,432</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued Vacation Pay</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">80,224</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">265,956</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,262,416</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">519,486</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,262,416</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,262,416</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name: Michael Boukaya</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination<br />
			for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Cause ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Voluntary<br />
			Termination by<br />
			Employee After<br />
			Provision of<br />
			Requisite Notice<br />
			($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination by<br />
			Company After<br />
			Provision of<br />
			Requisite Notice<br />
			($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination<br />
			upon Death of<br />
			Employee ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination</b><br />
			<b>w/o Cause or</b><br />
			<b>for Good<br />
			Reason ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Termination</b><br />
			<b>w/o Cause or</b><br />
			<b>for Good<br />
			Reason within<br />
			12 months of<br />
			Change in<br />
			Control ($)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 21%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Base Salary</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">129,213</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">129,213</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">129,213</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Study fund</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9,547</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9,547</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9,547</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Israeli Social Benefits</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$19,049</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$19,049</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$19,049</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued Vacation Pay</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 21%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">168,439</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10,630</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">168,439</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">168,439</p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:PvpTableTextBlock" id="c4" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="payv" title="payv" href="#"></a>Pay Versus Performance</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The compensation committee approves and administers our executive compensation program, which it designs to attract, incentivize, reward, and retain our executive officers. Our program aligns executive pay with shareholder interests and links pay to performance through a blend of short-term and long-term performance measures. In 2022, incentive pay made up 52% of our Chief Executive Officer&#x2019;s target total direct compensation and, on average, 37% of our other named executive officers&#x2019; target total direct compensation. This high utilization of incentive compensation results in higher total realized pay when our executive officers exceed the compensation committee-approved performance targets. Conversely, failure to achieve the approved targets results in lower realized pay, including the possibility that some awards pay zero at the end of their performance period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between the compensation actually paid to our named executive officers and certain aspects of our financial performance. For further information concerning our pay for performance philosophy and how the Company aligns executive compensation with our performance, please refer to &#x201c;<i>Executive Compensation </i>&#x2013;<i> Compensation Discussion and Analysis</i>.&#x201d;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Pay-Versus-Performance Table</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 8.7%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 80.7656px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary<br />
			Compensation<br />
			Table<br />
			Total for<br />
			PEO(1)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 156.234px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation<br />
			Actually<br />
			Paid to<br />
			PEO(2)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 263px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average<br />
			Summary<br />
			Compensation<br />
			Table<br />
			Total for<br />
			Non-PEO<br />
			Named<br />
			Executive<br />
			Officers<sup style="vertical-align:top;line-height:120%;">(</sup><sup style="vertical-align:top;line-height:120%;">1)</sup></b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 243px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average<br />
			Compensation<br />
			Actually<br />
			Paid to<br />
			Non-PEO<br />
			Named<br />
			Executive<br />
			Officers(2)</b></p>
			</td>
			<td colspan="2" style="vertical-align: bottom; width: 20.6%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of Initial<br />
			Fixed $100<br />
			Investment Based<br />
			On:</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income(5)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenues(6)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total<br />
			Shareholder<br />
			Return(3)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Peer<br />
			Group<br />
			Total<br />
			Shareholder<br />
			Return(4)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(c)</p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(d)</p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(e)</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(f)</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(g)</p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(h)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(i)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c6" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,064,442</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c7" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,356,748</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c8" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,184,102</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c9" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">848,334</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c10" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">95</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c11" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">158</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c12" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">23,183,000</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c13" contextRef="d_2022-01-01_2022-12-31" unitRef="Pure" name="ecd:CoSelectedMeasureAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">134,648,000</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2021</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c14" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,900,681</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c15" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">5,348,206</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c16" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,252,677</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c17" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,398,965</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c18" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">160</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c19" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">230</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c20" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:numdotdecimal" decimals="0">396,000</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c21" contextRef="d_2021-01-01_2021-12-31" unitRef="Pure" name="ecd:CoSelectedMeasureAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">122,706,000</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2020</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c22" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,046,985</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c23" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">5,057,919</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c24" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,284,745</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c25" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,290,490</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c26" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">169</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c27" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">161</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c28" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">2,379,000</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c29" contextRef="d_2020-01-01_2020-12-31" unitRef="Pure" name="ecd:CoSelectedMeasureAmt" scale="0" format="ixt:numdotdecimal" decimals="INF">100,326,000</ix:nonFraction></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported in columns (b) and (d) represent the amount of total compensation reported for the following executives for each corresponding covered year in the &#x201c;Total&#x201d; column of the table set forth under &#x201c;<i>Executive Compensation </i>&#x2013;&#x2013;<i> Compensation Tables </i>&#x2013;<i> 2022 Summary Compensation</i>.&#x201d;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PEO: Gideon Wertheizer, our Chief Executive Officer for each of the covered years.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Other Non-PEO named executive officers (Other &#x201c;NEOs&#x201d;) for each of the covered years: Yaniv Arieli, our Chief Financial Officer, Issachar Ohana, our former EVP, Worldwide Sales, and Michael Boukaya, our Chief Operating Officer.</p>
			</td>
		</tr>

</tbody></table>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:AdjToPeoCompFnTextBlock" id="c30" escape="true">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported in columns (c) and (e) represent the amount of &#x201c;compensation actually paid&#x201d; to our PEO, Mr. Wertheizer, as computed in accordance with Item 402(v) of Regulation S-K, and our other NEOs (Messrs. Arieli, Ohana and Boukaya) for each covered fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for each year to determine the &#x201c;compensation actually paid&#x201d;:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 6.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 16%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Executive</b></p>
			</td>
			<td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reported</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary Compensation Table Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 20.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reported</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Grant Date Fair Value of Equity Awards in Summary Compensation Table(a)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Award Adjustments(b)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 16.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation Actually Paid</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2022</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c32" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,064,442</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c33" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">845,081</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c34" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">137,387</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c35" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,356,748</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c36" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,184,102</ix:nonFraction></td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($<ix:nonFraction id="c37" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">397,635</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c38" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">61,866</ix:nonFraction></td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$<ix:nonFraction id="c39" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">848,334</ix:nonFraction></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2021</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c40" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,900,681</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c41" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">1,242,867</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c42" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,690,392</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c43" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">5,348,206</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c44" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,252,677</ix:nonFraction></td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($<ix:nonFraction id="c45" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">532,895</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c46" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,679,183</ix:nonFraction></td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$<ix:nonFraction id="c47" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,398,965</ix:nonFraction></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2020</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c48" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,046,985</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c49" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">1,989,128</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c50" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">4,000,062</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c51" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">5,057,919</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#xa0;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c52" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,284,745</ix:nonFraction></td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($<ix:nonFraction id="c53" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">768,919</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$<ix:nonFraction id="c54" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,774,664</ix:nonFraction></td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$<ix:nonFraction id="c55" contextRef="d_2020-01-01_2020-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:numdotdecimal" decimals="0">2,290,490</ix:nonFraction></td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">*Presented on an average basis.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:18pt;">&#xa0;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The grant date fair value of equity awards represents the total of the amounts reported in the &#x201c;Stock Awards&#x201d;&#xa0;and &#x201c;Option Awards&#x201d;&#xa0;columns in the Summary Compensation Table for each covered fiscal year, and were deducted from the applicable reported Summary Compensation Table Total.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:18pt;">&#xa0;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The equity award adjustments for each covered fiscal year were added to the applicable reported Summary Compensation Table Total and each include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the covered fiscal year that are outstanding and unvested as of the end of the covered fiscal year; (ii) the amount equal to the change as of the end of the covered fiscal year (from the end of the prior fiscal year) in fair value of any equity awards granted in prior fiscal years that are outstanding and unvested as of the end of the covered fiscal year; (iii) for equity awards that are granted and vest in same covered fiscal year, the fair value as of the vesting date; (iv) for equity awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for equity awards that are granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year, the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date that are not otherwise included in the total compensation for the covered fiscal year. The amounts deducted or added in calculating the equity award adjustments are as follows:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 6.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.6%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Executive</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.9%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year End Fair Value of Equity Awards Granted in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12.2%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards</b></p>
			</td>
			<td style="vertical-align: bottom; width: 9.1%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 14%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Award Adjustments</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c56" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">635,382</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c57" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">418,237</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c58" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c59" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">15,286</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c60" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">64,471</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c61" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c62" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">137,387</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$<ix:nonFraction id="c63" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">224,456</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">($<ix:nonFraction id="c64" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">104,730</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$<ix:nonFraction id="c65" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">50,827</ix:nonFraction></td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">($<ix:nonFraction id="c66" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">77,915</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$<ix:nonFraction id="c67" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">30,772</ix:nonFraction></td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$<ix:nonFraction id="c68" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$<ix:nonFraction id="c69" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">61,866</ix:nonFraction></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;2021</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c70" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">644,622</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($<ix:nonFraction id="c71" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">5,055</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c72" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c73" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,050,824</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c74" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c75" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c76" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,690,392</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$<ix:nonFraction id="c77" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">268,434</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">($<ix:nonFraction id="c78" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0" sign="-">10,021</ix:nonFraction>)</td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$<ix:nonFraction id="c79" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">$<ix:nonFraction id="c80" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,420,770</ix:nonFraction></td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$<ix:nonFraction id="c81" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$<ix:nonFraction id="c82" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$<ix:nonFraction id="c83" contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,679,183</ix:nonFraction></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c84" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">3,155,672</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c85" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">667,459</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c86" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c87" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">176,932</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c88" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c89" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c90" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">4,000,062</ix:nonFraction></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$<ix:nonFraction id="c91" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,547,785</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">$<ix:nonFraction id="c92" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">190,542</ix:nonFraction></td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$<ix:nonFraction id="c93" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">$<ix:nonFraction id="c94" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">36,338</ix:nonFraction></td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$<ix:nonFraction id="c95" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$<ix:nonFraction id="c96" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="-3">0</ix:nonFraction></td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$<ix:nonFraction id="c97" contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:numdotdecimal" decimals="0">1,774,664</ix:nonFraction></td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;">*Presented on an average basis.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;"><span style="text-decoration: underline; ">Equity Award Valuations</span>: PSU grant date fair values are calculated using the stock price as of the date of grant assuming target performance. The valuation assumptions<b> </b>used to calculate the fair values of the PSUs held by the PEO and other NEOs that were earned and vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price and performance accrual modifier as of year-end and as of the date of vest (or including the probable outcome of any such awards subject to performance conditions). RSU grant date fair values are calculated using the stock price as of date of grant. The valuation assumptions used to calculate the fair values of the RSUs held by the PEO and other NEOs that vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price as of year-end and as of each vesting date. The fair value of the tranches of Mr. Ohana&#x2019;s RSUs that were originally scheduled to vest in 2023, 2024, and 2025 have been calculated and included in the equity award adjustments for 2022 for our non-PEO NEOs, as the vesting of these award tranches was accelerated to December 31, 2022, upon his separation from the Company. PSUs held by Mr. Wertheizer (our PEO) and Mr. Ohana remained outstanding and unvested as of December 31, 2022 and are included above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(3)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cumulative total shareholder return (&#x201c;TSR&#x201d;) is calculated by dividing the sum of the cumulative amount of dividends during the measurement period, assuming dividend reinvestment, and the difference between our share price at the end of the applicable measurement period and the beginning of the measurement period (December 31, 2019) by our share price at the beginning of the measurement period.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Represents the weighted peer group TSR, weighted according to the respective companies&#x2019; stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is S&amp;P Semiconductors Select Index, a published industry index.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported represent the amount of net income (loss) reflected in our audited financial statements for each covered fiscal year.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Refers to total revenues as reported in our audited financial statements for each covered fiscal year.</p>
			</td>
		</tr>

</tbody></table>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:TabularListTableTextBlock" id="c98" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;"><b><i>Financial Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our compensation philosophy seeks to create a performance-oriented environment by rewarding executive officers for the achievement of our business objectives, both short-term and long-term. We believe that our executive officers&#x2019; compensation should not be based on the short-term performance of our stock, whether favorable or unfavorable, but rather that the price of our stock will, in the long-term, reflect our operating performance and ultimately the management of the company by our executive officers.&#xa0;For the most recently completed fiscal year, our key performance measures, in no particular order, were:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-1" name="ecd:MeasureName" id="c100">Total revenues</ix:nonNumeric></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-2" name="ecd:MeasureName" id="c101">Total licensing, NRE and related revenues</ix:nonNumeric></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-3" name="ecd:MeasureName" id="c102">Non-GAAP earnings per share</ix:nonNumeric></p>
			</td>
		</tr>

</tbody></table>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="c103" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Pay-versus-Performance table above and the charts below demonstrate that the compensation actually paid to our PEO and other NEOs is generally aligned with our performance for metrics presented in the tabular disclosure over the covered period, including TSR, net income and total revenues.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Company TSR</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">As shown in the chart below, the amount of compensation actually paid to our PEO<b> </b>and the average amount of compensation actually paid to our other NEOs as a group is generally aligned with our TSR relative to the S&amp;P Semiconductor Select Index, in that our compensation actually paid increased for 2021 following our TSR exceeding our peer group TSR in 2020, and our compensation actually paid decreased significantly for 2022 following the significant underperformance of our TSR compared to our peer group in 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i01.jpg" src="i01.jpg" /></p>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="c105" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Net Income</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The chart below illustrates the correlation between compensation actually paid to our PEO and average compensation actually paid to our other NEOs against the Company&#x2019;s net income. Our fiscal year 2022 net income was heavily influenced by the impact of a tax charge to record a valuation allowance in 2022, as well as by our decision to cease the development of the Immervision&#xa0;technology we acquired in 2019 and the related impairment charge, and increased research and development costs. We do not use net income, whether on a GAAP or non-GAAP basis, as a financial performance measure in our executive compensation program, but there is an indirect correlation between our profitability and compensation actually paid through the impact of EPS performance as an incentive plan metric on pay outcomes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i02.jpg" src="i02.jpg" /></p>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<div>&#xa0;</div>

<ix:nonNumeric contextRef="d_2022-01-01_2022-12-31" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="c107" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Total Revenue</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The chart below compares the compensation actually paid to our PEO and other NEOs with our revenue performance, the financial metric in our assessment is most important for linking pay and performance in the covered years. Our increase in compensation actually paid from 2020 to 2021 correlated with our 23% year-over-year increase in total revenues from 2020 to 2021. However in 2022, despite a 10% increase in revenues, compensation actually paid declined due to lower incentive plan payouts and stock price declines.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i03.jpg" src="i03.jpg" /></p>
</ix:nonNumeric>

<div>&#xa0;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a id="ccinter" title="ccinter" href="#"></a>Compensation Committee Interlocks and Insider Participation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The current members of the compensation committee of our board of directors are Meses. Andrietti and Marced, and Mr. Silver. No member of this committee is a present or former officer or employee of CEVA or any of its subsidiaries. No executive officer of CEVA served on the board of directors or compensation committee of any entity which has one or more executive officers serving as a member of our board or compensation committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">50</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="dircom" title="dircom" href="#"></a>DIRECTOR COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We use a combination of cash and stock-based incentive compensation to attract and retain qualified candidates to serve on our board. In setting director compensation, we consider the significant amount of time that directors expend in fulfilling their duties to the company as well as the skill-level we require of members of our board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2022 Director Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Cash Compensation Paid to Board Members</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Directors who are employees of CEVA do not receive any additional compensation for their services as directors. Directors who are not employees of CEVA are entitled to an annual retainer, payable in quarterly installments as follows (with fees for service as chair inclusive of fees for service as a member):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Member</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chair</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Board of Directors</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">40,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">62,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Compensation Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Nomination and Corporate Governance Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All directors are reimbursed for expenses incurred in connection with attending board and committee meetings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Equity Award </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Non-employee directors receive one equity award grant annually. Each director is granted shares of restricted stock units based on an annualized value of $124,670, which vests 50% on the first year anniversary of the grant date and the remaining 50% on the second year anniversary of the grant date. Any new director on the board would receive a number of restricted stock units based on the same annualized value with the same vesting schedule.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director Stock Ownership Guidelines</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our board of directors believes that, in order to align the interests of directors and stockholders, directors should have an equity stake in the company. In February 2015, the compensation committee recommended and the board adopted a set of stock ownership guidelines for directors so as to align the directors&#x2019; interests with those of our stockholders. Pursuant to the guidelines, existing directors are required to own (personally and collectively with members of the director&#x2019;s immediate family or with family trusts) by February 2020, an amount of common stock with a fair market value equal to at least two times the total annual retainer cash compensation paid by the company for board service (excluding for this purpose compensation that is not paid to all independent directors, such as compensation for committee or chair service). Newly appointed or elected directors would have up to five years from the date of appointment or election to meet this requirement for stock ownership. For purposes of this ownership guideline, vested equity awards would be considered when determining a director&#x2019;s stock ownership. Except for Ms. Liu who joined the board in February 2021 and Ms. Andrietti who joined the board in August 2019, as of December 31, 2022, all of our directors were in compliance with our stock ownership guidelines. Subsequent to his transition out of being our Chief Executive Officer, effective January 1, 2023, the stock ownership guidelines for directors applies to Mr. Wertheizer instead of the stock ownership guidelines for our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2022 Director Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 52%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 0%; padding: 0px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Directorship Fees Earned</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>or</b><br />
			<b>Paid in Cash ($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Equity Awards</b><br />
			<b>($) (1)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Total</b></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
			<td>&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Peter McManamon (2)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt; text-align: center;">62,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">124,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">187,157</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Bernadette Andrietti (3)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">48,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">124,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">173,407</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Eliyahu Ayalon (4)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">21,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">62,332</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">83,582</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Jaclyn Liu (5)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">40,955</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">159,597</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">200,552</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Zvi Limon (6)</p>
			</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 13%; text-align: center; margin-left: 3pt;">13,750</td>
			<td style="width: 1%; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 1%;">&#xa0;</td>
			<td style="width: 13%; text-align: center; margin-left: 3pt;">-</td>
			<td style="width: 1%; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">13,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Maria Marced (7)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">51,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">124,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">175,907</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Sven-Christer Nilsson (8)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">55,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">124,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">179,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Louis Silver (9)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">60,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">124,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 3pt;">184,657</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The amounts shown in this column do not reflect compensation actually received by the directors. Instead, the amounts represent the aggregate grant date fair value of the awards based on FASB ASC No. 718. In 2022, RSUs granted to our non-employee directors were made pursuant to our 2011&#xa0;Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. McManamon was granted 3,793 RSUs in 2022. As of March 27, 2023 Mr. McManamon had outstanding stock options to purchase 28,000 shares of our common stock and 5,130 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Ms. Andrietti was granted 3,793 RSUs in 2022. As of March 27, 2023, Ms. Andrietti had outstanding 5,130 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Ayalon retired from the board on August 12, 2022. Mr. Ayalon was granted 3,793 RSUs in 2022. As of March 27, 2023, Mr. Ayalon had no outstanding RSUs.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Ms. Liu was granted 4,458 RSUs in 2022. As of March 27, 2023, Mr. Liu had outstanding 6,022 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Limon retired from the board on March 28, 2022. As of March 27, 2023, Mr. Limon had no outstanding RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(7)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Ms. Marced was granted 3,793 RSUs in 2022. As of March 27, 2023, Ms. Marced had outstanding 5,130 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(8)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Nilsson was granted 3,793 RSUs in 2022. As of March 27, 2023, Mr. Nilsson had outstanding 5,130 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(9)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Silver was granted 3,793 RSUs in 2022. As of March 27, 2023, Mr. Silver had outstanding stock options to purchase 78,000 shares of our common stock and had outstanding 5,130 RSUs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">52</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop2" title="prop2" href="#"></a>PROPOSAL 2 - APPROVAL OF AN AMENDMENT AND RESTATEMENT OF </b><br />
<b>THE COMPANY</b>&#x2019;<b>S 2002 EMPLOYEE STOCK PURCHASE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors has approved, subject to stockholder approval, an amendment and restatement of our 2002 Employee Stock Purchase Plan (the &#x201c;Purchase Plan&#x201d;) to increase the number of shares of common stock reserved for issuance under the Purchase Plan from 3,050,000 shares to 3,450,000 shares. A copy of the proposed amended and restated Purchase Plan is attached hereto as Appendix A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The purpose of the Purchase Plan is to provide employees of the company and its subsidiaries with an opportunity to purchase our common stock through accumulated payroll deductions. The Purchase Plan is intended to qualify as an &#x201c;Employee Stock Purchase Plan&#x201d; under Section 423 of the Code. Accordingly, the provisions of the Purchase Plan will be construed so as to extend and limit participation in the Purchase Plan in a manner consistent with the requirements of the Code. The Purchase Plan is intended to advance the interests of our stockholders by enhancing our ability to attract, retain and motivate persons who make (or are expected to make) important contributions to us by providing those persons with equity ownership opportunities and performance-based incentives -- thereby better aligning the interests of those persons with those of our stockholders. At December 31, 2022, we had 485 employees. Our number of employees increased significantly by approximately 81 employees in comparison to 2020, the last time we sought an increase in the number of shares authorized for issuance under the Purchase Plan. Our board of directors believes that the amendment is necessary to assure that CEVA will have a sufficient reserve of common stock available for issuance under the Purchase Plan. As of March 27, 2023, the closing sales price of a share of our common stock as reported on the NASDAQ Global Market was $29.03.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Subject to stockholder approval, we plan to register the additional 400,000 shares reserved under the Purchase Plan on a Registration Statement on Form S-8.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A general description of the principal terms of the Amended and Restated Purchase Plan as proposed is set forth below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>General Description</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Purchase Plan was adopted by our board of directors and approved by our stockholders in 2002. There are currently 3,050,000 shares of common stock reserved for issuance under the Purchase Plan. If the amendment and restatement of the Purchase Plan is approved by the stockholders, the number of shares of common stock reserved for issuance under the Purchase Plan will be increased by 400,000 shares from 3,050,000 shares to 3,450,000 shares. As of March 27, 2023, a total of 3,020,184 shares have been purchased under the Purchase Plan, and 29,816 shares of common stock remained available for purchase thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The number of shares of our common stock reserved for issuance under the Purchase Plan is also subject to adjustment in the event of a stock split, stock dividend or other similar change in the common stock or the capital structure of the company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Purchase Plan is administered by our board of directors, or a committee of the board as designated by the board from time to time, which has the authority to determine the terms and conditions under which purchase rights are to be granted under the Purchase Plan for any offer period during the term of the Purchase Plan, and to resolve all questions relating to the administration of the plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The purpose of the Purchase Plan is to provide our employees who participate in the Purchase Plan with an opportunity to purchase our common stock through payroll deductions. The Purchase Plan is intended to qualify as an &#x201c;employee stock purchase plan&#x201d; under the provisions of Section 423 of the Code. Our employees, including officers, and employees of our subsidiaries are eligible to participate in the Purchase Plan. Payroll deductions may be in amounts equal to or greater than 1% but not exceeding 10% (in whole percentage increments) of a participant&#x2019;s compensation. Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code, a participant&#x2019;s payroll deductions may be decreased to zero percent during any offer period or purchase period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any person who is employed by the company or any subsidiary for at least 20 hours per week and more than five months in a calendar year is eligible to participate in the Purchase Plan, provided that the employee is employed on the first day of an offer period and subject to certain limitations imposed by Section 423(b) of the Code. Eligible employees become participants in the Purchase Plan by delivering to us a subscription agreement authorizing payroll deductions at least five business days prior to the commencement of the applicable offer period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">53</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Offer periods under the Purchase Plan will generally be overlapping periods of 24 months. Purchase periods will generally be six-month periods commencing on each February 1 and August 1. The exercise dates are the last day of each purchase period. In the event we merge with or into another corporation, sell all or substantially all of our assets, or enter into other transactions in which all of our stockholders before the transaction own less than 50% of the total combined voting power of our outstanding securities following the transaction, our board of directors or a committee designated by the board may elect to shorten the offer period then in progress. The maximum duration of an offer period is twenty-seven (27) months.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The price per share at which shares are sold under the Purchase Plan is equal to 85% of the fair market value of our common stock on the commencement date of the offer period or the last day of the purchase period, whichever is lower. The fair market value of the common stock on a given date is the closing sale price of the common stock on NASDAQ as of such date. The number of shares of common stock which may be purchased is subject to adjustment in the event of a stock split, stock dividend or other similar change in the common stock or the capital structure of the company. We make no cash contributions to the Purchase Plan, but bear the expenses of administration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">At the beginning of an offer period, each participant will be granted the right to purchase the number of shares determined by dividing $50,000 by the fair market value on the offer period commencement date. No employee shall be granted a purchase right under the Purchase Plan (1) if immediately after the grant of the purchase right, the employee would own 5% or more of the total combined voting power or value of all classes of stock of the company or a subsidiary of the company (including stock which may be purchased under the Purchase Plan or issued pursuant to any other options) or (2) which would permit the employee to buy more than $25,000 worth of stock (determined at the fair market value of the shares at the time the purchase right is granted) in any calendar year. No fractional shares will be purchased; any payroll deductions accumulated in a participant&#x2019;s account which are not sufficient to purchase a full share shall be carried over to the next purchase period or offer period, whichever applies, or returned to the participant, if the participant withdraws from the Purchase Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A participant may increase or decrease the rate of his or her payroll deduction for the remainder of an offer period by filling out a change of status notice and delivering it to us (or our designee). The participant&#x2019;s subscription agreement (as modified by any change of status notice) will remain in effect for the entire offer period and each subsequent offer period, unless the participant further modifies his subscription or terminates his participation in the Purchase Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A participant&#x2019;s interest in a given offer period may be terminated in whole, but not in part, by delivering to us a change of status notice which indicates the participant&#x2019;s withdrawal from the Purchase Plan. Such withdrawal may be elected at any time prior to the end of the applicable offer period. Any withdrawal by the participant of accumulated payroll deductions for a given offer period automatically terminates the participant&#x2019;s interest in that offer period. If a participant withdraws from an offer period, payroll deductions will not resume at the beginning of the succeeding offer period unless the participant delivers to us a new subscription agreement. Alternatively, a participant may elect to terminate future payroll deductions, but allow accumulated payroll deductions to be used to exercise the participant&#x2019;s option under the then-current offering period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No rights or accumulated payroll deductions of a participant under the Purchase Plan may be pledged, assigned or transferred for any reason and any such attempt may be treated by us as an election to withdraw from the Purchase Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event any change, such as a stock split or dividend, is made in our capitalization which results in an increase or decrease in the number of outstanding shares of common stock without receipt of consideration by us, an appropriate adjustment shall be made in the number of shares under the Purchase Plan and the price per share covered by each outstanding option. In the event of a sale of all or substantially all of our assets, or our merger with or into another corporation, each option under the Purchase Plan shall be assumed by such successor corporation or a parent or subsidiary of such successor corporation, unless the plan administrator determines, in the exercise of its sole discretion and in lieu of such assumption, to shorten the offer period then in progress by setting a new exercise date or an earlier date for termination of the offer period (the &#x201c;New Exercise Date&#x201d;). If the plan administrator shortens the offer period then in progress in lieu of assumption in the event of a sale of assets or merger as described above, the plan administrator shall notify each participant in writing, at least ten business days prior to the New Exercise Date, that the exercise date for his or her option has been changed to the New Exercise Date and that his or her option will be exercised automatically on the New Exercise Date, unless prior to such date he or she has withdrawn from the offer period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">54</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Amendment and Termination of the Purchase Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The plan administrator may amend the Purchase Plan at any time or from time to time or may terminate the Purchase Plan without approval of the stockholders. To the extent necessary to comply with applicable provisions of federal securities laws, state corporate and securities laws, the rules of any applicable stock exchange or national market system, and the rules of any foreign jurisdiction applicable to purchase rights granted to residents therein, we will obtain stockholder approval of any amendment to the Purchase Plan in such a manner and to such a degree as required. No action by the plan administrator or stockholders may alter or impair any option previously granted under the Purchase Plan without the consent of affected participants, provided that the Purchase Plan or any one or more offer periods may be terminated by the plan administrator on any exercise date or by the plan administrator establishing a new exercise date with respect to any offer period then in progress if the plan administrator determines that the termination of the Purchase Plan or such one or more offer periods is in the best interests of the company and its stockholders. Without stockholder consent and without regard to whether any participant rights may be considered to have been &#x201c;adversely affected,&#x201d; the plan administrator is entitled to limit the frequency and/or number of changes in the amount withheld during offer periods, change the length of purchase periods within any offer period, change the length of subsequent offer periods, determine whether subsequent offer periods shall be consecutive or overlapping, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable foreign jurisdictions, permit payroll withholding in excess of the amount designated by a participant in order to adjust for delays or mistakes in our processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of common stock for each participant properly correspond with amounts withheld from the participant&#x2019;s compensation, and establish such other limitations or procedures as the plan administrator determines in its sole discretion advisable and which are consistent with the Purchase Plan.&#xa0;The Purchase Plan will remain in effect until the earlier of the date terminated by the board or 20 years after shareholder approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Amended Purchase Plan Benefits. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The benefits to be received by our employees pursuant to the amended and restated Purchase Plan are not determinable at this time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth information with respect to purchases under the Purchase Plan through March 27, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Identity of Group</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</p>
			</td>
			<td style="vertical-align: bottom; width: 15%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>Purchases</b></td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 12%; text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>% of Total </b></p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Purchases (1)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="1" style="vertical-align: bottom; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Weighted Average Purchase</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Price Per Share</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer,</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Former Chief Executive Officer and Director</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">49,901</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.7%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$8.53</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Yaniv Arieli,</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Chief Financial Officer</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">34,596</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.1%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$10.48</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issachar Ohana,</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Former EVP, World Wide Sales</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">50,391</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.7%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$8.44</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Michael Boukaya,</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Chief Operating Officer</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">25,301</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">0.8%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$10.92</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Executive Group</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">59,897</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2.0%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$10.67</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-Executive Director Group (2)</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">49,901</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.7%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$8.53</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-Executive Officer Employee Group</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 3pt; text-align: center; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2,909,896</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">94.8%</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$11.37</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Based on a total of 3,020,184 shares of common stock purchased under the Purchase Plan through March 27, 2023.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The non-executive director group consists of Mmes. Andrietti, Liu and Marced and Messrs. McManamon, Nilsson, Silver and Wertheizer. Non-employee directors are not allowed to participate in the Purchase Plan, but this includes shares purchased by Mr. Wertheizer, who as of March 27, 2023 is an non-executive officer employee who serves as a director.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">55</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Certain Federal Income Tax Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following summarizes the federal income tax consequences of participation under the Purchase Plan and certain tax effects to the company based upon federal income tax laws in effect on the date of this proxy statement. This summary does not purport to be complete, and does not discuss any non-U.S., state or local tax consequences. In addition, the discussion does not address tax consequences which may vary with, or are contingent on, a participant&#x2019;s individual circumstances. Each participant in the Purchase Plan is strongly urged to consult with his or her tax advisor regarding participation in the Purchase Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Purchase Plan and the right of participants to make purchases thereunder are intended to qualify under the provisions of Section 421 and 423 of the Code. Under these provisions, no income will be taxable to a participant at the time of grant of the purchase right or purchase of shares. Amounts deducted from a participant&#x2019;s pay under the Purchase Plan are part of the employee&#x2019;s regular compensation and remain subject to federal, state and local income and employment withholding taxes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon disposition of the shares, the participant will generally be subject to tax and the amount of the tax will depend upon the participant&#x2019;s holding period. If the participant sells or disposes of the purchased shares more than two years after the start date of the offering period in which such shares were acquired and more than one year after the actual purchase date of those shares, then the participant will recognize ordinary income in the year of such sale or disposition equal to the lesser of (i) the amount by which the fair market value of the shares on the sale or disposition date exceeds the purchase price paid for those shares or (ii) 15% of the fair market value of the shares on the start date of the offering period, and any additional gain upon the disposition will be taxed as long-term capital gain. If the shares are disposed of before the expiration of the 2-year and 1-year holding periods described above, the excess of the fair market value of the shares on the purchase date over the purchase price will be treated as ordinary income. This amount of ordinary income will be added to a participant&#x2019;s basis in the shares and any further gain or loss on such disposition will be long-term or short-term capital gain or loss, depending on the holding period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is no income or employment tax withholding required upon the purchase or disposition of the shares by a participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are not entitled to a deduction for amounts taxed as ordinary income or capital gain to a participant except to the extent of ordinary income reported by participants upon disposition of shares within two years from date of grant of the purchase right or within one year of the date of purchase (subject to the requirements of reasonableness). We are required to report to the United States Internal Revenue Service any ordinary income recognized by a participant as a result of a disposition if such information is available to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>OUR BOARD OF DIRECTORS BELIEVES THAT THE AMENDMENT AND RESTATEMENT OF THE PURCHASE PLAN IS IN THE BEST INTERESTS OF BOTH OUR STOCKHOLDERS AND THE COMPANY AND RECOMMENDS A VOTE </b>&#x201c;<b>FOR</b>&#x201d;<b> THE AMENDMENT AND RESTATEMENT.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">56</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop3" title="prop3" href="#"></a>PROPOSAL 3 -</b>&#xa0;<b>APPROVAL OF AN AMENDMENT AND RESTATEMENT OF </b><br />
<b>THE COMPANY</b>&#x2019;<b>S 2011 EQUITY INCENTIVE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>General</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are asking our stockholders to approve an amendment and restatement of our 2011 Stock Incentive Plan (the &#x201c;2011 Plan&#x201d;), a copy of which is attached to this proxy statement as Appendix B. We use the 2011 Plan to attract and retain key talent and encourage stock ownership by our employees, non-employee directors and consultants. The proposed amendment and restatement of the 2011 Plan will (i) increase the number of shares of our common stock reserved for issuance under the plan by 1,150,000 shares, (ii) extend the term of the 2011 Plan until May 23, 2033, (iii) eliminate dividend equivalent rights as a form of award and prohibit paying dividends on unvested restricted stock, consistent with guidelines promulgated by Institutional Shareholder Services, (iv) update the Plan for changes in applicable law, such as the repeal of the performance-based compensation exception to Code Section 162(m), and (v) provide additional clarifying language for Code Section 409A purposes. The purpose of amending and restating the 2011 Plan is to enable us to continue to attract and retain talented employees, non-employee directors and consultants and, in certain cases, to better align with governance best practices. Furthermore, our board of directors finds it necessary to amend and restate the 2011 Plan to increase the number of our common shares as a result of additional awards made to compensate our new Chief Executive Officer and newly promoted Chief Commercial Officer. Our board of directors believes that the proposed increase of 1,150,000 shares of our common stock represents a reasonable amount of potential equity dilution and allows us to continue awarding equity incentives, which are an important component of our overall compensation program. On March 23, 2023, the board unanimously approved the amendment and restatement of the 2011 Plan, subject to approval of our stockholders at this annual meeting. As of March 27, 2023, the closing sales price of a share of our common stock as reported on the NASDAQ Global Market was $29.03. As of March 27, 2023, the potential number of employee participants in the 2011 Plan was approximately 399 and the potential number of consultant participants in the 2011 Plan was none. As of March 27, 2023, a total of 231,421 shares of our common stock remained available for issuance under the 2011 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We believe strongly that the approval of the amendment and restatement of the 2011 Plan is essential to our success. Our employees are our most valuable assets. Stock options, stock appreciation rights and the other awards permitted under the 2011 Plan are vital to our ability to attract and retain outstanding and highly skilled employees, especially in the competitive labor markets in which we compete. These awards also are crucial to our ability to motivate employees to achieve our goals. The terms of the 2011 Plan are designed to allow us to continue to attract, retain and motivate people whose skills and performance are critical to our success. We will continue to monitor the environment in which we operate and make changes to our equity compensation program to help us meet our goals, including achieving long-term stockholder value.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Code Section 162(m) limits the amount that we may deduct for compensation paid to certain of our executive officers to $1,000,000 per person in any year. Prior to December 22, 2017, when the Tax Cuts and Jobs Act of 2017 (&#x201c;TCJA&#x201d;) was signed into law, compensation that qualified as &#x201c;performance-based&#x201d; was excluded for purposes of calculating the amount of compensation subject to the $1,000,000 limit. Under the TCJA, this &#x201c;performance-based&#x201d; exception is repealed for taxable years beginning after December 31, 2017, except with respect to certain &#x201c;grandfathered&#x201d; compensation. The compensation committee reviews and considers the deductibility of executive compensation under Section 162(m) when determining the compensation of the Company&#x2019;s executive officers. However, the compensation committee retains the flexibility and discretion to approve compensation that is nondeductible under Section 162(m) as a means to ensure competitive levels of total compensation for our executive officers and promote varying corporate goals. In any event, the compensation committee intends to maintain an approach to executive officer compensation that strongly links pay to performance, and promotes the attraction and retention of qualified executives, but will also take into account tax-effectiveness of different compensation alternatives as it selects the right compensation mix..</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A general description of the principal terms of the 2011 Plan is set forth below. This description is qualified in its entirety by the terms of the 2011 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">57</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>General Description </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Purpose</i></b>. The purposes of the 2011 Plan are to attract and retain the best available personnel, to provide additional incentives to our employees, consultants and directors through ownership of shares of our common stock, and to promote the success of our business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Shares Reserved for Issuance under the 2011 Plan</i></b>. As originally adopted, the 2011 Plan had 1,100,000 shares of common stock reserved for issuance, plus any shares of our common stock that would otherwise return to our 2002 Stock Incentive Plan (which terminated upon stockholder approval of the 2011 Plan in 2011) as a result of forfeiture, termination or expiration of awards previously granted under the 2002 Plan, which has resulted in an increase in 469,200 shares under the 2011 Plan as a result of such rollover. In 2014, the stockholders approved an increase of 750,000 shares of common stock for issuance under the 2011 Plan. In 2020, our stockholders approved an increase of 850,000 shares of common stock for issuance under the 2011 Plan. In 2022, our stockholders approved an increase in the shares of common stock for issuance under the 2011 Plan by having shares of our common stock that would otherwise return to our 2003 Director Stock Option Plan as a result of forfeiture, termination or expiration of awards previously granted under the 2003 Director Stock Option Plan be rolled over to the 2011 Plan, which has resulted in an increase in 280,589 shares under the 2011 Plan as a result of such rollover. As of March 27, 2023, the number of shares that have transferred from the 2002 Stock Incentive Plan to the 2011 Plan was 469,220 as a result of forfeiture, termination or expiration of awards previously granted under the 2002 Plan. As of March 27, 2023, the number of shares that have transferred from the 2003 Director Stock Option Plan to the 2011 Plan was 280,589 as a result of forfeiture, termination or expiration of awards previously granted under the 2003 Director Stock Option Plan. As of March 27, 2023, a total of 466,519 shares of our common stock remained available for issuance under the 2011 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The maximum number of shares of our common stock with respect to which options and stock appreciation rights may be granted to a participant during a calendar year will be 500,000 shares of our common stock. In connection with a participant&#x2019;s commencement of service with the company or a related entity of the company, the participant may be granted options and stock appreciation rights for up to an additional 250,000 shares of our common stock, which would not count against the limit set forth in the previous sentence. For awards of restricted stock and restricted stock units, the maximum number of shares of our common stock subject to such awards that may be granted to a participant during a calendar year was 500,000 shares of our common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Share Counting. </i></b>Shares of our common stock issued in connection with awards will be charged against the 2011 Plan&#x2019;s share reserve on the basis of one share for each share issued in connection with such awards (and shall be counted as one share for each share that is returned or deemed not to have been issued from the 2011 Plan). Any shares of our common stock covered by an award which is forfeited, canceled, expires or is settled in cash shall be deemed not to have been issued for purposes of determining the maximum number of shares of our common stock which may be issued under the 2011 Plan. Shares of our common stock that have actually been issued under the 2011 Plan pursuant to an award shall not be returned to the 2011 Plan and shall not become available for future grant under the 2011 Plan, except where unvested shares of our common stock are forfeited or repurchased by the company at the lower of their original purchase price or their fair market value at the time of such repurchase. Shares of our common stock tendered or withheld in payment of an option exercise price, shares withheld by us to pay any tax withholding obligation, and all shares covered by the portion of a stock appreciation right that is exercised (regardless of whether shares of our common stock are actually issued in connection with such exercise) shall not be returned to the 2011 Plan and shall not become available for future issuance under the 2011 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Administration.</i></b> The 2011 Plan will be administered, with respect to grants to officers, employees, directors, and consultants, by the 2011 Plan administrator (the &#x201c;Administrator&#x201d;), defined as our board of directors or one or more committees designated by the board. The compensation committee will initially act as the Administrator. With respect to grants to officers and directors, the compensation committee shall be constituted in such a manner as to satisfy applicable laws, including Rule 16b-3 promulgated under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">58</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>No Repricings without Stockholder Approval.</i></b> We shall obtain stockholder approval prior to (i) the reduction of the exercise price of any option or the base appreciation amount of any stock appreciation right awarded under the 2011 Plan, or (ii) the cancellation of an option or stock appreciation right at a time when its exercise price or base appreciation amount exceeds the fair market value of the underlying shares of our common stock, in exchange for another option, stock appreciation right, restricted stock or other award or for cash (unless the cancellation and exchange occurs in connection with a Corporate Transaction (as defined in the 2011 Plan and as described below)). Notwithstanding the foregoing, cancelling an option or stock appreciation right in exchange for another option, stock appreciation right, restricted stock, or other award with an exercise price, purchase price or base appreciation amount that is equal to or greater than the exercise price or base appreciation amount of the original option or stock appreciation right will not be subject to stockholder approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Terms and Conditions of Awards.</i></b> The 2011 Plan provides for the grant of stock options, restricted stock, restricted stock units and stock appreciation rights (collectively referred to as &#x201c;awards&#x201d;). Stock options granted under the 2011 Plan may be either incentive stock options under the provisions of Section 422 of the Code, or nonqualified stock options. Incentive stock options may be granted only to employees. Awards other than incentive stock options may be granted to our employees, consultants and directors or to employees, consultants and directors of our related entities. To the extent that the aggregate fair market value of the shares of our common stock subject to options designated as incentive stock options which become exercisable for the first time by a participant during any calendar year exceeds $100,000, such excess options shall be treated as nonqualified stock options. Under the 2011 Plan, awards may be granted to such employees, consultants or directors who are residing in non-U.S. jurisdictions as the Administrator may determine from time to time. Each award granted under the 2011 Plan shall be designated in an award agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Subject to applicable laws and except as otherwise provided by the board of directors, the Administrator will have the authority, in its discretion, to select employees, consultants and directors to whom awards may be granted from time to time, to determine whether and to what extent awards are granted, to determine the number of shares of our common stock or the amount of other consideration to be covered by each award, to approve forms of award agreement for use under the 2011 Plan, to determine the terms and conditions of any award (including the vesting schedule applicable to the award), to amend the terms of any outstanding award granted under the 2011 Plan (provided that any amendment that would adversely affect a participant&#x2019;s rights under an outstanding award would not be made without the participant&#x2019;s written consent), to construe and interpret the terms of the 2011 Plan and awards granted, to establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable non-U.S. jurisdictions and to take such other action, not inconsistent with the terms of the 2011 Plan, as the Administrator deems appropriate. Dividends may be granted in connection with restricted stock; provided, that dividends will only be paid with respect to restricted stock if, and to the extent, the award (or portion of the award to which the dividend relates) vests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The term of any award granted under the 2011 Plan will be stated in the applicable award agreement but may not exceed a term of more than ten years (or five years in the case of an incentive stock option granted to any participant who owns stock representing more than 10% of our combined voting power or any parent or subsidiary of us), excluding any period for which the participant has elected to defer the receipt of the shares of our common stock or cash issuable pursuant to the award pursuant to a deferral program the Administrator may establish in its discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The 2011 Plan authorizes the Administrator to grant incentive stock options at an exercise price not less than 100% of the fair market value of our common stock on the date the option is granted (or 110%, in the case of an incentive stock option granted to any employee who owns stock representing more than 10% of our combined voting power or any parent or subsidiary of us). In the case of nonqualified stock options and stock appreciation rights, the exercise price, base appreciation amount or purchase price, if any, shall be not less than 100% of the fair market value per share on the date of grant. In the case of all other awards granted under the 2011 Plan, the exercise or purchase price shall be determined by the Administrator. The exercise or purchase price is generally payable in cash, check, shares or, with respect to options, payment through a broker-dealer sale and remittance procedure or a &#x201c;net exercise&#x201d; procedure, or any combination of the foregoing methods of payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the 2011 Plan, the Administrator may establish one or more programs to permit selected participants the opportunity to elect to defer receipt of consideration payable under an award, subject to compliance with Code Section 409A. The Administrator also may establish under the 2011 Plan separate programs for the grant of particular forms of awards to one or more classes of participants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">59</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Change in Capitalization.</i></b> Subject to any required action by the stockholders of the company, the number of shares of our common stock covered by outstanding awards, the number of shares of our common stock that have been authorized for issuance under the 2011 Plan, the exercise or purchase price of each outstanding award, the maximum number of shares of our common stock that may be granted subject to awards to any participant in a calendar year, as well as other terms that the Administrator determines require adjustment, shall be proportionally adjusted by the Administrator in the event of (i) any increase or decrease in the number of issued shares of our common stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the shares of our common stock or similar transaction affecting the shares of our common stock, (ii) any other increase or decrease in the number of issued shares of our common stock effected without receipt of consideration by the company or (iii) any other transaction with respect to our shares of our common stock including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution of stock or property), reorganization, liquidation (whether partial or complete), distribution of cash or other assets to stockholders other than a normal cash dividend, or any similar transaction; provided, however, that conversion of any convertible securities of the company shall not be deemed to have been &#x201c;effected without receipt of consideration.&#x201d; Such adjustment shall be made by the Administrator and its determination shall be final, binding and conclusive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Corporate Transaction.</i></b> Effective upon the consummation of a Corporate Transaction, all outstanding awards under the 2011 Plan will terminate unless the awards are assumed in connection with the Corporate Transaction. In addition, except as provided otherwise in an individual award agreement, for the portion of each award that is neither assumed nor replaced, such portion of the award shall automatically become fully vested and exercisable and be released from any repurchase or forfeiture rights (other than repurchase rights exercisable at fair market value) for all of the shares of our common stock (or other consideration) at the time represented by such portion of the award, immediately prior to the specified effective date of such Corporate Transaction, provided that the Grantee&#x2019;s Continuous Service has not terminated prior to such date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the 2011 Plan, Corporate Transaction includes a merger or consolidation in which the company is not the surviving entity, except for a transaction the principal purpose of which is to change the state in which the company is incorporated; the sale, transfer or other disposition of all or substantially all of the assets of the company; the complete liquidation or dissolution of the company; any reverse merger or series of related transactions culminating in a reverse merger in which the company is the surviving entity but (i) the shares of our common stock outstanding immediately prior to such merger are converted or exchanged by virtue of the merger into other property or (ii) in which securities possessing more than forty percent (40%) of the total combined voting power of the company&#x2019;s outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger or the initial transaction culminating in such merger; and an acquisition in a single or series of related transactions by any person or related group of persons (other than the company or by a company-sponsored employee benefit plan) of beneficial ownership of securities possessing more than fifty percent (50%) of the total combined voting power of the company&#x2019;s outstanding securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Amendment, Suspension or Termination of the 2011 Plan.</i></b> The board of directors may at any time amend, suspend or terminate the 2011 Plan. The 2011 Plan will terminate on May 23, 2033 unless earlier terminated by the board of directors. To the extent necessary to comply with applicable provisions of federal securities laws, state corporate and securities laws, the Code, applicable rules of any stock exchange or national market system, and the rules of any foreign jurisdiction applicable to awards granted to residents of the jurisdiction, the company shall obtain stockholder approval of any such amendment to the 2011 Plan in such a manner and to such a degree as required. No suspension or termination of the 2011 Plan will adversely affect any rights under awards already granted to a participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Awards to Israeli Residents</i></b><i>.</i> The 2011 Plan is designed to comply with the provisions of the Israeli Income Tax Ordinance New Version, 1961, as amended (the &#x201c;Tax Ordinance&#x201d;), and is intended to enable the Administrator to grant options under the 2011 Plan to participants who are, or are deemed to be, Israeli residents. Specifically, the 2011 Plan permits option awards to employees pursuant to Section 102 of the Tax Ordinance and option awards to non-employees pursuant to Section 3(i) of the Tax Ordinance. For this purpose, &#x201c;employee&#x201d; refers to employees, officers and directors of the company or a related entity who are not considered &#x201c;Controlling Shareholders&#x201d; pursuant to, or otherwise excluded by, the Tax Ordinance. In accordance with the terms and conditions imposed by the Tax Ordinance, participants who are, or are deemed to be, Israeli residents and who receive option awards under the 2011 Plan may be afforded certain tax benefits in Israel.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">60</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Certain U.S. Federal Tax Consequences </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following summary of the U.S. federal income tax consequences of the 2011 Plan transactions is based upon federal income tax laws in effect on the date of this Proxy Statement. This summary does not purport to be complete, and does not discuss state, local or non-U.S. tax consequences.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Nonqualified Stock Options</i></b>. The grant of a nonqualified stock option under the 2011 Plan will not result in any federal income tax consequences to the participant or to the company. Upon exercise of a nonqualified stock option, the participant is subject to income tax at ordinary rates on the difference between the option exercise price and the fair market value of the shares of our common stock at the time of exercise. This income is subject to withholding for federal income and employment tax purposes if such participant is an employee. The company is entitled to an income tax deduction in the amount of the income recognized by the participant, subject to possible limitations imposed by Section 162(m) of the Code and so long as the company withholds the appropriate taxes with respect to such income (if required) and the participant&#x2019;s total compensation is deemed reasonable in amount. Any gain or loss on the participant&#x2019;s subsequent disposition of the shares of our common stock will receive long or short-term capital gain or loss treatment, depending on whether the shares of our common stock are held for more than one year following exercise. The company does not receive a tax deduction for any such gain.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A nonqualified stock option can be considered deferred compensation and subject to Section 409A of the Code. A nonqualified stock option that does not meet the requirements of Code Section 409A can result in the acceleration of income recognition, an additional 20% tax obligation, plus penalties and interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Incentive Stock Options</i></b>. The grant of an incentive stock option under the 2011 Plan will not result in any federal income tax consequences to the participant or to the company. A participant recognizes no federal taxable income upon exercising an incentive stock option (subject to the alternative minimum tax rules discussed below), and the company receives no deduction at the time of exercise. In the event of a disposition of stock acquired upon exercise of an incentive stock option, the tax consequences depend upon how long the participant has held the shares of our common stock. If the participant does not dispose of the shares of our common stock within two years after the incentive stock option was granted, nor within one year after the incentive stock option was exercised, the participant will recognize a long-term capital gain (or loss) equal to the difference between the sale price of the shares of our common stock and the exercise price. The company is not entitled to any deduction under these circumstances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If the participant fails to satisfy either of the foregoing holding periods (referred to as a &#x201c;disqualifying disposition&#x201d;), he or she must recognize ordinary income in the year of the disposition. The amount of ordinary income generally is the lesser of (i) the difference between the amount realized on the disposition and the exercise price or (ii) the difference between the fair market value of the stock at the time of exercise and the exercise price. Any gain in excess of the amount taxed as ordinary income will be treated as a long or short-term capital gain, depending on whether the stock was held for more than one year. The company, in the year of the disqualifying disposition, is entitled to a deduction equal to the amount of ordinary income recognized by the participant, subject to possible limitations imposed by Section 162(m) of the Code and so long as the participant&#x2019;s total compensation is deemed reasonable in amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The &#x201c;spread&#x201d; under an incentive stock option-i.e., the difference between the fair market value of the shares of our common stock at exercise and the exercise price-is classified as an item of adjustment in the year of exercise for purposes of the alternative minimum tax. If a participant&#x2019;s alternative minimum tax liability exceeds such participant&#x2019;s regular income tax liability, the participant will owe the larger amount of taxes. In order to avoid the application of alternative minimum tax with respect to incentive stock options, the participant must sell the shares of our common stock within the calendar year in which the incentive stock options are exercised. However, such a sale of shares of our common stock within the year of exercise will constitute a disqualifying disposition, as described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">61</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Stock Appreciation Rights</i></b>. Recipients of stock appreciation rights (&#x201c;SARs&#x201d;) generally should not recognize income until the SAR is exercised (assuming there is no ceiling on the value of the right). Upon exercise, the recipient will normally recognize taxable ordinary income for federal income tax purposes equal to the amount of cash and fair market value of the shares, if any, received upon such exercise. Recipients who are employees will be subject to withholding for federal income and employment tax purposes with respect to income recognized upon exercise of a SAR. Recipients will recognize gain upon the disposition of any shares received on exercise of a SAR equal to the excess of (i) the amount realized on such disposition over (ii) the ordinary income recognized with respect to such shares under the principles set forth above. That gain will be taxable as long or short-term capital gain depending on whether the shares were held for more than one year. We will be entitled to a tax deduction to the extent and in the year that ordinary income is recognized by the recipient, subject to possible limitations imposed by Section 162(m) of the Code and so long as we withhold the appropriate taxes with respect to such income (if required) and the recipient&#x2019;s total compensation is deemed reasonable in amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A SAR can be considered non-qualified deferred compensation and subject to Section 409A of the Code. A SAR that does not meet the requirements of Code Section 409A can result in the acceleration of income recognition, an additional 20% tax obligation, plus penalties and interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Restricted Stock</i></b>. The grant of restricted stock will subject the recipient to ordinary compensation income on the difference between the amount paid for such stock and the fair market value of the shares of our common stock on the date that the restrictions lapse. This income is subject to withholding for federal income and employment tax purposes. The company is entitled to an income tax deduction in the amount of the ordinary income recognized by the recipient, subject to possible limitations imposed by Section 162(m) of the Code and so long as the company withholds the appropriate taxes with respect to such income (if required) and the participant&#x2019;s total compensation is deemed reasonable in amount. Any gain or loss on the recipient&#x2019;s subsequent disposition of the shares of our common stock will receive long or short-term capital gain or loss treatment depending on how long the stock has been held since the restrictions lapsed. The company does not receive a tax deduction for any such gain.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Recipients of restricted stock may make an election under Section 83(b) of the Code (&#x201c;Section 83(b) Election&#x201d;) to recognize as ordinary compensation income in the year that such restricted stock is granted, the amount equal to the spread between the amount paid for such stock and the fair market value on the date of the issuance of the stock. If such an election is made, the recipient recognizes no further amounts of compensation income upon the lapse of any restrictions and any gain or loss on subsequent disposition will be long or short-term capital gain to the recipient. The Section 83(b) Election must be made within thirty days from the time the restricted stock is issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Restricted Stock Units</i></b>. Recipients of restricted stock units generally should not recognize income until such units are converted into cash or shares of our common stock. Upon conversion, the recipient will normally recognize taxable ordinary income for federal income tax purposes equal to the amount of cash and fair market value of the shares of our common stock, if any, received upon such conversion. Recipients who are employees will be subject to withholding for federal income and employment tax purposes with respect to income recognized upon conversion of the restricted stock units. Participants will recognize gain upon the disposition of any shares of our common stock received upon conversion of the restricted stock units equal to the excess of (i) the amount realized on such disposition over (ii) the ordinary income recognized with respect to such shares of our common stock under the principles set forth above. That gain will be taxable as long or short-term capital gain depending on whether the shares of our common stock were held for more than one year. The company will be entitled to a tax deduction to the extent and in the year that ordinary income is recognized by the recipient, subject to possible limitations imposed by Section 162(m) of the Code and so long as the company withholds the appropriate taxes with respect to such income (if required) and the recipient&#x2019;s total compensation is deemed reasonable in amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Restricted stock units also can be considered non-qualified deferred compensation and subject to Section 409A of the Code. A grant of restricted stock units that does not meet the requirements of Code Section 409A will result in an additional 20% tax obligation, plus penalties and interest to such recipient.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2011 Plan Benefits </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Awards under the 2011 Plan are in the discretion of the Administrator. Accordingly, the benefits to be received by our executive officers and employees pursuant to the 2011 Plan are not determinable at this time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">62</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table shows, the number of equity awards that have been granted to the following individuals and groups pursuant to the 2011 Plan as of March 27, 2023:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="text-decoration: underline; ">Directors and Executive Officers</span></b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of shares of our<br />
			common stock subject </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>to stock options</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of shares of our<br />
			common stock subject to stock<br />
			appreciation rights</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of shares of our<br />
			common stock subject to<br />
			restricted stock units</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: bottom; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Gideon Wertheizer</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Former Chief Executive Officer and Director</i></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">56,695</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">266,084</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Yaniv Arieli</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Chief Financial Officer</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">37,752</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">153,906</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Issachar Ohana</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Former EVP, Worldwide Sales</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">28,112</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">114,865</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Michael Boukaya</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><i>Chief Operating Officer</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">21,006</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">127,760</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current Executive Officer Group</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">65,966</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">392,187</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-Executive Director Group (1)</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">-</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">56,695</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">489,423</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 39%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-Executive Officer Employee Group</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">42,915</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">517,043</p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2,333,961</p>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1) The non-executive director group consists of Mmes. Andrietti, Liu and Marced and Messrs. McManamon, Nilsson, Silver and Wertheizer.&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Please note that the level of past awards is not necessarily indicative of future awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE </b>&#x201c;<b>FOR</b>&#x201d;<b> THE APPROVAL OF THE AMENDMENT AND RESTATEMENT OF 2011 EQUITY INCENTIVE PLAN. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">63</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop4" title="prop4" href="#"></a>PROPOSAL 4 </b>-<b> ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, added Section 14A to the Securities Exchange Act of 1934, as amended, which enables our stockholders to vote to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with the SEC&#x2019;s rules.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As described in detail under the heading &#x201c;<i>Compensation Discussion and Analysis,</i>&#x201d; our compensation philosophy supports our key business objectives of creating value for, and promoting the interests of, our stockholders. In order to align the interests of our executives with those of our stockholders, we believe that our executive compensation arrangements must provide our named executive officers with competitive compensation opportunities, based upon both their contribution to the development and financial success of the company and their personal performance. We believe our executive compensation arrangements strike the appropriate balance between utilizing responsible, measured pay practices and effectively incentivizing our executives to dedicate themselves fully to value creation for our stockholders. This balance is evidenced by the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">We provide a significant part of executive compensation in the form of performance based incentives. The goals under the performance-based bonus plan and performance-based equity awards are generally challenging. Bonuses under the performance-based plan are capped and a significant portion of the bonuses would not be payable for a particular year if the company fails to achieve the specified financial goals.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">o</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">100% of the 2022 Executive Bonus Plan is based upon the company&#x2019;s achievement of financial performance targets, consisting of a 2022 total revenues target, North America revenue target and an annual non-GAAP fully diluted EPS target.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">o</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">A significant portion of the bonus payable to Messrs. Wertheizer Arieli and Boukaya is subject to financial thresholds such that if the company fails to meet the financial thresholds in 2022, a significant portion of the bonus would not be payable.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">o</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The bonus payable to Messrs. Wertheizer, Arieli and Boukaya is subject to target and maximum award opportunities to further incentivize our executive officers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">o</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">All executive officers received performance-based restricted stock grants.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">o</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The cash bonus plan for Mr. Ohana is subject to financial and strategic goals.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Our compensation arrangements for the named executive officers are simple, consisting principally of base salary, annual bonus, which may or may not be awarded annually based on a performance-based bonus plan established for that year, and long-term incentive award, currently in the form of restricted stock units performance-based restricted stock units for all executive officers, which again may or may not be awarded annually at the discretion of our compensation committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">We align base salaries with strong pay-for-performance orientation and our compensation committee generally takes a conservative approach on base salary increases.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">A significant portion of our named executive officers&#x2019;&#xa0;compensation is in the form of long-term incentive awards. Moreover, our compensation committee generally takes a conservative approach on grants of long-term incentive awards.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">We do not provide any nonqualified defined contribution or other deferred compensation plans to our named executive officers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">We do not provide tax gross-ups to our named executive officers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">64</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">None of the employment agreements with our named executive officers includes any &#x201c;single trigger&#x201d;&#xa0;change-in-control provisions or golden parachute arrangements.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The perquisites offered to our named executive officers based in Israel are those generally provided to all of our employees based in Israel.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The only prerequisite offered to our U.S.-based named executive officer is participating in and matching under our 401(k) plan, a prerequisite provided to all U.S. employees.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#x25cf;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Our compensation committee is updated on compensation best practices and trends. The committee from time to time, as appropriate, engages the services of a compensation consultant to provide advice on compensation trends and market information to assist the committee in designing our compensation programs and making compensation decisions.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The vote on this resolution is not intended to address any specific element of compensation; rather, the advisory vote relates to the compensation of our named executive officers, as described in this proxy statement. The vote is advisory, and therefore it is not binding on the company, our compensation committee or our board of directors. Our compensation committee will carefully consider the outcome of the vote when considering future executive compensation arrangements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The affirmative vote of a majority of the shares present or represented and entitled to vote either in person or by proxy is required to approve this Proposal 4. Virtual attendance at our annual meeting constitutes presence in person for purposes of the vote required under our bylaws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Accordingly, we ask our stockholders to vote on the following resolution at the annual meeting:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#x201c;RESOLVED, that the compensation of the named executive officers, as disclosed in the company&#x2019;s proxy statement for the 2023 annual meeting of stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&#x201d;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </b>&#x201c;<b>FOR</b>&#x201d;<b> THE ADVISORY VOTE ON NAMED EXECUTIVE OFFICER COMPENSATION, AS DISCLOSED IN THIS PROXY STATEMENT.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">65</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop5" title="prop5" href="#"></a>PROPOSAL 5 </b>-<b> ADVISORY VOTE ON THE FREQUENCY OF </b><br />
<b>AN ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Dodd-Frank Wall Street Reform and Consumer Protection Act also provides that stockholders must be given the opportunity to vote, on a non-binding, advisory basis, for their preference as to how frequently we should seek an advisory vote on the compensation of our named executive officers as disclosed in accordance with the SEC&#x2019;s compensation disclosure rules, which we refer to as an advisory vote on executive compensation. By voting on this Proposal 5, stockholders may indicate whether they would prefer that we seek future advisory votes on executive compensation once every one, two, or three years. Stockholders also may, if they wish, abstain from casting a vote on this proposal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In consideration of good corporate governance, our board of directors has determined that an advisory vote on executive compensation that occurs every year is the most appropriate for the company and therefore our board recommends that you vote for a one-year interval for the advisory vote on executive compensation. The company recognizes that the stockholders may have different views as to the best approach for the company, and therefore we look forward to hearing from our stockholders as to their preferences on the frequency of an advisory vote on executive compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Stockholders may cast a vote on the preferred voting frequency by selecting the option of one year, two years, or three years (or abstain) when voting in response to the resolution set forth below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#x201c;RESOLVED, that the stockholders determine, on an advisory basis, whether the preferred frequency of an advisory vote on the executive compensation of the Company&#x2019;s named executive officers as set forth in the company&#x2019;s proxy statement for the 2023 annual meeting of stockholders should be every year, every two years, or every three years.&#x201d;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This vote is advisory and not binding on the board of directors or the company in any way, however the board and the compensation committee will take into account the outcome of the vote when considering the frequency of future advisory votes on executive compensation. The board may decide that it is in the best interests of our stockholders and the company to hold an advisory vote on executive compensation more or less frequently than the frequency receiving the most votes cast by our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE FOR THE OPTION OF </b>&#x201c;<b>EVERY YEAR</b>&#x201d;<b> AS THE PREFERRED FREQUENCY WITH WHICH STOCKHOLDERS ARE PROVIDED WITH AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">66</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop6" title="prop6" href="#"></a>PROPOSAL 6 </b>-<b> RATIFICATION OF THE SELECTION OF KOST FORER GABBAY &amp; KASIERER </b><br />
<b>(A MEMBER OF ERNST &amp; YOUNG GLOBAL) AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our audit committee has selected Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) as our auditors for the current fiscal year, subject to ratification by our stockholders at the annual meeting. We expect a representative of Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) to be available via teleconference at the annual meeting to respond to appropriate questions and to make a statement if he or she so desires.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Neither our by-laws nor other governing documents or law require stockholder ratification of the selection of Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) as our independent accountants. However, the audit committee of the board of directors is submitting the selection of Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the audit committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the audit committee in its discretion may direct the appointment of different independent accountants at any time during the year if they determine that such a change would be in the best interests of the company and its stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Independent Auditors Fees and Other Matters </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table summarizes the fees for professional services provided by Ernst &amp; Young,* our independent auditors, billed to us for each of the last two fiscal years:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 68%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Fee Category</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2021($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022($)</b></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audit Fees (1)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">411,243</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">464,105</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audit-Related Fees(2)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">32,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,346</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Fees (3)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">44,799</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">129,149</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">Total Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">488,542</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 13%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">594,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">*Fees are billed by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Audit fees consist of fees for the annual audit, the reviews of the interim financial statements included in our quarterly reports on Form 10-Q, and statutory audits required internationally and services related to internal control reviews and assistance with Section 404 internal control reporting requirements. Fees for services related to internal control reviews and assistance with Section 404 internal control reporting requirements are based on fees received to date and estimated fees yet to be billed.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Audit-related fees consist of fees for assurance and related services that are reasonably related to the performance of the audit and the review of our financial statements and which are not reported under &#x201c;Audit Fees.&#x201d;&#xa0;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Tax fees consisted of fees for tax compliance, tax advice, tax audit and tax planning services, including with respect to cost sharing and transfer pricing.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">All fees described above were approved by the audit committee of the board of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Pre-Approval Policy and Procedures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The audit committee has adopted an audit and non-audit services pre-approval policy relating to the approval of all audit and non-audit services that are to be performed by our independent auditor. Under this policy, in 2021, the audit committee pre-approved the provision by Ernst &amp; Young of specified audit services, including the audit of CEVA&#x2019;s consolidated financial statements for 2022, review of CEVA&#x2019;s Annual Report on Form 10-K and Quarterly Report on Form 10-Q, audit of CEVA&#x2019;s effectiveness of internal control over financial report and statutory audit and tax returns for the Israeli subsidiary. The audit committee also pre-approved the provision by Ernst &amp; Young of specified audit related services, including services associated with SEC registration statements, consultation with company management about accounting or disclosure treatment of transactions or events and auditors&#x2019; confirmation on specific financial data. Furthermore, the audit committee also pre-approved the provision by Ernst &amp; Young of specified tax related services, including a project relating to implementation of the new revenue recognition rules, international and domestic tax planning and audit, advice and compliance, tax only valuation services, expatriation tax assistance and compliance, non-direct taxes consultation, relocation tax services and due diligence related services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">67</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Both the audit committee and the independent auditor believe the implementation of this policy will not adversely affect the auditor&#x2019;s independence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE </b>&#x201c;<b>FOR</b>&#x201d;<b> THE RATIFICATION OF KOST FORER GABBAY &amp; KASIERER (A MEMBER OF ERNST &amp; YOUNG GLOBAL) AS OUR AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">68</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="audit" title="audit" href="#"></a>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Notwithstanding anything to the contrary set forth in any of our previous or future filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate this proxy statement or future filings made by us under those statutes, the below audit committee report shall not be deemed filed with the United States Securities and Exchange Commission and shall not be deemed incorporated by reference into any of those prior filings or into any future filings made by us under those statutes.</i>&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The audit committee of our board of directors is composed of three members. The audit committee acts under a written charter, which is available for review on our website at www.ceva-dsp.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The audit committee has reviewed our audited financial statements for 2022 and has discussed these financial statements with our management and our independent auditors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our management is responsible for the preparation of our financial statements and for maintaining an adequate system of disclosure controls and procedures and internal control over financial reporting for that purpose. Our independent auditors are responsible for conducting an independent audit of our annual financial statements in accordance with generally accepted accounting principles and issuing a report on the results of their audit. The audit committee is responsible for providing independent, objective oversight of these processes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The audit committee has also received from, and discussed with, our independent auditors various communications that our independent auditors are required to provide to the audit committee, including the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board and the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our independent auditors also provided the audit committee with the written disclosures and the letter required by the Public Company Accounting Oversight Board regarding its communications with the audit committee concerning independence. Our auditors are required annually to disclose in writing all relationships that in their professional opinion may reasonably be thought to bear on their independence. The audit committee has discussed with the auditors their independence from us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based on its discussions with management and the independent auditors, and its review of the representations and information provided by management and the independent auditors, the audit committee recommended to our board of directors that the audited financial statements be included in our annual report on Form 10-K for 2022. The audit committee has also recommended the selection of Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) and, based on our recommendation, the board of directors has selected Kost Forer Gabbay &amp; Kasierer (a member of Ernst &amp; Young Global) as our independent auditors for the fiscal year ending December 31, 2023, subject to stockholder ratification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">By the Audit Committee of the Board of Directors of CEVA, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Louis Silver (Chair)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sven-Christer Nilsson</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Maria Marced</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">69</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="stockpro" title="stockpro" href="#"></a>STOCKHOLDER PROPOSALS FOR 2024 ANNUAL MEETING AND</b><br />
<b>NOMINATIONS OF PERSONS FOR ELECTION TO THE BOARD OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to Rule 14a&#x2011;8 under the Exchange Act and our by-laws, any proposal that a stockholder wishes to be considered for inclusion in our proxy statement for the 2024 annual meeting of stockholders, including nomination of directors, must be submitted to our office at CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850, Attention: Corporate Secretary, no later than December 14, 2023 (the date 120 days before the anniversary of the date of this proxy statement).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to Rule 14a-4(c) under the Exchange Act and our by-laws, the proxies to be solicited by our board of directors for the 2024 annual meeting will confer discretionary authority on the proxy holders to vote on any stockholder proposal presented at such annual meeting if we fail to receive notice of such stockholder&#x2019;s proposal for the meeting by February 27, 2024 (the date 45 days before the anniversary of the date of this proxy statement) or, if later, the date 90 days before the date of the 2024 annual meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition to providing timely advanced notice of any matter a stockholder wishes to present at an annual meeting of stockholders, with respect to general stockholder proposals, the stockholder also must submit the following relevant information in writing with respect to the proposal to the attention of our corporate secretary at our principle executive offices: (i) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (ii) the name and address, as they appear on our books, of the stockholder proposing such business, (iii) the class and number of shares of our common stock which are beneficially owned by the stockholder, (iv) any material interest of the stockholder in such business, (v) as to the stockholder giving the notice and any Stockholder Associated Person (as defined below), whether and the extent to which any hedging or other transaction or series of transactions has been entered into by or on behalf of, or any other agreement, arrangement or understanding (including, but not limited to, any short position or any borrowing or lending of shares of stock) has been made, the effect or intent of which is to mitigate loss or increase profit to or manage the risk or benefit of stock price changes for, or to increase or decrease the voting power of, such stockholder or any such Stockholder Associated Person with respect to any share of our common stock (each, a &#x201c;Relevant Hedge Transaction&#x201d;), (vi) as to the stockholder giving the notice and any Stockholder Associated Person, to the extent not set forth pursuant to the immediately preceding clause, (a) whether and the extent to which such stockholder or Stockholder Associated Person has direct or indirect beneficial ownership of any option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to our common stock, whether or not such instrument or right shall be subject to settlement in the underlying common stock or otherwise, or any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of our common stock (a &#x201c;Derivative Instrument&#x201d;), (b) any rights to dividends on the shares of our common stock owned beneficially by such stockholder that are separated or separable from the underlying common stock, (c) any proportionate interest in shares of our common stock or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder is a partner or, directly or indirectly, beneficially owns an interest in a partner and (d) any performance-related fees (other than an asset-based fee) that such stockholder is entitled to based on any increase or decrease in the value of shares of our common stock or Derivative Instruments, if any, as of the date of such notice, including without limitation, any such interests held by members of such stockholder&#x2019;s immediate family sharing the same household (which information shall be supplemented by such stockholder and beneficial owner, if any, not later than ten days after the record date for the meeting to disclose such ownership as of the record date); and (vii) any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Securities Exchange Act of 1934 in his or her capacity as a proponent to a stockholder proposal. A &#x201c;Stockholder Associated Person&#x201d; of any stockholder shall mean (i) any person controlling or controlled by, directly or indirectly, or acting in concert with, such stockholder, (ii) any beneficial owner of shares of our common stock owned of record or beneficially by such stockholder and (iii) any person controlling, controlled by or under common control with such Stockholder Associated Person. Subject to any exclusions permitted by applicable law, only stockholder proposals submitted in accordance with the above requirements will be presented at any annual meeting. The chairman of the meeting may, if the facts warrant, determine and declare at the meeting that business was not properly brought before the meeting and, if he should so determine, he may declare at the meeting that any such business not properly brought before the meeting will not be transacted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">70</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">With respect to recommendations of director nominee(s), in addition to providing timely advanced notice of any matter stockholders wish to present at an annual meeting of stockholders, the stockholder must submit the following relevant information in writing to the attention of our corporate secretary at our principle executive offices: (i) as to each person whom the stockholder proposes to nominate for election or reelection as a director: (A) the name, age, business address and residence address of such person, (B) the principal occupation or employment of such person, (C) the class and number of shares of our common stock which are beneficially owned by such person, (D) a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder, and (E) any other information relating to such person that is required to be disclosed in solicitations of proxies for elections of directors, or is otherwise required, in each case pursuant to Regulation 14A under the Securities Exchange Act of 1934 (including without limitation such person&#x2019;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected); and (ii) the information set forth in the above paragraph relating to general stockholder proposals. Once the nomination and corporate governance committee receives the stockholder recommendation, it may deliver to the prospective candidate a questionnaire that requests additional information about the candidate&#x2019;s independence, qualifications and other matters that would assist the nomination and corporate governance committee in evaluating the candidate, as well as certain information that must be disclosed about the candidate in our proxy statement or other regulatory filings, if nominated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="house" title="house" href="#"></a>HOUSEHOLDING OF PROXY STATEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some banks, brokers and other nominee record holders may be participating in the practice of &#x201c;householding&#x201d; proxy statements and annual reports. Under this procedure, certain stockholders of record who have the same address and last name, and who do not participate in electronic delivery of proxy materials, will receive only one copy of our Notice of Internet Availability of Proxy Materials and, as applicable, any additional proxy materials that are delivered until such time as one or more of these stockholders notifies us that they want to receive separate copies. If you receive a single set of proxy materials as a result of householding, and you would like to have separate copies of our Notice of Internet Availability of Proxy Materials, annual report, or proxy statement mailed to you, please call or write us at the following address or phone number: CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850, Attention: Corporate Secretary, +1 240-308-8328, ir@ceva-dsp.com. If you would like to receive separate copies of the annual report and proxy statement in the future, or if you have received multiple copies and in the future would like to receive only one copy for your household, you should contact your bank, broker, or other nominee record holder, or you may contact us at the above address and phone number. However, please note that if you want to receive a paper proxy or voting instruction form or other proxy materials for purposes of this year&#x2019;s annual meeting, follow the instructions included in the Notice of Internet Availability of Proxy Materials that was sent to you.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="other" title="other" href="#"></a>OTHER MATTERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our board of directors presently knows of no other business that will be presented for consideration at the annual meeting other than those described above. However, if any other business should come before the annual meeting, it is the intention of the persons named in the enclosed proxy to vote, or otherwise act, in accordance with their best judgment on such matters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>It is important that proxies be cast promptly. Therefore, stockholders are requested to cast their proxy as instructed in the Notice of Internet Availability of Proxy Materials whether or not they expect to attend the meeting. If you request a paper proxy card, please complete, date, and sign the form of proxy and return it promptly in the envelope provided. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By order of the board of directors,</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Amir Panush</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amir Panush</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 12, 2023<br />
Rockville, Maryland</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">71</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="TOCLink hf-cell" style="width: 100%; display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; "><a id="appa" title="appa" href="#"></a>APPENDIX A</span></b></p>

<div>&#xa0;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, INC.</b><br />
<br />
<b><i>AMENDED AND RESTATED 2002 EMPLOYEE STOCK PURCHASE PLAN</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Amended and Restated Effective May 23, 2023)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The following constitute the provisions of the Amended and Restated 2002 Employee Stock Purchase Plan of CEVA, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">1. <i>Purpose</i>. The purpose of the Plan is to provide Employees of the Company and its Designated Parents or Subsidiaries with an opportunity to purchase Common Stock of the Company through accumulated payroll deductions. It is the intention of the Company to have the Plan qualify as an &#x201c;Employee Stock Purchase Plan&#x201d; under Section 423 of the Code and the applicable regulations thereunder. The provisions of the Plan, accordingly, shall be construed so as to extend and limit participation in a manner consistent with the requirements of that section of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">2. <i>Definitions</i>. As used herein, the following definitions shall apply:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) &#x201c;<i>Administrator</i>&#x201d; means either the Board or a committee of the Board that is responsible for the administration of the Plan as is designated from time to time by resolution of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) &#x201c;<i>Applicable Laws</i>&#x201d; means the legal requirements relating to the administration of employee stock purchase plans, if any, under applicable provisions of federal securities laws, state corporate and securities laws, the Code and the applicable regulations thereunder, the rules of any applicable stock exchange or national market system, and the rules of any foreign jurisdiction applicable to participation in the Plan by residents therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) &#x201c;<i>Board</i>&#x201d; means the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(d) &#x201c;<i>Code</i>&#x201d; means the Internal Revenue Code of 1986, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(e) &#x201c;<i>Common Stock</i>&#x201d; means the common stock of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(f) &#x201c;<i>Company</i>&#x201d; means CEVA, Inc., a Delaware corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(g) &#x201c;<i>Compensation</i>&#x201d; means an Employee&#x2019;s base salary from the Company or one or more Designated Parents or Subsidiaries (as reported on the Employee&#x2019;s Federal Income Tax Withholding Statement (Form W-2) or equivalent thereof), including (A) such amounts of base salary as are deferred by the Employee (i) under a qualified cash or deferred arrangement described in Section 401(k) of the Code, or (ii) to a plan qualified under Sections 125 or 129 of the Code and (B) sales commissions. Compensation does not include overtime, bonuses, annual awards, other incentive payments, reimbursements or other expense allowances, fringe benefits (cash or noncash), moving expenses, deferred compensation, third party sick or disability pay, income or gains attributable to restricted stock, stock options, stock appreciation rights or other similar equity-based compensation, imputed income or other non-cash items, such as life insurance premiums and similar items, contributions (other than contributions described in the first sentence) made on the Employee&#x2019;s behalf by the Company or one or more Designated Parents or Subsidiaries under any employee benefit or welfare plan now or hereafter established, and any other payments not specifically referenced in the first sentence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(h) &#x201c;<i>Corporate Transaction</i>&#x201d; means any of the following transactions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(1) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the state in which the Company is incorporated;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(2) the sale, transfer or other disposition of all or substantially all of the assets of the Company (including the capital stock of the Company&#x2019;s subsidiary corporations);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(3) the complete liquidation or dissolution of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(4) any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#x2019;s outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(5) acquisition in a single or series of related transactions by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#x2019;s outstanding securities, but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(i) &#x201c;<i>Designated Parents or Subsidiaries</i>&#x201d; means the Parents or Subsidiaries of the Company which have been designated by the Administrator from time to time as eligible to participate in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(j) &#x201c;<i>Effective Date</i>&#x201d; means a date selected by the Board in its sole discretion. However, should any Parent or Subsidiary of the Company become a Designated Parent or Subsidiary after such date, then the Administrator, in its discretion, shall designate a separate Effective Date with respect to the employee-participants of such Designated Parent or Subsidiary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(k) &#x201c;<i>Employee</i>&#x201d; means any individual, including an officer or director, who is an employee of the Company or a Designated Parent or Subsidiary for purposes of Section 423 of the Code. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on sick leave or other leave of absence approved by the individual&#x2019;s employer. Where the period of leave exceeds three (3) months and the individual&#x2019;s right to reemployment is not guaranteed either by statute or by contract, the employment relationship will be deemed to have terminated on the day three (3) months and one (1) day following the expiration of such three (3) month period, for purposes of determining eligibility to participate in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(l) &#x201c;<i>Enrollment Date</i>&#x201d; means the first day of each Offer Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(m) &#x201c;<i>Exchange Act</i>&#x201d; means the Securities Exchange Act of 1934, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(n) &#x201c;<i>Exercise Date</i>&#x201d; means the last day of each Purchase Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(o) &#x201c;<i>Fair Market Value</i>&#x201d; means, as of any date, the value of Common Stock determined as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(1) If the Common Stock is listed on any established stock exchange or a national market system, including without limitation The Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(2) If the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, but selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(3) In the absence of an established market for the Common Stock of the type described in (1) and (2), above, the Fair Market Value thereof shall be determined by the Administrator in good faith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(p) &#x201c;<i>Offer Period</i>&#x201d; means an Offer Period established pursuant to Section 4 hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(q) &#x201c;<i>Parent</i>&#x201d; means a &#x201c;parent corporation,&#x201d; whether now or hereafter existing, as defined in Section 424(e) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(r) &#x201c;<i>Participant</i>&#x201d; means an Employee of the Company or Designated Parent or Subsidiary who has completed a subscription agreement as set forth in Section 5(a) and is thereby enrolled in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(s) &#x201c;<i>Plan</i>&#x201d; means this Employee Stock Purchase Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(t) RESERVED</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(u) &#x201c;<i>Purchase Period</i>&#x201d; means a period of approximately six months, commencing on February 1 and August 1 of each year and terminating on the next following July 31 or January 31, respectively; provided, however, that the first Purchase Period shall commence on the Effective Date and shall end on a date determined by the Administrator that shall be no later than twenty-seven (27) months after the Effective Date. The duration and timing of Purchase Periods may be changed pursuant to Section 19(b) of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(v) &#x201c;<i>Purchase Price</i>&#x201d; shall mean an amount equal to 85% of the Fair Market Value of a share of Common Stock on the Enrollment Date or on the Exercise Date, whichever is lower.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(w) &#x201c;<i>Reserves</i>&#x201d; means, as of any date, the sum of (1) the number of shares of Common Stock covered by each then outstanding option under the Plan which has not yet been exercised and (2) the number of shares of Common Stock which have been authorized for issuance under the Plan but not then subject to an outstanding option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(x) RESERVED</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(y) &#x201c;<i>Subsidiary</i>&#x201d; means a &#x201c;subsidiary corporation,&#x201d; whether now or hereafter existing, as defined in Section 424(f) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">3. <i>Eligibility</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) <i>General</i>. Any individual who is an Employee on a given Enrollment Date shall be eligible to participate in the Plan for the Offer Period commencing with such Enrollment Date. No individual who is not an Employee shall be eligible to participate in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) <i>Limitations on Grant and Accrual</i>. Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) if, immediately after the grant, such Employee (taking into account stock owned by any other person whose stock would be attributed to such Employee pursuant to Section 424(d) of the Code) would own stock and/or hold outstanding options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Parent or Subsidiary of the Company, or (ii) which permits the Employee&#x2019;s rights to purchase stock under all employee stock purchase plans of the Company and its Parents or Subsidiaries to accrue at a rate which exceeds Twenty-Five Thousand Dollars ($25,000) worth of stock (determined at the Fair Market Value of the shares at the time such option is granted) for each calendar year in which such option is outstanding at any time. The determination of the accrual of the right to purchase stock shall be made in accordance with Section 423(b)(8) of the Code and the regulations thereunder. In the event that an Employee may not be granted an option under the Plan because of the foregoing restrictions, the Employee shall be granted an option to purchase the maximum number of shares that would not violate the foregoing restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) <i>Other Limits on Eligibility</i>. Notwithstanding Subsection (a), above, the following Employees shall not be eligible to participate in the Plan for any relevant Offer Period: (i) Employees whose customary employment is less than 20 hours per week; (ii) Employees whose customary employment is for not more than 5 months in any calendar year; and (iii) Employees who are subject to rules or laws of a foreign jurisdiction that prohibit or make impractical the participation of such Employees in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">4. <i>Offer Periods</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) The Plan shall be implemented through overlapping or consecutive Offer Periods until such time as (i) the maximum number of shares of Common Stock available for issuance under the Plan shall have been purchased or (ii) the Plan shall have been sooner amended or terminated in accordance with Section 19 hereof. The maximum duration of an Offer Period shall be twenty-seven (27) months. Initially, the Plan shall be implemented through overlapping Offer Periods of twenty-four (24) months&#x2019; duration commencing each February 1 and August 1 following the Effective Date (except that the initial Offer Period shall commence on the Effective Date and shall end on a date determined by the Administrator that shall be no later than twenty-seven (27) months after the Effective Date).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) A Participant shall be granted a separate option for each Offer Period in which he or she participates. The option shall be granted on the Enrollment Date and shall be automatically exercised in successive installments on the Exercise Dates ending within the Offer Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) If on the first day of any Purchase Period in an Offer Period in which an Employee is a Participant, the Fair Market Value of the Common Stock is less than the Fair Market Value of the Common Stock on the Enrollment Date of the Offer Period (after taking into account any adjustment during the Offer Period pursuant to Section 18(a)), the Offer Period shall be terminated automatically and the Participant shall be enrolled automatically in the new Offer Period which has its first Purchase Period commencing on that date, provided the Employee is eligible to participate in the Plan on that date and has not elected to terminate participation in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(d) Except as specifically provided herein, the acquisition of Common Stock through participation in the Plan for any Offer Period shall neither limit nor require the acquisition of Common Stock by a Participant in any subsequent Offer Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">5. <i>Participation</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) An eligible Employee may become a Participant in the Plan by completing a subscription agreement authorizing payroll deductions in the form of Exhibit A to this Plan (or such other form or method (including electronic forms) as the Administrator may designate from time to time) and filing it with the designated payroll office of the Company at least five (5) business days prior to the Enrollment Date for the Offer Period in which such participation will commence, unless a later time for filing the subscription agreement is set by the Administrator for all eligible Employees with respect to a given Offer Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) Payroll deductions for a Participant shall commence with the first partial or full payroll period beginning on the Enrollment Date and shall end on the last complete payroll period during the Offer Period, unless sooner terminated by the Participant as provided in Section 10.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">6. <i>Payroll Deductions</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) At the time a Participant files a subscription agreement, the Participant shall elect to have payroll deductions made during the Offer Period in amounts equal to or greater than one percent (1%) but not exceeding ten percent (10%) of the Compensation which the Participant receives during the Offer Period. Prior to April 1, 2006, a Participant could elect to have payroll deductions made during the Offer Period in amounts up to twenty percent (20%) of the Compensation which the Participant receives during the Offer Period. Such payroll deductions shall be in whole percentages only.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) All payroll deductions made for a Participant shall be credited to the Participant&#x2019;s account under the Plan and will be withheld in whole percentages only. A Participant may not make any additional payments into such account.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) A Participant may discontinue participation in the Plan as provided in Section 10, or may increase or decrease the rate of payroll deductions during the Offer Period by completing and filing with the Company a change of status notice in the form of Exhibit B to this Plan (or such other form or method (including electronic forms) as the Administrator may designate from time to time) authorizing an increase or decrease in the payroll deduction rate. Any increase or decrease in the rate of a Participant&#x2019;s payroll deductions shall be effective with the first full payroll period commencing five (5) business days after the Company&#x2019;s receipt of the change of status notice unless the Company elects to process a given change in participation more quickly. A Participant&#x2019;s subscription agreement (as modified by any change of status notice) shall remain in effect for successive Offer Periods unless terminated as provided in Section 10. The Administrator shall be authorized to limit the number of payroll deduction rate changes during any Offer Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(d) Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Section 3(b) herein, a Participant&#x2019;s payroll deductions shall be decreased to 0%. Payroll deductions shall recommence at the rate provided in such Participant&#x2019;s subscription agreement, as amended, at the time when permitted under Section 423(b)(8) of the Code and Section 3(b) herein, unless such participation is sooner terminated by the Participant as provided in Section 10.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(e) At the time the option is exercised, in whole or in part, or at the time any of the Company&#x2019;s Common Stock issued under the Plan is disposed of, the participant must make adequate provision for the Company&#x2019;s federal, state, or other tax withholding obligations, if any, which arise upon the exercise of the option or the disposition of the Common Stock. At any time, the Company may, but shall not be obligated to, withhold from the participant&#x2019;s compensation the amount necessary for the Company to meet applicable withholding obligations, including any withholding required to make available to the Company any tax deductions or benefits attributable to sale or other disposition of Common Stock by the Employee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">7. <i>Grant of Option</i>. On the Enrollment Date of each Offer Period, each Participant shall be granted an option to purchase (at the applicable Purchase Price) up to a whole number of shares of Common Stock (the &#x201c;Option Shares&#x201d;) determined by dividing $50,000 by the Fair Market Value of a share of Common Stock on the Enrollment Date (subject to any adjustment pursuant to Section 18), and provided that such purchase shall be subject to the limitations set forth in Sections 3(b), 6 and 12 hereof. The option shall be exercisable as to 25% of the Option Shares on each Exercise Date during the Offer Period. Exercise of the option shall occur as provided in Section 8, unless the Participant has withdrawn pursuant to Section 10, and the option, to the extent not exercised, shall expire on the last day of the Offer Period with respect to which such option was granted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">8. <i>Exercise of Option</i>. Unless a Participant withdraws from the Plan as provided in Section 10, below, the Participant&#x2019;s option for the purchase of shares of Common Stock will be exercised automatically on each Exercise Date, by applying the accumulated payroll deductions in the Participant&#x2019;s account to purchase the number of full shares subject to the option by dividing such Participant&#x2019;s payroll deductions accumulated prior to such Exercise Date and retained in the Participant&#x2019;s account as of the Exercise Date by the applicable Purchase Price. No fractional shares will be purchased; any payroll deductions accumulated in a Participant&#x2019;s account which are not sufficient to purchase a full share shall be carried over to the next Purchase Period or Offer Period, whichever applies, or returned to the Participant, if the Participant withdraws from the Plan. Notwithstanding the foregoing, any amount remaining in a Participant&#x2019;s account following the purchase of shares on the Exercise Date due to the application of Section 423(b)(8) of the Code or Section 7, above, shall be returned to the Participant and shall not be carried over to the next Offer Period or Purchase Period. During a Participant&#x2019;s lifetime, a Participant&#x2019;s option to purchase shares hereunder is exercisable only by the Participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">9. <i>Delivery</i>. Upon receipt of a request from a Participant after each Exercise Date on which a purchase of shares occurs, the Company shall arrange the delivery to such Participant, as promptly as practicable, of a certificate representing the shares purchased upon exercise of the Participant&#x2019;s option. The Company may, in its sole discretion, and in compliance with applicable laws, authorize the book entry registration of shares in lieu of issuing certificates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">10. <i>Withdrawal; Termination of Employment</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) A Participant may either (i) withdraw all but not less than all the payroll deductions credited to the Participant&#x2019;s account and not yet used to exercise the Participant&#x2019;s option under the Plan or (ii) terminate future payroll deductions, but allow accumulated payroll deductions to be used to exercise the Participant&#x2019;s option under the Plan at any time by giving written notice to the Company in the form of Exhibit B to this Plan (or such other form or method (including electronic forms) as the Administrator may designate from time to time). If the Participant elects withdrawal alternative (i) described above, all of the Participant&#x2019;s payroll deductions credited to the Participant&#x2019;s account will be paid to such Participant as promptly as practicable after receipt of notice of withdrawal, such Participant&#x2019;s option for the Offer Period will be automatically terminated, and no further payroll deductions for the purchase of shares will be made during the Offer Period. If the Participant elects withdrawal alternative (ii) described above, no further payroll deductions for the purchase of shares will be made during the Offer Period, all of the Participant&#x2019;s payroll deductions credited to the Participant&#x2019;s account will be applied to the exercise of the Participant&#x2019;s option on the next Exercise Date (subject to Sections 3(b), 6, 7 and 12), and after such Exercise Date, such Participant&#x2019;s option for the Offer Period will be automatically terminated and all remaining accumulated payroll deduction amounts shall be returned to the Participant. If a Participant withdraws from an Offer Period, payroll deductions will not resume at the beginning of the succeeding Offer Period unless the Participant delivers to the Company a new subscription agreement. A Participant&#x2019;s withdrawal from an Offer Period shall not have any effect upon his or her eligibility to participate in any similar plan that may be hereafter adopted by the Company or in succeeding Offer Periods.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) With respect to the termination of employment of a Participant whose new Offer Period does not begin until either August 1, 2007 or February 1, 2008, upon termination of such Participant&#x2019;s employment relationship (as described in Section 2(k)) at a time more than three (3) months from July 31, 2007 or January 31, 2008, as the case may be, the payroll deductions credited to such Participant&#x2019;s account during the Offer Period ending on July 31, 2007 or January 31, 2008, as the case may be, but not yet used to exercise the option will be returned to such Participant or, in the case of his/her death, to the person or persons entitled thereto under Section 14, and such Participant&#x2019;s option will be automatically terminated without exercise of any portion of such option. With respect to the termination of employment of a Participant whose new Offer Period does not begin until either August 1, 2007 or February 1, 2008, upon termination of such Participant&#x2019;s employment relationship (as described in Section 2(k)) within three (3) months of July 31, 2007 or January 31, 2008, as the case may be, the payroll deductions credited to such Participant&#x2019;s account during the Offer Period ending on July 31, 2007 or January 31, 2008, as the case may be, but not yet used to exercise the option will be applied to the purchase of Common Stock on July 31, 2007 or January 31, 2008, as the case may be, unless the Participant (or in the case of the Participant&#x2019;s death, the person or persons entitled to the Participant&#x2019;s account balance under Section 14) withdraws from the Plan by submitting a change of status notice in accordance with subsection (a) of this Section 10. In such a case, no further payroll deductions will be credited to the Participant&#x2019;s account following the Participant&#x2019;s termination of employment and the Participant&#x2019;s option under the Plan will be automatically terminated after the purchase of Common Stock on July 31, 2007 or January 31, 2008, as the case may be. If, prior to July 31, 2007 or January 31, 2008, as the case may be, the Designated Parent or Subsidiary by which the Employee is employed shall cease to be a Parent or Subsidiary of the Company, or if the Employee is transferred to a Parent or Subsidiary of the Company that is not a Designated Parent or Subsidiary, the Employee shall be deemed to have been terminated for purposes of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) With respect to the termination of employment of a Participant whose new Offering Period begins on or after August 1, 2006, upon termination of such Participant&#x2019;s employment relationship (as described in Section 2(k)), the payroll deductions credited to such Participant&#x2019;s account during the Offer Period but not yet used to exercise the option will be returned to such Participant or, in the case of his/her death, to the person or persons entitled thereto under Section 14, and such Participant&#x2019;s option will be automatically terminated without exercise of any portion of such option. If, prior to the last day of the Offer Period, the Designated Parent or Subsidiary by which the Employee is employed shall cease to be a Parent or Subsidiary of the Company, or if the Employee is transferred to a Parent or Subsidiary of the Company that is not a Designated Parent or Subsidiary, the Employee shall be deemed to have been terminated for purposes of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">11. <i>Interest</i>. No interest shall accrue on the payroll deductions credited to a Participant&#x2019;s account under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">12. <i>Stock</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) The maximum number of shares of Common Stock which shall be made available for sale under the Plan shall be three million four hundred fifty thousand (3,450,000) shares, subject to adjustment upon changes in capitalization of the Company as provided in Section 18. With respect to any amendment to increase the total number of shares of Common Stock under the Plan, the Administrator shall have discretion to disallow the purchase of any increased shares of Common Stock for Offer Periods in existence prior to such increase. If the Administrator determines that on a given Exercise Date the number of shares with respect to which options are to be exercised may exceed (x) the number of shares then available for sale under the Plan or (y) the number of shares available for sale under the Plan on the Enrollment Date(s) of one or more of the Offer Periods in which such Exercise Date is to occur, the Administrator may make a pro rata allocation of the shares remaining available for purchase on such Enrollment Dates or Exercise Date, as applicable, in as uniform a manner as shall be practicable and as it shall determine to be equitable, and shall either continue all Offer Periods then in effect or terminate any one or more Offer Periods then in effect pursuant to Section 19, below. Any amount remaining in a Participant&#x2019;s payroll account following such pro rata allocation shall be returned to the Participant and shall not be carried over to any future Purchase Period or Offer Period, as determined by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) A Participant will have no interest or voting right in shares covered by the Participant&#x2019;s option until such shares are actually purchased on the Participant&#x2019;s behalf in accordance with the applicable provisions of the Plan. No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date of such purchase.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(c) Shares to be delivered to a Participant under the Plan will be registered in the name of the Participant or in the name of the Participant and his or her spouse as designated in the Participant&#x2019;s subscription agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">13. <i>Administration</i>. The Plan shall be administered by the Administrator which shall have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility and to adjudicate all disputed claims filed under the Plan. Every finding, decision and determination made by the Administrator shall, to the full extent permitted by Applicable Law, be final and binding upon all persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">14. <i>Designation of Beneficiary</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) Each Participant will file a written designation of a beneficiary who is to receive any shares and cash, if any, from the Participant&#x2019;s account under the Plan in the event of such Participant&#x2019;s death. If a Participant is married and the designated beneficiary is not the spouse, spousal consent shall be required for such designation to be effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) Such designation of beneficiary may be changed by the Participant (and the Participant&#x2019;s spouse, if any) at any time by written notice. In the event of the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living (or in existence) at the time of such Participant&#x2019;s death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Administrator), the Administrator shall deliver such shares and/or cash to the spouse (or domestic partner, as determined by the Administrator) of the Participant, or if no spouse (or domestic partner) is known to the Administrator, then to the issue of the Participant, such distribution to be made per stirpes (by right of representation), or if no issue are known to the Administrator, then to the heirs at law of the Participant determined in accordance with Section 27.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">15. <i>Transferability</i>. No payroll deductions credited to a Participant&#x2019;s account, options granted hereunder, or any rights with regard to the exercise of an option or to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution, or as provided in Section 14 hereof) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Administrator may, in its sole discretion, treat such act as an election to withdraw funds from an Offer Period in accordance with Section 10.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">16. <i>Use of Funds</i>. All payroll deductions received or held by the Company under the Plan may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions or hold them exclusively for the benefit of Participants. All payroll deductions received or held by the Company are subject to the claims of the Company&#x2019;s general creditors, and no Participant shall have rights greater than those of any unsecured creditor of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">17. <i>Reports</i>. Individual accounts will be maintained for each Participant in the Plan. Statements of account will be given to Participants at least annually, which statements will set forth the amounts of payroll deductions, the Purchase Price, the number of shares purchased and the remaining cash balance, if any.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">18. <i>Adjustments Upon Changes in Capitalization; Corporate Transactions</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) <i>Adjustments Upon Changes in Capitalization</i>. Subject to any required action by the stockholders of the Company, the Reserves, the Purchase Price, the maximum number of shares that may be purchased in any Offer Period or Purchase Period, as well as any other terms that the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, (ii) any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company, or (iii) as the Administrator may determine in its discretion, any other transaction with respect to Common Stock to which Section 424(a) of the Code applies; provided, however that conversion of any convertible securities of the Company shall not be deemed to have been &#x201c;effected without receipt of consideration.&#x201d; Such adjustment shall be made by the Administrator and its determination shall be final, binding and conclusive. Except as the Administrator determines, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason hereof shall be made with respect to, the Reserves and the Purchase Price.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) <i>Corporate Transactions</i>. In the event of a proposed Corporate Transaction, each option under the Plan shall be assumed by such successor corporation or a parent or subsidiary of such successor corporation, unless the Administrator, in the exercise of its sole discretion and in lieu of such assumption, determines to shorten the Offer Period then in progress by setting a new Exercise Date (the &#x201c;New Exercise Date&#x201d;). If the Administrator shortens the Offer Period then in progress in lieu of assumption in the event of a Corporate Transaction, the Administrator shall notify each Participant in writing at least ten (10) business days prior to the New Exercise Date, that the Exercise Date for the Participant&#x2019;s option has been changed to the New Exercise Date and that either:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(1) the Participant&#x2019;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offer Period as provided in Section 10; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:108pt;">(2) the Company shall pay to the Participant on the New Exercise Date an amount in cash, cash equivalents, or property as determined by the Administrator that is equal to the difference in the Fair Market Value of the shares subject to the option and the Purchase Price due had the Participant&#x2019;s option been exercised automatically under Subsection (b)(i) above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">For purposes of this Subsection, an option granted under the Plan shall be deemed to be assumed if, in connection with the Corporate Transaction, the option is replaced with a comparable option with respect to shares of capital stock of the successor corporation or Parent thereof. The determination of option comparability shall be made by the Administrator prior to the Corporate Transaction and its determination shall be final, binding and conclusive on all persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">19. <i>Amendment or Termination</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(a) The Administrator may at any time and for any reason terminate or amend the Plan. Except as provided in Section 18, no such termination can affect options previously granted, provided that the Plan or any one or more Offer Periods may be terminated by the Administrator on any Exercise Date or by the Administrator establishing a new Exercise Date with respect to any Offer Period and/or any Purchase Period then in progress if the Administrator determines that the termination of the Plan or such one or more Offer Periods is in the best interests of the Company and its stockholders. Except as provided in Section 18 and this Section 19, no amendment may make any change in any option theretofore granted which adversely affects the rights of any Participant without the consent of affected Participants. To the extent necessary to comply with Section 423 of the Code (or any successor rule or provision or any other Applicable Law), the Company shall obtain stockholder approval in such a manner and to such a degree as required.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:72pt;">(b) Without stockholder consent and without regard to whether any Participant rights may be considered to have been &#x201c;adversely affected,&#x201d; the Administrator shall be entitled to limit the frequency and/or number of changes in the amount withheld during Offer Periods, change the length of Purchase Periods within any Offer Period, determine the length of any future Offer Period, determine whether future Offer Periods shall be consecutive or overlapping, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable foreign jurisdictions, permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the Company&#x2019;s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with amounts withheld from the Participant&#x2019;s Compensation, and establish such other limitations or procedures as the Administrator determines in its sole discretion advisable and which are consistent with the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">20. <i>Notices</i>. All notices or other communications by a Participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Administrator at the location, or by the person, designated by the Administrator for the receipt thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">21. <i>Conditions Upon Issuance of Shares</i>. Shares shall not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. As a condition to the exercise of an option, the Company may require the Participant to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned Applicable Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">22. <i>Term of Plan</i>. The Plan shall become effective upon the earlier to occur of its adoption by the Board or its approval by the stockholders of the Company. It shall continue in effect for a term of twenty (20) years unless sooner terminated under Section 19.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">23. <i>Stockholder Approval</i>. The Plan is effective as of the date it is adopted by the Board. The Plan shall be submitted to the stockholders of the Company within twelve (12) months before or after the date the Plan is adopted for approval to obtain the benefits of Section 423 of the Code. However, the Plan shall not be conditioned upon such approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">24. <i>No Employment Rights</i>. The Plan does not, directly or indirectly, create any right for the benefit of any employee or class of employees to purchase any shares under the Plan, or create in any employee or class of employees any right with respect to continuation of employment by the Company or a Designated Parent or Subsidiary, and it shall not be deemed to interfere in any way with such employer&#x2019;s right to terminate, or otherwise modify, an employee&#x2019;s employment at any time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">25. <i>No Effect on Retirement and Other Benefit Plans</i>. Except as specifically provided in a retirement or other benefit plan of the Company or a Designated Parent or Subsidiary, participation in the Plan shall not be deemed compensation for purposes of computing benefits or contributions under any retirement plan of the Company or a Designated Parent or Subsidiary, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan is not a &#x201c;Retirement Plan&#x201d; or &#x201c;Welfare Plan&#x201d; under the Employee Retirement Income Security Act of 1974, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">26. <i>Effect of Plan</i>. The provisions of the Plan shall, in accordance with its terms, be binding upon, and inure to the benefit of, all successors of each Participant, including, without limitation, such Participant&#x2019;s estate and the executors, administrators or trustees thereof, heirs and legatees, and any receiver, trustee in bankruptcy or representative of creditors of such Participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">27. <i>Governmental Regulations</i>. The Company&#x2019;s obligation to sell and deliver Common Stock under this Plan is subject to listing on an established stock exchange or quotation on a national market system or an over the counter market (to the extent the Common Stock is then so listed or quoted) and the approval of all governmental authorities required in connection with the authorization, issuance, or sale of such stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">28. <i>Source of Shares</i>. Shares may be issued upon exercise of an option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">29. <i>Notification Upon Sale of Shares</i>. Each employee agrees, by participating in the Plan, to promptly give notice to the Company of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of the grant of the option pursuant to which such shares were purchased or within one year of the date of exercise of such option pursuant to which such shares were purchased.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">30. <i>Governing Law</i>. The Plan is to be construed in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of Delaware to the rights and duties of the parties, except to the extent the internal laws of the State of Delaware are superseded by the laws of the United States. Should any provision of the Plan be determined by a court of law to be illegal or unenforceable, the other provisions shall nevertheless remain effective and shall remain enforceable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">31. <i>Dispute Resolution</i>. The provisions of this Section 31 (and as restated in the Subscription Agreement) shall be the exclusive means of resolving disputes arising out of or relating to the Plan. The Company and the Participant, or their respective successors (the &#x201c;parties&#x201d;), shall attempt in good faith to resolve any disputes arising out of or relating to the Plan by negotiation between individuals who have authority to settle the controversy. Negotiations shall be commenced by either party by notice of a written statement of the party&#x2019;s position and the name and title of the individual who will represent the party. Within thirty (30) days of the written notification, the parties shall meet at a mutually acceptable time and place, and thereafter as often as they reasonably deem necessary, to resolve the dispute. If the dispute has not been resolved by negotiation, the parties agree that any suit, action, or proceeding arising out of or relating to the Plan shall be brought in the United States District Court for the Northern District of California (or should such court lack jurisdiction to hear such action, suit or proceeding, in a California state court in the County of San Francisco) and that the parties shall submit to the jurisdiction of such court. The parties irrevocably waive, to the fullest extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought in such court. THE PARTIES ALSO EXPRESSLY WAIVE ANY RIGHT THEY HAVE OR MAY HAVE TO A JURY TRIAL OF ANY SUCH SUIT, ACTION OR PROCEEDING. If any one or more provisions of this Section 31 shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Exhibit A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">CEVA, Inc. 2002 Employee Stock Purchase Plan</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>SUBSCRIPTION AGREEMENT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Effective with the Offer Period beginning on:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">&#x2610; &lt;<b>February 1, 20_</b>&gt; <b>or</b> &#x2610; &lt;<b>August 1, 20_</b>&gt;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Personal Information. &lt;</b><b><i>modify data requested as appropriate</i></b><b>&gt;</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Name (Please Print)</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Last) (First) (MI)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Location</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Department</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Street Address</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Daytime Telephone</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">City, State/Country, Zip</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">E-Mail Address</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Social Security No.</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee I.D. No.</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Manager</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mgr Location</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Eligibility</b>. Any Employee whose customary employment is 20 hours or more per week and more than 5 months per calendar year, and who does not hold (directly or indirectly) five percent (5%) or more of the combined voting power of the Company, a parent or a subsidiary, whether in stock or options to acquire stock is eligible to participate in the CEVA, Inc. 2002 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;); provided, however, that Employees who are subject to the rules or laws of a foreign jurisdiction that prohibit or make impractical the participation of such Employees in the ESPP are not eligible to participate.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Definitions</b>. Each capitalized term in this Subscription Agreement shall have the meaning set forth in the ESPP.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Subscription</b>. I hereby elect to participate in the ESPP and subscribe to purchase shares of the Company&#x2019;s Common Stock in accordance with this Subscription Agreement and the ESPP. I have received a complete copy of the ESPP and a prospectus describing the ESPP and understand that my participation in the ESPP is in all respects subject to the terms of the ESPP. The effectiveness of this Subscription Agreement is dependent on my eligibility to participate in the ESPP.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Payroll Deduction Authorization</b>. I hereby authorize payroll deductions from my Compensation during the Offer Period in the percentage specified below (payroll reductions may not exceed 10% of Compensation nor $____ per calendar year):</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Percentage to be Deducted (circle one) 1% 2% 3% 4% 5% 6% 7% 8% 9% 10%</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="text-decoration: underline; ">&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ESPP Accounts and Purchase Price</b>. I understand that all payroll deductions will be credited to my account under the ESPP. No additional payments may be made to my account. No interest will be credited on funds held in the account at any time including any refund of the account caused by withdrawal from the ESPP. All payroll deductions shall be accumulated for the purchase of Company Common Stock at the applicable Purchase Price determined in accordance with the ESPP.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Withdrawal and Changes in Payroll Deduction</b>. I understand that I may discontinue my participation in the ESPP at any time prior to an Exercise Date as provided in Section 10 of the ESPP, but if I do not withdraw from the ESPP, any accumulated payroll deductions will be applied automatically to purchase Company Common Stock. I may increase or decrease the rate of my payroll deductions in whole percentage increments to not less than one percent (1%) on one occasion during any Purchase Period by completing and timely filing a Change of Status Notice. Any increase or decrease will be effective for the full payroll period occurring after five (5) business days from the Company&#x2019;s receipt of the Change of Status Notice.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Perpetual Subscription</b>. I understand that this Subscription Agreement shall remain in effect for successive Offer Periods until I withdraw from participation in the ESPP, or termination of the ESPP.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">9.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Taxes</b>. I have reviewed the ESPP prospectus discussion of the federal tax consequences of participation in the ESPP and consulted with tax consultants as I deemed advisable prior to my participation in the ESPP. I hereby agree to notify the Company in writing within thirty (30) days of any disposition (transfer or sale) of any shares purchased under the ESPP if such disposition occurs within two (2) years of the Enrollment Date (the first day of the Offer Period during which the shares were purchased) or within one (1) year of the Exercise Date (the date I purchased such shares), and I will make adequate provision to the Company for foreign, federal, state or other tax withholding obligations, if any, which arise upon the disposition of the shares. In addition, the Company may withhold from my Compensation any amount necessary to meet applicable tax withholding obligations incident to my participation in the ESPP, including any withholding necessary to make available to the Company any tax deductions or benefits contingent on such withholding.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">10.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Dispute Resolution</b>. The provisions of this Section 10 and Section 31 of the ESPP shall be the exclusive means of resolving disputes arising out of or relating to the Plan. The Company and I, or our respective successors (the &#x201c;parties&#x201d;), shall attempt in good faith to resolve any disputes arising out of or relating to the Plan by negotiation between individuals who have authority to settle the controversy. Negotiations shall be commenced by either party by notice of a written statement of the party&#x2019;s position and the name and title of the individual who will represent the party. Within thirty (30) days of the written notification, the parties shall meet at a mutually acceptable time and place, and thereafter as often as they reasonably deem necessary, to resolve the dispute. If the dispute has not been resolved by negotiation, the Company and I agree that any suit, action, or proceeding arising out of or relating to the Plan shall be brought in the United States District Court for the Northern District of California (or should such court lack jurisdiction to hear such action, suit or proceeding, in a California state court in the County of San Francisco) and that we shall submit to the jurisdiction of such court. The Company and I irrevocably waive, to the fullest extent permitted by law, any objection we may have to the laying of venue for any such suit, action or proceeding brought in such court. THE COMPANY AND I ALSO EXPRESSLY WAIVE ANY RIGHT WE HAVE OR MAY HAVE TO A JURY TRIAL OF ANY SUCH SUIT, ACTION OR PROCEEDING. If any one or more provisions of this Section 10 or Section 28 of the ESPP shall for any reason be held invalid or unenforceable, it is the specific intent of the Company and I that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Designation of Beneficiary</b>. In the event of my death, I hereby designate the following person or trust as my beneficiary to receive all payments and shares due to me under the ESPP: &#x2610;&#xa0;I am single &#x2610;&#xa0;I am married</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Beneficiary (please print)</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Relationship to Beneficiary (if any)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Last) (First) (MI)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Street Address</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">City, State/Country, Zip</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Termination of ESPP</b>. I understand that the Company has the right, exercisable in its sole discretion, to amend or terminate the ESPP at any time, and a termination may be effective as early as an Exercise Date, including the establishment of an alternative date for an Exercise Date within each outstanding Offer Period.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:</p>
			</td>
			<td style="border-bottom:solid 3px #000000;vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Signature:</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">spouse&#x2019;s signature (if beneficiary is other than spouse)</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-A-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Exhibit B</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">CEVA, Inc. 2002 Employee Stock Purchase Plan</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>CHANGE OF STATUS NOTICE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; border-top: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Participant Name (Please Print)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Social Security Number</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="border-bottom:solid 3px #000000;vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"><b>Withdrawal From ESPP</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">I hereby withdraw from the CEVA, Inc. 2002 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) and agree that my option under the applicable Offer Period will be automatically terminated and all accumulated payroll deductions credited to my account will be refunded to me or applied to the purchase of Common Stock depending on the alternative indicated below. No further payroll deductions will be made for the purchase of shares in the applicable Offer Period and I shall be eligible to participate in a future Offer Period only by timely delivery to the Company of a new Subscription Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">&#x2610; <b>Withdrawal and Purchase of Common Stock</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Payroll deductions will terminate, but your account balance will be applied to purchase Common Stock on the next Exercise Date. Any remaining balance will be refunded.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">&#x2610; <b>Withdrawal Without Purchase of Common Stock</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Entire account balance will be refunded to me and no Common Stock will be purchased on the next Exercise Date provided this notice is submitted to the Company ten (10) business days prior to the next Exercise Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">&#x2610; <b>Change in Payroll Deduction</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">I hereby elect to change my rate of payroll deduction under the ESPP as follows (select one):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Percentage to be Deducted (circle one) 1% 2% 3% 4% 5% 6% 7% 8% 9% 10%</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">An increase or a decrease in payroll deduction will be effective for the first full payroll period commencing no fewer than five (5) business days following the Company&#x2019;s receipt of this notice, unless this change is processed more quickly.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-B-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">&#x2610; <b>Change of Beneficiary</b> &#x2610; I am married &#x2610; I am single</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">This change of beneficiary shall terminate my previous beneficiary designation under the ESPP. In the event of my death, I hereby designate the following person or trust as my beneficiary to receive all payments and shares due to me under the ESPP:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Beneficiary (please print)</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Relationship to Beneficiary (if any)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Last) (First) (MI)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Street Address</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">City, State/Country, Zip</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Signature:</p>
			</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align: middle; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">spouse&#x2019;s signature (if beneficiary is other than spouse)</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-B-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; "><a id="appb" title="appb" href="#"></a>APPENDIX B</span></b></p>

<div>&#xa0;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">Exhibit _____</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, INC.</b><br />
<b>2011 STOCK INCENTIVE PLAN</b><br />
<b>(as amended and restated effective May 23, 2023)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Purposes of the Plan</span>. The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company&#x2019;s business. This Plan is intended to replace, in whole or in part, the Prior Plans, and which some of the Prior Plans were automatically terminated and replaced and superseded by this Plan on the date on which this Plan was approved by the Company&#x2019;s stockholders. Any awards granted under the Prior Plans remain in effect pursuant to their terms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">2.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Definitions</span>. The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supersede the definition contained in this Section 2.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Administrator</span>&#x201d; means the Board or any of the Committees appointed to administer the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Affiliate</span>&#x201d; and &#x201c;<span style="text-decoration: underline; ">Associate</span>&#x201d; shall have the respective meanings ascribed to such terms in Rule 12b&#x2011;2 promulgated under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Applicable Laws</span>&#x201d; means the legal requirements relating to the Plan and the Awards, including under applicable provisions of federal securities laws, state corporate and securities laws, the Code, the rules of any applicable stock exchange or national market system, and the rules of any non-U.S. jurisdiction applicable to Awards granted to residents therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Assumed</span>&#x201d; means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing the agreement to assume the Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(e)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Award</span>&#x201d; means the grant of an Option, SAR, Restricted Stock, Restricted Stock Unit or other right or benefit under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(f)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Award A</span>g<span style="text-decoration: underline; ">reement</span>&#x201d; means the written agreement evidencing the grant of an Award executed by the Company and the Grantee, including any amendments thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(g)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Board</span>&#x201d; means the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(h)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Cause</span>&#x201d; means willful misconduct by the Grantee or willful failure by the Grantee to perform his or her responsibilities to the Company (including, without limitation, breach by the Grantee of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Grantee and the Company), as determined by the Company, which determination shall be conclusive. The Grantee shall be considered to have been discharged for Cause if the Company determines, within 30 days after the Grantee&#x2019;s resignation, that discharge for Cause was warranted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Code</span>&#x201d; means the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(j)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Committee</span>&#x201d; means any committee composed of members of the Board appointed by the Board to administer the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(k)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Common Stock</span>&#x201d; means the common stock of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(l)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Company</span>&#x201d; means CEVA, Inc., a Delaware corporation, or any successor entity that adopts the Plan in connection with a Corporate Transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(m)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Consultant</span>&#x201d; means any person (other than an Employee or a Director, solely with respect to rendering services in such person&#x2019;s capacity as a Director) who is engaged by the Company or any Related Entity to render consulting or advisory services to the Company or such Related Entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(n)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Continuin</span>g<span style="text-decoration: underline; "> Directors</span>&#x201d; means members of the Board who either (i) have been Board members continuously for a period of at least twelve (12) months or (ii) have been Board members for less than twelve (12) months and were elected or nominated for election as Board members by at least a majority of the Board members described in clause (i) who were still in office at the time such election or nomination was approved by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(o)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Continuous Service</span>&#x201d; means that the provision of services to the Company or a Related Entity in any capacity of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee, Director or Consultant can be effective under Applicable Laws. A Grantee&#x2019;s Continuous Service shall be deemed to have terminated either upon an actual termination of Continuous Service or upon the entity for which the Grantee provides services ceasing to be a Related Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company, any Related Entity, or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status as long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant (except as otherwise provided in the Award Agreement). Notwithstanding the foregoing, except as otherwise determined by the Administrator, in the event of any spin-off of a Related Entity, service as an Employee, Director or Consultant for such Related Entity following such spin-off shall be deemed to be Continuous Service for purposes of the Plan and any Award under the Plan. An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave. For purposes of each Incentive Stock Option granted under the Plan, if such leave exceeds three (3) months, and reemployment upon expiration of such leave is not guaranteed by statute or contract, then the Incentive Stock Option shall be treated as a Non-Qualified Stock Option on the day three (3) months and one (1) day following the expiration of such three (3) month period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(p)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Corporate Transaction</span>&#x201d; means any of the following transactions, provided, however, that the Administrator shall determine under parts (iv) and (v) whether multiple transactions are related, and its determination shall be final, binding and conclusive:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: -18pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the state in which the Company is incorporated;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;the sale, transfer or other disposition of all or substantially all of the assets of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;the complete liquidation or dissolution of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iv)&#xa0;&#xa0;&#xa0;&#xa0;any reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer followed by a reverse merger) in which the Company is the surviving entity but (A) the shares of Common Stock outstanding immediately prior to such merger are converted or exchanged by virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (B) in which securities possessing more than forty percent (40%) of the total combined voting power of the Company&#x2019;s outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger or the initial transaction culminating in such merger; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(v)&#xa0;&#xa0;&#xa0;&#xa0;acquisition in a single or series of related transactions by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#x2019;s outstanding securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">With respect to Awards that are &#x201c;deferred compensation&#x201d; under Section 409A of the Code, to the extent necessary to avoid incurring adverse tax consequences under Section 409A of the Code with respect to such Awards, each of the foregoing events shall only be deemed to be a Corporate Transaction for purposes of the Plan to the extent such event qualifies as a &#x201c;change in control event&#x201d; for purposes of Section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(q)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Director</span>&#x201d; means a member of the Board or the board of directors of any Related Entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(r)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Disabilit</span>y&#x201d; means as defined under the long-term disability policy of the Company or the Related Entity to which the Grantee provides services regardless of whether the Grantee is covered by such policy. If the Company or the Related Entity to which the Grantee provides service does not have a long-term disability plan in place, &#x201c;Disability&#x201d; means that a Grantee is unable to carry out the responsibilities and functions of the position held by the Grantee by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. A Grantee will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Administrator in its discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(s)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Employee</span>&#x201d; means any person, including an Officer or Director, who is in the employ of the Company or any Related Entity, subject to the control and direction of the Company or any Related Entity as to both the work to be performed and the manner and method of performance. The payment of a director&#x2019;s fee by the Company or a Related Entity shall not be sufficient to constitute &#x201c;employment&#x201d; by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(t)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Exchan</span>g<span style="text-decoration: underline; ">e Act</span>&#x201d; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(u)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Fair Market Value</span>&#x201d; means, as of any date, the value of Common Stock determined as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;If the Common Stock is listed on one or more established stock exchanges or national market systems, including without limitation The NASDAQ Global Select Market, The NASDAQ Global Market or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the Common Stock is listed (as determined by the Administrator) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;If the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;In the absence of an established market for the Common Stock of the type described in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Administrator in good faith and in a manner consistent with Applicable Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(v)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Grantee</span>&#x201d; means an Employee, Director or Consultant who receives an Award under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(w)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Incentive Stock Option</span>&#x201d; means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(x)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Non-Qualified Stock Option</span>&#x201d; means an Option not intended to qualify as an Incentive Stock Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(y)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Officer</span>&#x201d; means a person who is an officer of the Company or a Related Entity within the meaning of Section 16 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(z)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Option</span>&#x201d; means an option to purchase Shares pursuant to an Award Agreement granted under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(aa)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Parent</span>&#x201d; means a &#x201c;parent corporation&#x201d;, whether now or hereafter existing, as defined in Section 424(e) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(bb)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Plan</span>&#x201d; means this 2011 Stock Incentive Plan, (as amended and restated effective May 23, 2023).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(cc)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Prior Plans</span>&#x201d; means the Parthusceva, Inc. (subsequently known as CEVA, Inc.) 2002 Stock Incentive Plan (as amended and restated on May 15, 2007) and the Ceva, Inc. 2003 Director Stock Option Plan (amended and restated on May 15, 2007 and May 17, 2011).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(dd)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Related Entit</span>y&#x201d; means any Parent or Subsidiary of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(ee)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Replaced</span>&#x201d; means that pursuant to a Corporate Transaction the Award is replaced with a comparable stock award or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same (or a more favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator and its determination shall be final, binding and conclusive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(ff)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Restricted Stock</span>&#x201d; means Shares issued under the Plan to the Grantee for such consideration, if any, and subject to such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions as established by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(gg)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Restricted Stock Units</span>&#x201d; means an Award which may be earned in whole or in part upon the passage of time or the attainment of performance criteria established by the Administrator and which may be settled for cash, Shares or other securities or a combination of cash, Shares or other securities as established by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(hh)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Rule 16b</span><span style="text-decoration: underline; ">&#x2011;</span><span style="text-decoration: underline; ">3</span>&#x201d; means Rule 16b&#x2011;3 promulgated under the Exchange Act or any successor thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">SAR</span>&#x201d; means a stock appreciation right entitling the Grantee to Shares or cash compensation, as established by the Administrator, measured by appreciation in the value of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(jj)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Share</span>&#x201d; means a share of the Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(kk)&#xa0;&#xa0;&#xa0;&#xa0;&#x201c;<span style="text-decoration: underline; ">Subsidiar</span>y&#x201d; means a &#x201c;subsidiary corporation&#x201d;, whether now or hereafter existing, as defined in Section 424(f) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Stock Subject to the Plan</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;Subject to the provisions of Section 10, below, the maximum aggregate number of Shares which may be issued pursuant to all Awards is 4,350,000 Shares, plus any Shares which remain available for issuance or that would otherwise return to the Prior Plans as a result of forfeiture, termination or expiration of awards previously granted under the Prior Plans (ignoring the termination or expiration of the Prior Plans for the purpose of determining the number of Shares available for the Plan); provided, however, that the maximum aggregate number of Shares that may be issued pursuant to Incentive Stock Options is 1,467,256 Shares. The Shares to be issued pursuant to Awards may be authorized, but unissued, or reacquired Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily) shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under the Plan. Shares that actually have been issued under the Plan pursuant to an Award shall not be returned to the Plan and shall not become available for future issuance under the Plan, except that if unvested Shares are forfeited, or repurchased by the Company at the lower of their original purchase price or their Fair Market Value at the time of repurchase, such Shares shall become available for future grant under the Plan. Notwithstanding anything to the contrary contained herein: (i) Shares tendered or withheld in payment of an Option exercise price shall not be returned to the Plan and shall not become available for future issuance under the Plan; (ii) Shares withheld by the Company to satisfy any tax withholding obligation shall not be returned to the Plan and shall not become available for future issuance under the Plan; and (iii) all Shares covered by the portion of an SAR that is exercised (whether or not Shares are actually issued to the Grantee upon exercise of the SAR) shall be considered issued pursuant to the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Administration of the Plan</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Plan Administrator</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Administration with Respect to Directors and Officers</span>. With respect to grants of Awards to Directors or Employees who are also Officers or Directors of the Company, the Plan shall be administered by (A) the Board or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions under the Plan to be exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b&#x2011;3. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Administration With Respect to Consultants and Other Employees</span>. With respect to grants of Awards to Employees or Consultants who are neither Directors nor Officers of the Company, the Plan shall be administered by (A) the Board or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board. The Board may authorize one or more Officers to grant such Awards to Employees or Consultants who are neither Directors nor Officers and may limit such authority as the Board determines from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Administration Errors</span>. In the event an Award is granted in a manner inconsistent with the provisions of this subsection (a), such Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Powers of the Administrator</span>. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Administrator hereunder), and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;to determine whether and to what extent Awards are granted hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;to determine the number of Shares or the amount of other consideration to be covered by each Award granted hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iv)&#xa0;&#xa0;&#xa0;&#xa0;to approve forms of Award Agreements for use under the Plan;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(v)&#xa0;&#xa0;&#xa0;&#xa0;to determine the terms and conditions of any Award granted hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(vi)&#xa0;&#xa0;&#xa0;&#xa0;to amend the terms of any outstanding Award granted under the Plan, provided that (A) any amendment that would adversely affect the Grantee&#x2019;s rights under an outstanding Award shall not be made without the Grantee&#x2019;s written consent, provided, however, that an amendment or modification that may cause an Incentive Stock Option to become a Non-Qualified Stock Option shall not be treated as adversely affecting the rights of the Grantee, (B) the reduction of the exercise price of any Option awarded under the Plan and the base appreciation amount of any SAR awarded under the Plan shall be subject to stockholder approval, (C) canceling an Option or SAR at a time when its exercise price or base appreciation amount (as applicable) exceeds the Fair Market Value of the underlying Shares, in exchange for another Option, SAR, Restricted Stock, or other Award or for cash shall be subject to stockholder approval, unless the cancellation and exchange occurs in connection with a Corporate Transaction, or (D) take any other action that is considered a &#x201c;repricing&#x201d; for purposes of the shareholder approval rules of the applicable securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, without the requisite prior affirmative approval of the stockholders of the Company. Notwithstanding the foregoing, canceling an Option or SAR in exchange for another Option, SAR, Restricted Stock, or other Award with an exercise price, purchase price or base appreciation amount (as applicable) that is equal to or greater than the exercise price or base appreciation amount (as applicable) of the original Option or SAR shall not be subject to stockholder approval;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(vii)&#xa0;&#xa0;&#xa0;&#xa0;to construe and interpret the terms of the Plan and Awards, including without limitation, any notice of award or Award Agreement, granted pursuant to the Plan;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(viii)&#xa0;&#xa0;&#xa0;&#xa0;to grant Awards to Employees, Directors and Consultants employed outside the United States on such terms and conditions different from those specified in the Plan as may, in the judgment of the Administrator, be necessary or desirable to further the purpose of the Plan, and to set forth such terms and conditions in Award Agreements, and to adopt related sub-plans under the Plan; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ix)&#xa0;&#xa0;&#xa0;&#xa0;to take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The express grant in the Plan of any specific power to the Administrator shall not be construed as limiting any power or authority of the Administrator; provided that the Administrator may not exercise any right or power reserved to the Board. Any decision made, or action taken, by the Administrator or in connection with the administration of this Plan shall be final, conclusive and binding on all persons having an interest in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Indemnification</span>. In addition to such other rights of indemnification as they may have as members of the Board or as Officers or Employees of the Company or a Related Entity, members of the Board and any Officers or Employees of the Company or a Related Entity to whom authority to act for the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company to the extent permitted by law on an after-tax basis against all reasonable expenses, including attorneys&#x2019; fees, actually and necessarily incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by the Company) or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct; provided, however, that within thirty (30) days after the institution of such claim, investigation, action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at the Company&#x2019;s expense to defend the same.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Eligibility</span>. Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants. Incentive Stock Options may be granted only to Employees of the Company or a Parent or a Subsidiary of the Company. An Employee, Director or Consultant who has been granted an Award may, if otherwise eligible, be granted additional Awards. Awards may be granted to such Employees, Directors or Consultants who are residing in non-U.S. jurisdictions as the Administrator may determine from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Terms and Conditions of Awards</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Types of Awards</span>. The Administrator is authorized under the Plan to award any type of arrangement to an Employee, Director or Consultant that is not inconsistent with the provisions of the Plan and that by its terms involves or might involve the issuance of (i) Shares, (ii) cash or (iii) an Option, a SAR, or similar right with a fixed or variable price related to the Fair Market Value of the Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions. Such awards include, without limitation, Options, SARs, sales or bonuses of Restricted Stock, or Restricted Stock Units, and an Award may consist of one such security or benefit, or two (2) or more of them in any combination or alternative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Desi</span>g<span style="text-decoration: underline; ">nation of Award</span>. Each Award shall be designated in the Award Agreement. In the case of an Option, the Option shall be designated as either an Incentive Stock Option or a Non-Qualified Stock Option. However, notwithstanding such designation, an Option will qualify as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded. The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value of the Shares subject to Options designated as Incentive Stock Options which become exercisable for the first time by a Grantee during any calendar year (under all plans of the Company or any Parent or Subsidiary of the Company). For purposes of this calculation, Incentive Stock Options shall be taken into account in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the grant date of the relevant Option. In the event that the Code or the regulations promulgated thereunder are amended after the date the Plan becomes effective to provide for a different limit on the Fair Market Value of Shares permitted to be subject to Incentive Stock Options, then such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Conditions of Award</span>. Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions of each Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of any performance criteria. The performance criteria established by the Administrator may include (by way of example and not as an exhaustive list): (i) increase in share price, (ii) earnings per share, (iii) total stockholder return, (iv) operating margin, (v) gross margin, (vi) return on equity, (vii) return on assets, (viii) return on investment, (ix) operating income, (x) net operating income, (xi) pre-tax profit, (xii) cash flow, (xiii) revenue, (xiv) expenses, (xv) earnings before interest, taxes and depreciation, (xvi) economic value added and/or (xvii) market share. The performance criteria may be applicable to the Company, Related Entities and/or any individual business units of the Company or any Related Entity. Partial achievement of the specified criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the Award Agreement or as otherwise determined by the Administrator. In addition, the performance criteria may, but need not, be calculated in accordance with generally accepted accounting principles and may include such adjustments as determined by the Administrator. Additionally, the Administrator may adjust the performance criteria to take into account the effect (whether positive or negative) of any change in accounting standards, any extraordinary, unusual or nonrecurring item or such other event as determined by the Administrator. Dividends may be granted in connection with Restricted Stock; provided, that dividends will only be paid with respect to Restricted Stock if and to the extent the Award (or portion of the Award to which the dividend relates) vests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Acquisitions and Other Transactions</span>. The Administrator may issue Awards under the Plan in settlement, assumption or substitution for, outstanding awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity, an interest in another entity or an additional interest in a Related Entity whether by merger, stock purchase, asset purchase or other form of transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(e)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Deferral of Award Payment</span>. Subject to compliance with Code Section 409A, the Administrator may establish one or more programs under the Plan to permit selected Grantees the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under an Award. The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the Administrator deems advisable for the administration of any such deferral program.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(f)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Separate Programs</span>. The Administrator may establish one or more separate programs under the Plan for the purpose of issuing particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(g)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Individual Limitations on Awards</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Individual Limit for Options and SARs</span>. The maximum number of Shares with respect to which Options and SARs may be granted to any Grantee in any calendar year shall be 500,000 Shares. In connection with a Grantee&#x2019;s commencement of Continuous Service, a Grantee may be granted Options and SARs for up to an additional 250,000 Shares which shall not count against the limit set forth in the previous sentence. The foregoing limitations shall be adjusted proportionately in connection with any change in the Company&#x2019;s capitalization pursuant to Section 10, below. In applying the foregoing limitations with respect to a Grantee, if any Option or SAR is canceled, the canceled Option or SAR shall continue to count against the maximum number of Shares with respect to which Options and SARs may be granted to the Grantee. For this purpose, the repricing of an Option (or in the case of a SAR, the base amount on which the stock appreciation is calculated is reduced to reflect a reduction in the Fair Market Value of the Common Stock) shall be treated as the cancellation of the existing Option or SAR and the grant of a new Option or SAR.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Individual Limit for Restricted Stock and Restricted Stock Units</span>. For awards of Restricted Stock and Restricted Stock Units, the maximum number of Shares with respect to which such Awards may be granted to any Grantee in any calendar year shall be 500,000. The foregoing limitation shall be adjusted proportionately in connection with any change in the Company&#x2019;s capitalization pursuant to Section 10, below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(h)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Early Exercise</span>. The Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while an Employee, Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or to any other restriction the Administrator determines to be appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Term of Award</span>. The term of each Award shall be no more than ten (10) years from the date of grant thereof. However, in the case of an Incentive Stock Option granted to a Grantee who, at the time the Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, the term of the Incentive Stock Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Award Agreement. Notwithstanding the foregoing, the specified term of any Award shall not include any period for which the Grantee has elected to defer the receipt of the Shares or cash issuable pursuant to the Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(j)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Transferability of Awards</span>. Incentive Stock Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Grantee, only by the Grantee. Other Awards shall be transferable (i) by will and by the laws of descent and distribution and (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the Administrator but only to the extent such transfers are made to family members, to family trusts, to family controlled entities, to charitable organizations, and pursuant to domestic relations orders or agreements, in all cases without payment for such transfers to the Grantee. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee&#x2019;s Award in the event of the Grantee&#x2019;s death on a beneficiary designation form provided by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(k)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Time of Grantin</span>g<span style="text-decoration: underline; "> Awards</span>. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the determination to grant such Award, or such other later date as is determined by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">7.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Award Exercise or Purchase Price, Consideration and Taxes</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Exercise or Purchase Price</span>. The exercise or purchase price, if any, for an Award shall be as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;In the case of an Incentive Stock Option:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt;">(A)&#xa0;&#xa0;&#xa0;&#xa0;granted to an Employee who, at the time of the grant of such Incentive Stock Option owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, the per Share exercise price shall be not less than one hundred ten percent (110%) of the Fair Market Value per Share on the date of grant; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 90pt;">(B)&#xa0;&#xa0;&#xa0;&#xa0;granted to any Employee other than an Employee described in the preceding paragraph, the per Share exercise price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;In the case of a Non-Qualified Stock Option, the per Share exercise price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;In the case of SARs, the base appreciation amount shall not be less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iv)&#xa0;&#xa0;&#xa0;&#xa0;In the case of other Awards, such price as is determined by the Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(v)&#xa0;&#xa0;&#xa0;&#xa0;Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue such Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Consideration</span>. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase of an Award including the method of payment, shall be determined by the Administrator. In addition to any other types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration for Shares issued under the Plan the following, provided that the portion of the consideration equal to the par value of the Shares must be paid in cash or other legal consideration permitted by the Delaware General Corporation Law:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;cash;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;check;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;surrender of Shares or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require which have a Fair Market Value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which said Award shall be exercised;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(iv)&#xa0;&#xa0;&#xa0;&#xa0;with respect to Options, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(v)&#xa0;&#xa0;&#xa0;&#xa0;with respect to Options, payment through a &#x201c;net exercise&#x201d; such that, without the payment of any funds, the Grantee may exercise the Option and receive the net number of Shares equal to (i) the number of Shares as to which the Option is being exercised, multiplied by (ii) a fraction, the numerator of which is the Fair Market Value per Share (on such date as is determined by the Administrator) less the exercise price per Share, and the denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest whole number of Shares); or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(vi)&#xa0;&#xa0;&#xa0;&#xa0;any combination of the foregoing methods of payment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Administrator may at any time or from time to time, by adoption of or by amendment to the standard forms of Award Agreement described in Section 4(b)(iv), or by other means, grant Awards which do not permit all of the foregoing forms of consideration to be used in payment for the Shares or which otherwise restrict one or more forms of consideration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Taxes</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;No Shares shall be delivered under the Plan to any Grantee or other person until such Grantee or other person has made arrangements acceptable to the Administrator for the satisfaction of any U.S. and non-U.S., federal, state, or local income and employment tax withholding obligations, including, without limitation, obligations incident to the receipt of Shares. Upon exercise or vesting of an Award the Company shall withhold or collect from the Grantee an amount sufficient to satisfy such tax obligations, by surrender of the whole number of Shares covered by the Award (or through such other arrangement elected by Grantee in accordance with the terms of the Plan) sufficient to satisfy the minimum applicable tax withholding obligations incident to the exercise or vesting of an Award (reduced to the lowest whole number of Shares if such number of Shares withheld would result in withholding a fractional Share with any remaining tax withholding settled in cash).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 81pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;The Plan and Awards (and payments and benefits thereunder) are intended to be exempt from, or to comply with, Section&#xa0;409A, and, accordingly, to the maximum extent permitted, the Plan, Award Agreements and other agreements or arrangements relating to Awards shall be interpreted accordingly. &#xa0;Notwithstanding anything to the contrary, to the extent required to avoid accelerated taxation and/or tax penalties under Section&#xa0;409A, (A) a Grantee shall not be considered to have terminated Continuous Service and no payment or benefit shall be due to the Grantee under the Plan or an Award until the Grantee would be considered to have incurred a &#x201c;separation from service&#x201d; from the Company and the Related Entities within the meaning of Section&#xa0;409A and (B) if the Grantee is a &#x201c;specified employee&#x201d; (as defined in Section&#xa0;409A), amounts that would otherwise be payable and benefits that would otherwise be provided under the Plan or an Award during the six-month period immediately following the Grantee&#x2019;s separation from service shall instead be paid or provided on the first business day after the date that is six months following the Grantee&#x2019;s separation from service (or death, if earlier). &#xa0;Each amount to be paid or benefit to be provided under the Plan or an Award shall be construed as a separate identified payment for purposes of Section&#xa0;409A. &#xa0;The Company makes no representation that any or all of the payments or benefits provided under the Plan or an Award will be exempt from or comply with Section&#xa0;409A and makes no undertaking to preclude Section&#xa0;409A from applying to any such payment or benefit. &#xa0;The Grantee shall be solely responsible for the payment of any taxes and penalties incurred under Section&#xa0;409A, and the Company, the Related Entities and their respective employees, officers, directors, agents and representatives (including legal counsel) will not have any liability to any Grantee with respect to any taxes, penalties, interest or other costs or expenses the Grantee or any related party may incur with respect to or as a result of Section&#xa0;409A or for damages for failing to comply with Section&#xa0;409A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Exercise of Award</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Procedure for Exercise; Rights as a Stockholder</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the terms of the Plan and specified in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised has been made, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase price as provided in Section 7(b)(iv).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Exercise of Award Following Termination of Continuous Service</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&#xa0;&#xa0;&#xa0;&#xa0;An Award may not be exercised after the termination date of such Award set forth in the Award Agreement and may be exercised following the termination of a Grantee&#x2019;s Continuous Service only to the extent provided in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&#xa0;&#xa0;&#xa0;&#xa0;Where the Award Agreement permits a Grantee to exercise an Award following the termination of the Grantee&#x2019;s Continuous Service for a specified period, the Award shall terminate to the extent not exercised on the last day of the specified period or the last day of the original term of the Award, whichever occurs first.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(iii)&#xa0;&#xa0;&#xa0;&#xa0;Any Award designated as an Incentive Stock Option to the extent not exercised within the time permitted by law for the exercise of Incentive Stock Options following the termination of a Grantee&#x2019;s Continuous Service shall convert automatically to a Non-Qualified Stock Option and thereafter shall be exercisable as such to the extent exercisable by its terms for the period specified in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">9.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Conditions Upon Issuance of Shares</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;If at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision of an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares pursuant to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and shall be further subject to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation to effect any registration or qualification of the Shares under federal or state laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">10.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Adjustments Upon Changes in Capitalization</span>. Subject to any required action by the stockholders of the Company and Section 11 hereof, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the Plan, the exercise or purchase price of each such outstanding Award, the maximum number of Shares with respect to which Awards may be granted to any Grantee in any calendar year, as well as any other terms that the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Shares, or similar transaction affecting the Shares, (ii) any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company, or (iii) any other transaction with respect to Common Stock including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution of stock or property), reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however that conversion of any convertible securities of the Company shall not be deemed to have been &#x201c;effected without receipt of consideration.&#x201d; In the event of any distribution of cash or other assets to stockholders other than a normal cash dividend, the Administrator shall also make such adjustments as provided in this Section 10 or substitute, exchange or grant Awards to effect such adjustments (collectively &#x201c;adjustments&#x201d;). Any such adjustments to outstanding Awards will be effected in a manner that precludes the enlargement of rights and benefits under such Awards. In connection with the foregoing adjustments, the Administrator may, in its discretion, prohibit the exercise of Awards or other issuance of Shares, cash or other consideration pursuant to Awards during certain periods of time. Except as the Administrator determines, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">11.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Corporate Transactions</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Termination of Award to Extent Not Assumed in Corporate Transaction</span>. Effective upon the consummation of a Corporate Transaction, all outstanding Awards under the Plan shall terminate. However, all such Awards shall not terminate to the extent they are Assumed in connection with the Corporate Transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Acceleration of Award Upon Corporate Transaction</span>. Except as provided otherwise in an individual Award Agreement, in the event of a Corporate Transaction, for the portion of each Award that is neither Assumed nor Replaced, such portion of the Award shall automatically become fully vested and exercisable and be released from any repurchase or forfeiture rights (other than repurchase rights exercisable at Fair Market Value) for all of the Shares (or other consideration) at the time represented by such portion of the Award, immediately prior to the specified effective date of such Corporate Transaction, provided that the Grantee&#x2019;s Continuous Service has not terminated prior to such date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Effect of Acceleration on Incentive Stock Options</span>. Any Incentive Stock Option the vesting of which is accelerated under this Section 10 in connection with a Corporate Transaction shall remain exercisable as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">12.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Effective Date and Term of Plan</span>. The Plan is effective upon the earlier to occur of its adoption by the Board or its approval by the stockholders of the Company and shall remain effective until May 23, 2033 unless sooner terminated. Subject to Section 17, below, and Applicable Laws, Awards may be granted under the Plan upon its becoming effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">13.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Amendment, Suspension or Termination of the Plan</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;The Board may at any time amend, suspend or terminate the Plan; provided, however, that no such amendment shall be made without the approval of the Company&#x2019;s stockholders to the extent such approval is required by Applicable Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;No Award may be granted during any suspension of the Plan or after termination of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(c)&#xa0;&#xa0;&#xa0;&#xa0;No suspension or termination of the Plan (including termination of the Plan under Section 11, above) shall adversely affect any rights under Awards already granted to a Grantee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">14.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Reservation of Shares</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt;">(b)&#xa0;&#xa0;&#xa0;&#xa0;The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&#x2019;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">15.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">No Effect on Terms of Employment/Consulting Relationship</span>. The Plan shall not confer upon any Grantee any right with respect to the Grantee&#x2019;s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or any Related Entity to terminate the Grantee&#x2019;s Continuous Service at any time, with or without cause, including, but not limited to, Cause, and with or without notice. The ability of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way affected by its determination that the Grantee&#x2019;s Continuous Service has been terminated for Cause for the purposes of this Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">16.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">No Effect on Retirement and Other Benefit Plans</span>. Except as specifically provided in a retirement or other benefit plan of the Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan is not a &#x201c;Pension Plan&#x201d; or &#x201c;Welfare Plan&#x201d; under the Employee Retirement Income Security Act of 1974, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">17.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Stockholder Approval</span>. The grant of Incentive Stock Options under the Plan shall be subject to approval by the stockholders of the Company within twelve (12) months before or after the date the Plan is adopted excluding Incentive Stock Options issued in substitution for outstanding Incentive Stock Options pursuant to Section 424(a) of the Code. Such stockholder approval shall be obtained in the degree and manner required under Applicable Laws. The Administrator may grant Incentive Stock Options under the Plan prior to approval by the stockholders, but until such approval is obtained, no such Incentive Stock Option shall be exercisable. In the event that stockholder approval is not obtained within the twelve (12) month period provided above, all Incentive Stock Options previously granted under the Plan shall be exercisable as Non-Qualified Stock Options.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">18.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Unfunded Obligation</span>. Grantees shall have the status of general unsecured creditors of the Company. Any amounts payable to Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the Employee Retirement Income Security Act of 1974, as amended. Neither the Company nor any Related Entity shall be required to segregate any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times beneficial ownership of any investments, including trust investments, which the Company may make to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account shall not create or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee&#x2019;s creditors in any assets of the Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes in the value of any assets that may be invested or reinvested by the Company with respect to the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">19.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Construction</span>. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term &#x201c;or&#x201d; is not intended to be exclusive, unless the context clearly requires otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">20.&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline; ">Nonexclusivity of the Plan</span>. Neither the adoption of the Plan by the Board, the submission of the Plan to the stockholders of the Company for approval, nor any provision of the Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of Awards otherwise than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-15</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ceva-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 09:55PM UTC 2023-04-10--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ceva="http://www.ceva-dsp.com/20221231" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ceva-dsp.com/20221231">
  <xsd:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei-sub/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ceva_NEOEquityAwardAdjustmentsMember" name="NEOEquityAwardAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" name="NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" name="NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" name="NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOTotalEquityAwardAdjustmentsMember" name="NEOTotalEquityAwardAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" name="NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" name="NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" name="NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" name="NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOEquityAwardAdjustmentsMember" name="PEOEquityAwardAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" name="PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" name="PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" name="PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOTotalEquityAwardAdjustmentsMember" name="PEOTotalEquityAwardAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" name="PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" name="PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" name="PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" name="PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ceva-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 09:55PM UTC 2023-04-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOEquityAwardAdjustmentsMember" xlink:label="ceva_PEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOEquityAwardAdjustmentsMember" xlink:label="ceva_NEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ceva-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 09:55PM UTC 2023-04-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:to="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</link:label>
    <link:label xlink:label="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]</link:label>
    <link:label xlink:label="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:to="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOEquityAwardAdjustmentsMember" xlink:label="ceva_NEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Equity Award Adjustments [Member]</link:label>
    <link:label xlink:label="ceva_NEOEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Equity Award Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOEquityAwardAdjustmentsMember" xlink:to="ceva_NEOEquityAwardAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:to="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:to="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</link:label>
    <link:label xlink:label="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:to="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]</link:label>
    <link:label xlink:label="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:to="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOEquityAwardAdjustmentsMember" xlink:label="ceva_PEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Equity Award Adjustments [Member]</link:label>
    <link:label xlink:label="ceva_PEOEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Equity Award Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOEquityAwardAdjustmentsMember" xlink:to="ceva_PEOEquityAwardAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:to="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]</link:label>
    <link:label xlink:label="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:to="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_PEOTotalEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Equity Award Adjustments [Member]</link:label>
    <link:label xlink:label="ceva_PEOTotalEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Total Equity Award Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:to="ceva_PEOTotalEquityAwardAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOTotalEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Total Equity Award Adjustments [Member]</link:label>
    <link:label xlink:label="ceva_NEOTotalEquityAwardAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Total Equity Award Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:to="ceva_NEOTotalEquityAwardAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]</link:label>
    <link:label xlink:label="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:to="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember-label" xlink:type="arc"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:label xlink:label="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]</link:label>
    <link:label xlink:label="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:to="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ceva-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 09:55PM UTC 2023-04-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpDisclosure" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOEquityAwardAdjustmentsMember" xlink:label="ceva_PEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:label="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOEquityAwardAdjustmentsMember" xlink:label="ceva_NEOEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:label="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:label="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:label="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="locator"/>
    <link:loc xlink:href="ceva-20221231.xsd#ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:label="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:type="locator"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_PEOTotalEquityAwardAdjustmentsMember" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="ceva_NEOTotalEquityAwardAdjustmentsMember" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>i01.jpg
<TEXT>
begin 644 i01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MY\KK_O@?XT?;V_Y\KK_O@?XT 9W_  A/A@Z&-&/A_3CI@D,HM#;(8P_]X+C
M/O4]QX6T&ZT)-%N-&L9-+CQLLVMU,2XZ87&!5K[>W_/E=?\ ? _QH^WM_P ^
M5U_WP/\ &@#/F\%^&+A[=Y_#^FR-:V_V:!FM4)BBP1L7CA<$C'O2S>#?#5Q#
M817&@Z=+'IP LU>V1A;@<@)D<5?^WM_SY77_ 'P/\:/M[?\ /E=?]\#_ !H
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ME=?]\#_&C[>W_/E=?]\#_&@#.O\ P3X7U2\N+O4O#VFW5Q=*%GFEM49I ,$
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M1110 4444 5(_P#D+W'_ %QC_F]6ZJ1_\A>X_P"N,?\ -ZMT %%%% !1110
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MW+1*4 F$D>T'!(&5.>O8Y%6H=#U"RTS0'4)<7.E$^9#OP&5D9"%8]UW#&<9
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MHJ'[)'ZR?]_&_P :/LD?K)_W\;_&@":BH?LD?K)_W\;_ !H^R1^LG_?QO\:
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M();9&N!D]ZYJE2G*%HK7^OZ\S:,9IW;+-%%%<IJ%%%% !1110 4444 %%%%
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M_'SIUI-G_GI K?S%9L_@7PK<_P"N\.Z8WTM4'\A7#[QV<V ?V)+YI_H1V_Q
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MD;!=8<-F,,1D[<<TVW^'7ARUM);:""\6*23SB/[1N"5DR3O4[\JQ).2,$]Z
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M1M\IX;_9]?:O$_ 5CX9\0:_9V]VN@W9FA,CV<7AV2 @[<X$K?+P?SH ]XHH
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M?B!-;>54@,7E@'ELYS^%;%>=^'-;T_P]8ZAJ.K3^1;1A 2%+,S$\*J@$L3V
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M>'UK?66?:/\ 1^W]\5@+]]?K73+]Q?I730ZE(A\V?_GV_P#'Q1YL_P#S[?\
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M/!9M$IEN$F.(F7#$ $@_>(QWQ4K"T8NZB+E1L_V1-_>3\S_A1_9$W]Y/S/\
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M<]"1SCIBN<O?AG=W5J(+>[L+&.[TY--OX8+=R@A20LIBRV5;!(.[/7->C44
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>Z** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>i02.jpg
<TEXT>
begin 644 i02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MP&/C?O+'.3SCH!Q[U2LOC1XMU::76](TX7FF1Z@;9=(M]*N999( <&7[0JE
MXSG;0![Y12*=R@C(R,\TM !1110 4444 %%%% !1110 4444 %%%% !1110
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ME>UU76+;2I[O[9+HT-UMM7ESG. -P&0. <<5Z'10  8&!1110 4444 %%%%
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M+1;Z".9E$5K!)"4/SLZ,J'UXD* ^S'-=%X@L;B:^\-P/;P:BZ22"7[4,1L1
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MQH^QP?W/_'C0!/14'V.#^Y_X\:/L<']S_P >- $]%0?8X/[G_CQH^QP?W/\
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M+4'EW'_/P/\ OW_]>CR[C_GX'_?O_P"O7I%D]%0>7<?\_ _[]_\ UZ/+N/\
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M5$"HH50,  8 HM)A[3!4O@@YO^\[+[E_F>5?\(_\5?$_.LZ_:^'[9NL-D,R
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MOI8Z.Q[.,_>TX8E=59^J_P U9ENBBBK/-"BBB@ HHHH **** "BBB@ HHHH
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M^?>;\A_C1]I/_/O-^0_QH GHJ#[2?^?>;\A_C1]I/_/O-^0_QH GHJ#[2?\
MGWF_(?XT?:3_ ,^\WY#_ !H 9J?_ "";S_K@_P#Z":\F/WC]:]3U*X)TJ['D
M2C,#\D#^Z?>O+#U->-F/Q1,I[A6OX6_Y&6T^I_\ 03616KX9;;XBM3M9N3PO
M7[IK@H_Q8^J)6YZ=7+_$;PW_ ,)5X$U#3T3=<*GG6W_71>0/QY'XUT/VD_\
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M9[&W^PSHR+' 0\AECD4+)N#7(D*,6$NW )&1DUZ__:5K_P ]#_WR:/[2M?\
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MD;/YOE!3B+*%=V[.?X:J:#\0M6\0:+>W5G9Z&+FU2.9X)-2G0)$RL2[%K<'
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M0 4444 %%%% !1110!F^(?\ D7[O_<_J*\NKU'Q#_P B_=_[G]17EU>)F/\
M$7H93W"M/0/^0L/]QJS*T] _Y"P_W&KBI?&B5N=11117KFAIZ/\ >?Z?X5JU
ME:/]Y_I_A6K792^ I;!1116HPHHHH JZG_R"+S_K@_\ Z":\F/WC]:]9U/\
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MHHH **** "BBB@ K@F^$.B->'_B8:N-,:?SVT@79^R%L[L;,9VYYQFN]HH
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M S# ..36SIVGVNE:?%96$0BMX1A$!)QSD\GDDDDY-:J_4,14P\E^Z5G?]/\
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M@"G=S>=93QI%*6>-E'[L]2*X ^%]6+'_ $4]?6O2Z*YJV'A6:<NA+BF>9_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>i03.jpg
<TEXT>
begin 644 i03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MNX5T_6-3.N+/'8W]M<P:INWKA()$.TQCL>A /'2@#ZAFO;6WFCAGN88I9?\
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MWE8><&]LGFO?Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *"
M001D'J#110 V.-(EVQ(J+Z*,"A(HT+%$52QRQ QD^]1W4YMX0ZIO8LJ!<XR2
M<=?QJ+S[W_GR7_O^/\* )_L\(55$,>U3N4;1@'UK$\8^#M/\:^%KS0M1>6WM
M[PH99+;:LF58,.2".H]*U//O?^?)?^_X_P *//O?^?)?^_X_PH EM;6*SMTA
MA4 *H7.!EL#&3[U(L4:.SHBJS?>8#!/UJMY][_SY+_W_ !_A1Y][_P ^2_\
M?\?X4 3_ &>';M\F/;NW8VC&?7ZTIBC,HD,:EQP&*C(_&J_GWO\ SY+_ -_Q
M_A1Y][_SY+_W_'^% %AH(G9B\2,6&&)4'(]*&AB8*&C0A/NY4?+]*K^?>_\
M/DO_ '_'^%'GWO\ SY+_ -_Q_A0!86*-%94C50QRP"XS0(8A%Y0C3R_[FT8_
M*J_GWO\ SY+_ -_Q_A1Y][_SY+_W_'^% %@0QAU81J&4;5.T9 ]*41HLC.J*
M';JP')JMY][_ ,^2_P#?\?X4>?>_\^2_]_Q_A0!8$,:LS+&H9_O$*/F^M*D4
M<:;(T55_NJ,"JWGWO_/DO_?\?X4>?>_\^2_]_P ?X4 3BWA5 @AC"J=P4*,
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M%% !1110 4444 %%%% !1110!4U'_4Q?]=XO_0Q5B5_+A=\9VJ3CUQ5?4?\
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M2PA%@B%X9 AMSYHD7Y"QS%LWY&,9QC'.:J6'C.[N[>2_GAC2S,\(B2)CO"M
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M&G-8_9E-LS;V1B3N;=NW$GDG(SDTM_I5GJ30M>1%V@8M$ZR,C(2,'!4@].*
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M"?(\)*LL><YW>9&A^A;UK7O_  Y%J?B!;Z\8M;BS:W,*R.FXEPW.TC(P,8-
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M@U=K*^S36?ANWMKJ<7$T2Q(\H0+O(9<G X%:M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!4U'_ %,7_7>+_P!#%6ZJ:C_J8O\
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ME_[^)_C2-/.[*6TV1BIRI+IP<8R.?>K7F)_>7\Z/,3^\OYT 5OM5S_T#Y?\
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M/_O@5+10!%]F@_YXQ_\ ? H^S0?\\8_^^!4M% $7V:#_ )XQ_P#? H^S0?\
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M%BS,2269F))8DDDDG))J[0 4444 %%%% !1110 4444 %%%% !1110 4444
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M$="HQ@?A4@TZR&H&^%G;B\9=IN!$OF$>F[&<4 6**** "BBB@ HHHH ****
M(+^1HM-N9(SM=(F93Z$ UYR?$^K[C_IC]?05Z)J?_()N_P#K@_\ Z":\F;[Q
M^M>3CYRC*/*[&<V:O_"3ZO\ \_C_ )"K>D^(=4N-7M89KMF1Y55A@<C(KGJO
MZ%_R'K+_ *[I_P"A"N"G5J<Z]Y[]R+L]4HHHKZ4W"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BHS<0BW,YEC$(&XR;AM ]<]*AN-3L+/
M9]KOK:#S!E/-F5=P]1D\T 6J*B%W;FZ^S">+S]N_RMXW;?7'7'O4M !1110
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M8LX=;E#W"N-WF8Y)"?<P">H- '<T444 %%%% !1110 4444 %%%% '!>.O\
MD-0_]<!_Z$U<S73>.O\ D-0_]<!_Z$U<S7S>*_C2,9;A7>>!?^01/_UV/\A7
M!UWG@7_D$3_]=C_(5K@?XR".YT]%%%>^;!1110 4444 %%%% %;4_P#D$W?_
M %P?_P!!->3-]X_6O6=3_P"03=_]<'_]!->3-]X_6O&S'XHF<SF_%C3H+1XF
MN"JM_JHMXWMD8^9 <'K@$8YJ[IE\D7CJRDG?4%4P;) D+MY3$H0%VK@MP>>>
M?RK6I]EK&G:5K=DVIWT%HOFJW[Z0+P&&3S7'2E[T58ZZ5>\8TU"[5]O/Y$MK
M#93Z=J,MO::I!8R/$!8S6]TZJ0'_ 'TZ\,^XD96,GD*3WKO?!*W2>#=/6_CF
MCG5&!$^=V-QP<-R!C& >0, \U*_C'PW'8K>/KVG"W?.V0W*8;!QQSS7-:E\:
MO!6GDK%J$M\X_AM8&;/XG _6OHM%U.Z:Q&)7)"F]_-]+=COJ*\J_X6]K.K<>
M%? VI7@/W99P57Z\ C]:/,^,>N?=CTK0(V[MAV _\?I\RZ&?]G58_P 648^K
M7Y*[/5:S-1\2:)I )U/5K*UQVEG53^6<UY[_ ,*G\1:OSXI\=ZA<*>L-KE5_
M4X_\=K3T[X(^#+%@\]I<7\G4M=3L<GZ+@47EV#V.#A\=5O\ PK]7;\AVI?&S
MP78,4AOIK]Q_#:P,<GZM@?K65_PMS7=7X\*^!=1N@?NS7&57]!C_ ,>KT#3?
M#&A:0H&F:/96I'\4<"AOSQFM6BTNX>VP</@I.7^)_HK?F>5Y^,>N=M*T"-OH
M[ ?^/TG_  J37M7Y\4^.M1N0?O0VV57]3C_QVO5:*.5=0_M"K'^%&,?1+\W=
MGGVF_!+P78,'FLIK^0?Q74[')^BX%=99>%M TV$Q6.BV$",I5@ENOS ]03CG
M\:U:*:BD<]3%5ZOQS;^9FV?AS1-.N5N=/T?3[6=00LL%JB,,]>0,UI444S"4
MI2=Y.X4444$A1110 4444 %%%% !1110 4444 %%%% ' ?$8:E%J&GS:7J5C
M'<O#-%:VU]=?9U21E"F=3_&RAL;3ZY%5? VCVG@S7Y=/&K6D-O<0P00VRW*R
M27]P%)DN"O5"2<8'&%R>U=!XZUC2M,T^"'7?#U[K=K<OLV6]DMPJ-D!0P8C!
M)8 >M4O K^&IK^]30_",_A^ZMT0R_:]/2WD=7W8P022/E/M0!VU8WBW4-2TO
MPO=W6AP1W%^H40QR, &)8#C) )P20,C)P.];-5-3TNRUG3I;#4[=+FVF&'C<
M9![@^Q!Y![4 >9:C\2[RS\".#JMM'KAEGA$UQ:&W,'E(&(DB8D"4Y50H)!+@
MC@&MZ_\ %]VWPZT'4--NHGO-5EL[5[I4#B%I2%=]O3(.X8/&:Z/3_"VD:;X>
MDT6WM%-E,C).KDEI]PPS.W4L1U-0'P7H;R7'FV,;Q7%I#9M"<[1'$24 ]QG@
M]1@4 <)_PFGB2ZN7T6+4%M[BR?4?,U$VR'[2+;;L&T_*,[OFQZ<8ID?Q%U^^
MB_M>(K;6]G_9BR:?Y /VDW04N=Q^88W?+CTYS7?S^"?#ESI5OILVDP-:6S,T
M4?(VEOO<YR=V><GGOFII_"FA7.JVVI3:9;M=VH589-N-H7[O X.W/&1QVH U
MZA:ZB5BK%LCK\A_PJ:B@"#[9#ZM_WPW^%'VR'U;_ +X;_"IZ* //_&TBRZQ"
M4R1Y '((_B;UKG*Z;QU_R&H?^N _]":N9KYO%?QI&,MPKN/!$\<6DSAR0?.[
M*3V'I7#UWG@7_D$3_P#78_R%:X'^,@CN=!]LA]6_[X;_  H^V0^K?]\-_A4]
M%>^;$'VR'U;_ +X;_"C[9#ZM_P!\-_A4]% $'VR'U;_OAO\ "C[9#ZM_WPW^
M%3T4 0?;(?5O^^&_PH^V0^K?]\-_A4DT\5M"TUQ*D42#+/(P55'N37!:[\9O
M#.ES?9=,>;6[TG:L-BNY2?3=T/X9I-I;F]'#U:[M3BV=CJ-U$VEW0!;)A?\
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M4(31-,M[4XP9%7+M]6/)_.MBBFHI&%;&5ZRY92T[+1?<BMJ?_()N_P#K@_\
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MW>D1V#R2'?NRJC+=!\Q]?K0!Z/535-4L]%TR;4-3G$%M" 7<@GJ<  #DDD@
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M *":\F;[Q^M>IZC:QC2[L@R<0OUD;^Z?>O*S]X_6O&S'XHF<PJ_H7_(>LO\
MKNG_ *$*H5>T10VN68.<&9.AQW%>?3^->IGU/5:*A^R1^LG_ '];_&C[)'ZR
M?]_6_P :^I.@FHJ'[)'ZR?\ ?UO\:/LD?K)_W];_ !H FHJ'[)'ZR?\ ?UO\
M:/LD?K)_W];_ !H FHJ'[)'ZR?\ ?UO\:/LD?K)_W];_ !H FHJ'[)'ZR?\
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M5!*@C(W8^7.>U '145XE-XEL!X$@&K:MJ6^&]GMK:V74P4O9 H"[;H;284+
M[F/7KG %;NJZ[+'\.]*T]]>CO+N)K+^V+NTG)Q:N^UY/,7^$XP6!Z9/% 'J%
M%>%RZM.UO'%J6JW4/AM)=3_LZ\%Y(IF*;?LX\T'+X^?;DG=CO3CK.O/>02:K
M>7,/B)1I0T^T$S()D<#[0?+!P^?FW$@[<=J /<J**B9YPQVPJ1V/F8_I0!+1
M4/F7'_/!/^_G_P!:CS+C_G@G_?S_ .M0!Q'CK_D-0_\ 7 ?^A-7,UT?C8N=8
MA\Q I\@<!L_Q-7.5\WBOXTC&6X5T?AO_ (\9?^NG]!7.5T?AO_CQE_ZZ?T%&
M&_B"6YL4445Z9H;>E?\ 'F?][^@J[6=IK2BU/EQ*PW=2^.P]JM^9<?\ /!/^
M_G_UJ[J?PHI$U%0^9<?\\$_[^?\ UJ/,N/\ G@G_ '\_^M5C)J*A\RX_YX)_
MW\_^M1YEQ_SP3_OY_P#6H 9J?_()N_\ K@__ *":\F;[Q^M>IZB\_P#9=WF%
M0/)?)\S_ &3[5Y6?O'ZUXV8_%$SF%6=._P"0G;?]=5_G5:K.G?\ (3MO^NJ_
MSKS8_$C,[*BBBO:-2UI__'ZE;U<_8EA=+L4,?0G%;7F7'_/!/^_G_P!:NJC\
M+*1-14/F7'_/!/\ OY_]:CS+C_G@G_?S_P"M6XR:BH?,N/\ G@G_ '\_^M1Y
MEQ_SP3_OY_\ 6H FHJ'S+C_G@G_?S_ZU'F7'_/!/^_G_ -:@":BH?,N/^>"?
M]_/_ *U'F7'_ #P3_OY_]:@":BH?,N/^>"?]_/\ ZU'F7'_/!/\ OY_]:@":
MBH?,N/\ G@G_ '\_^M1YEQ_SP3_OY_\ 6H FHJ'S+C_G@G_?S_ZU'F7'_/!/
M^_G_ -:@":BF1M(W^LC"?1L_TK'\9W,]IX,U2:TOQITRP'9=F-G$)Z;L*"?Q
MP<=>U &W17AT>N:A-X8M;,7\ILH]9%O>W<^JL]L4,)956Z4!_++XSGD'Y<U4
MNO$%[<:'!-/>ZC9^5HK2:,'O'+7%XMP5X88\[@)M# Y5LX[T >^45%:-*UG"
MUR-LQC4R =FQS^M2T %%%% !1110!SGCQO+\(SS_ -H6^G_9Y8IC+=.RQ-MD
M5MC%><-C''K7,?";^SC/J3Z;K=KJ;M# UW]F,AW3DR,\AW@=2VT8[(,UT7Q$
M6-_!DZR7%Q YFA\EK:!)96E\Q=BJK_+DM@9/2LCX8W]U>"Z-]JE_>226UO<Q
MQWEK#%MCD#$,ICZY((.>A7WH [^D95="K@,K#!!'!%+10!!%8VD-K%;16T2P
MPJ$CC"#:@'8"D2QM8[B2=($$DD:QL<=5&<+].3^=6** &&*,H$,:E5Z+MX%*
M40N'*J67HQ'(IU% !1110 4444 <%XZ_Y#4/_7 ?^A-7,UTWCK_D-0_]<!_Z
M$U<S7S>*_C2,9;A71^&_^/&7_KI_05SE='X;_P"/&7_KI_048;^();FQ1117
MIFAMZ5_QYG_>_H*NU2TK_CS/^]_05=KNI_"BD%%%%6,**** *VI_\@F[_P"N
M#_\ H)KR9OO'ZUZSJ?\ R";O_K@__H)KR9OO'ZUXV8_%$SF)5G3O^0G;?]=5
M_G5:K.G?\A.V_P"NJ_SKS8_$C,[*BBBO:-2UI_\ Q^I6]6#I_P#Q^I6]751^
M%E(****W&%%%% !114*WEJUO+.MS"882PDD$@VIM^]D]L=_2@":BJUUJ5C9:
M>;Z]O;>WLPH8W$LJI& >AW$XQ52X\4:!:36\5WKFFP27*J\"2W<:F56. 5!/
MS GH1UH U**S;3Q'H=_J3Z?8ZSI]S>QE@]M#=(\BE>&RH.1COZ5I4 %%%% !
M1110 4$9&#R*** ((+*UM;-;2WMXX[=!A8E4!0/I4IB0[<HIV?=X^[]*=10
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MJD@J<\8&3Z"M[Q)XC7P_HL-V+?[1<74\5M;0;]@>61@%!;!P.Y.#P* -NBN
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MR[LKR%X7.XXQWJC-\52--M[RVT5W"Z8-4OHWN0K00%]@V\'>QP2!\O ZY.*
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MK!T__C]2MZNJC\+*04445N,**** "O/_ !Q_R'H_^N"_S->@5Y_XX_Y#T?\
MUP7^9KAQ_P#!^9$]CG****\ R.IT#_D$K_OM_.M*LW0/^02O^^W\ZTJ]BE_#
M1HM@K>TW_CPC_'^9K!K>TW_CPC_'^9KJH_$4BU111764%%%% !1110 4444
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M[U[#10 5$R3ECMF4#L/+SC]:EHH A\NX_P">Z_\ ?O\ ^O1Y=Q_SW7_OW_\
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MH JS6TT\$D,DZ[9%*MB/L1CUK#/@>Q/_ "VEKIJ*SG2A/XE<5DSF?^$&L/\
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M36\3!(^\:';E >^W!-=;10 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140428924833344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CEVA, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001173489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140428915198000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><a href="#" id="payv" title="payv"/>Pay Versus Performance</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The compensation committee approves and administers our executive compensation program, which it designs to attract, incentivize, reward, and retain our executive officers. Our program aligns executive pay with shareholder interests and links pay to performance through a blend of short-term and long-term performance measures. In 2022, incentive pay made up 52% of our Chief Executive Officer&#8217;s target total direct compensation and, on average, 37% of our other named executive officers&#8217; target total direct compensation. This high utilization of incentive compensation results in higher total realized pay when our executive officers exceed the compensation committee-approved performance targets. Conversely, failure to achieve the approved targets results in lower realized pay, including the possibility that some awards pay zero at the end of their performance period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between the compensation actually paid to our named executive officers and certain aspects of our financial performance. For further information concerning our pay for performance philosophy and how the Company aligns executive compensation with our performance, please refer to &#8220;<i>Executive Compensation </i>&#8211;<i> Compensation Discussion and Analysis</i>.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Pay-Versus-Performance Table</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 8.7%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 80.7656px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary<br/>
			Compensation<br/>
			Table<br/>
			Total for<br/>
			PEO(1)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 156.234px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation<br/>
			Actually<br/>
			Paid to<br/>
			PEO(2)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 263px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average<br/>
			Summary<br/>
			Compensation<br/>
			Table<br/>
			Total for<br/>
			Non-PEO<br/>
			Named<br/>
			Executive<br/>
			Officers<sup style="vertical-align:top;line-height:120%;">(</sup><sup style="vertical-align:top;line-height:120%;">1)</sup></b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 243px; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average<br/>
			Compensation<br/>
			Actually<br/>
			Paid to<br/>
			Non-PEO<br/>
			Named<br/>
			Executive<br/>
			Officers(2)</b></p>
			</td>
			<td colspan="2" style="vertical-align: bottom; width: 20.6%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of Initial<br/>
			Fixed $100<br/>
			Investment Based<br/>
			On:</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income(5)</b></p>
			</td>
			<td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total Revenues(6)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total<br/>
			Shareholder<br/>
			Return(3)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Peer<br/>
			Group<br/>
			Total<br/>
			Shareholder<br/>
			Return(4)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(c)</p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(d)</p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(e)</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(f)</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(g)</p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(h)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(i)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,064,442</p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,356,748</p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,184,102</p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$848,334</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$95</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$158</p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($23,183,000)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$134,648,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2021</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,900,681</p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,348,206</p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,252,677</p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,398,965</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$160</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$230</p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$396,000</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$122,706,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 8.7%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2020</p>
			</td>
			<td style="vertical-align: top; width: 80.7656px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,046,985</p>
			</td>
			<td style="vertical-align: top; width: 156.234px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,057,919</p>
			</td>
			<td style="vertical-align: top; width: 263px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,284,745</p>
			</td>
			<td style="vertical-align: top; width: 243px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,290,490</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$169</p>
			</td>
			<td style="vertical-align: top; width: 10.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$161</p>
			</td>
			<td style="vertical-align: top; width: 13.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($2,379,000)</p>
			</td>
			<td style="vertical-align: top; width: 13.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$100,326,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported in columns (b) and (d) represent the amount of total compensation reported for the following executives for each corresponding covered year in the &#8220;Total&#8221; column of the table set forth under &#8220;<i>Executive Compensation </i>&#8211;&#8211;<i> Compensation Tables </i>&#8211;<i> 2022 Summary Compensation</i>.&#8221;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PEO: Gideon Wertheizer, our Chief Executive Officer for each of the covered years.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Other Non-PEO named executive officers (Other &#8220;NEOs&#8221;) for each of the covered years: Yaniv Arieli, our Chief Financial Officer, Issachar Ohana, our former EVP, Worldwide Sales, and Michael Boukaya, our Chief Operating Officer.</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 2,064,442<span></span>
</td>
<td class="nump">$ 2,900,681<span></span>
</td>
<td class="nump">$ 3,046,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 1,356,748<span></span>
</td>
<td class="nump">5,348,206<span></span>
</td>
<td class="nump">5,057,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported in columns (c) and (e) represent the amount of &#8220;compensation actually paid&#8221; to our PEO, Mr. Wertheizer, as computed in accordance with Item 402(v) of Regulation S-K, and our other NEOs (Messrs. Arieli, Ohana and Boukaya) for each covered fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for each year to determine the &#8220;compensation actually paid&#8221;:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 6.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 16%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Executive</b></p>
			</td>
			<td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reported</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary Compensation Table Total</b></p>
			</td>
			<td style="vertical-align: bottom; width: 20.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Reported</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Grant Date Fair Value of Equity Awards in Summary Compensation Table(a)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Award Adjustments(b)</b></p>
			</td>
			<td style="vertical-align: bottom; width: 16.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation Actually Paid</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2022</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,064,442</p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($845,081)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$137,387</p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,356,748</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#160;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$1,184,102</td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($397,635)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$61,866</td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$848,334</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2021</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$2,900,681</p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($1,242,867)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,690,392</p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,348,206</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#160;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$1,252,677</td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($532,895)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$1,679,183</td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$2,398,965</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2020</p>
			</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,046,985</p>
			</td>
			<td style="vertical-align: top; width: 20.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($1,989,128)</p>
			</td>
			<td style="vertical-align: top; width: 19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$4,000,062</p>
			</td>
			<td style="vertical-align: top; width: 16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,057,919</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.4%;">&#160;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$1,284,745</td>
			<td style="vertical-align: top; width: 20.5%; text-align: center;">($768,919)</td>
			<td style="vertical-align: top; width: 19.5%; text-align: center;">$1,774,664</td>
			<td style="vertical-align: top; width: 16.5%; text-align: center;">$2,290,490</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">*Presented on an average basis.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(a)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221;&#160;and &#8220;Option Awards&#8221;&#160;columns in the Summary Compensation Table for each covered fiscal year, and were deducted from the applicable reported Summary Compensation Table Total.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:18pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(b)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The equity award adjustments for each covered fiscal year were added to the applicable reported Summary Compensation Table Total and each include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the covered fiscal year that are outstanding and unvested as of the end of the covered fiscal year; (ii) the amount equal to the change as of the end of the covered fiscal year (from the end of the prior fiscal year) in fair value of any equity awards granted in prior fiscal years that are outstanding and unvested as of the end of the covered fiscal year; (iii) for equity awards that are granted and vest in same covered fiscal year, the fair value as of the vesting date; (iv) for equity awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for equity awards that are granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year, the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date that are not otherwise included in the total compensation for the covered fiscal year. The amounts deducted or added in calculating the equity award adjustments are as follows:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 6.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.6%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Executive</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.9%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year End Fair Value of Equity Awards Granted in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12.2%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards</b></p>
			</td>
			<td style="vertical-align: bottom; width: 9.1%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.4%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 11.3%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year</b></p>
			</td>
			<td style="vertical-align: bottom; width: 14%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12.5%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Equity</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Award Adjustments</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$635,382</p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($418,237)</p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($15,286)</p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$64,471</p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$137,387</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#160;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$224,456</td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">($104,730)</td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$50,827</td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">($77,915)</td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$30,772</td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$61,866</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;2021</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$644,622</p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">($5,055)</p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,050,824</p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,690,392</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#160;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$268,434</td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">($10,021)</td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">$1,420,770</td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$1,679,183</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td style="vertical-align: top; width: 11.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align: top; width: 11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$3,155,672</p>
			</td>
			<td style="vertical-align: top; width: 12.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$667,459</p>
			</td>
			<td style="vertical-align: top; width: 9.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 11.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$176,932</p>
			</td>
			<td style="vertical-align: top; width: 11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$4,000,062</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6.3%;">&#160;</td>
			<td style="vertical-align: top; width: 11.6%; text-align: center;">Other NEOs*</td>
			<td style="vertical-align: top; width: 11.9%; text-align: center;">$1,547,785</td>
			<td style="vertical-align: top; width: 12.2%; text-align: center;">$190,542</td>
			<td style="vertical-align: top; width: 9.1%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 11.4%; text-align: center;">$36,338</td>
			<td style="vertical-align: top; width: 11.3%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 14%; text-align: center;">$0</td>
			<td style="vertical-align: top; width: 12.5%; text-align: center;">$1,774,664</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;">*Presented on an average basis.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;"><span style="text-decoration: underline; ">Equity Award Valuations</span>: PSU grant date fair values are calculated using the stock price as of the date of grant assuming target performance. The valuation assumptions<b> </b>used to calculate the fair values of the PSUs held by the PEO and other NEOs that were earned and vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price and performance accrual modifier as of year-end and as of the date of vest (or including the probable outcome of any such awards subject to performance conditions). RSU grant date fair values are calculated using the stock price as of date of grant. The valuation assumptions used to calculate the fair values of the RSUs held by the PEO and other NEOs that vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price as of year-end and as of each vesting date. The fair value of the tranches of Mr. Ohana&#8217;s RSUs that were originally scheduled to vest in 2023, 2024, and 2025 have been calculated and included in the equity award adjustments for 2022 for our non-PEO NEOs, as the vesting of these award tranches was accelerated to December 31, 2022, upon his separation from the Company. PSUs held by Mr. Wertheizer (our PEO) and Mr. Ohana remained outstanding and unvested as of December 31, 2022 and are included above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(3)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cumulative total shareholder return (&#8220;TSR&#8221;) is calculated by dividing the sum of the cumulative amount of dividends during the measurement period, assuming dividend reinvestment, and the difference between our share price at the end of the applicable measurement period and the beginning of the measurement period (December 31, 2019) by our share price at the beginning of the measurement period.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Represents the weighted peer group TSR, weighted according to the respective companies&#8217; stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is S&amp;P Semiconductors Select Index, a published industry index.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The dollar amounts reported represent the amount of net income (loss) reflected in our audited financial statements for each covered fiscal year.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Refers to total revenues as reported in our audited financial statements for each covered fiscal year.</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,184,102<span></span>
</td>
<td class="nump">1,252,677<span></span>
</td>
<td class="nump">1,284,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 848,334<span></span>
</td>
<td class="nump">2,398,965<span></span>
</td>
<td class="nump">2,290,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Pay-versus-Performance table above and the charts below demonstrate that the compensation actually paid to our PEO and other NEOs is generally aligned with our performance for metrics presented in the tabular disclosure over the covered period, including TSR, net income and total revenues.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Company TSR</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">As shown in the chart below, the amount of compensation actually paid to our PEO<b> </b>and the average amount of compensation actually paid to our other NEOs as a group is generally aligned with our TSR relative to the S&amp;P Semiconductor Select Index, in that our compensation actually paid increased for 2021 following our TSR exceeding our peer group TSR in 2020, and our compensation actually paid decreased significantly for 2022 following the significant underperformance of our TSR compared to our peer group in 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i01.jpg" src="i01.jpg"/></p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Net Income</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The chart below illustrates the correlation between compensation actually paid to our PEO and average compensation actually paid to our other NEOs against the Company&#8217;s net income. Our fiscal year 2022 net income was heavily influenced by the impact of a tax charge to record a valuation allowance in 2022, as well as by our decision to cease the development of the Immervision&#160;technology we acquired in 2019 and the related impairment charge, and increased research and development costs. We do not use net income, whether on a GAAP or non-GAAP basis, as a financial performance measure in our executive compensation program, but there is an indirect correlation between our profitability and compensation actually paid through the impact of EPS performance as an incentive plan metric on pay outcomes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i02.jpg" src="i02.jpg"/></p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure [Text Block]</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Compensation Actually Paid and Total Revenue</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The chart below compares the compensation actually paid to our PEO and other NEOs with our revenue performance, the financial metric in our assessment is most important for linking pay and performance in the covered years. Our increase in compensation actually paid from 2020 to 2021 correlated with our 23% year-over-year increase in total revenues from 2020 to 2021. However in 2022, despite a 10% increase in revenues, compensation actually paid declined due to lower incentive plan payouts and stock price declines.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="i03.jpg" src="i03.jpg"/></p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List [Table Text Block]</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;"><b><i>Financial Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our compensation philosophy seeks to create a performance-oriented environment by rewarding executive officers for the achievement of our business objectives, both short-term and long-term. We believe that our executive officers&#8217; compensation should not be based on the short-term performance of our stock, whether favorable or unfavorable, but rather that the price of our stock will, in the long-term, reflect our operating performance and ultimately the management of the company by our executive officers.&#160;For the most recently completed fiscal year, our key performance measures, in no particular order, were:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Total revenues</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Total licensing, NRE and related revenues</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Non-GAAP earnings per share</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (23,183,000)<span></span>
</td>
<td class="nump">$ 396,000<span></span>
</td>
<td class="num">$ (2,379,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">134,648,000<span></span>
</td>
<td class="nump">122,706,000<span></span>
</td>
<td class="nump">100,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure [Axis]: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Total revenues<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure [Axis]: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Total licensing, NRE and related revenues<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure [Axis]: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Non-GAAP earnings per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember', window );">PEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (845,081)<span></span>
</td>
<td class="num">$ (1,242,867)<span></span>
</td>
<td class="num">$ (1,989,128)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOEquityAwardAdjustmentsMember', window );">PEO Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">137,387<span></span>
</td>
<td class="nump">3,690,392<span></span>
</td>
<td class="nump">4,000,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember', window );">NEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(397,635)<span></span>
</td>
<td class="num">(532,895)<span></span>
</td>
<td class="num">(768,919)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOEquityAwardAdjustmentsMember', window );">NEO Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">61,866<span></span>
</td>
<td class="nump">1,679,183<span></span>
</td>
<td class="nump">1,774,664<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember', window );">PEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">635,382<span></span>
</td>
<td class="nump">644,622<span></span>
</td>
<td class="nump">3,155,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember', window );">PEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(418,237)<span></span>
</td>
<td class="num">(5,055)<span></span>
</td>
<td class="nump">667,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember', window );">PEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember', window );">PEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(15,286)<span></span>
</td>
<td class="nump">3,050,824<span></span>
</td>
<td class="nump">176,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember', window );">PEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">64,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember', window );">PEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_PEOTotalEquityAwardAdjustmentsMember', window );">PEO Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">137,387<span></span>
</td>
<td class="nump">3,690,392<span></span>
</td>
<td class="nump">4,000,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember', window );">NEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">224,456<span></span>
</td>
<td class="nump">268,434<span></span>
</td>
<td class="nump">1,547,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember', window );">NEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(104,730)<span></span>
</td>
<td class="num">(10,021)<span></span>
</td>
<td class="nump">190,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember', window );">NEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">50,827<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember', window );">NEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(77,915)<span></span>
</td>
<td class="nump">1,420,770<span></span>
</td>
<td class="nump">36,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember', window );">NEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">30,772<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember', window );">NEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=ceva_NEOTotalEquityAwardAdjustmentsMember', window );">NEO Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 61,866<span></span>
</td>
<td class="nump">$ 1,679,183<span></span>
</td>
<td class="nump">$ 1,774,664<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOEquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOEquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOEquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOEquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_PEOTotalEquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_PEOTotalEquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ceva_NEOTotalEquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ceva_NEOTotalEquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>ceva20230404_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ceva="http://www.ceva-dsp.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022q4"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:thunderdome="http://www.RDGFilings.com"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ceva-20221231.xsd" xlink:type="simple"/>
    <context id="d_2022-01-01_2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOTotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOEquityAwardAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ceva:PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="NonApplicable">
        <measure>thunderdome:item</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="d_2022-01-01_2022-12-31">0001173489</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="d_2022-01-01_2022-12-31">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="d_2022-01-01_2022-12-31" id="c2">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d_2022-01-01_2022-12-31" id="c3">CEVA, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="d_2022-01-01_2022-12-31" id="c4">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;a href="#" id="payv" title="payv"/&gt;Pay Versus Performance&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;The compensation committee approves and administers our executive compensation program, which it designs to attract, incentivize, reward, and retain our executive officers. Our program aligns executive pay with shareholder interests and links pay to performance through a blend of short-term and long-term performance measures. In 2022, incentive pay made up 52% of our Chief Executive Officer&#x2019;s target total direct compensation and, on average, 37% of our other named executive officers&#x2019; target total direct compensation. This high utilization of incentive compensation results in higher total realized pay when our executive officers exceed the compensation committee-approved performance targets. Conversely, failure to achieve the approved targets results in lower realized pay, including the possibility that some awards pay zero at the end of their performance period.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between the compensation actually paid to our named executive officers and certain aspects of our financial performance. For further information concerning our pay for performance philosophy and how the Company aligns executive compensation with our performance, please refer to &#x201c;&lt;i&gt;Executive Compensation &lt;/i&gt;&#x2013;&lt;i&gt; Compensation Discussion and Analysis&lt;/i&gt;.&#x201d;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Pay-Versus-Performance Table&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 8.7%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 80.7656px; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;br/&gt;
			Compensation&lt;br/&gt;
			Table&lt;br/&gt;
			Total for&lt;br/&gt;
			PEO(1)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 156.234px; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;br/&gt;
			Actually&lt;br/&gt;
			Paid to&lt;br/&gt;
			PEO(2)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 263px; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average&lt;br/&gt;
			Summary&lt;br/&gt;
			Compensation&lt;br/&gt;
			Table&lt;br/&gt;
			Total for&lt;br/&gt;
			Non-PEO&lt;br/&gt;
			Named&lt;br/&gt;
			Executive&lt;br/&gt;
			Officers&lt;sup style="vertical-align:top;line-height:120%;"&gt;(&lt;/sup&gt;&lt;sup style="vertical-align:top;line-height:120%;"&gt;1)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 243px; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average&lt;br/&gt;
			Compensation&lt;br/&gt;
			Actually&lt;br/&gt;
			Paid to&lt;br/&gt;
			Non-PEO&lt;br/&gt;
			Named&lt;br/&gt;
			Executive&lt;br/&gt;
			Officers(2)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: 20.6%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Value of Initial&lt;br/&gt;
			Fixed $100&lt;br/&gt;
			Investment Based&lt;br/&gt;
			On:&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.4%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Net Income(5)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="1" rowspan="2" style="vertical-align: bottom; width: 13.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total Revenues(6)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;br/&gt;
			Shareholder&lt;br/&gt;
			Return(3)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 10.3%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Peer&lt;br/&gt;
			Group&lt;br/&gt;
			Total&lt;br/&gt;
			Shareholder&lt;br/&gt;
			Return(4)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 8.7%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(a)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 80.7656px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(b)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 156.234px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(c)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 263px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(d)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 243px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(e)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(f)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(g)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(h)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(i)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 8.7%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 80.7656px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,064,442&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 156.234px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,356,748&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 263px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,184,102&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 243px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$848,334&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$95&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$158&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($23,183,000)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$134,648,000&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 8.7%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;2021&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 80.7656px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,900,681&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 156.234px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$5,348,206&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 263px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,252,677&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 243px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,398,965&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$160&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$230&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$396,000&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$122,706,000&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 8.7%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;2020&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 80.7656px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,046,985&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 156.234px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$5,057,919&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 263px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,284,745&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 243px;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,290,490&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$169&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 10.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$161&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($2,379,000)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 13.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$100,326,000&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;The dollar amounts reported in columns (b) and (d) represent the amount of total compensation reported for the following executives for each corresponding covered year in the &#x201c;Total&#x201d; column of the table set forth under &#x201c;&lt;i&gt;Executive Compensation &lt;/i&gt;&#x2013;&#x2013;&lt;i&gt; Compensation Tables &lt;/i&gt;&#x2013;&lt;i&gt; 2022 Summary Compensation&lt;/i&gt;.&#x201d;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 9pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;&#x25cf;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;PEO: Gideon Wertheizer, our Chief Executive Officer for each of the covered years.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 9pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;&#x25cf;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;Other Non-PEO named executive officers (Other &#x201c;NEOs&#x201d;) for each of the covered years: Yaniv Arieli, our Chief Financial Officer, Issachar Ohana, our former EVP, Worldwide Sales, and Michael Boukaya, our Chief Operating Officer.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c6"
      unitRef="USD">2064442</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c7"
      unitRef="USD">1356748</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c8"
      unitRef="USD">1184102</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c9"
      unitRef="USD">848334</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="INF"
      id="c10"
      unitRef="USD">95</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="INF"
      id="c11"
      unitRef="USD">158</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c12"
      unitRef="USD">-23183000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="INF"
      id="c13"
      unitRef="Pure">134648000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c14"
      unitRef="USD">2900681</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c15"
      unitRef="USD">5348206</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c16"
      unitRef="USD">1252677</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c17"
      unitRef="USD">2398965</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="INF"
      id="c18"
      unitRef="USD">160</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="INF"
      id="c19"
      unitRef="USD">230</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c20"
      unitRef="USD">396000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="INF"
      id="c21"
      unitRef="Pure">122706000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c22"
      unitRef="USD">3046985</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c23"
      unitRef="USD">5057919</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c24"
      unitRef="USD">1284745</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c25"
      unitRef="USD">2290490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="INF"
      id="c26"
      unitRef="USD">169</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="INF"
      id="c27"
      unitRef="USD">161</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c28"
      unitRef="USD">-2379000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="INF"
      id="c29"
      unitRef="Pure">100326000</ecd:CoSelectedMeasureAmt>
    <ecd:AdjToPeoCompFnTextBlock contextRef="d_2022-01-01_2022-12-31" id="c30">
&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;The dollar amounts reported in columns (c) and (e) represent the amount of &#x201c;compensation actually paid&#x201d; to our PEO, Mr. Wertheizer, as computed in accordance with Item 402(v) of Regulation S-K, and our other NEOs (Messrs. Arieli, Ohana and Boukaya) for each covered fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for each year to determine the &#x201c;compensation actually paid&#x201d;:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: bottom; width: 6.4%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 16%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Executive&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary Compensation Table Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 20.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Grant Date Fair Value of Equity Awards in Summary Compensation Table(a)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 19.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Award Adjustments(b)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 16.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation Actually Paid&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,064,442&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($845,081)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$137,387&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,356,748&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$1,184,102&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%; text-align: center;"&gt;($397,635)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$61,866&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%; text-align: center;"&gt;$848,334&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;2021&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$2,900,681&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($1,242,867)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,690,392&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$5,348,206&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$1,252,677&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%; text-align: center;"&gt;($532,895)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$1,679,183&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%; text-align: center;"&gt;$2,398,965&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;2020&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,046,985&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($1,989,128)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$4,000,062&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$5,057,919&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.4%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$1,284,745&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 20.5%; text-align: center;"&gt;($768,919)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 19.5%; text-align: center;"&gt;$1,774,664&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 16.5%; text-align: center;"&gt;$2,290,490&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"&gt;*Presented on an average basis.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="width:18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align:top;width:18pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;(a)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:top;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;The grant date fair value of equity awards represents the total of the amounts reported in the &#x201c;Stock Awards&#x201d;&#160;and &#x201c;Option Awards&#x201d;&#160;columns in the Summary Compensation Table for each covered fiscal year, and were deducted from the applicable reported Summary Compensation Table Total.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="width:18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align:top;width:18pt;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;(b)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:top;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;The equity award adjustments for each covered fiscal year were added to the applicable reported Summary Compensation Table Total and each include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the covered fiscal year that are outstanding and unvested as of the end of the covered fiscal year; (ii) the amount equal to the change as of the end of the covered fiscal year (from the end of the prior fiscal year) in fair value of any equity awards granted in prior fiscal years that are outstanding and unvested as of the end of the covered fiscal year; (iii) for equity awards that are granted and vest in same covered fiscal year, the fair value as of the vesting date; (iv) for equity awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for equity awards that are granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year, the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the covered fiscal year prior to the vesting date that are not otherwise included in the total compensation for the covered fiscal year. The amounts deducted or added in calculating the equity award adjustments are as follows:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: bottom; width: 6.3%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.6%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Executive&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.9%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year End Fair Value of Equity Awards Granted in Covered Fiscal Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 12.2%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 9.1%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.4%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.3%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 14%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 12.5%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Award Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$635,382&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($418,237)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($15,286)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$64,471&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$137,387&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%; text-align: center;"&gt;$224,456&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%; text-align: center;"&gt;($104,730)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%; text-align: center;"&gt;$50,827&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%; text-align: center;"&gt;($77,915)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%; text-align: center;"&gt;$30,772&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%; text-align: center;"&gt;$61,866&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;2021&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$644,622&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;($5,055)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,050,824&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,690,392&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%; text-align: center;"&gt;$268,434&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%; text-align: center;"&gt;($10,021)&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%; text-align: center;"&gt;$1,420,770&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%; text-align: center;"&gt;$1,679,183&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2020&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$3,155,672&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$667,459&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$176,932&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$4,000,062&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: 6.3%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.6%; text-align: center;"&gt;Other NEOs*&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.9%; text-align: center;"&gt;$1,547,785&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.2%; text-align: center;"&gt;$190,542&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 9.1%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.4%; text-align: center;"&gt;$36,338&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 11.3%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 14%; text-align: center;"&gt;$0&lt;/td&gt;
			&lt;td style="vertical-align: top; width: 12.5%; text-align: center;"&gt;$1,774,664&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;"&gt;*Presented on an average basis.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;"&gt;&lt;span style="text-decoration: underline; "&gt;Equity Award Valuations&lt;/span&gt;: PSU grant date fair values are calculated using the stock price as of the date of grant assuming target performance. The valuation assumptions&lt;b&gt; &lt;/b&gt;used to calculate the fair values of the PSUs held by the PEO and other NEOs that were earned and vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price and performance accrual modifier as of year-end and as of the date of vest (or including the probable outcome of any such awards subject to performance conditions). RSU grant date fair values are calculated using the stock price as of date of grant. The valuation assumptions used to calculate the fair values of the RSUs held by the PEO and other NEOs that vested during or were outstanding as of the end of each covered fiscal year have been adjusted using the stock price as of year-end and as of each vesting date. The fair value of the tranches of Mr. Ohana&#x2019;s RSUs that were originally scheduled to vest in 2023, 2024, and 2025 have been calculated and included in the equity award adjustments for 2022 for our non-PEO NEOs, as the vesting of these award tranches was accelerated to December 31, 2022, upon his separation from the Company. PSUs held by Mr. Wertheizer (our PEO) and Mr. Ohana remained outstanding and unvested as of December 31, 2022 and are included above.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="width: 18pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(3)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;Cumulative total shareholder return (&#x201c;TSR&#x201d;) is calculated by dividing the sum of the cumulative amount of dividends during the measurement period, assuming dividend reinvestment, and the difference between our share price at the end of the applicable measurement period and the beginning of the measurement period (December 31, 2019) by our share price at the beginning of the measurement period.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(4)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;Represents the weighted peer group TSR, weighted according to the respective companies&#x2019; stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is S&amp;amp;P Semiconductors Select Index, a published industry index.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(5)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;The dollar amounts reported represent the amount of net income (loss) reflected in our audited financial statements for each covered fiscal year.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;(6)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="margin: 0pt; text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;Refers to total revenues as reported in our audited financial statements for each covered fiscal year.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c32"
      unitRef="USD">2064442</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c33"
      unitRef="USD">-845081</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c34"
      unitRef="USD">137387</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c35"
      unitRef="USD">1356748</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c36"
      unitRef="USD">1184102</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c37"
      unitRef="USD">-397635</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c38"
      unitRef="USD">61866</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c39"
      unitRef="USD">848334</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c40"
      unitRef="USD">2900681</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c41"
      unitRef="USD">-1242867</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c42"
      unitRef="USD">3690392</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c43"
      unitRef="USD">5348206</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c44"
      unitRef="USD">1252677</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c45"
      unitRef="USD">-532895</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c46"
      unitRef="USD">1679183</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c47"
      unitRef="USD">2398965</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c48"
      unitRef="USD">3046985</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c49"
      unitRef="USD">-1989128</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c50"
      unitRef="USD">4000062</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c51"
      unitRef="USD">5057919</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c52"
      unitRef="USD">1284745</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember"
      decimals="0"
      id="c53"
      unitRef="USD">-768919</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOEquityAwardAdjustmentsMember"
      decimals="0"
      id="c54"
      unitRef="USD">1774664</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2020-01-01_2020-12-31"
      decimals="0"
      id="c55"
      unitRef="USD">2290490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c56"
      unitRef="USD">635382</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c57"
      unitRef="USD">-418237</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="-3"
      id="c58"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c59"
      unitRef="USD">-15286</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="0"
      id="c60"
      unitRef="USD">64471</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c61"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c62"
      unitRef="USD">137387</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c63"
      unitRef="USD">224456</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c64"
      unitRef="USD">-104730</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c65"
      unitRef="USD">50827</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c66"
      unitRef="USD">-77915</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="0"
      id="c67"
      unitRef="USD">30772</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c68"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c69"
      unitRef="USD">61866</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c70"
      unitRef="USD">644622</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c71"
      unitRef="USD">-5055</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="-3"
      id="c72"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c73"
      unitRef="USD">3050824</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="-3"
      id="c74"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c75"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c76"
      unitRef="USD">3690392</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c77"
      unitRef="USD">268434</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c78"
      unitRef="USD">-10021</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="-3"
      id="c79"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c80"
      unitRef="USD">1420770</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="-3"
      id="c81"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c82"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2021-01-01_2021-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c83"
      unitRef="USD">1679183</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c84"
      unitRef="USD">3155672</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c85"
      unitRef="USD">667459</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="-3"
      id="c86"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c87"
      unitRef="USD">176932</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="-3"
      id="c88"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c89"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-PEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c90"
      unitRef="USD">4000062</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember"
      decimals="0"
      id="c91"
      unitRef="USD">1547785</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="c92"
      unitRef="USD">190542</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember"
      decimals="-3"
      id="c93"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember"
      decimals="0"
      id="c94"
      unitRef="USD">36338</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember"
      decimals="-3"
      id="c95"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember"
      decimals="-3"
      id="c96"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2020-01-01_2020-12-31_AdjToCompAxis-NEOTotalEquityAwardAdjustmentsMember"
      decimals="0"
      id="c97"
      unitRef="USD">1774664</ecd:AdjToCompAmt>
    <ecd:TabularListTableTextBlock contextRef="d_2022-01-01_2022-12-31" id="c98">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:-10pt;"&gt;&lt;b&gt;&lt;i&gt;Financial Performance Measures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;Our compensation philosophy seeks to create a performance-oriented environment by rewarding executive officers for the achievement of our business objectives, both short-term and long-term. We believe that our executive officers&#x2019; compensation should not be based on the short-term performance of our stock, whether favorable or unfavorable, but rather that the price of our stock will, in the long-term, reflect our operating performance and ultimately the management of the company by our executive officers.&#160;For the most recently completed fiscal year, our key performance measures, in no particular order, were:&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 9pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;&#x25cf;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;Total revenues&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 9pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;&#x25cf;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;Total licensing, NRE and related revenues&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 9pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;&#x25cf;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;Non-GAAP earnings per share&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:TabularListTableTextBlock>
    <ecd:MeasureName
      contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-1"
      id="c100">Total revenues</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-2"
      id="c101">Total licensing, NRE and related revenues</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="d_2022-01-01_2022-12-31_MeasureAxis-MeasureAxis.domain-3"
      id="c102">Non-GAAP earnings per share</ecd:MeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="d_2022-01-01_2022-12-31" id="c103">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Relationship Between Compensation Actually Paid and Performance Measures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;The Pay-versus-Performance table above and the charts below demonstrate that the compensation actually paid to our PEO and other NEOs is generally aligned with our performance for metrics presented in the tabular disclosure over the covered period, including TSR, net income and total revenues.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;&lt;i&gt;Compensation Actually Paid and Company TSR&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"&gt;As shown in the chart below, the amount of compensation actually paid to our PEO&lt;b&gt; &lt;/b&gt;and the average amount of compensation actually paid to our other NEOs as a group is generally aligned with our TSR relative to the S&amp;amp;P Semiconductor Select Index, in that our compensation actually paid increased for 2021 following our TSR exceeding our peer group TSR in 2020, and our compensation actually paid decreased significantly for 2022 following the significant underperformance of our TSR compared to our peer group in 2021.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;img alt="i01.jpg" src="i01.jpg"/&gt;&lt;/p&gt;
</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="d_2022-01-01_2022-12-31" id="c105">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;&lt;i&gt;Compensation Actually Paid and Net Income&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"&gt;The chart below illustrates the correlation between compensation actually paid to our PEO and average compensation actually paid to our other NEOs against the Company&#x2019;s net income. Our fiscal year 2022 net income was heavily influenced by the impact of a tax charge to record a valuation allowance in 2022, as well as by our decision to cease the development of the Immervision&#160;technology we acquired in 2019 and the related impairment charge, and increased research and development costs. We do not use net income, whether on a GAAP or non-GAAP basis, as a financial performance measure in our executive compensation program, but there is an indirect correlation between our profitability and compensation actually paid through the impact of EPS performance as an incentive plan metric on pay outcomes.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;img alt="i02.jpg" src="i02.jpg"/&gt;&lt;/p&gt;
</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="d_2022-01-01_2022-12-31" id="c107">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;&lt;i&gt;Compensation Actually Paid and Total Revenue&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;The chart below compares the compensation actually paid to our PEO and other NEOs with our revenue performance, the financial metric in our assessment is most important for linking pay and performance in the covered years. Our increase in compensation actually paid from 2020 to 2021 correlated with our 23% year-over-year increase in total revenues from 2020 to 2021. However in 2022, despite a 10% increase in revenues, compensation actually paid declined due to lower incentive plan payouts and stock price declines.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;img alt="i03.jpg" src="i03.jpg"/&gt;&lt;/p&gt;
</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MWD"9@6(C[?9LX+TNTF$+^:H/%#2 -TC+0QL_;.FX0E4=!QKX 1!5VP+*ZEI
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MP%067-MWHGXB/-#.M7PK<GKW&L<##>TP&+L;6+4ODP9?GS3TE^8_T0-<M%%
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MAG'L1@!S*PA##(&W$4<P!: !0\*POP>/[J-@>T\%NS^?Z4]02P,$%     @
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MFM_>3>_CJ%IC'B+VYEY(E>,4QA^T_ )02P,$%     @  X*,5HWW+%JT
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MVO@S7PWOR>834$L! A0#%     @  X*,5@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  #@HQ6*]YI
MP.\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  #@HQ6F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  ."C%9&&<V^<0(  .P&
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  #@HQ6(V&H[T08   MBP  &               @(&U"@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @  X*,5K+WPF_N
M @  B0X   T              ( !+R,  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  #@HQ6EXJ[',     3 @  "P              @ %()@  7W)E;',O
M+G)E;'-02P$"% ,4    "  #@HQ6LDS[;U0!  #% @  #P
M@ $Q)P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @  X*,5HWW+%JT
MB0(  !H              ( !LB@  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @  X*,5FZG)+P> 0  5P0  !,              ( !
MGBD  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      H "@"$ @  [2H

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>60</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>19</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ceva20230404_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ceva20230404_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" original="ceva20230404_def14a.htm">ceva20230404_def14a.htm</File>
    <File>ceva-20221231.xsd</File>
    <File>ceva-20221231_def.xml</File>
    <File>ceva-20221231_lab.xml</File>
    <File>ceva-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>i01.jpg</File>
    <File>i02.jpg</File>
    <File>i03.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022q4</BaseTaxonomy>
    <BaseTaxonomy items="96">http://xbrl.sec.gov/ecd/2022q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ceva20230404_def14a.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022q4": 4,
    "http://xbrl.sec.gov/ecd/2022q4": 96
   },
   "contextCount": 60,
   "dts": {
    "definitionLink": {
     "local": [
      "ceva-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ceva20230404_def14a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ceva-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ceva-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ceva-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_def.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_lab.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_pre.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"
     ]
    }
   },
   "elementCount": 231,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 20,
   "memberCustom": 18,
   "memberStandard": 1,
   "nsprefix": "ceva",
   "nsuri": "http://www.ceva-dsp.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ceva20230404_def14a.htm",
      "contextRef": "d_2022-01-01_2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "995100 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ceva20230404_def14a.htm",
      "contextRef": "d_2022-01-01_2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ceva20230404_def14a.htm",
      "contextRef": "d_2022-01-01_2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "2",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "ceva20230404_def14a.htm",
      "contextRef": "d_2022-01-01_2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 19,
   "tag": {
    "ceva_NEOEquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Equity Award Adjustments",
        "label": "NEO Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "NEOEquityAwardAdjustmentsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year",
        "label": "NEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "NEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year",
        "label": "NEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "NEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table",
        "label": "NEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]"
       }
      }
     },
     "localname": "NEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOTotalEquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Total Equity Award Adjustments",
        "label": "NEO Total Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "NEOTotalEquityAwardAdjustmentsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation",
        "label": "NEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]"
       }
      }
     },
     "localname": "NEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year",
        "label": "NEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "NEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year",
        "label": "NEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "NEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards",
        "label": "NEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]"
       }
      }
     },
     "localname": "NEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOEquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Equity Award Adjustments",
        "label": "PEO Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "PEOEquityAwardAdjustmentsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year",
        "label": "PEO Fair Value as of Vesting Date of Equity Awards Granted and Vested in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "PEOFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year",
        "label": "PEO Fair Value at End of Prior Fiscal Year of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions during Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "PEOFairValueAtEndOfPriorFiscalYearOfEquityAwardsGrantedInPriorFiscalYearsThatFailedToMeetVestingConditionsDuringCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table",
        "label": "PEO Reported Grant Date Fair Value of Equity Awards in Summary Compensation Table [Member]"
       }
      }
     },
     "localname": "PEOReportedGrantDateFairValueOfEquityAwardsInSummaryCompensationTableMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOTotalEquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Total Equity Award Adjustments",
        "label": "PEO Total Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "PEOTotalEquityAwardAdjustmentsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation",
        "label": "PEO Value of Dividends or other Earnings Paid on Stock or Option Awards in Covered Fiscal Year Prior to Vesting Date not Otherwise Included in Total Compensation [Member]"
       }
      }
     },
     "localname": "PEOValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsInCoveredFiscalYearPriorToVestingDateNotOtherwiseIncludedInTotalCompensationMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year",
        "label": "PEO Year End Fair Value of Equity Awards Granted in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "PEOYearEndFairValueOfEquityAwardsGrantedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year",
        "label": "PEO Year over Year Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in Covered Fiscal Year [Member]"
       }
      }
     },
     "localname": "PEOYearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorFiscalYearsThatVestedInCoveredFiscalYearMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ceva_PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards",
        "label": "PEO Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]"
       }
      }
     },
     "localname": "PEOYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember",
     "nsuri": "http://www.ceva-dsp.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the contained file.",
        "label": "Contained File Information, File Description"
       }
      }
     },
     "localname": "ContainedFileInformationFileDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_ContainedFileInformationFileName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the contained file.",
        "label": "Contained File Information, File Name"
       }
      }
     },
     "localname": "ContainedFileInformationFileName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The SEC Document Number of the contained file.",
        "label": "Contained File Information, File Number"
       }
      }
     },
     "localname": "ContainedFileInformationFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_ContainedFileInformationFileType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.).",
        "label": "Contained File Information, File Type"
       }
      }
     },
     "localname": "ContainedFileInformationFileType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentCopyrightInformation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The copyright information for the document.",
        "label": "Document Copyright Information"
       }
      }
     },
     "localname": "DocumentCopyrightInformation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentCreationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different.",
        "label": "Document Creation Date"
       }
      }
     },
     "localname": "DocumentCreationDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the document.",
        "label": "Document Description"
       }
      }
     },
     "localname": "DocumentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases.",
        "label": "Document Effective Date"
       }
      }
     },
     "localname": "DocumentEffectiveDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement",
        "label": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b).",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Text Block]"
       }
      }
     },
     "localname": "DocumentInformationTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_DocumentName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'.",
        "label": "Document Name"
       }
      }
     },
     "localname": "DocumentName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentSubtitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'.",
        "label": "Document Subtitle"
       }
      }
     },
     "localname": "DocumentSubtitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentSynopsis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'",
        "label": "Document Synopsis"
       }
      }
     },
     "localname": "DocumentSynopsis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'.",
        "label": "Document Title"
       }
      }
     },
     "localname": "DocumentTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentVersion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The version identifier of the document.",
        "label": "Document Version"
       }
      }
     },
     "localname": "DocumentVersion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAccountingStandard": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element.",
        "label": "Entity Accounting Standard"
       }
      }
     },
     "localname": "EntityAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses.",
        "label": "Entity Address, Address Description"
       }
      }
     },
     "localname": "EntityAddressAddressDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityContactPersonnelLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Contact Personnel [Line Items]"
       }
      }
     },
     "localname": "EntityContactPersonnelLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityHomeCountryISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element.",
        "label": "Entity Home Country ISO Code"
       }
      }
     },
     "localname": "EntityHomeCountryISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityLegalForm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc.",
        "label": "Entity Legal Form"
       }
      }
     },
     "localname": "EntityLegalForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'.",
        "label": "Entity Listing, Depository Receipt Ratio"
       }
      }
     },
     "localname": "EntityListingDepositoryReceiptRatio",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "pureItemType"
    },
    "dei_EntityListingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security.",
        "label": "Entity Listing, Description"
       }
      }
     },
     "localname": "EntityListingDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingForeign": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt.",
        "label": "Entity Listing, Foreign"
       }
      }
     },
     "localname": "EntityListingForeign",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityListingPrimary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity.",
        "label": "Entity Listing, Primary"
       }
      }
     },
     "localname": "EntityListingPrimary",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'",
        "label": "Entity Listing, Security Trading Currency"
       }
      }
     },
     "localname": "EntityListingSecurityTradingCurrency",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Phone Fax Numbers [Line Items]"
       }
      }
     },
     "localname": "EntityPhoneFaxNumbersLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityReportingCurrencyISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'.",
        "label": "Entity Reporting Currency ISO Code"
       }
      }
     },
     "localname": "EntityReportingCurrencyISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "currencyItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to serve as parent of six Entity related Table concepts.",
        "label": "Entity [Text Block]"
       }
      }
     },
     "localname": "EntityTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r48",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_FormerFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former end date of previous fiscal years",
        "label": "Former Fiscal Year End Date"
       }
      }
     },
     "localname": "FormerFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LegalEntityIdentifier": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI.",
        "label": "Legal Entity Identifier"
       }
      }
     },
     "localname": "LegalEntityIdentifier",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "legalEntityIdentifierItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NameChangeEventDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type.",
        "label": "Name Change Event Date [Axis]"
       }
      }
     },
     "localname": "NameChangeEventDateAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table.",
        "label": "Name Change Event [Line Items]"
       }
      }
     },
     "localname": "NameChangeEventLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period.",
        "label": "Name Change Event [Table]"
       }
      }
     },
     "localname": "NameChangeEventTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherAddressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other address for entity",
        "label": "Other Address [Member]"
       }
      }
     },
     "localname": "OtherAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_ParentEntityLegalName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity",
        "label": "Parent Entity Legal Name"
       }
      }
     },
     "localname": "ParentEntityLegalName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PhoneFaxNumberDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Phone or Fax Number",
        "label": "Phone Fax Number Description"
       }
      }
     },
     "localname": "PhoneFaxNumberDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940.",
        "label": "Registration Statement Amendment Number"
       }
      }
     },
     "localname": "RegistrationStatementAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r56",
      "r68",
      "r84",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r55",
      "r67",
      "r83",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r51",
      "r63",
      "r79",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r52",
      "r64",
      "r80",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r59",
      "r71",
      "r87",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r54",
      "r66",
      "r82",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r101": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r102": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r104": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r105": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r106": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r107": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r109": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r111": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r112": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r113": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r114": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r116": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r117": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r118": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r119": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r121": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r122": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r123": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r124": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r125": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r126": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r127": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r128": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r88": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r98": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r99": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-23-010081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-010081-xbrl.zip
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MDXJ(,-Y#VA#?,7S+B^ S08<+WD3:V/+3LDAT5X3)KR1,H*WZXZ^ 3O%)%V^
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M=O30?"6\F#<_YHM6/?,_4$L#!!0    (  ."C%9WRJCD<08  #Y=   5
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M\'O323L6$6$BY1JS43'F,)JO$YL6JOVJ_+C0/[WY3PWAS49-\FFBXD+$R82
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MM>=@3FG9OG8[+A\A+>=GY2B[GF=:/KYUVU%S^MRW-=1.#\T.V>>7]7ZC_/P
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MVXIZ$)8H!F&Q\6?%/ A+$(.P^/CR_#T(BQN#L,#8T<0@K,09+XXQO$3(M#A
M6U&L7023>(GP=1' M:*8VG@0GEL,PF+CVXIZ$)8H!F&Q\6?%/ A+$(.P^/CR
M_#T(BQN#\'3845,GHXE!>) S7JA:*$T,0A.#\ RP=A%,XB7"UT4 UXIB:N-!
M>&XQ"(N-;ROJ05BB&(3%QI\5\R L00S"XN/+\_<@+&X,P@)C1Q.#L!)GO#C&
M\!(AT^( ;46Q=A%,XB7"UT4 UXIB:N-!>&XQ"(N-;ROJ05BB&(3%QI\5\R L
M00S"XN/+\_<@+&X,PM-AQVR5C$7K9+3 %42.NL?/P;%RS38>#.L7^V1/U3A.
M@!L04\#9YC"-@^@L'XUD,G7M^G-L@K5T6'!?6UY%C#EY'KS@FFVLZ,FN&B^X
MQRT_0XR9C>I=-)UI@2.>&YWII[!^L4]VU?CD,NA,"XPQC<[TC$]VU7C!,NA,
MBYWK\AQXP5/I!0OL7V[T@H7D!0N,,8U>\(Q/=M5XP3+H!8_?6/PD3]1,9W$]
M!/QIWJ]M+/[Q=7#Y/E%IG">>2F%L_#Q4TB=0^,$%?(7_^[?_OI0;'_0W_-5?
M/HY%FDU#P(H^+&VM+T=!.'W_/^=PCJDX4A-Q&H]D]#\?Z-<T^(]ZW]X89_SQ
M0B8!'.#[*$Y&,OP !S4(HO?X,^Q$BF&B^G]_\=]9[+VHFT/\[<\\SCY49N(O
M/XAB/H$3OOA$QR[BOMA#$ +3^/A:PN[&N)/:/50&OLD.\&C69!@,HO<>3*&2
MRIYZGWX[.CCO[HNS\\YY]^SCZ][CK^"LN_?;Z<'Y0?=,=([V1?=?>[]TCKYV
MQ=[QX>'!V=G!\=&3+.MWF0Z#:)#%44OLK^^MB\V-G>W=ZY;R\WAF</J1M_LQ
M'<O(S+8&7'0MN%P;!C[PR_?>YHM/9WN_=/=_^]85[>W.Q]?X\">"12\1KX'H
M>I]>GN: SNUMN=;>:+]ZMG Z./IR?'K8.0>T%*?=?_YV< K4<W D3DZ/__4'
MD]%A]^C\V>[?Q0/A *.,#"=)?#D59QD(#I17 H1!FL,\(HO%F?)0ZL$ +^4K
MY'_94.&7>1)D@4K+ W4O/8KU$1TOPV?;NUO;2PK;T@Q?,#Y7]*:T^5,U"-(,
M50<!,V^^:6]>.?=2[4^*$U UIB+&6'G8+3"9VBU?O9QEV/+>4'D_:'-R/$[B
M,3R9*=&++]\_XLXR4BIZ<0*JTM]?;+P0G@K#L?0Q+LY^!N[MF<^W!\0D\+,A
M_+GQ5[V.M5#UL_<RSV+S11(,AOJ;%Y_^\E]_^:__^ICU8A\4U2R!S_C1-S-?
MJ"0+/!EJMC,"D1,J/8D= =YXD#,SN,<P/$E4&(R""/1S4>%@!%Y<QNO,OV8'
M63R^Z?+OY? +XKG9^AX7PJ#<]MGHDF%+?(D3\5NJ#-<'*V@4I&A=\0$<1^%4
MO)2I "-C%&09LQ"K6+QYJ5Z]W'SUJKI9^)?0ZF[89>CG3H#[J9<?%*_E+%+\
M')P>F@HW-17NJWX 1F!PH7Z""!_XH)<5X^YS%X_%E1U\Z/B<PB1#<0@X 2.$
M:8,4B[2+QT**LYC<8Z#%6$P0>01*3R$MVIL+AQI_@7]9#WI-BMJRZ;M7F8?"
M_/<=FXK!);P5'>4C.!Q/:#?A*3K0YCB27XA(HC/75\'[+ODU"R/A"'YY06Y%
M;PMTBN[W3DL<1-XZ.0:+:1[3+!PF9I*A(G57M,>7'V"C89R\%_^]0?_W0?2D
M]V.0Q(";:]6?&%\$:=):97\O8#/J@]#3BBV$Z0NRA9\+GL"<+_$X40=TK$!0
M^L[&RD/7O"^"2!QDJ=@;@NFHDE=/;1D^1\RYE;-:?V%V*/06[63TB'/H0I^Z
M<]0G*DGCZ&7Z2GP)0F3;%=VN)8*^H(1Z<3[K)'AR%/A9Z74BI^0( TCH_7]1
M2KQDGX$,0_03P 394&;H/@BGKQJOP8)[#8R]<A2+/IQEHO[,@T3YZ_>J=3RQ
MXM @QD_HJ$CA8QGX8IRHBR#.TW *G#L;XF?K9QH9.^;]'&N].?HE/7HO'HUS
M=&'%(,T(F*#6J,MAT LRRRW0OW4 $E!L[KSLO4*_ERA=>: UDVKG5_#J9?N5
MD)$O-M;:[1NC2^EZO')C_AB(!%,)+Y1I^O<7)U\__VH1I:3$N.?/ZD0) 03=
MF%?&^G)^:@>K43Y<+:GR[K"_EL23V2\1I<7)UZ/?#E^4(57^QU7A3CI?NVN?
M3[N=7]<Z7\Z[I^]!FD_D-*WJ9:7=&KUO\U9Z'VMS)1#\LE\/ H3CG0%P?KSW
M+8A^V('](!V'$E3&( +-1:WUPMC[4=;W:+XK8R0F>LODRD'=D7$*GZA^:=7,
MRK-5=?0&FFQ+T-<MD0*3[7^8&W11<\A7TXB8(9+*5+-KGJLL(_">[#Y7V])'
M>^M+>JUZ"Y]$>V=S>T><#:4_%5^3^ (LC%CZ+7&6!YD2VQL;3[>T4R"IBR ,
M54L<@EH0(I??W'BW<^62EO]$CF*0V$2/G2C*T:VK%#GUX!LJS#:,0V"BJ0X(
MR&+14\ ]0Q*JAW(J-K=: *?-K24$4VF&\Y@LWM39,W$IZ^EZ3'/P 1 !(V.#
M_M2=E'X-(KP;?+_UAJ& E^>,"*,"$>8#I26DV%>AG,@$]:UD'"<44=D"T8<V
M=8$KY[E*?3EME9 &7L^ .;_?VA!R?02C=64*Z!H1)V^)BR#)8"F@M5\$DH[G
M +$Y4MEZ"3GM9"1; $?# (:!15S$&0R#I)SFO1%H?7_F6.\HCE+13^(1_#(%
M17 $3PD0J;1R]@ ,96KG0M=IA"$S%T'&*PGQ*F2B>AZL%O7',!X,$%2@7DJ0
MFA@%JY>>#@$PO$H-SW702E\C ''_ZP( #I SZX]B,1Y.4]2ABP7UXZ1\ K!!
MF<'^?'I=C', >W&E6SF^@)Z'+:0!.N<1%@@5D8]C]O'TXS",)_CH"$=-TF7P
M>Y24.1>/@;5=SAHJ<PP4@9$"+ZI6C!Y[M[3:64^"60+ST?EVS;6*2E5/N1:"
M[2L]''I=U]I;][*NJQD,<545 NW D!<J$CY87%X6)S '$%C*[F:/*#P%0@-,
M!^,\8+P$9)3>4*'QCG[*M/!3 C[#"H$$\R@+0GH8B&G[6L:5%"\$@!*YYZDT
MA<4(9%ZT3)@-">1/&(;\X/,N\)?-);#2Y+*Y5.1"H6L7R,:%!'3WR6F-2)DH
M2P*&U6]N;&R*[F@<QE.E6")BH*<'TDN)$U!AQ4M\##TC&VWO0^DG_M+_\*K!
M\6> XUO/&,?;;<$9/*AQ8AS;11URTW,-8C\WQ-Y>'L3N^!<!J!-3UJ^S LTQ
MJL(7ZE)Y.2%OW >E!W1QSTE!:Y#U&2#KSO(@*W!A4,7C$;+?%AFNZ"9?ZP54
MP%4;SI.AHGB \F^.4CV#ZLB17;1VXHS'8&PS;][]D,ZC"3 *AG&.'@//RQ,!
M1@/04QS!6K))C!I\-DQ U9EB;>N&9)X!R;Q9+I*1^#4["LE@U"C^:YQF&%H/
M%/%5]GIR*OXF1^,/XE>9!@J_?2G!+*5T9GBZFT3P.#_Q1YP#27T-XYX,7Z%1
MC&</Y..32I3[ 5K+AHH\IB+R")'KAHKG$C4(Q<2YKSR>9ZO-+K8/J%@UE++\
ME/)VJ2@%@\92B8Z?W!OJW+->G@:12E-$\Q'0".9HJ22<(EX#.BA :U7CPD3Q
MA-U=$+T1^\= ;&.0"53G 66"]/\=YTG$GW$F%?=G@/7\ H!OYM$_!C':BV7B
M(Q.Q_C>,@$GA*0 ^NKJC6/R(XDFH_ 'YD1',E3/CFQ]SK.@HRVK.:GU5+DD0
M5P<Q.=C!7B4.7: WH/$(<;F?HV?35ZF7!#V.JKW*L[D2P#N.B&1[<9Z)SC@)
M0M'>-)=!$WT3,I+PM13%W:2]BNE<P$^R%X3H#L"@5H*@345!+ 56,'-AA:IN
MHJ\L$^!'FV]Y2KY B7@>FAK#Y"6<4P B.LD]OBN"]X;Q! <G?7=*4^#-3DI>
M"_V;)'\R.C5(-4CBB,+NQ[10?(6/V\:;N7PM&P9I%1UH;'Q/DUA")4[(^UVZ
M^QH&L".][I1>P)!^NO*)P\"72*S]()*1ASD:=GA>.U-Y$/7Q.(TZ$R"X54IS
MP697 B]_F<46/C4TDN*(86Z8GA?J"S=+\S.HQ9<*F$6!>=@9F5LJT";2[3&[
M-1]%]/W'9@5/Z">-L:O+JS\&Q*[Y1,KW0Z4;:K* ]:6M?8*) LXVG+9FKJ!;
M'$KJ7MD&T=J8HNPMB,7O2N3)@'A&<6];=T];W'67+I0U0RO=.-_VCOF7>(*&
M-%V<@6&>)YJ% :*P%L"$7XLD+3$.%=X9,!Z!?1[CHREJ86F :CS[;?M86T"'
M4.AKO3(/19L%QJ"+N>B.1(#91H\9(=4$3C:!DTW@Y.T")Y<^:GVF>L2-LU!O
M47?B9Z/5/@-[1 @;S]"LA=>Z>^V!>X3 73.;;[$$1K6U7IQE\>@]J;R8SF>Y
MTM,=TNOTM>B,@D2<R"A/APMQ( ^WV]79Z=XP4'W1M7<7QWQW\;,>IWLL.?)
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M?]E^13=3[+(C+1I_K#%M6V8YI.S)']IT(E**V5U>J]O;:Y7(JET)0=54F).
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MW\R7W(0X?53\V&W+AG;URN**F[4YPEG+Y/E).&DAC,CXUW;<NIBK?VPOSRY
M9)J /Z-+JI)%U@OX9@<)+KUBSSOS]SQ1VL30IK*VIC$=EQ(C*7LO\J;&F2&M
M$X%E 0MI$*6U4EI3\%7)A_-NI*Q70\L<#&>+DZD]E')*>%19;=ROV/1EK?ZV
MD.TXSKC"_Q7%QO.EYP>M'V:Q_-6U-EP18;2@]'I_VAQO&NVX3*(MP&RBTOG>
M&CO$G"WH:B,EG^&3JI-+R'CG7'3K BKVKMM^+EUW=TV9%2RFY@9OK\J-]^_6
MI),)54=0#D1F8MK+)0"*;'M /M NC$O4U(.H"XGG_#K*9N/X]&#4RQ/0_&:\
M-QZL/_9A<VG+DF\+?O1S+X"Y\$/AVF",=P(KV5-6S<RNWMMKI3"86WH''IAH
M%:9V(U;SGIEK7>P;/:AE714<$3 :A_%4%32IJVQQC08*&N:IW#IS3MI@J-A7
M2\PNB2/05Q'B !OID8M'%5GA(R4CN^T\TIJG#O;VKUV@RZ"+Z#ZR;31K1W<1
M%H""V:9%QH,^5!:N#FB!7:_%_;4QP%YE)4!7R^YQ1K\#\F?$FE*PDB91$6&G
M/Y9#[-CBF(ICPJ9A,*9;/[ ?,)["J3G O].Y'<H(Z.=Y5,.\>;R.8VT1CJ4J
M(VLO&[IUF%JZ@E<U(JTP4>KN80S<K]! @39?RE?L+2LB9TC'FHH?$=9P@$=R
M+JR#'^P40$8C3J^1D=CYJ^$&;@#1_'E;XF5/SZI_M<K'/#=I<7-$Y56\).A9
M%8!T1B5I4C/0QP#$HQG%[;C.9\^/;7TH_01,+P7&358Q]W;K ,.8I@&5)S4K
MX %Z"LX-]N&5]U$.P)W1X)CKO_1?,4@X/K?RTNSF^:84PQ+&[! Q54<PD&7N
MY/- B?:#]_K^LER:H)C'#(K9:H)BFJ"850J*F:E0A%*-:FQ9#\2<VBI<2<Z$
MS%Q;O9-Y<Q$_H"-HTM+U,S[S&I.ZHPN5\J4H?U_U:,^/MV46#M(660"H/'R)
MV9,IA^#<(;2\1C>X,H8VS7O_ULM$6SJ;KO'L&$KDIT[:" B/Q M2QM"D]%%[
MC=]HK_', FA3.OS"76S5K$==/,^,"E- I:QJX,E7DY!-, ^I'6,=2H':O+D3
MOO_9BWPG7L,ZXA$Z@J5;O(=*Y\991,6E)SA6&*@+5>1U&7N/)31YLS&\ASWY
M%A'<.IQNKB.,,&JQ.P9,#!M2@LC[$UA9K/\QY3DKO2R7_OX"Y FR^S$::]'
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MCWZ Q06E./.&RL?R[.VMKZ\[M<54Y]01P-SM?\@HQ\KUFV^*4CWC..%$[<$
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MFQT_OQTWZN/=@:DM[%_D1 8!^R=/)&<6'Z2AY-OZ54>P9L?-CI_?CAOE\N[
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M%R P:3!\[%N0\W>;;=,4( $0A7$T6.-U^L[9)BJC!K18^RG*PFF+N@%_3G(
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MATR AX>0*L0I.SWP/L!AJMQ6+%%#=@^W;/_3>IQS^DL.L$"V5AE25V>H.2S
M 0\P2B.I;2J9H&"E9H C/+W";:@[ UV-<?-%J^F!;'?,DLM#WRT]8+5JTT/7
MTPW<YGAGP$BEP+UH#EQ:Y1ZV]:.TQ F*8G'HH9-ZA XY[;EAR>\.'>=90FWG
MV/E'5T&TRHJPIXT=(>BP-C$"9%]Y_(&E+\E&7!?[]F!(M$'RS,B[]C;[KD'N
MEJCR)2J-6M<G53&>H*=/EDK][VS:4O]!FN;*UY>R&=&N[O9MV[F\HAZ'8),2
MC:?Y"% X^(]NF49Z1]'%O.J[XH'[?7(ZP])#4J:U#A(DL]S 8!SH 'UL6D->
M<:[XOH9N_J*A/5"9[QQEI==:2]P$$.U; 4+WVO-Y*Z0Q&90H?'0,)CI?5(B(
MC+,X_D&*/0$BTEW/)%_G$,',4NH ^R ;]"0-1#_K:HQ1!(8&&AA^GAAMJ1^C
MVQ/;%R9Z(0!RJ2^H86T17Q%%MBQV 'P^9>VJ)Z,?:]1/,,8#JXJIXFK*D59X
M5:E9-UTV&8TN'0*?L,("&;WU?)-V3K-24^4#W049P0NX0"NU;;$8--J;WFZ;
MXS+(O[E1GD@#@G11I@5"24M=6WQ+M5F+#EO;MZ*+910_=VDZ-5$A[)M=_E8L
M3U31@TH#O8+)=&)5T<*-.'1W X4:!)B#'AB:U,85>UZ6C$ABF]4QD"5HUL-N
M$+K[@Z',NR =0EH#&L>%B$JUX9@HK5#5RCRSP\:O_JA^]3>-7[WQJS^!7WWQ
M&ZW,B0-^E'8I[1V@(0T-A.?EXY<=_1A\^AT% PBB7U F?'P=?'J@HO/\O-W\
M.]R\'@J LN"QT@RJ7T , J1.C:8Z#UI.5/H#Q)FW'<@M0IAY 2AA_KO+"0O&
MP8,N1]1.L=/7!+#,7C+T%'>^=%PN:SV9*G_]@5-E7.Q[8BB=9=AT'2^?4!W3
M82)NKV,!-E >V::SV(4]FY:-?W077!'XJ/LH@TR\P1CLK2J\##&/ 1+!=H?6
M_GT\,HJZJ9Z>MN@P8 -T4DSR0S=$RPF#*=JCEB)!0,D$;!@DDK3+NE62WHO&
MC6X(;2ZG9M<P4ED2>#5A8&X4[Q;90V9"ZY&\>DLX'_DAT%\.ZBXJWAR2UQ*=
M)%!AT!*?X_R'G$J&_'G\9VY"5FZU]H:QU)+,[\HP$'N3X-XQK!#S>+(+O9I+
MKUO?)%7"^O$^:?8QO%PZF V]+U^9.9=DK;HP?Q[/1![H4/^6O9=S[^/*-W M
MXS>AGJ!TS<57T(QV"%3C-Z8H.PT2\A5?>R'G9F)P>&K10-2&M-5<X?$R;IH.
M43<R<WB=M8%/I#)$G9]#9TV\8"^IW.%PM"Z'*I)S5HT"[;:*V=$Z#-QX7QWQ
M0%?E'$*<N(&2Y'Q,,P8CQP>"_*) C")YI!1[:-S:*KH(DCAB9^_O-T&BFX&A
MSG$.R/$W.1I_Z- 2NV=?K2>=PC#S7AAX161SP[+K&=6>8=0N .EV >D)782)
MSJ*@H]/QY_\_>V^VW#:2K0M?__LI$-[E<Z0(2$U2HH9RM2-DE^U2=]O6L5Q5
MI_^[))@4T08!-@;)ZHO][&<-.0$$J<$2!REW]';9$H9$YIJ';STS27['6;V%
MBID7,7K9MN3#%@7A4YR:?'BNPSDB 2<_HY0G7N>\@^*SW+A ]=<X81>L-1&4
MHE"%Q;,EP71V-)%7U2]3GI<93:1T[J-<3"06)].CAS@Z-DDDYS--=9#Z=/Q*
M$CJ4 24)4?M<NSF(&/$?MDJI  B#";?\3@K,&!5'44LG$TU%4]>F X2:4DI;
MK::_6[4D:(E])0<!2"[,!P2_8)-L+; UQ%X)VI>?67-@*.I5\.+UU=75;B0O
MQ<ZPF.["H_]B5H+U5->__ 4?]7KWX>>AS:5(-Y*S++..(LQ4*L#[W,H"I$JH
M+C\2TQC'D-8+?;#JS^:Q-:D" =Y%.#^JU WFRJY5&=*F/,/V#KA5%5C;)BG#
M!)<\C/C^0;F\+EOXT.TCX8+^D=V 2QC@5SC$7'5D.>S"^1B2?\JEKN7C:YXT
M67@RE2/P:$G&)2@046I3V621C4K5X6N[2%#',*]A/( T#B>N'1=6]<<5H4,Q
M9-RQ(*.9[UBB2'EO( +EX)<Q;0M;H$]:S-7B$15L4,(Q&4KF:_^F9M?/J9)^
M*_,(#NT4PY7O0)%B'1TI.FYL$J[J3V6)G(VW=?O67-6>G6.TXUD5$5OHHU@F
M0ZR6Q*99Y4LB5H1.AU_P#,<+,54/*LP]U'"4Z38EN/XJ R)TEK0;_-8TORE1
MC04PMN/+5#O7ZIL#+GBQ#5#67U ?9,38/)G_U! <WH+%5*74UX6;K6MY3DVY
M;&E'=&/)M%O/L:%EB7=.MW]UV@>3A*I :J $5,&A0QI7.9K9*9FB:F.I6%LK
MO:(:J  +[&91JXY!VJ<WJ)H6+K<9-LM<*5MOZI!T*]Y=? "G%<(IAS+=</I6
ML%!!%@ML/4 K-H^QR(A0(>KN@RK8U;48SE=3;+I>H8B1(NY#!$[E6Z8Q [FI
M,B8NJZ$&OD:_A<"N1^./;WSQ[YT)\6U]=P57[&-J1,7K@':<:-Z(FQ\H_$*2
M4%?HE39/<&DK_+CHE?K5X?<76,I#K\FH0U(5:^B>E1^BOT!U)[>0FG.ZY,$Y
M:]8]S;50)&*,4*1/U2>&31)T@T]SW0(;P7>6Q T;W#Q"Z:8D_H852;PN9^/'
M8H;=W;>"P4E3N8U]&XC1"'8/.!ZCI13VNP"R1Q]4Z@)H=23TC>Q(8LV:9.VH
MBGRP94@;0+ WPVJ:T *XQM-9CB^;66K9S*$OF_%E,QO<CGIGO>0:A53C>Q4K
MG!*I@G*.:"0-@5)T&D>UMCT=4]#5@$4%4J]I1F7!&^W'6+LT^DMFT$ED<&[-
M%@3Z"$$[1+LA^"^]_7YP/A;#:\0G 2'Y)<,2W/,*HV[[G4X(/XB^76)LD3)%
MUSB@ !RKHWYG$ZV+F5'!>3:.!['N7#M#9"Z=0?E-_9U(G&,'L(M5KD!UGX>9
M?U;E12524\X?J]0#V %DJ.JX+EI9MO2@7EOOMLFUU4((K%6 ^[%7U/8RH(4Q
M5<<C58$M!6"X<Y'[E=D^03-Y"L]-6,\7YI08ZD6X,#<J!ZF_QZV3#IF[1,'/
MUHF\:85!':X>MRU(\CN7N^_@3F!I,<BJ2XY_.Z$EJM:9NO @>L/2S+9!9BTU
M(A2.FA)2W! O&//?D I-L!SKR9N]K:8N9$X3N$S'W.IK%T,U&-AY3)V:Y !=
MBCC102;*.5P'5P+C NRG:#91Z\*_@N-6[U=S($D6'?]3D")OLR%I0@/U]%8!
MIE"6LP1+]=G(BWD-C,-L2DAA0+R\5\;NCYR]DK17Z,Q3U<600@J)<GY5S145
M[QM)HW!_FMFD%I=F-K7T )DEG4KB\ ,N&"/"Q2A6S=8YUEWI[F5Z$OWX7.0#
M 5^_\_E[ L[H251RN++3"X-/)^>_GOR?(*\H"#DE]P4M+715,9<(NTG-2>9K
MU0T?*=IKP(E.-7H:FF=YENS@#RYRBCR^U[E#W3VBVO[?6E]T%)QS=PUR[>?\
M0J3Q?[2MPH+L:R[%$.QSOHL1"+=ZG>Z>34UNVWT)L?(.)09WAH^Q;3345@W&
M3BE-VG!,TQ%\/+=J$6 9.-\U:6(0XL#GR[CP#RZ]C+-$!P,(.Y,@>1GM0N5#
M85-MFYZSQXF@6#MO?:I!/Q6$ '[*M +**J15<$/*'6/_*[7>72$2VS S*%$Z
M:#OG^\<@N0N']$528P>4RRFN7)N$%Y@'QCM@$1QJ(MR]TNDMU&P5&\XBX 6*
M8%^HM*U^%PB!%#NO3HQX-U$F^K(VA3DKP=4N:U:? $D,;!U@EB(@!=.7@&,K
M;<3C]B]F5IJ(F#A(%UX:(=!XI7J;<\Z9KMTTZ6=5"P1KL[6>[TW;LH')G+=
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M"R-!'$FC+":-H-0 $ZIMW;'!G-740+G0'26<6C6.$1R:BW*L^]GI[T,N/Z#
M0)5JX& .H&VB?3PSMN1Z@-DX&I;#%/*K* 7V$"K/]TEJ@S]5[97F1=U]79<B
MCL.M QH,PE";/S&+U*!WTR"XVS$2N0.)W!39S8$'9E%7W.)!*[:"H%+C!L /
M+X.H?HQE"58C2B3JB3"BS 9A\$>@T^()098:X.=Z'1IS2Q,KG^/%IOK-C1M;
M7(K:#(_:VLB5UYM!?KQIZ@SGC'?)E61 ;55BD0!5"6% )[G6SKZ3O;0'8.,9
M3X%5]5@W4+ X[Y(#,J4[>#CXJ (F&\JT]RXEM\8,@6&3,G'*"4"SAZ:/7ROR
M"XGUIU-P\S'%CCTQCL9P9I#5)JL:BT74SH &FW"(4<6L2!"XT_^PIU8G_C $
M5Q*\HFZ*YB II4IO>,Z5<(>Z@,XOF0^&C/EFK$N&-$&.+O,XLECHJF+416V'
M=V&23<.LI ;@FU$A"O6Q*H'OCM)]"FSU=68\W!=5XD %-,]GS-_G5+:0_]]$
ME%RGX*)4(0,Y%S)%["(<$I+R()Z/69Y3P)N0@8+W&19;PJ_^\8\SA56J$ND\
M?0C1[ N9@*-P<9$3<#]VTV'/?4Q6[X+'F<)[;*H/F"9G2QVN3&W0=U)PP!T_
M=7;[6 V38"OP<SA,+1DIU$7)+2QW08>3<4\X@P+[[\Q7J+4[-P;YS<[L"\X)
MK=4^0B-2LF&BWW7-J*Y.HX-VC=$D04=&C:_"_(B9__XKL"#U5V.1T :>UVSC
M"!I-87""5'E)Y6#!%SB$D>.I+!!$/-KIN0BB6:U^E2-EI+HOQ8X=TM5HW-+:
M&/6IYWR!L:ZS&Q9^<$PI)ZT'9Z:2N3-/.2NL\@)M)O$$Z]:574Q)TBF7E:GF
MYG%M753SEJO6MC2SGT!3EVI?H*JGG@(#_(-$_QD:Y'+XG$S4KQQI-'$F2A"C
M5LIC#?'-&\(XS':L/1*/%L*AR<]CLAG^FL3DN(U4I(VJ+J^4.L:86T[S8@<R
ME8BAP8[2B$.6A/O<?ZE'NE*TGT#X5,6 '9QK'J_J.DV;D[Z7:'MFC6';"G$\
MKW;+E+-"U@13O1BJFN ,M8<N(U4^=S4 XR&&8Y#T*YK59G=0#X6\]3.> C=]
MRD#[N@4%?V!?/PA JU_ +)/Y!5KUL!6?J2+7&4T[&>@!2<^%#S_/2\D/LZAB
M T9!WF/8AIH0&T4;NI;&&*'"V6R@2-IN(CQWL*W9:64PU02\-IGH:< T%,'
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M\6X\R=8,]CH\D9-:4IRQO,8/D"9D9V'0WVJWO.YX.3XH+G!6 9W3"]"S.BG
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M'=_;+%'B2GK8QEOT8'H,GB5A\/0]!H_'X'E:&#Q&L=>3HFE1)2755'K-K@$
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M4_ <#54.)(.4S(%6#DX83)UG^++#.9&R5.W8[GM"=AB_:QC[X[Y!*\"W(3R
MM2D,M H?)V@E?8R--1).@;[Z_><O]C+5YSUKD&PZ-G0+0YPQOCHVZ&H;)!O-
MH>P-)NP[J[ :1\^U3#E&590*>AC'GDW-AB*U@#],&$!.]W!8&P_@H#93F 7H
ME73+M,J+"K4;M7'-XF?8EAHS;X$)N/N*9AW,@$+7F<_ ?]CI" OO6%!"I[9
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M\8/@]UO YHH\=?A)C:Q'U8N$HY@/W.^3I,BH[2@NU 1R%;#A]:E&Z[R=)^F
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MO7!GAM<:KYK'[BV*'S>OP7K$YXJ"_OH"3AX/1C5NF7\74Q'I?[>Q)KTC3A'
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M@M?5_O-?OXP-LYZ=?'BW\^;+NY._[YR\__KN"Y![<B6N"SU$!<W>5-:^Z54
M!$";TP,Q$*@HN9;IP6P 7?WJ!8[0J>_D;[^V[R0ST3WW\>OGM_^(TV_FP<.X
MF"8"-BA.DSB5.X,DB[ZU,"UH !&,<SGZZXO_+K.H/OKV2GURG,9EC%X GP5>
MT?RA<1@:U\X[M]N+AQ>OOY(H!W[$"5X\2U6\;CUD<];WF\6^>(KWS.:U:IR;
MU(PZMU&<TF>U,^A#[=VL KL-[]]>RRDKX $E?T,;/=2##5L=+#;>'OQ]BU\W
M5]X]X!*.7K*9IU=A!S\]^H>OYJTMVVUF:G5O5C4/N9R>V@6<"AR!))#*X,A&
MO".KW15/\Y[F'VWKG>&"GM8]K?OM]MOMM]MO]QVWNZ56S?L@GJPVD8N7;8_-
M.OHUK^1^^>(;WWK'[+'Z:FTQ_IY>RJ*40VLQS@]4/U'+<6W(Y&AMJ82GQ7L:
M\32R@$9XH+TG$D\D\XGD1.4//95X*IE/)?N=[M:W[> L$:FG%$\I"RCE-RF2
M<OR,:>09NY0^4O%T1,]L*N.-*&1P+A*17S_'=,;:R'Z,702JO,)6Y*VA*C@?
MBQQ>FHV"+[(H\SA248W@F6J&U;/P^RH=>M9=A>R4J1S%9>$%YRIV_P\1<<V)
MW_T5[/Y'\4WN^)U?1?%)6E2Y2"/Y' G?^V$K]<,<]ZG-1GS %\,6?!(3N6KR
MOB6[UUNCJ"N*^Z,0;:83!OB_[4>5"EL_;2\2!\JS<%?X"%6AZR$C5N_3W9(<
MUC]M?5YFT;?@]Q2-W!J%+<'-:R79C:0T+QW\F?DS>PYG=B:N W]NFW=N?XZS
M1/J3V\"3\V>V>6?V-2M%LJ[<=@<W^U;@HIN6%%V9'_+B]8=X*+/4 258AW32
MZKW)E56'M'UG_<1V@BVQ$'1CR:+67O6 ;'?SZWH/^+X6 FAUT+L'W;!WU%O2
M+LRN:OV.X>B1@Y)M>] ]"O=Z1_X05GH(^\=A;[_K#V&EA] [# \/._X05GH(
M.W[__?X_X_WO]0_"@][ZJ((?=R;K<[N\,WEK9_+VPZ97QQ[+]AD.]H[#HYY7
MT@W7;=E2ZG@O/,:IH_X45J@J?AF\WID7>USY,6QXA'K>>=[68GH64:,5A2OV
M#P_6DN2?SR'L]</#HWU_""L]A(.]\&C?Z^#5'L)1OQL>':P/*_SBD=WGG</1
M+8EVM0CPBY-1:HVK18 _J_*B G* [0[&L0L#;]':PX#QU^&<Z9I<EG%.OT%L
M=I%JO/=+!(\>Q9',P^!C7H-SA[LB>'><5O@0O"N ]Y0[)2POD)-IDEU+":\!
M:HB_!Q.X=%R$].^K<1R-@[$$XRE)@H&$YTRF,BT(H5[ "F#EF+\?8.=HP9VC
MV2@0TVF>?8\G<%ER'?S4V]\/]P[W0L*5AT7E4HQ GO!#87-@Z;0H6&11)25N
M"+X<O@WI';<#7K%X:;F,)&[!['(,CO[LNC!M=GQXM!M\'<N6&_0WQRD\OIC*
MJ&1$_?P2=KF ?<<?P3[ X<%5\.3+> C_'%S/['^*@/U[N^L#H+_^TF5!M.@F
M@//FM]\H>+=Z]Q85#[XP1]S\JRK*>'1=7^M)0>P,OX(W +4";3$"+7.7H%\#
MG2>PWWC&%S*5N4B W(%,X;]!5N6!QJS5O \KO#(4C(PH<KPVNZ+6(N0V)/:T
MD"A^$A!0($;@<3AMH@+&P1=/1(RP]70#< G^"I^R);]'285D%4QE7A GE^([
M-@VG05$!!P^X<7([5!PM)EF5*K;ZJ;>',2KX;R_<ZQ[3BWX"O^6H>T"K^C@S
MNB(,3O(8/PTO55-Q0\V^(""2:[P:/J[(S/?F,IX,0!*S4(7%3R2LTGQQG$95
MGC-C-V9F,$\M?CL+JRS_9B=[5/DT*[AO^J=N>- %R8C_W>^H#PR[1_W&HN>(
MCD7!Y(=0X3\T=NV6-EC3_'J,#UVJ--G;'&GRA4BR0%X#S3Z)BP)'T*#Z' +[
M%L"=65J!/+D2.;(X,,O4,5F0R2FBSO-H$#O($^H&$>K^YA#J&R+)+#6J*Q%@
MO<"?5P4JOAF-AEH0I'E<)JQ)"@F'0<H)S+N@FL*3P *=Q*G0DY+X3E(!;'Q>
M@P06H+%"U !*AUGC.PP&>DG(!I.L*,D(A=O)2@6%ZUJA6Z#] I3G,9CH093'
M\/98;)-!B5K0K'L"!G ,VIOU#3XZK6CD$UQY+45>--;:? "IMXGX)LG(-]<<
M[>[M[;VD>X5S]?^B>9;'KXK61:/%D,+7ZQYCV!;4B;AAHRJE?<7=Q.TJT349
M5665RR")Q2!.XI),:3)"X$(T.XRYT7H J$-SY]-",!2^X::#89'A%"RT"VA'
MV$0 L93 "0VO@Z$$?1J7/",++YB[Y-W@U#H59/3,;E7=23BXUZ9EZ.7,7X;V
MA&([W8N_"99SC<X$#N@:YN(JU41@Z"-+$T6_EA;)@3&[DNNQ8KQ7@^P239P1
M>%VPDB%Y@GD\H EA!<WWNL+12O!?7K3FI(*Q)95Y9HR7QNVT@T-<%EPY%LG(
M[-;=K"2O-S9(;_0W1V\X,_:0&RY%4AG_9$Q =@Z7#C2&B_'E@9G1EV<C!\F5
MQ!RMWU4+RLG23SP[^XR/N,C%) PNXX)D#;K) KRT85QH\8@/3.*1(Z]V@_,8
M'@Z.T_S%68].Y+*V5'+O1B1J?]\]WU5VG)&ZGL<VB,<.-H?'_G2H4-.>&UJP
M?&)X*:0+29<YE)J*"=+K;#R3YE4*"CO!>9>@74C+7M>T$2LBI2\QOAE'\50@
MYX-5@*]3$*?3A(P:\EE@&ZK!OS"RAP^$)X#>KR;(1*SW&X^RFM_$02E6"WRL
M;#M8_^F7<^#J"; JZF54\:S:\[HHHN^@>"S_VGP*6WY541,^]LWJ*Y0]Y'EZ
M@WCZ<'-X>FZ8T8TM*I6S.)K8&F_4' W<70IXMN(!C+TID[IF9P9;A[O]E]9)
M<.SM;9TJF+7."T+0)TL[AY=0#%*%WNK!QF(.\]TAR*?D":ED,*6--/#\N4'\
M>;0Y_+DP'H+J1?]<C0@X!YV:H\UYFL+32B#T9H1$,UXIOKLI,&13U'!I!4^)
MQ)2#UMVP=WB($7WKF$Y%K'G'"<W?A7GNE1][Q!2\GS*]=^"G3/LIT_<2<HN5
MQDU3IEO?V:3/NS+W+X/7I*,_Y.+_L?>FS6TC2<+PYV=^!4+3O2L] <D\);+M
M5H0LRQ[OM"6]EKL[YOFR 1)%$6T0X."0K/GU;V96%5"X>(DB0:HV=K<M$D15
MY9U9>8A\ )IVP$7I!5YQA&GCXLV(F'6=<[:Z4"_JVZ>T"PP8IGDE/!T@9!')
M;A#YY/<@<+AC9G'@W"/@1%2D\N;55*(EBH ?.2%H?@IA*\)^BQ HR8=8, EB
M#694;QKE1.*S)I:O:4<%6RQOL$T<VW99IJYG'=E0\VS:>=NHQ2ZZM=B%AH6&
MQ39@D71&Z29B<L'>0E4UD&ONIS'7G7R&(,]:;8MW3 &#Y I4U80NUC[RR]-;
MZ\F/T2R3=DC==OP[:-' N/:]XZM_Q]RCQ&>=!U;?/9.=)RR\P^;1O+:E:Z)<
MS7([Q7)&?>F7>*Z^V\L+ G6*7!WW*R5!:T\D084)D-O%6@V1^N'4=8T;3&"I
M+]E1 ^WZ;H]SQ2_S6*(NAF;:@D\;X-H9T32R"S12<B>XJ=!57B6O,715W45W
MX%K#[QO6E@6YGHY.65RH[[L!4R^4+:2>Z=:BOM;#!_"H-)7M/)5=8/+[@^5J
M0M.$]J)HO)95+?6EM#3&6=\]9F,N]=TG'QOUB5\@UW>;AW^?&Q*J2]2WVK?1
M<D;!Z+=QP,*Q[]:9Z'ZJ.]%I0EN T. #5F,#75/9/E#9%UZAHLE,D]EKUYJU
M-]4TH>V!UM14M@=45G^MJ<EL#\B,Q[3J2V5U#K:%8RN@EFCUW:(?UQBWV+[+
MKW$ ,*3I\75&+Y]O[]<8QQ1$K>_V0(D9U/RNUHI,!U#W+K'N9HI= NJ[OWQF
M7>TVF+V,&P18:(M[!*'(Z\8=5F.Y0]G1[I/CW==WCYQ$:PQ$[8'L@["^^L&"
MH1.R6ILQ6'!MW ;.L,850_[(V VM4M_]'?[TYFY<=Z&BK<'ED'KI^F&M%2W)
M%:/.?+M+B9RUV]U."!4M2!;D J/>Q/;1<@+C#]DREL>'L*W);E@&QN%/1]3B
MO<@K^UF'\0Q>W#N)H&&A8:%AH6&A8:%AH6&Q]5UH6&A8:%AH6&A8:%ALL"M"
M22]E;%S4:G1,H]7NP?_K=H^V[+-O,GJ2C91\<FR&81P=1ZP#-AJM-\VS-]@:
M6&-$8Z3.&-&:3,-"PT+#0L-"PT+#8O>LG/EWJ'VSW^YJHT<3JX;%;C%NIW'2
M.M6,6U\$M?L@6WOMS26DZ!#8+!<_'=^DF:8>&-%!%XV1W<"(MH(T+#0L-"SJ
M*,'G&Z*GYEE#>PHU1E"S8_8;!4=!8ZA&&#HS>[V.QI 6^!H6&A:[*L5TR+#N
M"&HUS?99P?E^W2%#+4\T++;-NCI,IJFSOM2YP%U4QVPU-;76&D,ML]G208 :
MHZC;/C-/6TV-(BWS-2PT+#0L-"PVM8O(GVX;$.H67B\4]KE4LMNE>(\.^M2:
M+FH$BZ2C9'O1CI*:1EX;C6A8:%AH6&A8:%AH6&A8O )8U,!)TZ[JOKNJ=<I/
MV-X]]+\LSWG0UQ'U0(9."M 8V0V,:+M&PT+#0L-"PT+#0L-B]ZR<^9E*9V:G
MJ_.4-+%J6.P8X]:]0F>K,P3KAJP6-O@Y.]/5.O5P]R\"A[E.C9EGSQE&!U_J
MCY&>QHBVAC0L-"PT+'9"@B]@A)JM=IT]AE>/H([9/^UK!-4705U D*Z[U.)>
MPT+#8F>%F X<[A"RFIV&V>GI-C]:MFA8U(IU=<!,4V=]J7,!Q=(UFZV>IM8Z
M8ZAIMLYT/*#&*&JU3LU^4W.1EOD:%AH6&A8:%AH6V]_%G@>HMEU0J7O_:'[1
ML-"PT+#0L-"PJ,4N-"PT+#0L-"PT+#0L-"RT_[XSF1S;N['_'(;6<&SI">\U
MP8<N M,8V0V,U%:O:5AH6&A8:%AH6&A8[!@LZI76A65>NB>2)E8-BQUC7%W:
MM$/(:K7[9K_?T*5-]7#W;\:69]68=_:<7W3L16-D%S&BC2$-"PT+#8LZ2O %
M:NS,LYXNWZHQ@MIF_ZRC$51?!'7,,]VS2HM[#0L-BQT68CINN#O(:C9;9KM;
MT#DO%S?4)6YUD1H:%AH6&A8:%AH6&A8:%AH6&A8:%AH6&A8:%O4*&.@2MSJD
M+'QQAF.+N36.:^UY+$MGD&B,[")&:JO6-"PT+#0L-"PT+#0L=@P6];I#U15N
MFE@U+':0<76FR@XA2U>XU<K=?^_'WZTG7>-6$W3HZ(O&R&Y@1)M#&A8:%AH6
M=93@NL9MYQ&D:]QJCB!=XZ;%O8:%AL5N"S$=.=P=9&V\QFT7(H=:MFA8;)MU
M=<!,4V=]J7,!Q=(R6PU]\U]K#+7,1E,+E#JCJ-<&%.F8FI;Y&A8:%AH6&A8:
M%MO?Q9X'J$IK*O\&_QWX]M,Y_-<:N.S\;W\K-Y/^.[?H?[]-%VBB59.QA80I
M)*R>1F;]*:Y!B\%Q YL%OQXT#L!0<MVI9=N.=Y_\#= :RK_%EB2J&HV?A:'E
M>#9#ZZLQ_4%V'D6W^)'2(%<>SI$_+<:BQ+O[<ZA(;F&N85D 60Y%"H86@^!A
M\VB6R2@V9L61__(;4XS<O^(P<D9/V;U^9=. A8"9T(C&#/X/_AK[KFT:$3S&
M(L/R;+"*?SB3>&)8$S_&)Z?6$]%%Y!M?6!@&X8GQ)V!NS& O@6E<! YS'?JE
M2,4SIG$0QK M_ FN@Z$4X^H'&\:1\\#@,2\.C5O7\DQC8(7,-GR/GF,_AF/+
MNV=&8$7,\$?&]><[P_'@+;^?W)T8MN^Z5A :5F1\8$,V&;# :#=->OV)\=$/
MC(D?,/C!"*$1.;Z'L&/T:ML)AW$8PF?P/7UR^>&_K,GT[841 ZT&]-'0FN*O
M#" S<*>';R\\+[9<X](*Q\9G#[T&W/[%HQ78)_P9^ZW"0,60KF;D76+DUIXS
MLA6&_M !UK)!E45C^N5]@'P*K#9E ;$-D#F<RA]^![YPD/L57O;C )BMV33N
MZ(&4)9"73XQO\+ZJUUC F&$\^(L-Z4WJ8W8< !D"\[G,LZW >&)6P$4&'@(V
MZ1D/+(1-/A";!L#1^ C DT[1?-.F[_$=P+O,&H[Q/'BXD1/ [_A/+,^#G08A
MP!F0(Q[@I[<!)"\B/^@0=V,_B(Z_L6!BW*:G/GY/@N\K;#QPAH@2#M/? 5I<
MPB"84IEY,QHY0]A^(G>TQ-D#B=/>68F3R(T@I>!GB(V*MVR [S4?+<='63)4
M(Z@+.T49-ZA9 ,)L;M@&FW9VEDVM^_N W:,UG9*\,;*<P'BPW)A)?K!0X82I
M,?[QXNZ]<7%W:5S[)\99LV<F*HVS\*4_F3(O)!V9-80/Y8/Y5\C'CKBFM52-
M"KO [=#KT$J))Z1'0Z%:B[M!K7SMPU&:J7P!57L)O_%=QR83YZ/C@:)UP'Z_
MB^"#"<'$\89N;,.WH,23GUG<S _8%#0U'1]@#2@X_F?=I(/M/!A#%R#TZ\'M
MI_?_+.=^_O-CEXTBP9CBD\"Y'_./@$RS[_KX[6ORLK*;$F6!W&_'H^/ ?RQ^
MB'+*N/UT_?N7F2_.TWQ6B.2@AUFU9^_>P$*P7.8_?WLW3F3:[<6GJ^/W7Z\N
M_GE\\?';U5=@3??1>@K?"K&*=T(>RYSIK0'>+ &G!=+2$*DR?V_0_Y1ET8BO
M#HPW>4C^XT,Y)!$=*\/QV\WE;X[W/7DQ\,[4M0! CN<Z'CL>N,"5V3LN6N_@
M_)UE@!H<_7KP=V#<@PR)/HHC.Z!J';PBX[C )_(?)K=IN6>K\+9X1.S@_!MI
M/! !P+T1,NF[-]9Y*9(37*\F7HM[SFBO//!RK%>Z9IX^EV7N=X/S=\[Y31R%
M$?@Z:,E<_3MVHB?N 5"DXR.(21!._P++Y_@*_"&>EN( A."W,[:V9LFSKN//
MUE^JX=(^I5V@=3CR7==_1/!P\RAD(,K!DP(K4''6@&W!L@P\?"[VV \6#!W4
M9Q6VY9BYMC%X2@Q'5 >>-8&G6.)U^<+K J6$CY1$G;Z1V^<.8]?B*@L=W42/
MXCN'KA_BEOC:4]@)JW[=S:Q-T(X]U'<IO?A"4U:]<8,DPG$SSUX5DFWD>,3X
MY2I,X=3^,X1+T1!>1#DN;BW+BX$UW 8HQG5J6:[IO5+KM'H_SW2$U[Q<LV*U
M],:E,]\T6,-VBBCG=L Q1Q]L=/K#(+N1DF,;IH'_>Y3>]YS^_!*Y*BEAKY"K
M@HIC<,Z-<:$KN$(02J'"55G7M@6#JQ"<A?:2!&?-2FMEI=9.<%*SKHQT'9/6
M]$<9)JKC3N_&8&" K@]JO]/?R<K:!9"2%/TVMJ+:;_4?U@,%/FJ_T3_ YF8V
M;7$0H).,>QR<'_[]J,9J2@OPG17@7ZS@.]L!MA!!U]IO=/?4C)&*<4.*2:-*
M#/UT5&=S>9MRJ'U@!/YC/B.NUC*I6U>A)&)YV?M.X:[]8B0VI_&[QZS PQ0
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M-H7]#L*:2_.A%:.0)!>47$@F?JZ:,@,?Y"W^80-Q#\%X$G2%,A4T5<A?UVZ
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M2^5\J 5/:;DAWS&XSN!>@ICVZ:(P\;E"<5>*!_%-O*]!HU#$(^#34/4>@>9
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M')4B##B8&SOE8@OIB:\6!XGLR5VR<&>*(PG-_3)$F1DL$7%'U@\&X@TQ>/B
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M9J>)@=;\Y<&I>=IN<:F0^^JT;3;:0"YIJUDT)61[G5)7$0FENMM[<?OY9*B
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M3;L#&^1$AMG^J& ;2@I.[V7S 80\-DJDMC-[-$U.-@EHEH9^_$5*&PU_2 -
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MLL.E;+4ZZ,9R$)\]'\32I49'^AF0;IKM[JEYUNFM#=+;4.GE4.X]$\K7O@>
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M,=\,11AHGHJ4#Z%I/GM"\'&YA[]Y\2+9=M=L]]:8CT;6>2V2.[LK58,+7-W
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ME84RUL!I.^#+G)V:_?8:I6=M[B!ZBXUMT'<0.W\'T5MU?L2K]<1V_0ZBO^K
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M;3*G;Y_2DC= TIE)KM.Q [+:GXZ?@%_8=^**8< P#&ZI(?IC/W#XY1;S'IS
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MIC)6+JW%PP9@2.[*6T*&'1@6> WF:3X9'F C.6XF!_*1FLXF]]V&%\M$Q7D
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MST))N#5A']EE4>&"CMGI]A;F OQU7A^<FMB_2^N#?2'HA;+^:D+01)*3F>I
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MG"9Q!WPR5_)N!(68;)0.O4EI$"D3-P7/CY!KX,C'/+\&1!J S<'A:,?'"(:
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M?UYAL@FJ!E-P,?*Q-&^9/QGGLC.2L$S[NWEO.3%*J1>>FCI<$#"_CP?I(S3
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MDXP.92P5NHR-<F:J#$9URL<D W&BYAWZ)J5K12COIDCE1>:N<SQT;FK:1C(
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M7F<,TO!S0;9;*(./ZY5NV*ZH<CD<GUC6&::,9/.BRL" G0<([L>M_+"E!T7
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M]!+5\'8=;E]O^C!NC=C9BN_6"%8J('$G.)ETW PYR76OS_T7Z9X3\M,PM"?
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M\CF9,KJD3#Y+6B ,N-_&B- *6? N'A8U;M ]VEJ#^@K;2>R9H :20G,J1&U
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M1COW+HXD\HFEATX#5Q$#M4<9+&3<0,)CX5_^;,=963/O;V46W!)[WM*FOEY
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MF;O.&N>*;30"@Q8PH[-*TD_:O*^1X!*/QZ6<Z>)&:#&&Q45L^*#L+S$ 6]K
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MB?4$&0')ZI;DQWC6$6VI/:.]MJR5VNN=^V4#),%NC$" !LAN]?[ZF\^JK +
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M: R,4F%>!EI<_*3\ [@+I #%++.D;N6\C+Z.(<>5STOB94YA-LZD2%7ZM*C
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M6C\^" 7R$"Y\O %7?>R#>9MCE0CF5R;Y&E>P H=RV*&K_!2.;:A? #M4ILH
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M)Q-V:=N30Y3$$B?@+.P(X</N?B[+I11/2SK'=.=F-#/3;N;9P[D05P8>OA=
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M#<!BP\!APSQU !0  (, \S\;\+<& PL'CX"(A(R"BO:\H 8+@(6!@X.%AT-
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M/P'A[-535M251K4+RI<.':WKJ%J;O<AH7&UIN*[WNUF6"24%)%-6 Y_)LH9
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MP.'XS$?@ 3\Y:D /3<*<6!RKIP*=BF!]M\74D_5_;?5!E]/_!5!+ P04
M"  #@HQ6?ZS"00M:  !&:   !P   &DP,BYJ<&?LNW547.FV+[H([DYP0G!W
M=P@>(+A#$AR"NQ82)&B X!J<8,$=0O#@[N[N#E6W>K_=NWN_[G//.??<_]Y;
MC#E&C5IKS#5]_N;\"L@L9!7 4I"1EP%@8&" M] _ +(&,$M[6)D#@)(2P @
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MFGDU_L@9@MP?CYU$ZG'U07\G:\#J"NSL+;7URMP-'RX$L#86N6SS-(Y=*#*
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M(X>VCG;?Q5GA, -U'V>6+B+?OC5U3$\G9[(VI-WL*"U]CDJ:&K'-U_$T<YR
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MJ<S[C>0.;K7*'+*06<<AP%ITPC53)*J+I:G,&X4&DZQMS-'PHS_9UUBR5I:
M-K70R$%AVOZ"+B?[#Q/^R>H%;__=G']B\!L$\G2GN#@5.UF! $8QK!M@/\2G
M!PAP\!L4^I][[O_D587,S@CP!6A"4<G@&AB65ZQE\T=E6AY1/XO</O(OXUU2
MN_:V*AI)/P4597UJBKFV2Q-V6JSMBEM<?O51OS2V*J]2N= 1SE^X"F.1_ O,
MOIM>1DC.!+KH_?SNCP<:+(6*K?K<MZ>^47H5O+?N7_>UO)9JNWN2>%/0$T,Q
MTAQHI(UK#)CB#!V4MV#%^'RG]KC_^D,7B;U>O7/Y%E=/Y[(T\[/MI$(%FO,N
M=BL<I0]0V#^#)DXGT@,/>"WA*\J!)XB=T!WF:]?CB([XD!;=WI+$9KU.]YJ:
M!QB0T-A_8.]:6?Y[+USY[;2PW1V\<X6_.9.$H_^3F,0].3ZH)I*.PF,S6C2%
MYT"4$@+$^IT\C>PS#91T#XJ%M2+9,M!.#4MV&G#.+D6I:%M&VN7G1\IXB'62
ML)7S]_651W0V1?06Y!K82"Z;:ST=.K\P-\@H&E\M-5U]=OM#X$0+O@9&]Q7V
MD?EBY]L.T7:]E=,/!%"D.R:)_]74C)%=NYQCS^#2-%^+UU!Y[KV5@G8DRS=?
ML3[;VJ7ERNS=UZZMRB0/"_W,HQT.7U%RF[GBGN.\PX7I@24EKLRUT2OQD0&/
MQ!WK?YXP*)OT\U'!<ZRXSPEK%S;UR3[ND><?49VS%BR(ROD1MY^4Z*;:(^9F
M[JK48K(U4I_O,)_4DX6BNR1H^=W@X'G5.T<+!+[840)^NE.$UANS9B&K!X5]
MA0RF0E#"XV.,0IXY4GYZL.ID?*1V NBGXIE*UZ.E'UG]J&U:WLT.*V(Y"00(
MXRXYC="9T9'?B"%<,8:=GI\\C/3S 6WD9/%<RXBI!8MM3"GV>X^<3IP)MMJL
M&W]T(1OP+M-O*8$ S+8CJ7>7/W<HHIF^@"*)"^JVQ6!O11]4^W\T-)!0/?$_
MSFJKY_APG(8$U99>6M(D>"DY"6^/5 Q]%@.82C0TQ(N^:J !"$#.^+LC=HTV
M)('V$R&V1E#*EO%IS*/FF9C@<+O-VH/Y ?KG07]?**Z/*)FW@.8.>@=[X_1.
MZ_2Q<Z)W<9B:7U#68.IE./V6H31S3VNCU3SJP[>5: CP*>HI--^RB6Q13R;#
MQCP0$0*H8JGYJ4]&*WE6^VY<5>A,0H!-7$\(8$ ! 21X-GM/*,H\B6*Z<0=+
MZ!B,E-?TP 30>(J;V ==XNKB5ZS9WQ'9BA;^]FB'[&WEE8R-4U)@S".EV'/7
M"N3^<YW]H*,ZX!(Q3L./)/01T"Z=27XTGRBLJ1YO>5? =F\>ZE2Z"<*3#C6V
MG:60X=GUTLI'J,S3L^:U;4(M2M00[3)O2Q04(A_FNJE9^V2HF?4- O"8Z^>$
M,XYP_W=.?WXGJ:A"$8XA#WU#HPCS"34(T&5\&FC+D=(3@ZU2O9.U8@%*BME8
M2/=S/0Z%4?8R23T-J4I?$&UHLBN& $C:G&G8ZZ24H6[RYQPWH+W,P^OK;$RW
M2/HH2=]%-%^&R4E&$[5T!EA2M\*_0!X$^S#0IG$S!'"^#S_?OZ+X(V6WIM;-
MQ;J,0M07F89\=->6O+7.7#OW!&VWQCEI)^ ^_%B3\=+.UY98;;_#C+G?7OG5
M^'V\5J-YUVWK=NYMB;=<R9*^NE@G!;RP*/<"TPDVS='3Y6>9\VY7!LVH\$!M
M6,2@7MI67,71FC(<;(+80KVY HZPEZA9Q6363_B7U@P?-'T,O4YNXFS=]F[@
M\51?;Z'0Y_C_1HS[H'/D%@A0C@D!LE//36YBIELM_M(U-\S%\%X7-FBU![=O
MFM7<9SW!34O;W.J#9?15H/8:57)0!3/[JC(YC[H:\J*;R#5/5#QW>:[*K2P2
MUNVYTY&AX*THHMUQGP8JL'1G+L(\>Z5S+E)O^D2H7:@=[S$)^HE[YBU]9@JB
MB2X2[?:3%?<@B5FK@0 _T'V9:]Q%TBE.K$;0[DLJ-,'6NU>I] ?CX=5#OXO_
MWR&JQN2%^7[V</E(:QU9+/@L,G_^[99GQP_2#5,RM?FW]N(VS80D:E-ZZ@QR
MZ?UA1S\WZ=-OX+";VH*$P]=I3K/"OUKE5)Z19[#4#)/67G^.>XTD %=5%?IN
M7\8C&^/7M+.S%=X1VG<B+([P-[ %WEA<0XH:-1%,:>@B[]HGS2;M.'6/::0E
MNS(#- #@D/$(P--.W@?33'X099")MSYTZ7"%S]&;$[93S7!2L]2QIXE&BI6?
M%W+]!B8_RUC,PCTQ-FIL_UZ5]-H3W.L)][G3G," "><'S!>#I+W&, 1_$;WP
M<\4*G/V-'EP5VZ(AFOF#@W<8B;3D!HGFZ ^/;7</"Q  ;?U[? _YB_I1H_T!
M[<:6S OI!\,[3]BG0!.'(H68.XM@BSLOG\9>*+-UZ"0-[RM\8_2BZL%E/CKK
MG<_+ZN94>YZ4UPJ#T,B.0%,1O3TR](FI=,+.FI,&!,.#CNC OMN/H;=CU_$0
M0/3"3^K1\EGAGQ/ALM7/:1Y]]MS,.+X8=M)[)E7[4S($P/8B4G$H#^H G5-0
M7 VU)SA?M:[NS%4\PTZ[L?T9OMD) 8A%\\I&I'.R'^2A\,*SG1+,[9L' 49:
M5CY#[]V;.'DQ8M9DW=VDG5-LR,ZK/#X,W6&>92/O%HF.@W:6[?M 41168A<G
M?)MB/?YT_P$7P!Q:T5ZDC=RO0J$+<@6MF,>3S>054Z!+2>6F A?LN3AX[Z:"
M643)8PY:&!F._ZT,QNJU$=FVO:P5TFT49C-NL@F,.3/9_Z2?F6'0WF6/#@%^
M:JXJ2:F\6G(HWM$'S4AO8O;&WLY(_6&D?PG$<WEDJ'.0KZ;QC3%V22B]XN<(
M#NBGTBH)0X'OC%ON8;W 02,_W),VXEEY3TM$9U46[*/U9(U6]*N)VLL'S6\F
MA/'Q 2,/&^"["JT_=,RY%*R<W$!9'+TU.V'+NA/Y6[,4K?V'=LG\>[_^WS#Y
MGUA/)#H-(L8S[C3"0GGKT5?PG$'[EJM9]!3WG%V-:[1NJF5>(B$KJQ8/G##-
M#1,]'8WR>&<X</F-J<]U!&LI?RHIC&IJ_KCW,)&9>W,R<WIK,&K $[F#I5$9
MN0,(T!,5.J-2_);'JW>@LW>ZYU[/X&CEA.N[2",>6>_;**#\U UXV>)OH*ZW
M8RF5R+J[>HNT%9)MI\ )JO7ATX9;3OYZ#>J.&W0'82S/EK'!'MSGGWRZS*JQ
M5E\:*);PN<](AZ(7WG#;RB.5.XNG1?>#(<"K[$_;;"3'FN.]:)N=#%"G'V&0
M;EO]>+D/R[5-@79=8^.TF3P+C#0$2/0.\W/JG''UQ31BVLA@TP\R:&^HKLTD
MT4AX6Q/8*1GH2'<\^I7YES+R<MZE6HDX^1C6,SP@D#<2>W2BN-+T5<KJ$=&0
MH#]#?Y[5^?Z8=9RNY,R8C(EB8)!7\8O8K,Z[^U2VFC0R!8;Q\VD&T3'D0%EZ
M/FZ+;SOE(M^V\&!T70ZHFQ7SJOT-J/WT!E^23(DUD1#UUF);3;\A&B1P.TN+
M3_GU*G=([.BMSTJ4;HX_96UU766]OC>)1]E7XV92>FS940Q&Z[^"TZVI_7\#
MHEV#H+!6M,*&/S>W^UWAYQ" $NIL@X4[;5J*V[$K&CLO,CQ5X]=V>*K2P.^D
M^3<0Q6OXKQG;,^A'GZ+B4 9"!?4-6%V)W2.7AL^<UC]&UF6I_];95G,?=>YS
MM'8*5*7QKQ!VTGPLQ^E F+JW\4HD]I=,P1DZKK-R(YN26=D\B[N"+8(0(/30
M5=_X2MNAU!_D$MOWB"&[IE5A2SG)3%?=)'YJ(#,F5]CTO0,*EY(Z#OIK;):<
M?]Q'Q(LF.(SK[]SFF$QZ6T"S'[9HWJ@PKQT49%/&!WIP/;D1&[P2I,\IO9#\
MCU:8WZSUE$(J[3Y;)SHL=<4QA\=EOR52EGCLUH<VZOX"'257],EIK7,#<0Z\
M,IRDF*>)R)B?V3'BX[EUY^C!+;%W1XYU<@G^L<F5?K*(=&668^)8(E%Y297+
M\C:HAC+Y:FZ1S]]X(^S#8\WJZ2\..=K;P*D/2R1J1#+)@\](LWH*H6UR<$98
MNN#6;5Z@5GY.>'H!3[5G7)[)BY&>&ORLYB#Z-OP^TLLW?IZWF,P_H6V)-3*@
M/);WL=EY>'QV498?FK_#*6>(,I/VZU6)+%+*#1EUDDU1D9^1]<=T0Y"OAVV*
MRF'7!NMGGO.E4<_8<8LQ\@8J^0)IP_U]RISJ))XB]]J@_R=MYN;=KGKQ5Y>)
MJL[L0WF.^+0@P$=9_<Q3U( 2.7O\Q,O&05,F7H3YFV\73^JZ9WE^[)D+/Z]Q
MK FL7N"2*> %+HM]P=U2P-B& &WZ<)G>;Q#]\JH"99#),*WU1L;LRZ_0A?N+
M9GF"!YU:U%[I.\45DB1\YRPLXL?_^I?C***V/X?QI(\4!'CYM/*0-:F=]!_T
MKU$/-K#4!KBQ_KS\M=A9[K["XB74XVW)BW^&IB50S-1'>P%N$ ,'VO3'+(OI
M766H@"7XLJXZ(, EKM%KO[/[F:CD1U7.S']"\,3_"(*_*AMYG1/.M(_^LR5K
MG3,+T4=F5-@68++E>HIXT^M*%0A:%8": =ZKVQDL<+I_6]*1&O)%G+,?VQ+Y
MZ.5Y>U'O:&H*4VXUO!YW"2LH>/>)/.9QZ.KM/A&2V;O/LHZ*!FP_*;!Y6U>9
M/.P^/=BEKIADZ%<,W$ KNO^JKT3Y?JJ[-D>%C(;UK_3ZUU"]S"G_LY6@@5@W
MB7:2=$UC)OWQY8!NQ/)L/^B:PP'E<WL+-09)1MZ%8;?C"I;+R!%,;@O7GODQ
M20'!M%>-V=%QQN=(+(%%!#GAC52@]U85SDG>MVB/P&%/3[@RS^H=00$;R N9
M]G6@I$^^S/+MD)>29\7/.UL>%A.MR;7F4? XE:*5+3<_.;W,]'MJVU5[ZDT$
M6$(R)2_-?U08*K1B,H^*3%=;H==CM70U4S68F/.&;(-C2NL1_IW"D=%3ER(>
M]3%E/F4VVKSWYNTH _QQWKLUR1:A QPY;7-D 12.<G:\GRUAYW)ZXY)[>*-#
M18HO9R' %)UQD^#5;P."8Y*?8$/];11%"+@#S2$N8GMQ^+UG/:M[%\J10RO2
M4C-=0#<Q6\25?@79P-J3WO P[+5[.K/RPWHG\$T1H*:1HRY$'1U%M)!VX!/#
M9K5MD>!]4 0=6O*HYLD]I(U<M+0^_'AH=C[?J !9#U 0V-O6C-3M"]K6+1R)
M'=U_<.B;ZTAXC\Q 56ZH+-N0C:F6T[B"<AMXH=4P5?.D1T\UR9T6"S?T07_@
M,R>BEN%B- D<A<*N[A2"86",FJ,XJK3L=1AHYQMH13*F!AK\(NK@>SP8V2ZQ
M<[8E"-#X).WIZN4>1ONI!O5[%:60( )Y3DM/R^O>VXC17][!+N2HT#'B%CI:
MV#Z69)5! (2F@A;4[ZI;]=0;M4[O($ 4A9K63HZJZE,.Q=U^ULUH[A&TA8QH
M0.,UV)>CD0:?8AZ:?9G07/%%$1W#?+Q2>=A] _=% V09"O8J?+JD?W@E=C$E
M=O)5'.=O>0!2?TTS6V6/Z'@WN"(5* KI$FNR^:4"_?:LFB*<%CJ5&?]<.>><
M]U6!/OVRMH6]PT?>6L>?TY/N*=X #Q1!H0'-Y7E&L7_9P?>?KZPHXJ/.R?U=
M&-D_A ;.2]ANO_H)&^A1+.UETL4,QCR4\,KW/ETU@'YT>PUYCO084CTH=NR5
M6)W33W+K!B\RE_+9PMGU3L"TK_),WYIT:2U3G;:&E)'&5LR_0SMH\*D82SI]
M$1Z<6[GWOMU7AC"Z'?5*W_?@G->R"/Q/^ZC^[J[2"WGZOW[K_Q\(&A<>\X?=
M*'ZW[S.%O]$V&_D/OFJ?<DR"8Y$OT>AA+E4-+");_#+) Z=J:FI:+RPL"QKB
M-CX0'&:3Q0F&S Z-VOT841<GR\#O,_1H5@_M)B>O)#9 ?E=B2I+K1"W4$D^)
M]#P0@:.97R34JS#7 WRB>H;_A4MWH2"I>,E03[>)R_/7J05-[VO>Z1Y!QVE_
MH2:FH"G1%TLZMXG[A(='"PK?V^LFCO/,[?G[V>$XH].TG3;)57A2( "J^?9X
MYX/ZFXG5!_BM_*GAS._-GED-OLVF?;U#GYT$7;;]140;[#\16P_8VX*PIVS+
ML8T06B=8NCNE<!G0B#F=@[):<E\$Z/GAGY%=%Q=;IVK5PM>XW[O''4X'1]K%
M%6SU'$L0OGCBTB.GGZ8>%>;R+NY$&;S>1=*FIA^ :0S;I!_>B/XQBHBZ]GS4
MMD71ZBG MM08B>7E]SKTPA9LW1Y.PZ5%^O?=$>2%H]I%VNBG-[W:HJR)EN7P
M7]HTFQ0F=*KQHP:JDA=$,'\1.H]>& []HUPA%N*OS=?%EQZD3E>RYJ\6@:=O
M4#Y1WS_(HB!((S>Q_!",S_2'[=M']X[R:(^V<VEFL=&JA_;/I%</K(W4,L>P
MUC/:?;_P-62_7Q'^.NY!YL_&-(_$C]+P1P*P!-6+*S=^O;8@D>%S+7R#R%7D
M03ZB?D;JE3&UM;%06NPTC:#VSFJ"A+ICRP%F]2UNH)>SD7'H]+=X>:MB:\D]
MV_SZJD3%'*7/G[<B+4BJ?VS&.7"D'A1E8YCY($*AOVUY/G62&GN*G=Y<_B";
M ZY%NC9IVXJ/>X]U#05:BQAZV51+X/XZ45E4J3SW'4&E_4H5,Z"!T-'?O^K<
M[7KY!D$K:.W &+/3@66KH3%SWUAP?7NOLY]K%9 ',   0%28-/MM9WK,8)F-
MX,D!C67NWWYL3/X:=#$D=A*KDN//^2B!9])Y8_HRJ/K[#?XV_M]#5"C4",+C
M;8,%9!.79&O?_@.Q$B(^.=MO&22#-F0G$QIW?^<I&T_Q>*'RL*F^6U' 1[39
M"P&$)\!W>'^\7#0<L/CG,ZK_NGU/#Y/Y%P;9*'KIJE&TAV&3%%"A0I_BC=1^
M@P"E^Z!SI'_?S;1\Z%W_].4&9?JT 7U=4?P'=CP4,KA,*]EX& 2LV[#+P56_
MM:CX]:\Y-.%OQ.)D&K ZI@DD"<M+)?6LS T<VRF05;T=9WG*[1>V<H45:1C\
M10W7O;)-UDY\'^2D0BMVMYUUTY?;'P/V+'PZ9X3]IH.J4ZYT];T^);"7(<5-
M0 00Z."Q]J=,'5]>1Z9,Q?/85(O.EWT1B6VD?YH_$BJL4G$+A3"(A_$D:2\W
M$B,WQ+Y*W:9>A9_'A,?*K\40W()ZM:S=%GZQV =" #P+_I%5 ] *#\Z$^O@/
M\$46&GA^XE%1\^;H0D3]GQ+0GYM "Y?5;[\VITP4"L.QU!%VHC=]-QK(B2Y:
M>B'SM\[_'[KG3Q%%'\[NA"UQC;=/#Y2[&YW:%E3CH.JG13$J#6V+?$+>H5J5
M*V_HM(,EHGIQSI23XR] 4A'JQC544%M7\FVV-_^%(KUM@?CG=[RF=I+R3#/4
M5X44H?,N?'Q\6MI\E<I[#K9)(S_U%-D[^PEA&;LNTM--5U$.Z+,Q=/TH]FR+
M]5<,%HU4F,V1Z632;MS5)9O5K)X3,0M>=?SHX^[S(]G%KOWUJYZ/X$**&WM!
MB=>D3E[?)9 CLEQ%1%GH?=,O>E@*\=.APM"V\5,55U='MU\6C<WQ/M'X;D5]
MP%N8@&[-LZ.KX8Q56X7M'BO*!@UIV7!*JL?ADF#UCO<8"![]^&/:?&?(1^H_
M!'.-%TA*0"SNW3O<XH\'@<,MWX("Y0[1@;>// ^OW;4K%3*IPK$"$GA\!4ET
M;G#[C9F=EAN/C(*AT9"\(%5J[599FS$Y .=$4B:DD7J.GI_\0?2=D(&)L"O^
MOL8_3E"P/TOLV@RR^J%)F%#C>BAJVL#:>R3UV[L_&R%*P) =Z?+WMN/9NUK/
MY Z7.L,X7KX?76J=*)S-%:4GL*U_'\DL?I:(2+09+TX^V3C/M^$FT%O&PLL1
M-HD="=/C'.X*_'FV_(W,;T/!T@_M-V)%%:P5JF>8CQ$WH&.0JI&A$:W)H_2N
MF<C/PE/0IS+<=<1K2?UE)4:9Y0^5XD;\:99O":-EX9PCG1"L48(D3NVO"[LB
ME$P>9.30JY*DH_$P&S 0'DT+OZ7OQ([.B#Y/6F *%\J,^>KQP_J^=CC#-<_8
MRIU#GV73R@4OY:TY(PF*O'J"@%8'>4(B!, 91]ZL:3H%%]KZ'*#.Z2F\UV[2
M-<BA: \;ENCSP5:S%$6;OF1@-1.E>W#M7BRZ6!QY1YCP0SCPQT4OX/#\^S<'
M'^YF6R;-FJE'Z:>"^\2>N/4-I>#TJCJ9PTW.Z  /@)S=LR*7ESI^/=^_YB)[
MO*+0QF,K22V:B\@&+ER*-!C\0920]YGI9^3R;3Y=$UTJREA_,ZH&GA^8'^L<
M]BKG]NYKAU(5[6G*<]Z'<%SW90Q4;1#&Q/W W\40.6B/Y@FGCN:HQ98L(O//
M1OS]W[ZU?]LF2_]YFWP@F/48R"9V$ 0!=FE;DI\VKBI(.&YSH+9N3(OB4XU?
MSPSU+;"*,^ZKDGD^N$[_,TXW*%0KTM_)@_([ J;"7HEZIQJS$66M)P8>;J9(
ME./:3K\FI]:&"[UT5C2K:\BI7V%>MPW>=\F7]3)\?A_Z].1-EW5G,S7E5NT$
M=O!CG%>'U&ZTIX+K0RTJZQ_0=OLJ?TCUF45+H]*NSKR4C-11K =B8^.-VI_R
M;:#0!_/IW!(\7@LM.*'@.YY+G[-C>^>N[5.5,(R0FXJ<NZHEPT6DFK5"R?<!
M-.'<BR^XWA.P$%$&B2[&2?3C'[:15S5.^' 5Z*PH[A@LZ$GCC1,,[V@ Z3>;
MKB4.RU)"MI^JO"Y?%A2D>@-:8A'<A"U*:TI2<LF8E\ER,F(_-Q+$@F#T\=09
M<;]0YY.-[:P@U.ZYBL%# +,5'+9+*Z6\OB7)F.:L3B8( %,A44'3  '"GV\,
MJL= P29]#+1&NEJ,7"S%/-S:3'\SJ8T^]*$ZTM3QX=(V_G8G%(RGJN&Y]K\;
MU73:V 53;V7?"!)S+=]Y2+_2?L_)9ZNU6K<TBQCHJ*\Y^"C>P''+>[U,TG!T
M7(Y'35FA-=E_@?Y#KC<F22P8FE48V]L[6I/$(PJM$]S&M&RL)$<B+"0C1!B:
MVHEP@+S(,+P[_O8*ZIK<%=-Y(M.'UTR)Y)3$T<>@)LR!JPKY?RQ#@/1G*M:G
M[7B&EEZA86QS//*4-5/"C:R)QACRP@?)DW['[]O9?B&(-3D;[7KBK]X/NA,K
MUY;MG5N#N::8'[=M"JJQ2KU]&FY*A-Z>$CF) \]$A@#O&H_S>#NW(\(1/5=>
M9D\&?_%Y=G1!?Q0F1A#N;MW\I1Y+3SZ<5V0G@]U0_XC$+O*A8.840=+Z$ZKN
M%/7$Y<)5ZA8LNS%+@BG*@DXN%JR_!XU\-V"KJG.T/H3O(\XMTZ;JHV\^%%7O
MM[3 MV'WU'(T[#A?LG![T.FN:M1/4$R19$:4:N%B9LR,TSSYF:]<AK.1:-U?
M$(5)3&:&^\EO[)B[<;"8-$0 ?\-RF8_B9]\/SG0L3[(#R7\<7G#]V_*AZ,]5
M"Y<#_/*2,W--G_QY@XVMI2"@W'.@<U68#>K3 35,=4O/Y]#8N5/,7X <Q:C
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M-/&!:U$E89M(0Q'=L9)ZL$C\_+&+>6X/Q9X&H@!O)DE7!?NW]3>6:!MBQLG
ML=]G9AV+"PH7ET5:4<S'VOTP/'WK8Y@1=NOOO]:J?THX@0398\;@6X3HV<)
MHD8IV*.0YYMHWS%I-(&:0V45-1B5S>E&2#F?=A-PV$R>VS.NP"86[^(^-9OQ
MA_V@PZ@1(^>!?9<UY-0K#%%4C/VV=,*4>-_P<0<1&^#TN5 CF_J$Y"S0'KNX
MN$J=P)I"2&,M0@PMT>;CW5$GP=KNB>*_HJ#H"@63SS 9@:0\ET\Q-(P!44,<
M"L2T:NK() RPTN*#FP7=$,YBJONU2.:#*N"8T7M/<2E6F%C3YN8DB;S>I>T[
MU)(%!6DJU-254*0/;^Y;)GQ48]HLGLHPKGXDS5X.1SNJ:-LH$'A$W%6RKXO3
M/EXP;V9GPU!+^R'L^U?3=2G":!3E^L'+<'TB=P7H\L3@J]1'XOK%E;ZM>YOW
MC,[K[]:3 N:(KD#>))-6Y,T,3@2QFCT7K2Q5C*(5&\"8MO-M&=59_.V-Q4*?
MG4V<B9T!(8AXN;\S8)/8U9&\L,,\]+:S.>+HPJ8]RN1!?(9^ETP]&=/9:WJQ
MT1Z,(7(*;%SC\,%K8QF5.7B!!2U$$DIXTT4WC<BK1$!&3U;P%3@*,W9P(EOD
MF+SG8RY"1EGY$G=$A]3*9,]1*H;X27Q'HR(/[H*?HI3>;=3%+2;[ >NZ_"U"
M1!8KOO.SJ<2I;ZRU<(#OWV],1!J=8&5F"1!&_[4A2[4Q7=C0'JA?=;_X,11Y
M"2)#LI>5+2-]WV>=9#*R%BL18T.K&*%8O9\4'C':AW>WX$SG:9+3AA2US(6E
M[U(0-O$D(M,)W!<:PR%\)B(QB+&<0TOJTSE'>=XM:R',L ]W0N<1LQ31RQ18
M%K]$/B[3NQ7:^A]=N '@S%O@P#7_33&C4RDW/<-)KH-]HESU8AF.(1N7<%LS
MN!L_8,%X*-+^,AU[,R'C_.M@I2>V%A$4MU5# .$7*4)X]XO'DX=?4R!<45OB
M9I&OH565UK/F1+O&L&))\B=1;L"Q,#H*UK[!%QLV*:1YLW>+S9X'_=G!W/U[
M(C#</)@&BSWN.C,IH $7O!X5G$ AUE-<!>$3A\5R8U @$])X^^-'!B?^B=8#
M$5C,#?6?NKNF8H>S&?&ZFYT@-(94RA[CH[6ZC\*G.,[!DBC#K45D<K![8H"C
MK?F#UW#5+QLWQ-A/&4:F%7#&NVGN1JAW*C2>\H8<V]=%4@D6=,%K3L80WA<8
MK)>#6VN9AGW241_.'LW41NQ[4=N7Q)4$^I!V!DAY#*0>G^65X#;S59O/\FI7
M*)>XI# .B\)BG6.)T/HUV4Y_0!+U>)F"3Q'1^.MP7./25V37*JE0>@6-6#V"
MEY1B#5A#"Q=OG",E[.>V,ACR(V:O-_ZT24++TX\6 :Z$NKSHL(:ZN)A-+_:W
M+=<=F#(2[;"^FF'9<'"]AP@_<RNV:67Q\'%^"+_02ITQ@B>/E6R-%[/EE.Q@
MMNSOV7HGTLOW&_KX*80QB2)D>GR!4U4Y^F?S6H":!=W1I,:=]<K"@9T=NPP:
M?S;X*6DB-82?9AV@*(;Q7R$PY3\F#]9_=(2I94AB=1;9V75T13AC\PMKA'Z/
M)AC(M,=DQ[A$]=O8G$*XFC,*#Y'A@PK^1;EV.'N"<O5;*SAGA9''GHJ&@NEY
M>@LZ%%E] LNU99)>ZO&]=%Q\C@(E/-JTXDI.N856/D/7@E5%(SUTW-_SPZ6[
MR5B[[8BE+REK[X8)T(M-/YI$JP7<4SHJ?*!'-^>\?? $:7Y;\&T$Q9-9??OB
MS)4\+JKO#S>&TSG&F3[&VH9B:.,E_9P^VAZZ9N53O_V(M]A>7)\P90[]@83,
MAMW-UR1KL87/6X%S(_9%UE!N8CAP4P'(&[Q@JZ9K..$(P]W[9-QTT!V78L*S
M.JZ-7"C8$.9"&#WE/=;L7!,=HA$"F_K9[Q*]M7UBBQ&&9Z.< F]DH65(,!NR
M=KGL8Z!^]<>97 >H/18J.0]48<)4UIP$>\S/1K&V0('64J?+NX09TYWP-)B(
M;I1AM?=?OY[#!%B?</2?W.A8A7=;LIY_(Y4IPAW59G/DT;9U5]5XF5.=^U8?
MM-"7[D/XHVK MEW9<%CRK \1 UL;H@\'VE< DI>MANZ]<>\V3$RFII-;/VAF
M/5E7HODBCW/C8+U\6S7F(ZLA*?(KT ;B%K#+N"XL+,CZ&DBH:Z4ISB+:, ;/
M_Z5S])($TM?=Q*X?ASP%.-IOF9)\5W-*$MVT%:7M3=:Z*16@X6=9_G%VI@O'
M*A;3U21N%^EQ34J_<0S&67P)L]P'>7$E$U5C:35_OU$+_UN+VVW2C#*]B;F)
M+S,RY[DO#40YE_,&CQ';KQJTC^6M7V /X([OIK+\P6!(KLA:NUX!T:EEIR&:
MLJ\6# 86Q2?,0:?BPY\-.Y(0]=V_<^1BWQQI?@O7/9)"^(KONAZ' AOP?4G^
M!^MR/SU^ PU$>T[K"5V$:]EJ:[N6$S-O8N"F1;4&1+;-M:\1]7 N;M^0O_ES
MVVB#*@N[9K@\>P-]T;Q], &<"S. ##8&$3#ARZ=IT1\3WG^0.QW)9W(/?SEO
M,!N8J4_9-$5V::F3/.P@0])$8?B-'!)1GVMHEJ.MHH\=)/H^0'HD;RG85Z^-
M$X, Y=20F^A[$83WPL/$%4MM<^ :TPJ+)#ZQ]N?K735.O.74^:H5H!XDD; R
M/6FIU>$>_NZ$'C8J&\;,$KG>>YEC+J_JNTE;8X#",L*@XN8C:UY^-V%/U;!1
M%L76.ML(X#REEJY)'6R<,7N,K;:AVJC2'LEMK,#&NKO+4(?4$M3/_/DR'+[%
MA:K)QLPSYA4P9>$$H6H>(Q^WF5@%";9PKD<I"A.V_-WZ))3D@/P**I4IHW/*
MWU.%R0S?AW:$R,0CRCTKOH-@?X[*V6HY.;83LV4B[?=>NF3>F-Z>/LXO\#[^
MAH[ 4!2&^@_"Y!"Z.[.YG?R/;<'G?&WUM/ M7EX&,!3%_H(TO"EFCSU9UA_+
M=9]ULD 0=#BX%-%9#C^W(N7!?3EH*JA.-SXZ-S-FVC]H?7#QH0@AP%:S$WN'
M6K'KPT<)[P@6I"1F;D[$*"O4Y:S9/3=HTN'Z!53+2O,U00F\V%9Z,^UDUR\%
MV"NJ0'JA"H#OM,B5$BR)<@2IZIFIO$/P= OR9EY6LX'@.983PB@S:HS4XL,U
MF9C21$A=Y?C\<Y;[HG>T?,IZRU!@#Z(Y)U3T@+?J:0^\[<E>RKI=R<8XAMB4
MQ @:IHWK6$WH"B7QY87Z;CJ31:BU(YW(P,?-AQ<HORG-?( 9>@5\T)],'U7&
MGB&V7X&.D!<.DV'Y4Z9=B:3,%;U17SJODMT7OXM78+7G%< 3G'9X!83O?4XW
M?"(T+M$?A^['=ZAO$R^SX%?-FUZ!+,^.VW.AWE2*B1%<*<>^&&36LO&8/L%Z
MF[_F:!DGRRZ+L6 X@.]?%CX>_?.&G./?>M-*L(^+5_\J:"8+IRW- MS!4EP6
M*GSVB)F>G^3/2P7_#H6_Y^7BQ1%,ZU](Q_^ S7SL[YRB_HX=4/T#4O9_DZ3V
M[TAR_SZY,&;['Y 2_P%;V7W(\_;3WM^Q_X:RJ==^!7X+ZCW>96Y*_!?DFF"_
M;'EOQ2E.:Y_7;&L7'NEU,/O_G'!J&6[O\E(LP\N85=)AA<J9_E^T;O@)S<U!
M@UA*5#IR.XX_NR'F'E6_<_U1[81B)/K+L$(?/G,L?UWL7D#:*?>FX+R)P:5
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MDOV8^1M:)E-USWR*DX[/%H]*2,Q:FMU4X10A^:K*]3U%TN 2]*+ACM;3AVL
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M^.<4!]CWOB("IH-5Z;TG@;/$+F\B.MHYK_8]>VLF^22' YAEXGCGT.S/M+[
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M));V;+$*CKK#ZN&X%=,%$>_S(9W^_?S^$9TEXKVY5N/&-<^AC!M[1U!I 76
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M0]06K-/MC@4,?=K'RSZ"T ?.UA,]/UVPE.U=*UH[<CX>.B_6M>HA0Z1>^7S
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M?6$S!;V1JC&GLUP7ZZ&MWH^USR<$!0_N.\7UGNC2-&$3>?GHE,]EAN*<#["
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M<-P^]9^:2R, R] +V$WUPVDP BVT!S1 ^\FN$TM$;S. Y<$E>),'Y&"BLFV
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M,#(R,3(S,5]L86(N>&UL4$L! A0#%     @  X*,5G#9BNT=!   \RP  !4
M             ( !UP\  &-E=F$M,C R,C$R,S%?<')E+GAM;%!+ 0(4 Q0
M   (  ."C%;'M<I*Q1," *!,%  7              "  2<4  !C979A,C R
M,S T,#1?9&5F,31A+FAT;5!+ 0(4 Q0    (  ."C%80'(F.V&,  %)Q   '
M              "  2$H @!I,#$N:G!G4$L! A0#%     @  X*,5G^LPD$+
M6@  1F@   <              ( !'HP" &DP,BYJ<&=02P$"% ,4    "  #
M@HQ6J:IJ>EI6   D9@  !P              @ %.Y@( :3 S+FIP9U!+!08
1    "  ( .P!  #-/ ,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
